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  Abstract	  The	   amino	   acid	   dehydrogenase	   superfamily	   has	   good	   potential	   for	  biotechnological	  use	  for	  example,	  either	  as	  enzymes	  for	  the	  production	  of	  non-­‐natural	  amino	  acids,	  or	  for	  use	  as	  biosensors.	  Despite	  many	  years	  work	  on	  this	  family,	  there	  is	  still	  a	  gap	  understanding	  aspects	  of	  both	  substrate	  and	  cofactor	  binding	   and	   reaction	   mechanism.	   The	   crystal	   structures	   of	   M.	   smegmatis	  Glutamate	  dehydrogenase	  (GluDH)	  have	  been	  determined	  in	  two	  crystal	  forms,	  one	  of	  a	  ternary	  complex	  (GluDH/NADP+/2oxoglutarate)	  at	  1.64Å,	  and	  one	  of	  a	  binary	  complex	  (GluDH/NADPH)	  at	  1.78Å.	  The	  binary	  complex	  structures	  of	  C.	  
symbiosum	  GluDH,	  with	  NAD+	  and	  L-­‐glutamate	  have	  also	  been	  solved	  at	  1.80	  Å	  and	  1.24Å	  respectively.	  Comparison	  of	  these	  structures	  has	  allowed	  the	  nature	  of	  coenzyme	  specificity	  in	  GluDHs	  to	  be	  structurally	  characterized.	  Analysis	  of	  
M.	   smegmatis	   GluDH/NADP+/2oxoglutarate	   ternary	   complex	   showed	   that	   2-­‐oxoglutarate	   bound	   to	   the	   enzyme	   as	   the	   gem-­‐diol	   in	   an	   extended	  conformation,	  which	  mimics	   the	  structure	  of	   the	  carbinolamine	   intermediate.	  This	   structure,	   together	   with	   the	   high	   resolution	   C.	   symbiosum	   GluDH/L-­‐glutamate	  complex	  structure,	  where	  the	  substrate	  binds	   in	  a	  compact,	  curved	  conformation	   have	   given	   valuable	   insights	   into	   the	   progress	   of	   the	   reaction.	  They	   show	   that	   the	   substrate	   alters	   its	   conformation	   during	   the	   reaction,	  explaining	  how	  the	  abortive	  reduction	  of	  the	  keto	  acid	  to	  the	   	  hydroxy	  acid	  is	  prevented,	  and	  showing	  the	  stereochemistry	  of	  attack	  by	  ammonia	  on	  the	  keto	  acid	  substrate,	  aspects	  of	  the	  mechanism	  that	  have	  been	  poorly	  understood.	  In	  addition,	   the	   structure	   of	   the	   AADH	   family	   member	   Bacillus	   sphaericus	  phenylalanine	   dehydrogenase	   in	   complex	   with	   NADH	   has	   been	   determined.	  Furthermore,	   initial	   experiments	   towards	   the	   structure	   of	   mycobacterium	  
smegmatis	   typeII	   NADH:	   menaquinone	   oxidoreductase,	   which	   is	   a	   potential	  anti	  bacterial	  drug	  target	  are	  described.	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Chapter	  one:	  Introduction	  	  
	  	  	  	  	  	  	  	  	  	  1.1	  Amino	  acid	  dehydrogenases	  	  Amino	   acid	   dehydrogenase	   enzymes	   catalyse	   the	   oxidative	   deamination	   of	  amino	   acids	   to	   their	   corresponding	   2-­‐oxo	   acids	  with	   associated	   reduction	   of	  NAD(P+)	   to	  NAD(P)H.	  This	   family	  of	  enzymes	  belongs	   to	   the	  oxidoreductases,	  that	   catalyze	   the	   transfer	  of	   electrons	   from	  one	  molecule	   (electron	  donor)	   to	  another	  (electron	  acceptor).	  	  
L-­‐amino	  acid	  +	  H2O	  +	  NAD(P)	  +	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2-­‐oxo	  acid	  +	  NH3	  +	  NAD(P)H	  +	  H+	  
	  	  Amino	   acid	   dehydrogenases	   have	   a	   substantial	   industrial	   potential,	   due	   to	  their	  applications	  in	  diagnostic	  kits	  to	  screen	  serum	  levels	  of	  amino	  acids	  that	  accumulate	  in	  a	  range	  of	  metabolic	  diseases	  (Nakamura	  et	  al,	  1996).	  Also	  these	  enzymes	  are	  used	  in	  the	  synthesis	  of	  pure	  form	  of	  amino	  acids	  that	  have	  been	  used	  in	  pharmaceutical	  and	  food	  industries	  (Baker	  et	  al,	  1997;	  Hummel	  &	  Kula,	  1989)	  (Paradisi	  et	  al,	  2007).	  The	  sequence	  homology	  between	  all	  members	  of	  Glu,	   Leu,	   Phe	   and	  Val	   dehydrogenase,	   obviously	   indicates	   the	   existence	  of	   an	  enzyme	  superfamily	  that	  are	  related,	  but	  with	  some	  differences	  (Britton	  et	  al,	  1993b;	   Takada	   et	   al,	   1991).	   For	   example;	   phenylalanine	   dehydrogenase	  (PheDH)	   and	   leucine	   dehydrogenase	   (LeuDH)	   from	   Bacillus	   sphaericus	   show	  significant	   amino	   acid	   sequence	   homology	   to	   each	   other,	   where	   the	   identity	  between	  them	  is	  about	  50%.	  However,	  there	  is	  a	  low	  but	  important	  degree	  of	  homology	  between	  LeuDH	  and	  PheDH	  on	  the	  one	  hand	  and	  GluDH	  on	  the	  other	  (Britton	  et	  al,	   1993b;	  Britton	   et	   al,	   1992).	  Despite	   this	   homology,	   amino	   acid	  dehydrogenases	   show	   different	   substrate	   specificities.	   In	   general,	   glutamate	  dehydrogenase	   prefers	   the	   glutamate	   as	   a	   substrate	   to	   all	   other	   amino	   acids	  (Syed	   et	   al,	   1991),	   while	   LeuDHs	   catalyses	   the	   oxidation	   of	   aliphatic	   amino	  acids	   only	   	   (Ohshima	   et	   al,	   1978;	   Ohshima	   et	   al,	   1994).	   Phenylalanine	  dehydrogenases	  have	  a	  preference	  for	  aromatic	  amino	  acids	  as	  a	  substrate,	  but	  they	  also	  show	  some	  activity	  with	  nonpolar	  aliphatic	  amino	  acids	  (Asano	  et	  al,	  1987a;	  Baker	  et	  al,	  1997).	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  The	   above	   reaction	   allows	   the	   inter-­‐conversion	   of	   L-­‐glutamate	   to	   2-­‐oxoglutarate	   and	   ammonia	   and	   in	   coupling	   with	   other	   aminotransferases	  GluDH	  acts	  as	  a	  clearing	  house	  for	  α-­‐amino	  groups	  (Braunstein,	  1957).	  	  
1.1.2	  Phenylalanine	  dehydrogenase	  	  Phenylalanine	  dehydrogenase	  was	  discovered	  by	  Hummel	  in	  1984	  in	  a	  strain	  of	  
Brevibacterium	   sp.	   That	   was	   isolated	   from	   soil	   (Hummel	   et	   al,	   1984).	  Thereafter,	   it	   was	   found	   in	   a	   number	   of	   bacterial	   strains	   including	   Bacillus	  (Asano	  et	  al,	  1987),	  Nocardia	  (Pasquo	  et	  al,	  1998),	  Rhodococcus	  (Misono	  et	  al,	  1989),	  and	  Mycobacterium	  (Asano	  et	  al,	  1998).	   	  Phenylalanine	  dehydrogenase	  has	   been	   used	   as	   a	   biocatalyst,	   for	   the	   production	   of	   enantiomerically	   pure	  non-­‐natural	  amino	  acids,	  which	  have	  been	  used	  as	  drug	  precursors	  (Asano	  et	  al,	   1990),	   and	   in	   the	   production	   of	   L-­‐phenylalanine	   a	   component	   of	   the	  
L-­‐glutamate	   2-­‐oxoglutarate	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artificial	  sweetener	  aspartame	  (Brunhuber	  et	  al,	  2000).	  Moreover,	  this	  enzyme	  also	  has	  been	  used	  as	  a	  biosensor	  to	  monitor	  serum	  levels	  of	  L-­‐phenylalanine	  in	  genetic	  disorders,	  such	  as	  phenylketonuria	  (PKU)(Huang	  et	  al,	  1998).	  Phenylalanine	   dehydrogenase	   catalyzes	   the	   reversible	   oxidative	   deamination	  of	  L-­‐phenylalanine,	  and	  some	  of	  its	  analogues,	  to	  the	  corresponding	  keto	  acids	  in	  the	  presence	  of	  NAD+	  as	  a	  coenzyme,	  and	  it	  acts	  in	  the	  first	  catabolic	  step	  of	  phenylalanine	  degradation	  in	  bacteria.	  	  	  
	  	  
	  
1.2	  The	  biological	  function	  of	  amino	  acid	  dehydrogenases	  Amino	   acid	   dehydrogenases	   play	   an	   important	   role	   in	   nitrogen	   and	   carbon	  metabolism.	  These	  enzymes	   link	   the	  metabolism	  of	   amino	  acids	   to	   the	  Krebs	  cycle	  by	  an	  oxidative	  deamination	  reaction	  that	  converts	  the	  amino	  acids	  to	  2-­‐keto	   acids,	   which	   act	   as	   metabolites	   for	   tricarboxylic	   acid	   (TCA)	   cycle	  (Brunhuber	  &	  Blanchard,	  1994).	  	  
1.2.1	  Biological	  role	  of	  GluDHs	  GluDHs	   are	   widely	   distributed	   over	   the	   eukaryotic,	   bacterial	   and	  archaebacterial	  kingdoms,	  where	  the	  function	  of	  GluDH	  in	  metabolic	  processes	  varies	   from	   organism	   to	   organism.	   In	   lower	   organisms,	   the	   GluDH	   role	   is	  commonly	   unidirectional	   with	   either	   a	   catabolic	   or	   anabolic	   function.	   The	  particular	   function	   of	   GluDHs	   in	   vertebrates	   is	   a	   debatable	   issue,	   and	   these	  enzymes	  are	  implicated	  in	  several	  pathways	  of	  metabolism	  (Goldin	  &	  Frieden,	  1971).	  	  
L-­‐Phenylalanine	   Phenylpyruvate	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1-­‐ GluDH	   from	  mammalian	  sources	   is	   involved	   in	   the	  reaction	   that	   incorporates	  nitrogen	  into	  an	  organic	  compound.	  2-­‐ L-­‐glutamate	   acts	   as	   a	   nitrogen	   donor	   for	   the	   transamination	   reaction	   that	  converts	  oxaloacetate	  to	  aspartate.	  Because	  the	  ∝-­‐amino	  group	  at	  aspartate	  is	  lost	  through	  the	  urea	  cycle,	  GluDH	  also	  provides	  a	  link	  to	  nitrogen	  excretion.	  3-­‐ The	   conversion	   of	   L-­‐glutamate	   and	   2-­‐oxoglutarate	   leads	   to	   a	   flux	   of	   carbon	  skeletons	  between	  the	  Krebs	  cycle	  and	  protein	  biosynthesis.	  Generally,	  glutamate	  dehydrogenases	  can	  be	  divided	  into	  one	  of	  the	  metabolic	  categories;	   glutamate	   catabolism	   or	   glutamate	   biosynthesis	   (ammonia	  assimilation)	  
1.2.1.1	  Ammonia	  assimilation	  	  In	  most	   cells,	   ammonia	   enters	   into	   an	   organic	   compound	   by	   one	   or	  more	   of	  three	  main	  reactions.	  In	  eukaryotes,	  nitrogen	  assimilation	  can	  be	  accomplished	  by	  carbamoyl-­‐phosphate	  synthetase,	  using	  ammonia,	  carbon	  dioxide	  and	  ATP,	  to	  produce	  carbamoyl-­‐phosphate.	   In	  this	  reaction,	  nitrogen	  can	  be	  added	  into	  pyrimidines	   and	  by	   the	  urea	   cycle	   lead,	   via	   citrulline,	   to	   the	   incorporation	  of	  nitrogen	  into	  arginine	  (Berg	  et	  al,	  2002).	  	  In	   prokaryotes,	   there	   are	   two	   pathways	   for	   ammonium	   assimilation:	   under	  limiting	   nitrogen	   conditions	   the	   glutamine	   synthetase	   (GS)	   and	   glutamate	  synthase	   (GOGAT)	   cyclic	   pathway	   (figure1.1a)	   is	   activated	   because	   of	   the	  affinity	   of	   GS	   for	   ammonium	   is	   quite	   high	   (Harper	   et	   al,	   2010).	   Glutamine	  synthetase	  catalyzes	   the	   formation	  of	  glutamine	  by	  condensation	  of	  ammonia	  and	   glutamate.	   Glutamine	   is	   a	   main	   nitrogen	   donor	   in	   the	   biosynthesis	   of	  several	  of	  organic	   compounds,	   such	  as	  purines,	  pyrimidines	  and	  a	  number	  of	  amino	  acids.	  The	  glutamine	  also	  can	  pass	  on	  its	  nitrogen	  in	  the	  transamination	  reaction	  catalyzed	  by	  glutamate	  synthetase.	  	  The	  glutamate	  dehydrogenase	  route	   (figure1.1b)	   is	  activated	  under	  abundant	  nitrogen	  conditions	  and	  has	  a	  main	  assimilatory	  function	  due	  to	  the	  low	  affinity	  of	   GluDH	   for	   ammonium.	   Glutamate	   dehydrogenase	   catalyzes	   the	   reductive	  amination	   of	   2-­‐oxoglutarate	   to	   produce	   glutamate	  with	   oxidation	   of	   pyridine	  nucleotides	  NAD(P)H	  (Harper	  et	  al,	  2010).	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Figure	  1.1.	  Illustrates	  ammonium	  assimilation	  by	  two	  routes	  (a)	  glutamine	  synthetase	  (GS)	  and	   glutamate	   synthase	   (GOGAT)	   pathway;	   (b)	   glutamate	   dehydrogenase-­‐NADP+-­‐linked	  (GDH1)	  and	  glutamate	  dehydrogenase-­‐NAD+-­‐linked	   (GDH2).	  This	  diagram	   is	   adapted	   from	  (Harper	  et	  al,	  2010).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(a)	   (b)	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1.2.1.2	  Amino	  acid	  degradation	  Amino	  acids	   that	   are	  extra	   to	   those	  needed	   for	  protein	   synthesis	   are	  used	  as	  metabolic	  intermediates	  for	  energy,	  and	  are	  also	  utilized	  as	  building	  blocks	  of	  several	  biologically	  vital	  nitrogen-­‐containing	  compounds,	  such	  as	  nucleotides,	  nucleotide	  coenzymes,	  active	  amines	  and	  glutathione	  (Voet	  et	  al,	  2011).	  	  The	  first	  step	  of	  amino	  acid	  catabolism	  is	  the	  transfer	  of	  the	  α-­‐amino	  group	  by	  transaminase	   (or	   aminotransferase)	   enzymes	   to	   2-­‐oxoglutarate	   to	   form	  glutamate	   and	   the	   α-­‐keto	   acid.	   The	   resultant	   glutamate	   can	   be	   oxidized	   by	  GluDH	  to	  yield	  ammonium	  ion	  and	  2-­‐oxoglutarate	  that	  is	  then	  ready	  to	  accept	  another	   α-­‐amino	   group.	   The	   ammonium	   ion	   produced	   from	   this	   reaction	   is	  used	  for	  the	  biosynthesis	  of	  nitrogen	  compounds.	  In	  mammals,	  excess	  NH+4	  is	  converted	   to	   urea	   for	   excretion.	   The	   fates	   of	   the	   carbon	   skeletons	   that	   are	  produced	  from	  amino	  acid	  catabolism	  reaction	  vary	  according	  to	  which	  one	  of	  the	  twenty	  amino	  acids	  has	  been	  degraded.	  The	  end	  result	  of	  the	  breakdown	  of	  the	  twenty	  fundamental	  amino	  acids	  is	  only	  seven	  molecules:	  pyruvate,	  acetyl	  CoA,	  acetoacetyl	  CoA,	  2-­‐oxoglutarate,	  succinylCoA,	   fumarate	  and	  oxaloacetate.	  All	  of	   these	  metabolites	  are	  able	   to	  enter	   to	  the	  citric	  acid	  cycle	  and	  generate	  energy.	   The	  metabolic	   pathways	  of	   the	   carbon	   skeletons	   are	   shown	   in	   figure	  1.4.	  The	  amino	  acids	  can	  be	  sorted	  into	  three	  groups	  based	  on	  their	  metabolic	  fate.	  A	  ketogenic	  amino	  acid	  is	  the	  term	  used	  for	  those	  amino	  acids	  that	  break	  down	  to	  acetyl	  CoA	  or	  acetoacetyl	  CoA	  and	  can	  thus	  produce	  ketone	  bodies	  or	  fatty	   acids.	   Amino	   acids	   that	   are	   catabolized	   to	   pyruvate,	   2-­‐oxoglutarate,	  succinylCoA,	   fumarate	   or	   oxaloacetate	   are	   named	   glucogenic	   amino	   acids,	  because	  they	  are	  able	  to	  ultimately	  produce	  glucose	  (Berg	  et	  al,	  2002).	  
1.3	  Molecular	  weight	  and	  quaternary	  structure	  GluDHs	  characterized	  so	  far	  have	  an	  oligomeric	  structure,	  and	  can	  be	  classified	  into	   two	  subgroups	  based	  on	  the	  subunit	  composition	  as	  either	  hexameric	  or	  tetrameric.	  	  Hexameric	   GluDHs	   described	   to	   date	   are	   homo-­‐hexamers,	   with	   subunit	  molecular	  weights	  between	  48	  kDa	  and	  55	  kDa.	  These	  enzymes	  from	  fungi	  and	  bacteria	  have	  a	  smaller	  molecular	  weight;	   for	  example,	   the	  subunit	  molecular	  weights	  of	  GluDHs	  from	  Mycobacterium	  smegmatis	  and	  Peptoniphilus	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Figure	  1.2.	  Amino	  acid	  metabolism	  and	  the	  fate	  of	  their	  carbon	  skeletons.	  Blue	  boxes	  represent	  glucogenic	  amino	  acids	  and	  orange	  boxes	  represent	  ketogenic	  amino	  acids.	  This	  figure	  is	  taken	  from(Berg	  et	  al,	  2002).	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asaccharolyticus	   are	   approximately	   49	   kDa	   (Sarada	   et	   al,	   1980)	   (Hornby	   &	  Engel,	   1984).	   On	   the	   other	   hand,	   vertebrate	   GluDHs	   such	   as	   bovine	   liver	  GluDHs	  have	  larger	  subunit	  molecular	  weights,	  which	  are	  about	  55	  kDa	  (Moon	  &	   Smith,	   1973).	   GluDHs	   with	   tetrameric	   structure	   are	   considered	   as	  uncommon	  enzymes	  among	  GluDHs	  family.	  Only	  a	  few	  enzymes	  fall	  within	  this	  group,	  all	  of	  which	  are	  NAD+-­‐linked,	  and	  all	  of	   those	   found	  to	  date	  have	  been	  isolated	   from	   fungal	   and	   protozoan	   parasite	   sources.	   The	   subunit	   molecular	  weight	  of	  the	  tetrameric	  GluDHs	  is	  around	  115	  kDa	  (Veronese	  et	  al,	  1974).	  The	  quaternary	  structure	  of	  PheDHs	  has	  substantial	  variation,	  and	  there	  is	  no	  clear	  majority	  oligomer.	  For	  example,	  the	  PheDHs	  that	  are	  characterized	  from	  
S.	   ureae,	  B.	   sphaericus	  and	  B.	   badius,	   have	   been	   shown	   to	   be	   octamers,	   with	  molecular	   weights	   of	   305	   kDa,	   340	   kDa	   and	   335	   kDa	   respectively	   (Asano	   &	  Nakazawa,	   1985;	   Asano	   et	   al,	   1987a;	   Asano	   et	   al,	   1987b).	   The	   structures	   of	  PheDHs	   from	  Thermoactinomyces,	  Rhodococcus.	   sp	  M4,	  R.	  maris	  and	  Nocardia	  are	  hexameric	  (270	  kDa),	  tetrameric	  (150	  kDa)	  (Ohshima	  et	  al,	  1991),	  dimeric	  (70	   kDa)	   (Misono	   et	   al,	   1989)	   and	  monomeric	   (42	   kDa)(Deboer	  et	   al,	   1989),	  respectively.	  	  The	   leucine	   dehydrogenases	   described	   to	   date,	   from	   a	   number	   of	   organisms,	  can	  be	  categorized	  into	  two	  oligomeric	  classes;	  either	  hexameric	  or	  octameric.	  For	   example,	   the	   quaternary	   structure	   of	  B.	   stearothermophilius	  enzyme	   is	   a	  hexamer	  of	  subunit	  molecular	  weight	  245	  kDa	  (Ohshima	  et	  al,	  1985),	  whereas	  the	  LeuDH	  from	  B.	  sphaericus	  has	  an	  octomeric	  structure	  of	  340	  kDa	  (Turnbull	  et	  al,	  1994).	  
1.4	  Structures	  and	  conformational	  changes	  of	  amino	  acid	  dehydrogenases	  
1.4.1	  Structures	  of	  glutamate	  dehydrogenase	  
1.4.1.1	  Bacterial	  GluDHs	  The	   three-­‐dimensional	   crystal	   structure	   of	   the	   NAD+-­‐linked	   GDH	   from	  
Clostridium	   symbiosum	   was	   the	   first	   protein	   structure	   of	   an	   amino	   acid	  dehydrogenase	  to	  be	  determined.	  It	  was	  solved	  in	  both	  a	  free	  enzyme	  form,	  and	  with	  NAD+	  using	   the	  X-­‐ray	  diffraction	   (Baker	  et	  al,	  1992b).	  The	  C.	  symbiosum	  GluDH	   is	   a	   hexameric	   protein	   made	   up	   from	   six	   identical	   subunits	   of	   449	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residues	  arranged	  in	  D3	  point	  group	  symmetry.	  Each	  subunit	  is	  organized	  into	  two	   globular	   domains	   separated	   by	   a	   deep	   cleft.	   	   Domain	   I	   the	   N-­‐terminal	  substrate	   binding	  domain	   is	   slightly	   larger	   than	  domain	   II	   and	   is	   involved	   in	  subunit	  assembly	  into	  the	  hexameric	  oligomer,	  and	  consists	  of	  residues	  1-­‐200	  and	   424	   to	   449.	   The	   polypeptide	   chain	   of	   domain	   I	   folds	   into	   a	   sequence	   of	  successive	  α/β	  secondary	  structure	  units.	  Mixed	  β	  sheets	  of	  parallel	  and	  anti-­‐parallel	  beta-­‐strands	  form	  the	  core	  of	  this	  domain	  and	  are	  flanked	  by	  α-­‐helices	  on	   both	   sides.	   Domain	   I	  makes	   the	  main	   intersubunit	   interactions	   along	   the	  three-­‐fold	  and	   two-­‐fold	  axes,	  and	   the	  substrate	  binding	  pocket	   is	   located	   in	  a	  deep	  cleft	  that	  separates	  the	  two	  domains.	  The	  second	  domain	  (domain	  II)	  or	  C-­‐terminal	   domain	   contains	   seven	   β-­‐strands	   surrounded	   by	   α-­‐helices	   and	   is	  analogous	  to	  the	  classical	  dinucleotide-­‐binding	  fold	  that	  is	  known	  as	  Rossmann	  fold	   (Rossmann	   et	   al,	   1974),	   with	   one	   an	   exception,	   namely	   that	   one	   beta	  strand	  is	  antiparallel	  to	  the	  others.	  This	  domain	  contains	  the	  NAD+-­‐binding	  site	  and	  comprises	  the	  residues	  201	  to	  423	  (Baker	  et	  al,	  1992b).	  	  
1.4.1.2	  Mammalian	  GluDHs	  The	  hexameric	  GluDHs	   from	  mammalian	   sources	   are	   generally	   similar	   to	   the	  bacterial	   protein,	   but	   they	   differ	   from	   each	   other	   due	   to	   the	   presence	   of	   an	  alpha-­‐helical	   domain	   containing	   48	   residues	   in	   the	  mammalian	   GluDHs.	   This	  domain	  makes	  an	  antenna	  structure	  elongating	  from	  the	  top	  of	  the	  nucleotide	  binding	   domain	   and	   is	   near	   to	   the	   3-­‐fold	   axis	   of	   the	   hexamer.	   This	   antenna	  domain	   has	   been	   suggested	   to	   be	   involved	   in	   the	   allosteric	   control	   of	   the	  catalytic	   activity	   that	   is	   unique	   to	   the	  mammalian	  GluDH	   (Peterson	  &	   Smith,	  1999;	  Smith	  et	  al,	  2001).	  Studies	  on	  the	  allosteric	  regulation	  of	   the	  activity	  of	  GluDH	   from	  mammals	   indicate	   that	   GTP	   is	   a	   negative	   and	   ADP	   is	   a	   positive	  effector,	   respectively.	   (Bailey	   et	   al,	   1982;	   Hudson	   &	   Daniel,	   1993).	   This	  regulation	  might	  be	  assisted	  by	  the	  interactions	  of	  the	  subunit	   in	  the	  antenna	  domain	  (Peterson	  &	  Smith,	  1999).	  
1.4.1.3	  Conformational	  change	  of	  GDHs	  The	  structures	  of	  the	  different	  GluDHs,	  in	  different	  complexes	  have	  shown	  that	  the	   two	   domains	   in	   the	   GluDH	   subunit	   exhibit	   conformational	   flexibility	   and	  vary	  between	  an	  open	  and	  a	  closed	  form.	  Although	  a	  closed	  form	  is	  required	  for	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catalysis,	  the	  presence	  of	  substrate	  does	  not	  appear	  to	  be	  required	  for	  domain	  closure,	   indicating	   that	   the	   domains	   more	   freely	   in	   solution	   Figure	   1.3.	   For	  example,	   in	  the	  structure	  of	  substrate-­‐free	  GluDH	  from	  C.	  symbiosum	  and	  also	  its	  binary	  complex	  with	  cofactor,	  the	  two	  domains	  are	  organized	  in	  a	  relatively	  open	   orientation	  with	   respect	   to	   each	   other,	  which	   is	   essential	   for	   substrate	  binding	   (Baker	   et	   al,	   1992a).	   The	   structure	   of	   the	   Peptoniphilus	  
asaccharolyticus	  GluDH	  adopts	  the	  open	  conformation	  in	  the	  apo	  state,	  with	  the	  relative	   orientation	   of	   the	   two	   domains	   resembling	   that	   of	   the	   apo	   C.	  
symbiosum	  GluDH	   (Oliveira	   et	   al,	   2012).	   In	   contrast,	   the	   structure	   of	   GluDH	  from	  E.	  coli,	  in	  the	  free	  enzyme	  state	  has	  a	  closed	  form,	  but	  the	  conformation	  of	  this	   structure	   is	   not	   completely	   closed,	  when	   compared	   to	   the	  NADP+-­‐binary	  complex	   of	   bovine	   GluDH	   (Sharkey	   et	   al,	   2013).	   The	   crystal	   structure	   of	   C.	  
symbiosum	  GluDH	  co-­‐crystallized	  with	  L-­‐glutamate	  is	  in	  a	  closed	  form,	  and	  this	  closed	   conformation	   is	   thought	   to	   be	   required	   for	   catalytic	   activity,	   in	  which	  the	  C4	  in	  nicotinamide	  and	  the	  L-­‐glutamate	  are	  in	  the	  appropriate	  orientation	  for	   hydride	   transfer	   and	   thus	   the	   oxidation/reduction	   reaction	   could	   occur	  (Burgi	  &	  Dunitz,	  1983).	  The	  structural	  rearrangement	  between	  the	  two	  forms	  (open	  and	  closed	  form)	  can	  be	  described	  as	  a	  rigid	  body	  movement	  of	  roughly	  14°	   about	   an	   axis	   being	   between	   the	   two	   domains.	   (Stillman	   et	   al,	   1993).	  Furthermore,	   the	   motion	   of	   these	   domains	   with	   respect	   to	   each	   other	   is	  accompanied	  by	  substantial	  changes	  to	  the	  torsion	  angles	  of	  some	  crucial	  side-­‐chains	   in	   the	   active	   site	   (residues	   200-­‐379	   and	   391-­‐434)	  which	   enhance	   the	  interactions	  between	  the	  GluDH	  and	  its	  substrate	  (Stillman	  et	  al,	  1993).	  
1.4.2	  Structure	  of	  Leucine	  dehydrogenase	  Structures	   have	   also	   been	   determined	   of	   other	   amino	   acid	   dehydrogenases,	  such	   as	   the	   three-­‐dimensional	   structure	   of	   LeuDH	   from	   Bacillus	   sphaericus	  (Baker	   et	   al,	   1995).	   There	   is	   no	   large	   difference	   between	   the	   structure	   of	  LeuDH	   from	   B.	   sphaericus	   and	   other	   superfamily	   members,	   such	   as	   C.	  
symbiosum	  GluDH,	   especially	   in	   the	   folding	   arrangement	   of	   the	   polypeptide	  chain	  (Stillman	  et	  al,	  1999).	  The	  structure	  determination	  of	  GluDH	  and	  LeuDH	  has	  shown	  that	  these	  enzymes	  are	  different	  in	  the	  quaternary	  structures,	  since	  	  	  




	  	  	  	  	   	  
	  
Figure	  1.3.	  Schematic	  diagram	  showing	  the	  domain	  I	  and	  domain	  II	  with	  N-­‐terminus	  in	  red	  color	  and	  C-­‐terminus	  in	  blue	  color	  for	  glutamate	  dehydrogenase	  subunit	  of	  a)	  C.	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GluDH	  adopts	  a	  hexameric	  structure,	  as	  mentioned	  above	  (Baker	  et	  al,	  1992a;	  	  Stillman	   et	   al,	   1993)	  while	   the	   quaternary	   structure	   of	   LeuDH	   is	   an	   octamer	  (Baker	   et	   al,	   1995).	   Despite	   these	   differences,	   the	   dimeric	   structure	   of	   the	  LeuDH	   is	  very	  similar	   to	   that	   seen	   in	  GluDH,	  but	   in	   the	  case	  of	   the	  octameric	  LeuDH	  four	  dimers	  assemble	  to	  an	  octamer	  in	  D4	  symmetry,	  compared	  to	  the	  three	  dimers	  in	  the	  D3	  hexamer	  of	  GluDH.	  	  The	  structure	  of	  B.	  sphaericus	  LeuDH	  (at	  resolution	  of	  2.2Å)	  has	  shown	  that	  like	  GluDH,	   the	   subunit	   has	   two	   domains	   separated	   by	   a	   deep	   cleft.	   Domain	   I	  contains	   residues	   1-­‐136	   and	   332-­‐364	   and	   is	   comprised	   of	   six	   strands	   of	   a	  mixed	  beta-­‐sheet,	   surrounded	  by	  α-­‐helices	   on	   each	   side.	  Domain	   II	   (residues	  137-­‐331)	  is	  similar	  to	  the	  classical	  NAD+-­‐binding	  domain	  (Rossmann	  fold),	  and	  includes	  six	  strands	  of	  parallel	  beta-­‐sheet	  positioned	  in	  the	  centre	  and	  flanked	  by	  two	  helices	  on	  both	  sides	  (Baker	  et	  al,	  1995).	  This	  is	  unlike	  the	  dinucleotide	  domain	   in	   C.	   symbiosum	   GDH	   that	   involves	   one	   beta-­‐strand	   in	   the	   reverse	  direction	  (Baker	  et	  al,	  1992a).	  	  	  Structure	  analysis	  of	  B.	  sphaericus	  LeuDH	  (Baker	  et	  al,	  1995),	  has	  shown	  that	  the	   enzyme’s	   two	   domains	   can	   exist	   in	   different	   conformations,	  which	   offers	  more	  evidence	  in	  support	  the	  necessity	  of	  a	  conformational	  rearrangement	  in	  the	  catalytic	  activity	  of	  this	  enzyme	  (Baker	  et	  al,	  1995).	  	  Domain	   movement	   in	   this	   family	   is	   discussed	   in	   more	   detail	   in	   chapter	   4	  (section	  4.5).	  
1.4.3	  PheDH	  structure	  For	   phenylalanine	   dehydrogenase,	   only	   that	   from	   Rhodococcus	   sp.	   M4	   has	   a	  published	   structure	   (Vanhooke	   et	   al,	   1999).	   This	   enzyme	   has	   been	   solved	   in	  ternary	   complexes	   to	   a	   resolution	   1.5	   Å	   and	   2.3	   Å	   for	   enzyme-­‐NAD+-­‐phenylpyruvate	   and	   enzyme-­‐NAD+-­‐β-­‐phenylpropionate	   respectively.	   Analysis	  of	   both	   ternary	   complexe	   structures	   has	   shown	   that	   this	   PheDH	   is	   a	   dimeric	  enzyme	  made	  up	  from	  two	  homo-­‐subunits,	  again	  each	  with	  the	  standard	  amino	  acid	   dehydrogenase	   structure.	   The	   domains	   are	   separated	   by	   a	   deep	   groove	  containing	  the	  catalytic	  pocket	  (Vanhooke	  et	  al,	  1999).	  Although	  this	  structure	  is	   dimeric,	   the	   dimer	   is	   constructed	   in	   the	   same	  way	   as	   the	   dimer	   from	   the	  other	  family	  members	  (Vanhooke	  et	  al,	  1999).	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Figure	  1.5.	  A diagram	  displaying	  the	  domain	  motion	  in	  GDH	  from	  C.	  symbiosum.	  The	  open	  form	  (apo-­‐enzyme)	  chain	  is	  colored	  blue	  and	  the	  closed	  form	  (glutamate	  bound)	  chain	  is	  red.	  The	  subunits	  were	  superimposed	  on	  the	  basis	  of	  domain	  I	  residues	  using	  LSQ	  superpose	  in	  COOT.	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1.5	  Coenzyme	  specificity	  of	  amino	  acid	  dehydrogenases	  One	  main	  characteristic	  of	  glutamate	  dehydrogenase	  enzymes	  is	  the	  distinction	  in	  cofactor	  specificity.	  Glutamate	  dehydrogenases	  from	  prokaryotes	  commonly	  utilize	  either	  NAD+	  or	  NADP+	  as	  coenzymes,	  whereas	  eukaryotic	  GluDHs	  have	  dual	  specificity	  and	  are	  able	  to	  act	  with	  both	  cofactors.	  The	  structural	  basis	  of	  coenzyme	  specificity	  has	  been	  proposed	  in	  a	  number	  of	  studies	  (Oliveira	  et	  al,	  2012;	   Sharkey	   et	   al,	   2013)	   and	   is	   addressed,	   later	   in	   this	   thesis	   (chapter4,	  section4.4.5).	   NADP+	   dependent	   GluDHs	   are	   usually	   involved	   in	   processes	   of	  ammonia	   assimilation,	   by	   incorporating	   the	   ammonia	   into	   2-­‐oxoglutarate	   to	  produce	   glutamate	   (anabolic	   function)(Ohshima	   &	   Soda,	   1990).	   The	   gene	  transcription	   of	   bacterial	   NADP+	   dependent	   GluDH	   can	   be	   controlled	   by	   a	  change	   of	   growth	   conditions,	   such	   as	   presence	   of	   carbon	   and	   nitrogen	   (	  Hanssler	  et	  al,	  2009;	  Schwacha	  &	  Bender,	  1993)	  In	  contrast,	  NAD+	  dependent	  GluDHs	   are	   generally	   involved	   in	   processes	   of	   oxidative	   degradation	   of	  glutamate	  (catabolic	  function)	  (Ohshima	  &	  Soda,	  1990),	  and	  do	  not	  seem	  to	  be	  regulated	  in	  response	  to	  nitrogen	  availability	  (Chavez	  &	  Candau,	  1991;	  Harper	  et	  al,	  2010).	  However,	  dual	  specificity	  GluDHs	  utilize	  the	  two	  cofactors	  and	  are	  involved	   in	   both	   catabolic	   and	   anabolic	   functions.	   These	   enzymes	   show	   a	  similar	  affinity	  for	  NAD+	  and	  NADP+	  in	  some	  species	  (such	  as	  chicken	  GluDH),	  whereas	  with	  both	  dogfish	  liver	  and	  frog	  liver	  GluDHs	  the	  affinity	  for	  NAD+	  is	  much	  greater	  than	  NADP+(Corman	  &	  Kaplan,	  1967;	  Fahien	  et	  al,	  1965).	  All	   phenylalanine	   dehydrogenases	   and	   leucine	   dehydrogenases	   characterized	  so	   far	   require	   NAD+	   as	   a	   coenzyme	   for	   the	   oxidative	   deamination	   reaction.	  However,	   a	   number	   of	   alternative	   nucleotide	   substrates	   have	   been	   analysed	  with	  PheDH	  from	  Rh.	  maris	  (Misono	  et	  al,	  1989)	  and	  LeuDH	  from	  B.	  sphaericus	  enzyme	  (Ohshima	  et	  al,	  1978).	  The	   reactivity	  of	  NAD+	  analogues	  with	  PheDH	  was	  as	  following:	  the	  activity	  of	  the	  PheDH	  with	  NADP+	  is	  very	  low	  (about	  6.6%	  of	  the	  NAD+	  reactivity),	  this	  is	  contrast	  to	  the	  relative	  rate	  of	  3-­‐acetylpyridine-­‐NAD+	   that	   was	   much	   higher	   (241%)	   compared	   to	   that	   with	   NAD+	   (100%),	  while	   the	   reactivity	   of	   deamino-­‐NAD+	   and	   thionicotinamide-­‐NAD+	  were	   86%	  and	  101%	  respectively,	  which	  are	  similar	  to	  NAD+	  (Misono	  et	  al,	  1989).	  In	  the	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Figure1.7.	  The	  overall	  organization	  of	  B.	  sphaericus	  LeuDH	  octamer	  with	  each	  subunit	  individually	  coloured.	  a)	  view	  down	  a	  molecule	  two-­‐fold	  axis	  used	  to	  form	  the	  dimer,	  with	  the	  four-­‐fold	  axis	  vertical.	  b)	  view	  down	  the	  four-­‐fold	  axis	  (Accession	  number	  in	  PDB	  1LEH).	  	  	  
(a)	   (b)	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case	  of	  LeuDH,	  the	  reactivity	  of	  a	  pyridinodeamino-­‐NAD+	  (100%)	  is	  similar	  to	  NAD+,	  but	  the	  relative	  rate	  of	  acetylpyridine-­‐NAD+	  (166%)	  is	  higher	  than	  NAD+,	  conversely	   to	   the	   reactivity	   of	   pyridinaldehyde-­‐NAD+	   (19%)	   and	   thio-­‐NAD+	  (21%)	  which	  are	  much	  lower	  than	  NAD+	  (Ohshima	  et	  al,	  1978).	  	  
1.5.1	  Coenzyme	  stereospecificity	  NAD(H)	   and	   NADP(H)	  act	   as	   electron	   carriers	   in	   all	   organisms	   by	   reversibly	  receiving	   or	   releasing	   	   a	   hydride	   ion	   at	   the	   C-­‐4	   position	   of	   the	  nicotinamide/dihydronicotinamide	   ring.	   When	   the	   coenzyme	   interacts	   with	  the	  protein,	   just	  one	  face	  of	   the	  nicotinamide	  ring	   is	  exposed	  to	  the	  substrate	  and	   the	   second	   face	   is	   packed	   against	   the	   protein	   surface.	   Fisher	   and	  coworkers	   showed	   that	   at	   the	   C-­‐4	   position,	   the	   two	   hydrogen	   atoms	   are	  enzymatically	  non-­‐equivalent	  (prochiral)	  and	  thus	  the	  coenzyme	  transfers	  the	  hydride	  ion	  stereospecifically	  to	  the	  substrates	  (Fisher	  et	  al,	  1953).	  According	  to	  the	  Fisher	  findings	  the	  NAD(P+)-­‐dependent	  enzymes	  can	  be	  divided	  into	  two	  classes;	  class	  A	  enzymes	  eliminate	  the	  hydrogen	  from	  the	  4-­‐pro-­‐R	  (A	  side/re-­‐face)	  with	   those	   that	   transfer	   the	  hydrogen	   from	   the	  4-­‐pro-­‐S	   (B	   side/si-­‐face)	  are	  called	  class	  B	  enzymes.	  The	  GluDHs	  that	  have	  been	  characterized	  so	  far	  are	  all	  B-­‐stereospecific	  enzymes	  (You	  et	  al,	  1978).	  The	  LeuDHs	  and	  PheDH	  are	  also	  B-­‐stereospecific	  proteins	  (Ohshima	  et	  al,	  1978;	  Ohshima	  et	  al,	  1991).	  
1.6	  Substrate	  specificity	  of	  amino	  acid	  dehydrogenases	  	  
1.6.1	  Glutamate	  dehydrogenase	  	  Although	  having	  a	  marked	  preference	  for	  glutamate	  as	  substrate,	  GluDHs	  can	  catalyse	  oxidation	  of	  a	  number	  of	  carboxylic	  compounds	  that	  are	  analogues	  of	  glutamate.	   Struck	   and	   Sizer	   in	   1960	   and	  Hornby	   et	  al	   in	   1983	   observed	   that	  GluDHs	  from	  bovine	  liver	  can	  use	  monocarboxylic	  amino	  acids	  such	  as	  leucine	  and	   alanine	   in	   addition	   to	   glutamate	   as	   a	   substrate.	   However,	   the	   catalytic	  activity	  of	   these	  analogues	   is	  very	   low	  compared	  to	  L-­‐glutamate,	  and	   it	   is	  not	  more	  than	  1%	  of	  that	  of	  glutamate	  (Hornby	  et	  al,	  1983;	  Struck	  &	  Sizer,	  1960).	  In	   addition,	  Mycobacterium	  smegmatis	   GluDH	  was	   isolated	   and	   characterized	  by	   Sarada	   et	   al.,	   1980.	   The	   findings	   from	   this	   study	   showed	   that	   this	  enzymecatalyzes	  the	  reductive	  amination	  of	  2-­‐oxoglutarate	  at	  pH=8.0	  and	  the	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Figure	   1.8.	   Schematic	   diagram	   representing	   a	   single	   subunit	   for	   PheDH	   from	  
Rhodococcus	  sp.	  M	  (Accession	  number	  in	  PDB	  1C1D).	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Figure1.9.	  Two	  subunits	  come	  together	   to	   form	  the	  dimer	  around	  the	   two-­‐fold	  axis,	  mediated	  via	  β	  strands	  of	  N-­‐terminal	  domain	  (here	  the	  two-­‐fold	  axis	  comes	  out	  of	  the	  paper	   toward	   you).	   a)	   C.	   symbiosum	   GluDH,	   b)	   Rhodococcus	   sp.	  M.	  PheDH	  and	   c)	   B.	  
sphaericus	  LeuDH.	  	  	  	  	  
(a)	   (b)	  
(c)	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optimal	   pH	   for	   oxidative	   deamination	   of	   glutamate	   was	   between	   8.8-­‐9.8.	  Moreover,	   substrate	   specificity	   of	   this	   enzyme	   was	   investigated	   for	   several	  amino	   and	   keto	   acids	   and	   the	   results	   illustrated	   that	   aspartate	   and	   leucine	  showed	   a	   minor	   activity	   of	   10%	   of	   the	   activity	   with	   glutamate,	   while	   the	  activity	  of	  isoleucine,	  valine,	  and	  lysine	  was	  5%.	  Insignificant	  activity	  was	  seen	  with	  phenylalanine,	  serine,	  glycine	  and	  norvaline.	  In	  this	  study	  2-­‐oxoglutarate,	  2-­‐oxobutyrate,	   2-­‐oxoisovalerate,	   oxovalerate	   were	   classified	   as	   poor	  substrates.	  (Sarada	  et	  al,	  1980).	  	  
1.6.2	  Phenylalanine	  dehydrogenase	  The	  specificity	  of	  phenylalanine	  dehydrogenases	  for	  amino	  acids	  and	  keto	  acids	  varies	   between	   the	   enzyme	   sources.	   For	   example;	   the	   PheDH	   from	   T.	  
intermedius	   is	   very	   selective	   for	   L-­‐phenylalanine	   (Ohshima	   et	   al,	   1991),	  whereas	  B.	  sphaericus	  PheDH	  catalyzes	  the	  oxidation	  of	  	  L-­‐phenylalanine	  and	  L-­‐tyrosine	  at	  nearly	  a	  similar	  rate	  (Asano	  et	  al,	  1987a),	  since	  the	  relative	  rates	  of	  oxidative	  deamination	  reaction	  of	  L-­‐phenylalanine	  and	  L-­‐tyrosine	  were	  100%	  and	  72%	  respectively.	  In	  the	  same	  reaction	  direction,	  PheDH	  from	  B.	  sphaericus	  can	  utilize	  other	  aromatic	  amino	  acids,	   such	  as	  L-­‐phenylalanine	  methyl	  ester,	  (reactivity	   10%)	   and	   L-­‐tyrosine	   methyl	   ester,	   (reactivity	   7.3%).	   In	   addition,	  some	  aliphatic	  L-­‐amino	  acids	  also	  showed	  some	  slight	  activity	  as	  a	  substrate,	  for	  instance	  the	  activity	  with	  L-­‐norleucine	  was	  3.9%.	  Substrate	  specificities	  for	  
B.	   sphaericus	  PheDH	  have	   been	   tested	   in	   the	   reductive	   amination	   reaction.	   A	  number	   of	   α-­‐keto	   acids	   have	   been	   shown	   to	   be	   active	   as	   substrates	   for	   this	  enzyme,	  with	   different	   relative	   activities.	   	   For	   example,	   if	   the	   reactivity	  with	  phenylpyruvate	   is	   100%,	   ρ-­‐hydroxyphenylpyruvate	   was	   136%,	   similarly	  activities	  were	  seen	  with	  2-­‐oxovalerate	  (6.2%),	  2-­‐oxoisovalerate	  (5.5%)	  and	  2-­‐oxoisocaproate	  (7.8%)	  (Asano	  et	  al,	  1987a).	  	  	  	  	  
1.6.3	  Leucine	  dehydrogenase	  	  Leucine	   dehydrogenases	   catalyze	   the	   reversible	   oxidative	   deamination	   of	  branched	   chain	   aliphatic	   L-­‐amino	   acids.	   For	   instance;	   the	   relative	   activity	   of	  LeuDH	  from	  B.	  sphaericus	  in	  the	  direction	  of	  oxidative	  deamination	  was	  100%	  with	   L-­‐leucine;	   this	   activity	  was	   decreased	  with	   valine	   (74%)	   and	   isoleucine	  (58%).	   Besides	   these	   L-­‐amino	   acids,	   which	   are	   the	   favourite	   substrates	   for	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LeuDH,	  the	  unbranched	  chain	  aliphatic	  L-­‐amino	  acids	  such	  as	  norvaline	  and	  L-­‐α-­‐aminobutyrate	   also	   act	   as	   substrate	   with	   LeuDH,	   where	   their	   relative	  activities	   were	   41%	   and	   14%	   respectively.	   D-­‐amino	   acids,	   L-­‐alanine,	   L-­‐glutamate,	  L-­‐threonine,	  L-­‐phenylalanine	  and	  ω-­‐amino	  acids	  are	  not	  substrates	  (Ohshima	  et	  al,	  1978).	  	  
1.7	  Homology	  and	  sequence	  alignment	  of	  amino	  acid	  dehydrogenases	  A	  multiple	  alignment	  of	  the	  amino	  acid	  sequences	  of	  PheDH,	  LeuDH	  and	  GDH,	  shows	   a	   significant	   homology	   between	   these	   enzymes,	   but	   with	   some	  differences	   (Britton	  et	   al,	  1993b).	  The	  are	  higher	   levels	  of	   identities	  between	  PheDH	  from	  Bacillus	  sphaericus	  and	  LeuDH	  from	  B.	  stearothermophilus	  (around	  50%)	  compared	  to	  those	  seen	  between	  the	  GluDH	  from	  C.	  symbiosum	  to	  PheDH	  or	   LeuDH,	   which	   are	   about	   20%.	   Although	   the	   general	   level	   of	   sequence	  identity	  between	  all	  these	  enzymes	  is	  low,	  the	  main	  features	  of	  secondary	  and	  tertiary	   structure	   can	   be	   recognized	   between	   these	   members	   of	   this	  homologous	  superfamily.	  Furthermore,	  a	  comparison	  of	  the	  structures	  of	  these	  enzymes	   has	   revealed	   that	   key	   residues	   responsible	   for	   catalysis,	   and	   for	  maintenance	   of	   the	   three-­‐dimensional	   structure	   are	   conserved	   across	   these	  enzymes	   (Britton	   et	   al,	   1993b).	   For	   example,	   the	   residues	   involved	   in	   the	  overall	   design	   of	   the	   catalytic	   pocket	   are	   conserved,	   including	   five	   glycine	  residues	  that	  are	  responsible	  for	  the	  shape	  of	  the	  active	  site	  (G122	  and	  G123),	  orientation	  of	   functional	  groups	  at	   the	  catalytic	  centre	   (G90	  and	  G91)	  and	   lie	  close	   to	   the	   binding	   site	   for	   the	   nicotinamide	   ring	   (G376)	   (figure1.10).	  Additionally,	   lysine	   residue	   113	   (K113)	   that	   interacts	   with	   the	   α-­‐carboxyl	  group	   of	   L-­‐glutamate	   in	   GluDH,	   lysine125	   (K125)	   that	   enhances	   the	  nucleophilicity	   of	   the	   water	   molecule	   and	   aspartate	   165	   (D165),	   which	   is	  involved	   in	  proton	   transfer	   in	   the	   catalytic	  mechanism	   (Stillman	  et	   al,	   1993),	  are	   also	   conserved	   (figure1.10)	   (Britton	   et	   al,	   1993b).	   As	  might	   be	   expected,	  the	   residues	   involved	   in	   stabilizing	   the	   common	   elements	   of	   the	   amino	   acid	  substrate	   are	   conserved,	   whereas	   those	   residues	   at	   the	   base	   of	   the	   binding	  pocket	   which	   are	   responsible	   for	   the	   main	   interactions	   that	   determine	  substrate	   specificity	   vary	   across	   the	   superfamily	   (Britton	   et	   al,	   1993b).	   For	  example,	   in	   the	   C.	   symbiosum	   GluDH	   (as	   mentioned	   above)	   the	   essential	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interactions	  that	  are	  implicated	  in	  substrate	  specificity	  are	  formed	  between	  the	  γ-­‐carboxyl	   group	   of	   L-­‐glutamate	   and	   the	   amino	   group	   of	   K89	   and	   the	   side-­‐chain	  hydroxyl	  group	  of	  S380	  residues	  conserved	  across	  all	  GluDH	  (Stillman	  et	  al,	   1993).	   With	   regard	   to	   LeuDH	   and	   PheDH,	   these	   two	   residues	   (K89	   and	  S380)	  are	  different,	  being	  a	  leucine	  and	  valine,	  respectively,	  making	  the	  active	  site	  more	  hydrophobic.	  	  In	  addition	  to	  the	  differences	  in	  the	  active	  site,	  there	  are	  a	  number	  of	  structural	  differences	  located	  at	  the	  N	  and	  C	  termini,	  and	  also	  a	  number	  of	  insertions	  and	  deletions	   between	   secondary	   structure	   elements.	   These	   variances	   play	   a	  principal	   role	   for	   the	   determination	   of	   the	   quaternary	   structure	   of	   these	  enzymes.	   In	   GluDHs,	   amino	   acid	   residues	   that	   are	   involved	   in	   the	   trimer	  interface,	   especially	   residues	   responsible	   for	   formation	   the	   loops	   which	   lie	  nearby	  to	  the	  three-­‐fold	  axis	  (residues	  388	  to	  390,	  185	  to	  188	  and	  157	  to	  159)	  are	   deleted	   in	   PheDHs	   and	   LeuDHs.	   Residues	   that	   are	   implicated	   in	   the	  interactions	   of	   the	   two	   trimers	   are	   also	   deleted	   in	   PheDHs	   and	   LeuDHs	  (figure1.10)(Britton	   et	   al,	   1993b).	   However,	   there	   are	   some	   resemblances	   at	  the	  dimer	  interface	  between	  these	  enzymes.	  In	  GluDHs	  the	  two-­‐fold	  interaction	  is	  centred	  on	  the	  binding	  between	  the	  extended	  antiparallel	  βa	  in	  domain	  I	  and	  its	   2-­‐fold	   symmetry	   related	   strand	   βa,	   with	   hydrophobic	   interaction	   formed	  between	   the	   side	   chains	   of	   Val57	   and	   Ile58	   (figure	   1.9a),	  which	   is	   similar	   to	  that	   observed	   in	   LeuDHs	   and	   PheDHs	   (figure	   1.9b,c).	   Figure1.10	   shows	   the	  sequence	  alignment	  between	  the	  GluDH,	  LeuDH	  and	  PheDH.	  	  
1.8	  Chemical	  mechanism	  of	  GluDHs	  Several	   mechanisms	   have	   been	   proposed	   to	   explain	   the	   catalytic	   activity	   of	  GluDHs.	  Smith	  et	  al	  (1975),	  have	  suggested	  that	  a	  lysine	  residue	  (126	  in	  bovine	  liver	  and	  125	  in	  Clostridium)	  plays	  an	  important	  role	  in	  GluDHs	  catalysis,	  with	  this	  residue	  implicated	  in	  the	  reductive	  amination	  step,	  where	  it	  is	  thought	  to	  form	  a	  Schiff	  base	  intermediate	  by	  an	  interaction	  between	  the	  amino	  group	  of	  the	  Lys	  side-­‐chain	  and	  the	  carbonyl	  group	  of	  the	  2-­‐oxoglutarate.	  The	  resultant	  ε-­‐imino	   intermediate	   liberates	   a	   water	   molecule,	   before	   the	   ammonium	   ion	  attacks	  the	  Schiff	  base	  to	  generate	  2-­‐iminoglutarate	  moiety.	  The	  last	  step	  in	  this	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Phedh_T1  -------------------------------------------MRDVFEMMDRYGHEQVIFCRHP-----   22 
PheDHBS1  ------------------------MAKQLEKSS-------KIGNEDVFQKI--ANHEQIVFCNDP-----   32  
LeuDHBS1  --------------------------------------------MEIFKYMEKYDYEQLVFCQDE-----   21   
GDHCS  1  SKYVDRVIAEVEKKYADEPEFVQTVEEVLSSLGPVVDAHPEYEEVALLERM--VIPERVIEFRVPWEDDN   68 
                                  hhhhhh             hhhhhhhhh     eeeeeeee 
 
  
PhedhTi 23 --QTGLKAIIALHNTTAGPALGGCRMIPYASTDEALEDVLRLSKGMTYKCSLADVDFGGGKMVIIGDPKK 90  
PheDHBS 33 --VSGLQAIIAIHDTTLGPALGGTRMYPYKNVDEALEDVLRLSEGMTYKCAAADIDFGGGKAVIIGDPEK 100 
LeuDHBS 22 --ASGLKAVIAIHDTTLGPALGGARMWTYNAEEEAIEDALRLARGMTYKNAAAGLNLGGGKTVIIGDPFA 89 
GDHCS   69 GKVHVNTGYRVQFNGAIGPYKGGLRFAPSVN----LSIMKFLGFEQAFKDSLTTLPMGGAKGGSDFDPNG 134 
             eeeeeeeeeee          eeee    hhhhhhhhhhhhhhhhhhhhh       eeeeee   
        
 
Phedh_Ti91 DKSPELFRVIGRFVGGLN-----GRFYTGTDMGTNPEDFVHAARES---------KSFAGLPKSYGGKGD  146  
PheDHBS 101DKSPALFRAFGQFVESLN-----GRFYTGTDMGTTMDDFVHAQKET---------NFINGIPEQYGGSGD  156  
LeuDHBS 90 DKNEDMFRALGRFIQGLN-----GRYITAEDVGTTVDDMDLIHQET---------DYVTGISPAFGSSGN  145  
GDHCS   135KSDREVMRFCQAFMTELYRHIGPDIDVPAGDLGVGAREIGYMYGQYRKIVGGFYNGVLTGKARSFGGSLV  204  
             hhhhhhhhhhhhhhh        ee        hhhhhhhhhh           eee   hhh           
 
PhedhTi 147TSIPTALGVFHGMRATARFLWGTDQLKGRVVAIQGVGKVGERLLQLLVEVGAY-CKIADIDS--------  207  
PheDHBS 157SSIPTAQGVIYALKATNQYLFGSDSLSGKTYAIQGLGKVGYKVAEQLLKAGAD-LFVTDIHE--------  217  
LeuDHBS 146PSPVTAYGVYRGMKAAAKEAFGSDSLEGLAVSVQGLGNVAKALCKKLNTEGAK-LVVTDVNK--------  206  
GDHCS   205RPEATGYGSVYYVEAVMKHEND--TLVGKTVALAGFGNVAWGAAKKLAELGAKAVTLSGPDGYIYDPEGI  272  
              hhhhhhhhhhhhhhhhhh        eeeee   hhhhhhhhhhhh   e eeeee  h  
 
PhedhTi 208--VRCEQLKEKY-------------GDKVQLVDVNRIHKESCDIFSPCAKGGVVNDDTIDEF---RCLAI  259  
PheDHBS 218--NVLNSIKQKSE----------ELGGSVTIVKSDDIYSVQADIFVPCAMGGIINDKTIPKL---KVKAV  272  
LeuDHBS 207--AAVSAAVAE---------------EGADAVAPNAIYGVTCDIFAPCALGAVLNDFTIPQL---KAKVI  256  
GDHCS   273TTEEKINYMLEMRASGRNKVQDYADKFGVQFFPGEKPWGQKVDIIMPCATQNDVDLEQAKKIVANNVKYY  342  
            hhhhhhhhhh           hhh   ee            eeee        hhhhhh      eee  
 
PhedhTi 260VGSANNQLVEDRHGALLQKRSICYAPDYLVNAGGLIQVADELEG------FHEERVLAKTEA-IYDMVLD  322  
PheDHBS 273VGSANNQLKDLRHANVLNEKGILYAPDYIVNAGGLIQVADELYG------PNKERVLLKTKE-IYRSLLE  335  
LeuDHBS 257AGSADNQLKDPRHGKYLHELGIVYAPDYVINAGGVINVADELYG------YNRTRAMKRVDG-IYDSIEK  319  
GDHCS   343IEVANMPTTNEALRFLMQQPNMVVAPSKAVNAGGVLVSGFEMSQNSERLSWTAEEVDSKLHQVMTDIHDG  412 
           ee        hhhhhhhhh   eee hhhh  hhhhhhhhhhh         hhhhhhhhhh hhhhhhh 
 
PhedhTi 323IFHRAKNENI--TTCEAADRIVMERLKKLTDIRRILLED--PRNSARR-  366  
PheDHBS 336IFNQAALDCI--TTVEAANRKCQKTIEGQQTRNSFFSRGRRPKWNIKE-  381  
LeuDHBS 320IFAISKRDGV--PSYVAADRMAEERIAKVAKARSQFLQD--QRNILNGR  364 
GDHCS   413SAAAAERYGLGYNLVAGANIVGFQKIADAMMAQGIAW------------  449  
 
           hhhhhhhh     hhhhhhhhhhhhhhhhhhhhhhh       hh  
 
      
Figure	  1.10.	  Sequence	  alignment	  of	  C.	  symbiosum	  GluDH	  with	  B.	  spaericus	  LeuDH	  and	  
B.	  sphaericus	  PheDH	  and	  T.	  intermedius	  PheDH.	  The	  residues	  that	  share	  in	  catalysis	  are	  highlighted	  in	  different	  colors.	  The	  conserved	  residues	  are	  highlighted	  in	  yellow	  color	  and	   those	   that	   are	   involved	   in	   binding	   the	   side	   chain	   of	   the	   substrate	   are	   coloured	  green.	   The	   insertions	   in	   the	   GluDH	   sequence	   at	   153-­‐157,	   181-­‐189	   and	   387-­‐392	   are	  involved	  in	  interactions	  around	  the	  three-­‐fold	  axis	  of	  the	  hexamer.	  The	  residues	  are	  in	  the	  octameric	  LeuDH	  and	  PheDH	  from	  B.	  spaericus,	  which	  have	  different	   interactions	  around	  the	  4-­‐fold	  axis.	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supposed	  mechanism	  is	  the	  reduction	  of	  the	  2-­‐iminoglutarate	  by	  the	  transfer	  of	  the	   hydride	   ion	   from	   the	   cofactor,	   to	   yield	   L-­‐glutamate.	   However,	   another	  mechanism	  for	  GluDH	  catalysis	  has	  been	  proposed,	  based	  on	  studies	  of	  the	  pH	  profiles	  for	  binding	  oxo-­‐acids	  and	  analogues	  to	  bovine	  GluDH	  (Rife	  &	  Cleland,	  1980a).	  This	  mechanism	  (shown	  in	  figure	  1.7)	  suggests	  that,	  in	  the	  direction	  of	  reductive	  amination	  of	  2-­‐ketoglutarate	  to	  yield	  L-­‐glutamate,	  the	  first	  step	  is	  the	  binding	   between	   the	   substrate	   and	   the	   enzyme-­‐NADPH	   complex,	   where	   2-­‐oxoglutarate	  uses	  its	  Υ-­‐carbonyl	  group	  to	  bind	  to	  a	  protonated	  amino	  group	  of	  the	  enzymatic	  lysine	  residue.	  Ammonium	  that	  is	  present	  in	  the	  active	  site	  then	  reacts	  with	  the	  α-­‐keto	  group,	  which,	  in	  turn,	  receives	  a	  proton	  from	  the	  active	  side	   Lys	   residue,	   producing	   a	   carbinolamine	   intermediate.	   The	   hydroxyl	  oxygen	   of	   the	   resultant	   carbinolamine,	   accepts	   a	   proton	   from	   an	   enzymatic	  carboxyl	   group,	   which	   concurrently	   deprotonates	   the	   amino	   group	   of	   this	  intermediate.	   The	   carbinolamine	   is	   thus	   converted	   to	   the	   imine	   with	   the	  liberation	  of	  a	  water	  molecule.	  The	  imine	  intermediate	  then	  accepts	  a	  hydride	  ion	   from	  NADPH	   and	   is	   converted	   to	   unprotonated	   L-­‐glutamate,	   that	   takes	   a	  proton	  from	  the	  enzymatic	  carboxyl	  group,	  to	  produce	  protonated	  L-­‐glutamate	  (Rife	  &	  Cleland,	  1980a).	  	  The	   suggested	   chemical	  mechanism	  of	   glutamate	   dehydrogenase	   by	  Rife	   and	  Cleland	  was	  the	  first	  mechanism	  to	  propose	  the	  formation	  of	  a	  carbinolamine,	  instead	   of	   a	   Schiff	   base	   intermediate,	   however,	   later	   studies	   have	   shown	   a	  number	  of	  inconsistencies	  in	  some	  of	  the	  details	  of	  this	  mechanism.	  Srinivasan	  and	  Fisher	   checked	   the	   redox	  portion	   of	  Rife	   and	  Cleland’s	   suggested	  model,	  using	  proline	   and	   its	   keto	   acids	   as	   substrates	   (Srinivasan	  &	  Fisher,	   1985).	   In	  this	   study	   the	   authors	   concluded	   that	   protonation	   of	   an	   α-­‐iminoglutarate	  intermediate,	   after	   it	   is	   formed	   in	   the	   active	   site,	   is	   necessary	   to	   undergo	  oxidation	   by	   the	   cofactor.	   This	   result	   corresponds	   with	   the	   proposed	  mechanism	  by	  Rife	  and	  Cleland	  (Rife	  &	  Cleland,	  1980a).	  Another	  conclusion	  in	  this	   study	   of	   Srinivasan	   and	   Fisher	   is	   that	   the	   amino	   acid	   substrate	   (L-­‐glutamate)	  binds	  and	  reacts	  in	  the	  deprotonated	  state,	  which	  is	  opposite	  to	  Rife	  and	   Cleland	   model.	   Srinivasan	   and	   Fisher	   proposed	   a	   modified	   mechanism,	  which	   focuses	   on	   the	   conversion	   of	   the	   carbinolamine	   to	   an	   imine.	   In	   this	  revised	   mechanism,	   the	   authors	   suggested	   that	   once	   the	   carbinolamine	   is	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formed,	   a	  proton	   from	   its	  amino	  group	   is	   removed	  by	  a	   lysine	   residue	   in	   the	  active	   site	   leading	   to	   breakdown	   of	   the	   carbinolamine	   into	   imine	   with	   the	  cleavage	  of	  the	  hydroxyl	  α-­‐carbon	  bond	  with	  the	  removal	  of	  a	  proton	  from	  the	  active	   site	   carboxyl	   group.	   At	   this	   step	   the	   NADPH	   reduces	   the	   protonated	  imine,	   and	   the	   neutral	   form	   of	   the	   amino	   acid	   is	   released	   as	   a	   product	  (Srinivasan	  &	  Fisher,	  1985).	  In	  1993	  Stillman	  et	  al	  determined	  the	  crystal	  structure	  of	  the	  binary	  complex	  of	  glutamate	  dehydrogenase	  with	  L-­‐glutamate,	  at	  1.96Å	  resolution.	  This	  structure	  provided	   the	   crucial	   breakthrough	   in	   the	   catalytic	   mechanism	   of	   glutamate	  dehydrogenases.	   In	   general,	   the	   suggested	   mechanism	   by	   Stillman	   et	   al	   is	  similar	   to	   the	   Rife	   and	   Cleland	   model	   (see	   above).	   In	   this	   binary	   complex	  structure,	   electron	  density	   showed	   that	  a	  bound	  water	  molecule	  was	  present	  behind	  the	  2-­‐carbon	  of	  the	  glutamate	  substrate	  and	  the	  amino	  group	  of	  the	  side	  chain	   of	   the	   enzymic	   Lys125.	   In	   addition,	   the	   carboxyl	   side	   chain	   of	   Asp165	  was	  in	  an	  appropriate	  position,	  due	  to	  a	  conformational	  rearrangement	  of	  the	  two	  domains,	   to	  act	  as	  a	  general	  base,	   to	  deprotonate	  the	  amino	  group	  of	   the	  substrate.	   This	   agreed	   with	   the	   Rife	   and	   Cleland	   model	   of	   the	   function	   of	   a	  catalytic	   carboxyl	   as	   a	   general	   base.	   The	   position	   of	   the	   NAD+	   cofactor	   was	  modeled	   into	   the	  GluDH/L-­‐glutamate	  binary	   complex,	  using	   the	  GluDH/NAD+	  complex	  as	  a	  guide.	  From	  these	  models	  of	  the	  open	  and	  closed	  conformations	  of	   C.	   symbiosum	   GluDH,	   together	   with	   biochemical	   findings	   on	   the	   enzyme	  mechanism	   (Rife	   &	   Cleland,	   1980b),	   Stillman	   et	   al	   proposed	   a	   chemical	  mechanism	  for	  GluDH	  catalysis.	  Firstly,	  the	  α-­‐amino	  group	  of	  the	  L-­‐glutamate	  substrate	  is	  deprotonated	  by	  the	  side	  chain	  carboxyl	  group	  of	  Asp165	  working	  as	  a	  general	  base,	  which	  causes	  the	   transfer	   of	   a	   hydride	   ion	   to	   the	   Si	   face	   of	   the	   NAD+,	   and	   produces	  animinoglutarate	   intermediate.	   In	   the	   second	   step	   of	   this	   mechanism,	   an	  enzyme	   bound	   water	   molecule	   whose	   nucleophilic	   character	   is	   activated	   by	  Lys	   125,	   is	   proposed	   to	   attack	   the	   iminoglutarate	   intermediate	   to	   form	   a	  carbinolamine.	   In	   the	   production	   of	   carbinolamine	   intermediate	   and	   its	  subsequent	   breakdown	   to	   the	   2-­‐oxoacid,	   Asp165	   is	   essential	   for	   proton	  transfer	   to	  and	   from	  the	  substrate.	   In	   the	   final	  step	  of	   this	  proposed	  reaction	  scheme,	  losing	  a	  proton	  from	  Lys125	  and	  Asp165	  to	  bulk	  solution	  is	  required	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Figure	   1.11	   Glutamate	   dehydrogenase	   chemical	   mechanism	   proposed	   by	   Rife	   and	  Cleland	  (adapted	  from	  Brunhuber	  and	  Blanchard.,	  1994).	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for	  the	  completion	  of	  the	  catalytic	  cycle	  (Stillman	  et	  al,	  1993).	  
1.9	  Chemical	  mechanism	  for	  phenylalanine	  dehydrogenase	  	  	  	  	  In	  1999	  Vanhooke.	  J.	  L.	  and	  co-­‐workers	  have	  proposed	  a	  chemical	  mechanism	  for	  phenylalanine	  dehydrogenase	  based	  on	  X-­‐ray	  crystal	  structures	  of	  ternary	  complexes	   of	  Rhodococcus	  sp.	  M4	   PheDH	  with	  NAD+	   and	  phenylpyruvate	   and	  NAD+	   plus	   β-­‐phenylpropionate	   (Vanhooke	   et	   al,	   1999).	   In	   this	   study,	   the	  authors	   tried	   to	   answer	   questions	   that	   had	   not	   been	   explained	   in	   previous	  mechanisms	   (Rife	   &	   Cleland,	   1980b)	   of	   amino	   acid	   dehydrogenases	   such	   as	  why	   these	   enzymes	  do	  not	   catalyze	   the	   reduction	  of	  bound	  2-­‐oxo	  acids	   to	  2-­‐hydroxy	  acids.	  Analysis	  of	  the	  structures	  of	  the	  two	  PheDH	  ternary	  complexes	  has	  provided	  a	   logical	  basis	   for	   the	  differentiation	  between	   the	  keto	  acid	  and	  the	  imino	  acid	  as	  substrate	  for	  reduction	  by	  these	  enzymes.	  Findings	  from	  this	  study	   were	   used	   to	   suggest	   modified	   chemical	   mechanism	   of	   amino	   acid	  dehydrogenases.	  As	  shown	  in	  figure	  1.10,	  the	  first	  three	  steps	  of	  this	  chemical	  mechanism	  are	  similar	   to	   that	  of	  proposed	  by	  Rife	  and	  Cleland	   for	  glutamate	  dehydrogenase	   (Rife	   &	   Cleland,	   1980b).	   At	   the	   start	   of	   the	   reaction	   the	  phenylpyruvate	  is	  interacting	  by	  hydrogen	  bonding	  through	  its	  keto	  oxygen,	  to	  the	   side	   chain	   amino	   group	   of	   the	   lysine	   residue	   78	   in	   the	   active	   site.	   This	  bonding	   pattern	   is	   proposed	   to	   lead	   to	   the	   prohibition	   of	   phenylpyruvate	  reduction	   via	   NADH.	   In	   the	   first	   step,	   ammonia	   that	   exists	   in	   the	   active	   site,	  attacks	   the	   carbonyl	   group	   of	   phenylpyruvate	   and	   lys78	   protonates	   the	   keto	  oxygen,	   producing	   a	   carbinolamine	   intermediate	  with	   its	   amino	   group	   in	   the	  protonated	   form.	   In	   step	   2,	   transfer	   a	   proton	   is	   facilitated	   by	   the	   side	   chain	  carboxyl	   group	   of	   Asp118	   in	   the	   active	   site,	   which	   makes	   the	   charge	   of	   the	  carbinolamine	   hydroxyl	   group	   positive.	   Consequently,	   a	   water	   molecule	   is	  removed	   from	   the	   carbinolamine	   in	   the	   third	   step,	   producing	   another	  intermediate	  and	  the	   iminophenylpyruvate.	  Following	  this	  step	  (step4)	   in	  the	  Rife	   and	  Cleland	  mechanism,	  NAD(P)H	   reduces	   the	   imino	   group	   to	   an	   amino	  group,	  which	  then	  undergoes	  protonation	  by	  a	  carboxyl	  group	  in	  the	  active	  site.	  In	   step	   4	   of	   the	   PheDH	   mechanism,	   the	   side	   chain	   carboxyl	   group	   of	   the	  enzymic	   Asp118	   donates	   a	   proton	   to	   Lys78	   after	   the	   removal	   of	  water.	   This	  transfer	  of	  the	  proton	  generates	  a	  negative	  charge	  on	  the	  carboxyl	  group	  of	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Figure	   1.12.	   Modified	   chemical	   mechanism	   proposed	   by	   Srinivasan	   and	   Fisher,	   1985	  (adapted	  from	  Brunhuber	  and	  Blanchard.,	  1994).	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Asp118,	  which	   stabilizes	   the	  positive	   charge	   on	   the	   imine,	   and	  positions	   this	  imine	   for	   hydride	   transfer.	   NADH	   then	   reduces	   the	   iminophenylpyruvate	   in	  step	  5,	  producing	  phenylalanine	  that	  is	  subject	  to	  protonation	  by	  Lys78,	  prior	  to	  liberation	  from	  the	  active	  site	  (Vanhooke	  et	  al,	  1999).	  	  
1.10	  Previous	  structures	  of	  amino	  acid	  dehydrogenases	  A	  number	  of	  three-­‐dimensional	  structures	  have	  been	  determined	  of	  members	  of	   the	   amino	   acid	   dehydrogenase	   superfamily	   from	   both	   prokaryotic	   and	  eukaryotic	   sources	   (table1.1).	   Although	   they	   have	   different	   quaternary	  structure,	   the	   basic	   structure	   of	   the	   subunit	   is	   the	   same,	   the	   two	   domains	  separated	  by	  a	  deep	  cleft.	  (For	  details	  see	  sections;	  1.4.1,	  1.4.2	  and	  1.4.3).	  	  
1.11	  Project	  Aim	  	  	  Despite	   the	  wealth	   of	   studies	   on	   the	   amino	   acid	   dehydrogenase	   superfamily	  over	  the	  last	  50	  years,	  there	  are	  a	  number	  of	  question	  that	  remain	  unanswered,	  in	   coenzyme	   specificity,	   substrate	   specificity,	   and	   catalytic	   mechanism.	   The	  promising	   use	   of	   bacterial	   amino	   acid	   dehydrogenases	   in	   many	  biotechnological	   applications,	   requires	   a	   full	   understanding	   of	   the	   structure/	  function	   relationships	   in	   this	   enzyme	   superfamily,	   to	   aid	   in	   the	   design	   of	  mutant	  enzymes	  with	  added	  commercial	  potential.	  Although	  many	  structures	  of	   GluDH	   from	   bacteria,	   archaea	   and	   mammals	   have	   been	   determined,	   a	  GluDH/cofactor/substrate	   structure	   of	   a	   bacterial	   enzyme	   has	   not	   been	  deposited	   in	   the	  Protein	  Data	  Bank.	   In	  addition,	   the	   ternary	  complexes	  of	   the	  eukaryotic	  GluDHs	  that	  have	  been	  determined	  are	  only	  at	  medium	  resolution,	  precluding	   precise	   identification	   of	   the	   orientations	   of	   the	   various	   groups	   in	  the	   active	   site.	   Furthermore,	   only	   two	   leucine	   dehydrogenase	   structures	   and	  know	  and	  one	  phenylalanine	  dehydrogenase	  (from	  Rhodococcus.	  sp)	  which	  is	  a	  dimer.	   Structures	   that	   are	   not	   present	   in	   the	   database,	   and	   preclude	   a	   full	  understanding	  of	  the	  enzyme	  superfamily	  are	  a	  ternary	  complex	  of	  a	  bacterial	  GluDH,	  a	  binary	  complex	  of	  a	  bacterial	  GluDH	  with	  cofactor,	  a	  PheDH	  structure	  of	  the	  octameric	  form	  of	  the	  enzyme,	  and	  any	  truly	  high-­‐resolution	  structure	  of	  binary	  or	  ternary	  complexes	  of	  GluDH.	  The	  aims	  of	  this	  thesis	  were	  therefore	  to:	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Figure	   1.13.	   The	  main	   steps	   (a)	   to	   (d)	   of	   the	   proposed	  mechanism	  of	   GluDHs.	   This	  scheme	  illustrates	  the	  reaction	  pathway	  in	  the	  direction	  of	  the	  oxidative	  deamination	  of	   glutamate	   to	   2-­‐oxoglutarate.	   This	   diagram	   is	   based	   on	   that	   from	   Stillman	   and	  coworkers	  (Stillman	  et	  al,	  1993).	  	  	  	  	  	  	   	  
a	   b	  
c	   d	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i) Determine	   the	   structure	   of	   an	   octameric	   bacterial	   phenylalanine	  dehydrogenase	  from	  B.	  sphaericus	  in	  complex	  with	  substrate	  and	  cofactor.	  ii) Determine	  the	  structure	  of	  a	  ternary	  complex	  of	  GluDH	  from	  a	  bacterial	  source	  (M.	  smegmatis)	  	  iii) Determine	   a	   high-­‐resolution	   structure	   of	   the	   C.	   symbiosum/	   NAD+	   binary	  complex.	  	  Determination	   of	   the	   three-­‐dimensional	   structure	   of	   these	   amino	   acid	  dehydrogenases	   will	   offer	   insights	   into	   the	   catalytic	   mechanism	   and	   aid	   in	  increased	   understanding	   of	   the	   molecular	   basis	   of	   how	   these	   enzymes	  differentiate	  between	  amino	  acid	   substrates,	  which	  will	   help	   in	   the	  design	  of	  new	  mutant	  enzymes	  active	  with	  non-­‐natural	  amino	  acids,	  which	  can	  be	  used	  in	  the	  pharmaceutical	  industry.	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Figure	   1.14.	  The	  modified	  chemical	  mechanism	  for	  phenylalanine	  dehydrogenase	   in	  the	   direction	   of	   reduction	   of	   phenylpyruvate	   to	   produce	   phenylalanine.	   Taken	  from(Vanhooke	  et	  al,	  1999).	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  a)	  Glutamate	  dehydrogenases	  
Accession	  
number	  PDB	  
Species	   Ligands	   Resoluti
on	  Å	  
Subunit	   Reference	  
1HRD	   Clostridium	  
symbiosum	  
	   1.96	   49,165	   (Baker	   et	   al,	  1992b)	  1BGV	   Clostridium	  
symbiosum	   Glutamate	   1.90	   49,165	   (Stillman	   et	  al,	  1993)	  1B26	   Thermotoga	  
	  maritima	  
	   3.0	   45,689	   (Knapp	   et	   al,	  1997)	  1NR7	   Bos.	  taurus	   	   3.30	   55,561	   (Banerjee	   et	  al,	  2003)	  1NQT	   Bos.	  taurus	   ADP	   3.50	   55,561	   (Banerjee	   et	  al,	  2003)	  1HWZ	   Bos.	  taurus	   Glu;GTP;NADPH	   2.80	   55,561	   (Smith	   et	   al,	  2001)	  1HWY	   Bos.	  taurus	   2-­‐Oxoglutaric	  acid,	  NAD	  	   3.20	   61,512	   (Smith	   et	   al,	  2001)	  3MW9	   Bos.	  taurus	   Glu;GTP;	  NADH	   2.50	   61,512	   (Peterson	   &	  Smith,	  1999)	  1L1F	   Human	   	   2.70	   61,393	   (Smith	   et	   al,	  2002)	  1BVU	   Thermococcus.	  
litoralis	  
	   2.50	   46,608	   (Britton	  et	  al,	  1999)	  1EUZ	   Thermococcus.p
rofundus	  
	   2.25	   46,699	   (Nakasako	   et	  al,	  2001)	  1GTM	   Pyrococcus.	  
furiosus	   DSM	  
3638	  
	   2.20	   47,114	   (Yip	   et	   al,	  1995)	  
2BMA	   Plasmodium	  
falciparum	  
	  
	   2.70	   52,546	   (Werner	   et	  al,	  2005)	  
3R3J	   Plasmodium	   	   3.10	   57,343	   (Zocher	   et	   al,	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falciparum	  3D7	   2012)	  1V9L	   Pyrobaculum	  
islandicum	  
NAD	   2.80	   46,906	   (Bhuiya	   et	   al,	  2005)	  3MVO	   Bos.	  taurus	   Eu3+	   3.23	   61,512	   (Bailey	   et	   al,	  2011)	  3MVQ	   Bos.	  taurus	   Zinc	  	   2.94	   61,512	   (Bailey	   et	   al,	  2011)	  3QMU	   Bos.	  taurus	   Epicatechin-­‐3-­‐gallate	   3.62	   61,512	   (Li	   et	   al,	  2011)	  3ETE	   Bos.	  taurus	   Hexachlorophene	   3.0	   61,512	   (Li	   et	   al,	  2009)	  3ETD	   Bos.	  taurus	   Bithionol	   2.50	   61,512	   (Li	   et	   al,	  2009)	  2YFQ	   Peptoniphilusas.
accharolyticus	  
	   2.94	   46,514	   (Oliveira	   et	  al,	  2012)	  3AOG	   Thermus.	  




Species	   Ligands	   Resolu-­‐
tion	  Å	   Subunit	   Reference	  
1BGX	   Rhodococcus.	  sp	   NAD+	   +	   beta-­‐phenylpropionate	   2.30	   36,609	   (Vanhooke	   et	  al,	  1999)	  1BW9	   Rhodococcus.	  sp	   NAD+	   +	  Phenylpyruvate	   1.50	   36,609	   (Vanhooke	   et	  al,	  1999)	  1C1X	   Rhodococcus.	  sp	   NAD+	   +	   L-­‐3-­‐ 1.40	   36,609	   (Brunhuber	   et	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phenyllactate	   al,	  2000)	  1C1D	   Rhodococcus.	  sp	   NADH	   +	  Phenylalanine	   1.25	   36,609	   (Brunhuber	   et	  al,	  2000)	  	  c)	  Leucine	  dehydrogenase	  
Accession	  
number	  PDB	   Species	   Ligands	   Resolution	  Å	   Subunit	   Reference	  1LEH	   Lysinibacillus.	  
sphaericus	   	   2.20	   39,043	   (Baker	   et	   al,	  1995)	  3VPX	   Sporosarcina	  
psychrophila	   	   2.55	   39,345	   	  	  
Table	  1.1	  shows	  structures	  of	  some	  amino	  acid	  dehydrogenases	  in	  the	  PDB	  	  
a)	   Glutamate	   dehydrogenases,	   b)	   Phenylalanine	   dehydrogenases	   and	   c)	   Leucine	  dehydrogenases.	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Chapter	  Two:	  Materials	  and	  Methods	  
	  	  	  	  	  	  	  	  	  	  2.0	  Overview	  This	   chapter	   describes	   the	   molecular	   biology	   and	   X-­‐ray	   crystallographic	  techniques	   used	   for	   the	   structure	   determination	   of	   target	   proteins	   in	   this	  thesis.	  
2.1	   Gene	   amplification,	   cloning	   and	   overexpression	   of	   glutamate	  	  	  	  
dehydrogenase	  from	  M.	  smegmatis	  
2.1.1	  The	  design	  of	  primers	  Gene	   amplification	   using	   the	   polymerase	   chain	   reaction	   (PCR)	   needs	   two	  oligonucleotide	  primers;	  a	  forward	  and	  a	  reverse	  primer.	  These	  primers	  were	  designed	   for	   the	   target	   gene	   (msmeg5442)	   using	   the	   genome	   sequence	   of	  
Mycobacterium	  Smegmatis	  strain	  MC2	  155.	  Pairs	  of	  primers	   should	  be	  exactly	  matching	   to	   the	   sequence	   at	   the	   3’	   end	   of	   every	   strand	   of	   the	   DNA	   to	   be	  amplified.	   There	   are	   some	   conditions	   that	   must	   be	   available	   in	   the	   selected	  primers	  to	  amplify	  the	  target	  gene:	  the	  length	  of	  primers	  is	  usually	  between	  18	  to	  30	  bases,	  they	  should	  have	  %GC	  of	  40	  to	  60,	  the	  melting	  point	  should	  be	  in	  the	  range	  of	  52°C	  to	  60°C,	  and	  the	  primers	  must	  not	  be	  self-­‐complementary.	  The	  primers	   used	   for	   the	   amplification	   of	  msmeg5442	   were	   20	   and	   21	   bases	   in	  length	  and	  included	  6	  nucleotides	  sequence	  upstream	  of	  the	  restriction	  site	  for	  cutting	   the	   PCR	   products	   by	   restriction	   enzymes.	   The	   forward	   primer	   was	  designed	  to	  have	  an	  NdeI	  (CATATG)	  restriction	  site	  followed	  by	  16	  nucleotides	  of	   the	  msmeg5442	   gene.	   The	   reverse	   primer	   contained	   a	   HindIII	   (AAGCTT)	  restriction	  site	  followed	  by	  17	  nucleotides	  of	  genomic	  DNA	  from	  downstream	  of	  the	  gene.	  The	  sequence	  of	  primers	  that	  used	  for	  amplification	  of	  target	  gene	  is	  described	  below:	  Forward	  primer	  5’-­‐CATATGAGCGAACTACACCC-­‐3’	  	  Reverse	  primer	  5’-­‐AAGCTTTCAGATGAGCCCGAG-­‐3’	  	  
2.1.2	  Amplification	  of	  target	  gene	  using	  polymerase	  chain	  reaction	  (PCR)	  	  Firstly	  genomic	  DNA	  of	  Mycobacterium	  smegmatis	  (M.	  smegmatis)	  strain	  MC2-­‐	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155	  (a	  gift	  from	  Prof	  J.	  Green,	  Sheffield)	  was	  prepared.	  Bacterial	  genomic	  DNA	  was	  prepared	  by	  growing	  the	  bacteria	  in	  LB	  medium	  (1%	  tryptone,	  0.5%	  yeast	  extract	  and	  1%	  NaCl)	  at	  37C°	  on	  a	  shaker	  at	  250rpm	  for	  72	  hours.	  Extraction	  of	  the	   genomic	   DNA	   from	   the	   culture	   was	   carried	   out	   using	   Keyprep	   Bacterial	  DNA	  extraction	  kit.	  Successful	  extracting	  was	  confirmed	  by	  running	  a	  sample	  of	  the	  DNA	  on	  1%	  gel	  agarose	  electrophoresis	  (AGE).	  The	  gene	  of	  interest	  was	  amplified	  using	  the	  Polymerase	  Chain	  Reaction	  (PCR)	  with	  the	  genomic	  DNA	  as	  a	  template.	  For	  the	  PCR	  reaction	  the	  following	  materials	  were	  added	  to	  the	  PCR	  tube:	  Sterile	  H2O	   	  	  	  	  	  	  	  	  	  27.5µl	  	  DNA	  Polymerase	  Buffer	  5x	   10µl	  dNTPs	  (5mM)	   2.5µl	  Forward	  primer	  (5µM)	   	  4.0µl	  Reverse	  primer	  (5µM)	   	  4.0	  µl	  Genomic	   DNA	   (M.	  
smegmatis)	   	  2.0µl	  DNA	  polymerase	   	  	  1.0	  µl	  
Total	  volume	   	  	  50	  µl	  	   The	  tube	  was	  the	  placed	  in	  a	  PCR	  machine	  and	  the	  reaction	  was	  set	  up	  under	  the	  following	  conditions:	  Initial	  denaturation	   	  	  	  	  98°C	   	  	  	  	  	  	  	  	  2:0	  min	  	   	  Denaturation	   98°C	   30	  sec	   	  	  X	  	  	  25	  Cycles	  Annealing	   60°	  C	   	  	  	  	  	  	  	  	  	  30	  sec	  	  Elongation	   72°C	   	  	  	  	  	  	  	  	  	  	  1:30	  min	  	  Final	  Elongation	   72°C	   7:0	  min	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2.1.2.1	  Purification	  of	  PCR	  products	  from	  agarose	  gel	  The	  resulting	  DNA	  fragments	  were	  run	  on	  a	  1%	  TAE	  agarose	  gel	  at	  100	  V	  for	  one	   hour	   to	   separate	   the	   DNA.	   The	   gel	   was	   visualized	   over	   a	   UV	   trans	  illuminator	  and	  the	  bands	  that	  had	  the	  expected	  size	  were	  removed	   from	  the	  gel	  using	  a	  clean	  scalpel	  blade	  and	  transferred	  to	  an	  Eppendorf	  tube.	  The	  DNA	  fragments	   were	   purified	   from	   the	   agarose	   gel	   slices	   using	   a	   QiaQuick®Gel	  Extraction	  Kit	  (Qiagen)	  and	  the	  standard	  protocol.	  The	  tube	  that	  contained	  the	  agarose	   gel	   slices	   was	   weighed	   and	   3	   volumes	   of	   buffer	   QG	   (a	   proprietary	  buffer	  containing	  guanidine	  thiocyanate)	  was	  added	  to	  each	  volume	  of	  agarose	  (e.g.	  300μl	  to	  100mg	  agarose).	  The	  tube	  was	  then	  transferred	  to	  a	  heat	  block	  at	  50°C	   for	   10	  min,	  with	   gently	   vortexing	   every	   two	  minutes.	   Once	   the	   agarose	  had	  dissolved,	  one	  gel	  volume	  of	  isopropanol	  was	  added	  to	  the	  microfuge	  tube	  and	  mixed	  before	  the	  contents	  were	  poured	   into	  a	  MinElute	  spin	  column	  and	  centrifuged	  at	  12470	  g	  for	  1	  minute.	  After	  centrifugation,	  the	  flowthrough	  was	  discarded	  and	  500μl	  of	  buffer	  QG	  added	  before	  centrifuging	  at	  112470	  g	  for	  1	  minute.	  Again	  the	   flowthrough	  was	  discarded,	  before	  the	  addition	  of	  750μl	  of	  buffer	   PE	   (a	   proprietary	   buffer	   containing	   ethanol)	   and	   centrifugation	   to	  remove	  salt	  and	  carbohydrates,	  the	  flowthrough	  was	  again	  disposed	  of,	  and	  the	  spin	   column	   was	   centrifuged	   at	   12470	   g	   for	   1	   minute	   to	   remove	   residual	  ethanol.	  The	  spin	  column	  was	  then	  transferred	  to	  a	   fresh	  microfuge	  tube	  and	  10-­‐50μl	  of	  EB	  buffer	  (10mM	  Tris-­‐HCl,	  pH	  8.0)	  was	  added	  to	   the	  centre	  of	   the	  silica	  matrix	  and	  incubated	  at	  room	  temperature	  for	  1	  minute	  before	  elution	  of	  the	  purified	  DNA	  by	  centrifugation	  at	  12470	  g	  for	  1	  minute.	  The	  purified	  DNA	  was	  then	  used	  in	  the	  ligation	  step.	  	  
2.1.3	  Preparation	  of	  pET21a	  plasmid	  A	   small-­‐scale	   plasmid	   preparation	   was	   completed	   using	   the	   QIAprep	   Spin	  Plasmid	   Miniprep	   system.	   This	   system	   applies	   the	   principles	   of	   the	   alkaline	  lysis	   method	   of	   Birnboim	   and	   Doly	   (Birnboim	   &	   Doly,	   1979)	   followed	   by	  plasmid	  purification	  from	  a	  silica	  resin.	  The	  kit	  was	  purchased	  from	  Qiagen	  and	  used	  as	   follows:	  A	  single	  white	  colony	  of	  DH5α	  E.	  coli	   containing	   the	  plasmid	  pET21a	  (figure	  2.1)	  was	  picked	  from	  an	  LB	  agar	  plate	  and	  used	  to	  inoculate	  3	  ml	  of	  LB	  medium	  supplemented	  with	  50µg/ml	  ampicillin.	  The	  culture	  was	  left	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to	  grow	  overnight	  at	  37°C	  on	  rotary	  shaker	  at	  200	  rpm.	  The	  overnight	  culture	  containing	  the	  required	  plasmid	  was	  pelleted	  by	  centrifugation	  at	  4500	  rpm	  for	  10	  minutes.	  The	  supernatant	  was	  discarded	  and	  the	  cells	  resuspended	  in	  250µl	  of	  buffer	  P1	  (50mM	  Tris-­‐HCl,	  pH=8.0,	  10mM	  EDTA	  and	  100	  µg/ml	  of	  RNAase	  A)	  and	  transferred	  to	  a	  1.5	  ml	  tube.	  250µl	  of	  buffer	  P2	  (200mM	  NaOH	  and	  1%	  SDS)	  was	   then	  added	   to	   lyse	   the	   cells,	   and	   the	   tube	   contents	  were	  mixed	  via	  inversion.	   350µl	   of	   buffer	   N3	   (3M	   Potassium	   acetate	   pH=5.5)	   was	   added	   to	  neutralize	  the	  lysis	  reaction	  and	  the	  tube	  was	  gently	  inverted	  several	  times	  to	  mix	   the	   contents.	   The	   bacterial	   lysate	   was	   centrifuged	   at	   12470	   g	   for	   10	  minutes.	   The	   supernatant	   was	   recovered	   and	   applied	   to	   a	   QIAprep	   spin	  column,	   seated	   in	   a	   2	   ml	   microcentrifuge	   tube.	   The	   spin	   column	   was	   then	  centrifuged	   at	   1300	   rpm	   for	   1	   minute	   and	   the	   flowthrough	   discarded.	   The	  column	   was	   washed	   by	   adding	   075	   ml	   of	   buffer	   PE	   (60%	   Ethanol,	   60mM	  Potassium	  acetate,	  8.3mM	  Tris-­‐HCl,	  0.04mM	  EDTA)	  and	  centrifuged	  at	  1247	  g	  rpm	  for	  1.0	  minute.	  The	  flowthrough	  was	  removed	  and	  a	  second	  centrifugation	  at	  12470	  g	  was	  used	   to	   remove	  any	   residual	  buffer	  PE.	  The	  QIAprep	   column	  was	  then	  transferred	  to	  a	  fresh	  1.5ml	  tube	  and	  the	  DNA	  was	  eluted	  by	  adding	  50µl	  of	  EB	  buffer	  (10	  mM	  Tris-­‐HCl,	  pH	  8.5)	  and	  incubated	  at	  room	  temperature	  for	  2	  minutes	  before	  centrifugation	  at	  13000rpm	  for	  one	  minute	  to	  collect	  the	  pure	  plasmid.	  
2.1.4	  Restriction	  digestion	  	  DNA	   fragments	   and	   pET21a	   plasmid	   were	   cleaved	   with	   restriction	  endonucleases,	  NdeI	  (NEB)	  and	  HindIII	  (NEB)	  in	  order	  to	  provide	  appropriate	  ends	   for	   cloning	   experiments	   or	   to	   confirm	   the	   presence	   of	   particular	   gene	  fragments	  within	   a	   vector.	   Each	  was	   incubated	  with	  DNA	   (PCR	  products	   and	  pET21a	   plasmid)	   in	   NEBuffer	   (Buffer	   4)	   to	   achieve	   optimum	   activity	   in	   the	  restriction	  digest.	  The	  reaction	  was	  carried	  out	  as	  following:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pET21a	  vector	  	  	  	  	  	  	  	  	  	  	  	  	  	  msmeg5442	  gene	  
	  DNA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10µl	  	  	  	  	  	  	  	  	  	  	  	  	  HindIII	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.0µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.0µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  NdeI	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.0µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.0µl	  	  Buffer	  4(NEB)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.0µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.0µl	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  Sterile	  H2O	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.0µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.0µl	  
Total	  volume	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  20µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  20µl	  Reactions	  were	  incubated	  at	  37°C	  for	  3	  hours.	  The	  resulting	  digested	  DNA	  (PCR	  products	  and	  pET21a	  plasmid)	  were	  visualized	  by	  agarose	  gel	  electrophoresis	  and	   the	   PCR	   products	   (msmeg5442	   gene)	   and	   pET21a	   vector	   were	   purified	  using	   a	   QiaQuick®Gel	   Extraction	   Kit	   (Qiagen)	   and	   the	   protocol	   as	   described	  above	  (2.1.2.1).	  	  
2.1.5	  Ligation	  of	  PCR	  product	  into	  plasmid	  	  	  DNA	  fragments	  were	  ligated	  into	  the	  linearized	  vectors	  (pET21a	  and	  pET14b)	  expression	   vector	   using	   the	   reaction	   catalyzed	   by	   bacteriophage	   T4	   ligase	  (Sambrook	   &	   Russell,	   2001)	   This	   enzyme	   forms	   phosphodiester	   bonds	  between	  adjacent	  3’-­‐OH	  and	  5’-­‐phosphate	  ends	  of	  DNA.	  T4	   ligase	   is	  capable	  of	  joining	   both	   cohesive	   and	   blunt	   ended	   DNA	   fragments.	   Ligations	   were	  performed	   in	  20µl	   volumes	  using	  an	  approximate	  molar	   ratio	  of	  1:1,	  1:3	  and	  3:1	  (plasmid:	  insert).	  Ligation	  buffer	  was	  added	  to	  a	  final	  concentration	  of	  1X.	  The	  ligation	  reaction	  was	  set	  up	  as	  follows:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Tube	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  tube2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  tube3	  T4	  ligation	  buffer	  5X	  	  	  	  	  	  	  	  	  	  	  	  	  	  4µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4µl	  Vector	  DNA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9µl	  Insert	  DNA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3µl	  	  	  	  	  T4	  ligase	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1µl	  
Total	  volume	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  20µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  20µl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  20µl	  
	  All	  tubes	  were	  mixed	  well	  and	  incubated	  at	  room	  temperature	  for	  1.0	  hour.	  
2.1.5.1	  Transformation	  of	  ligation	  mixes	  into	  DH5α 	  E.	  coli	  	  100µl	   aliquots	   of	   competent	   DH5α	   E.	   coli	  were	   removed	   from	   -­‐80°C	   storage	  and	  defrosted	  on	   ice	   for	  5	  minutes.	  When	   the	  cells	  had	   thawed,	  5µl	   from	   the	  various	   ligation	   mixes	   were	   added	   to	   competent	   cells	   before	   being	   left	   to	  incubate	  on	  ice	  for	  30	  minutes.	  Cells	  were	  then	  shocked	  at	  42°C	  for	  90	  seconds	  and	   returned	   to	   ice	   for	   2	   minutes.	   400µl	   of	   LB	  medium	  was	   added	   and	   the	  bacteria	  were	   incubated	  at	  37°C	  at	  200	  rpm	  for	  1.0	  hour.	  After	  centrifugation	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for	  1.0	  minute	  at	  12470	  g,	  the	  transformed	  cells	  were	  resuspended	  in	  100µl	  of	  LB	  before	  plating	  on	  LB	  agar	  supplied	  with	  50µg/ml	  ampicillin	  and	  the	  plates	  were	  incubated	  at	  37	  °C	  overnight.	  
2.1.5.2	  Screening	  of	  possible	  clones	  A	   general	   procedure	   of	   screening	   transformed	   plasmids	   in	   E.	   coli	   was	  performed	   by	   plating	   the	   transformed	   cells	   on	   media	   containing	   suitable	  antibiotics.	   The	   choice	   of	   antibiotics	   is	   dependent	   upon	   the	   existence	   of	  selectable	  antibiotic	  marker	  in	  the	  cloning	  vector.	  The	  selectable	  marker	  that	  is	  present	   in	   pET21a	   is	   ampicillin,	   and	   therefore,	   the	   transformed	   cells	   were	  screened	   on	   LB	   agar	   containing	   50µg/ml	   ampicillin	   (section	   2.1.5.1).	   Some	  colonies	   from	   the	   transformed	   agar	   plate	   were	   picked	   to	   inoculate	   5ml	   LB	  medium,	  supplemented	  with50µg/ml	  ampicillin	  and	  grown	  overnight	  at	  37	  °C	  at	  200rpm.	  Plasmids	  were	  extracted	  from	  the	  cells	  as	  described	  in	  section	  2.1.3	  Transformed	   cells	   were	   initially	   screened	   for	   the	   insertion	   by	   restriction	  digestion	   as	   described	   in	   section	   2.1.4.	   The	   extracted	   plasmids	   were	   also	  sequenced	  using	  T7	  forward	  and	  reverse	  primers.	  
2.1.6	  Protein	  Expression	  
2.1.6.1	  BL21	  (DE3)	  transformation	  protocol	  	  Transformation	  of	  the	  recombinant	  plasmids	  into	  E.	  coli	  cells,	  BL21(DE3)	  was	  carried	   out	   for	   overexpression	   of	   the	   target	   protein.	   100µl	   aliquots	   of	  competent	   cells	  were	   removed	   from	   -­‐80°C	   storage	  and	  defrosted	  on	   ice	   for	  5	  minutes.	   When	   the	   cells	   had	   thawed	   2µl	   of	   the	   plasmid	   preparation	   were	  added	  before	  being	  left	  to	  incubate	  on	  ice	  for	  30	  minutes.	  The	  cells	  were	  then	  shocked	  at	  42°C	  for	  90	  seconds	  and	  returned	  to	  ice	  for	  2	  minutes.	  400µl	  of	  LB	  medium	  was	  added	  and	  the	  bacteria	  were	  incubated	  at	  37°C	  at	  200	  rpm	  for	  1.0	  hour.	   100µl	   from	   the	   culture	   was	   plated	   on	   LB	   agar	   supplied	  with	   50µg/ml	  ampicillin	  and	  the	  plate	  was	  incubated	  at	  37	  °C	  overnight.	  	  
2.1.6.2	  Small-­‐scale	  overexpression	  trials	  The	  cells	  containing	  the	  recombinant	  vector	  were	  grown	  overnight	  in	  5	  ml	  LB	  media	  containing	  50µg/ml	  ampicillin.	  1ml	  from	  this	  primary	  culture	  was	  added	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to	   50ml	   LB	   medium	   supplemented	   with	   the	   same	   antibiotic	   and	   grown	   at	  different	   temperatures	   (37°C,	   30°C	   and	   25°C)	   on	   a	   rotary	   shaker	   at	   200	   rpm.	  The	  cells	  were	  grown	  until	  an	  OD600n.m	  of	  0.6	  was	  reached.	  A	  1ml	  sample	  of	  the	  culture	  was	  removed	  and	  cells	  pelleted	  on	  a	  micro-­‐centrifuge	  at	  13000	  pm	  for	  1	  minute.	   The	   supernatant	  was	   then	  discarded	   and	   the	   cell	   pellet	   stored	   at	   -­‐20°C.	   After	   that,	   1mM	   IPTG	   was	   added	   to	   the	   culture	   in	   order	   to	   induce	  expression	  of	  the	  protein	  of	  interest.	  The	  cells	  were	  then	  grown	  for	  a	  further	  4	  hours	  under	  the	  same	  conditions	  before	  centrifuging	  at	  4499	  g	  for	  20	  minutes	  at	  4°C.	  The	  supernatant	  was	  discarded	  and	  the	  cell	  pellets	  stored	  at	  -­‐20°C.	  The	  level	   of	   over-­‐expression,	   protein	   solubility	   and	   optimum	   temperature	   were	  determined	  by	  analyzing	  the	  samples	  using	  SDS-­‐PAGE.	  
2.1.6.2.1	  Expression	  Level	  and	  Solubility	  Test	  Although	   it	   is	   sometimes	  possible	   to	   refold	   active	   protein	   from	   the	   insoluble	  fraction,	  crystallization	  usually	  works	  better	   if	   the	  protein	   is	  expressed	   in	  the	  the	  soluble	  form.	  For	  testing	  the	  whole	  protein	  content	  and	  its	  solubility,	  cells	  were	  lysed	  using	  the	  BugBuster®	  reagent	  (NoVagen),	  a	  commercial	  reagent	  for	  rapid	   bacterial	   cell	   lysis,	   using	   the	   manufacture’s	   protocol.	   2	   ml	   BugBuster	  reagent	  plus	  5µl	  Benzonase	  were	  added	  to	  the	  Falcon	  tube	  containing	  the	  cell	  pellets,	   with	   repeated	   pipetting	   until	   the	   cells	   were	   completely	   suspended.	  Benzonase	   is	   an	   endonuclease	   enzyme	   and	  was	   used	   to	   degrade	   all	   forms	   of	  DNA	  and	  RNA	  present	  in	  the	  sample.	  After	  this,	  the	  Falcon	  tube	  contents	  were	  incubated	  on	  ice	  for	  30	  minutes	  before	  centrifugation	  at	  4499	  g,	  at	  4°C	  for	  20	  minutes,	   to	   pellet	   all	   the	   insoluble	   fraction,	   and	   leave	   soluble	   proteins	   in	   the	  supernatant.	   For	   analysis	   of	   the	   insoluble	   fraction,	   the	   remaining	   pellet	   was	  resuspended	  in	  2ml	  50mM	  Tris-­‐HCl	  pH=8.0	  and	  disrupted	  by	  three	  sonication	  bursts	  of	  20sec	  at	  16micron	  amplitude.	  
2.1.6.3	  Large-­‐scale	  over-­‐expression	  	  When	   a	   suitable	   condition	   had	   been	   determined	   for	   protein	   expression,	   the	  growth	  was	  scaled	  up	  using	  one	  litre	  of	  medium	  in	  500	  ml	  aliquots	  using	  2	  litre	  Erlenmeyer	  culture	   flasks.	  10	  ml	  samples	   from	  overnight	  cultures	  were	  added	  to	  two	  culture	  flasks	  containing	  500ml	  LB	  with	  50µg/ml	  ampicillin	  and	  grown	  at	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Figure	  2.1.	  pET21a	  vector.	  The	  plasmid	  contains	  the	  multiple	  cloning	  sites	  (black	  arrow),	  T7	  promoter	  (311-­‐327),	  T7	  terminator	  (26-­‐72),	  lactose	  operator	  protein	  sequence	  (lacI)	  (714-­‐1793)	  and	  ampicillin	  resistance	  (Ap)	  (3988-­‐4845).	  	  	   	  
	  	  
Figure	   2.2.	   pET14b	   vector.	   The	   plasmid	   contains	   the	   multiple	   cloning	   sites	   (black	  	  arrow),	   T7	   promoter	   (464-­‐662),	   T7	   terminator	   (404-­‐450)	   and	   ampicillin	   resistance	  (Ap)	  (3606-­‐4463).	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37°C	  with	   shaking	   at	   200	   rpm	  until	   the	  optical	   density	   at	   600nm	  reached	  0.6.	  The	   cell	   cultures	   were	   then	   induced	   with	   1	   mM	   IPTG	   and	   were	   left	   to	   grow	  under	   the	   same	   conditions	   for	   a	   further	   4	   hours.	   Cells	  were	   then	   pelleted	   by	  centrifugation	  at	  4499	  g	   for	  20	  minutes	  at	  4°C	   in	  a	  Beckman	  centrifuge	  before	  resuspension	  in	  about	  100	  ml	  of	  LB	  medium.	  The	  cell	  pastes	  were	  collected	  in	  a	  Falcon	  tube	  and	  harvested	  by	  centrifugation	  again	  under	  same	  conditions.	  The	  supernatant	  was	  discarded	  and	  the	  cell	  pellets	  stored	  at	  -­‐80°C,	  until	  required.	  	  	  
2.1.6.3.1	  Production	  of	  Seleno-­‐L-­‐Methionine	  incorporated	  protein	  	  A	  starter	  culture	  growth	  in	  LB	  medium	  supplemented	  with	  50µg/ml	  ampicillin	  was	  used	  to	  inoculate	  1.0	  liter	  of	  LB	  containing	  the	  same	  antibiotic	  split	  between	  two	   2	   litre	   Erlenmeyer	   culture	   flasks,	   yielding	   2%	   inoculation.	   The	   cultures	  were	  left	  to	  grow	  at	  37°C	  with	  shaking	  at	  200	  rpm	  until	  the	  A600	  reached	  0.6.	  	  At	  this	  point	   the	  cells	  soft	  pelleted	  at	  1844	  g	   for	  20	  min	  prior	   to	  resuspension	   in	  about	   100	   ml	   minimal	   medium	   (table2.1	   describes	   the	   minimal	   media	  composition).	   The	   cells	   were	   centrifuged	   at	   1844	   g	   for	   20	   min	   before	   being	  resuspended	   in	   50	   ml	   seleno-­‐L-­‐methionine	   substituted	   minimal	   medium	  supplemented	  with	  50µg/ml	  ampicillin.	  This	  culture	  was	  used	  to	  inoculate	  2x2	  litre	   conical	   flasks	   containing	   500	   ml	   substituted	   minimal	   medium	   with	   40	  mg/litre	   Seleno-­‐L-­‐methionine.	   The	   cells	   were	   left	   to	   grow	   at	   37°C	   until	   with	  shaking	  at	  200	  rpm	  the	  A600	  reached	  0.6	  before	  adding	  IPTG	  for	  induction.	  The	  cells	  were	  allowed	   to	  grow	  8	  hours,	  under	   the	  same	  condition.	  The	  cells	  were	  harvested	  by	  centrifugation	  and	  stored	  at	  -­‐80°C,	  until	  required.	  
2.1.6.4	  SDS	  Polyacrylamide	  Gel	  Electrophoresis	  (SDS-­‐PAGE)	  Analysis	  of	  fractions	  obtained	  during	  preparation	  of	  cell	  free	  extracts	  or	  protein	  purification	  was	  carried	  out	  using	  SDS-­‐PAGE	  gels.	  
	  	  	  	  	  	  	  	  	  	  	  i)	  Sample	  preparation	  
	  For	   analysis	   of	   the	   protein	   samples	   by	   SDS-­‐PAGE	   gel,	   15-­‐20µl	   from	   these	  samples	  were	  mixed	  with	  5µl	  loading	  buffer	  (250mM	  Tris-­‐HCl,	  pH=8.0,	  15%SDS,	  50%	  Glycerol,	  0.01%	  bromophenol	  blue	  and	  β-­‐mercaptoethanol)	   in	  Eppendorf	  tubes,	  and	  boiled	  for	  10	  min	  prior	  to	  loading	  on	  the	  SDS	  gel.	  	  	  
ii)	  Gel	  preparation	  Gels	  were	  constructed	  using	  a	  Biorad	  gel	  former.	  A	  1	  mm	  gel	  plate	  was	  used	  and	  
	   45	  
	   Selenomethionine-­‐minimal	  medium	  To	  Autoclave	   Chemicals	   Concentration	  	   Potassium	  dihydrogen	  phosphate	   4.5g/litre	  	   Dipotassium	  phosphate	   10g/litre	  	   Tri-­‐sodium	  citrate	   0.5g/litre	  	   Ammonium	  sulfate	   1.0g/litre	  	   Glycerol	   5.0ml/litre	  	   Adenine	   0.5g/litre	  	   Guanosine	   0.5g/litre	  	   Thymine	   0.5g/litre	  	   Uracil	   0.5g/litre	  	   Deionized	  water	   980	  ml	  After	  autoclaving	   Chemicals	   Concentration	  	  	  	  	  	  	  	  	  	  	  	  	   Lysine	  	   100	  mg/litre	  	   Phenylalanine	   40	  mg/litre	  	   Threonine	   100	  mg/litre	  	   Isoleucine	   50	  mg/litre	  	   Leucine	   25	  mg/litre	  	   Valine	   50	  mg/litre	  	   Magnesium	  sulfate	   1.0	  mg/litre	  	   Thiamine	   4	  mg/litre	  	   Selenomethionine	   40	  mg/litre	  	  
Table	  2.1.	  Minimal	  Seleno-­‐L-­‐methionine	  (SeMet)	  medium	  composition.	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gels	  were	   comprised	   from	  a	  12%	  acrylamide	   separating	   gel	  with	  6%	  stacking	  gel.	  
12%	  Resolving	  Gel	  
	  	  	  	  	  	  	  	  	  30%	  Acrylamide	  	  	  	  	  	  	  	  	  	  	  2.5	  ml	  	  	  	  	  	  	  	  	  1M	  Tris-­‐HCl	  pH8.8	  	  	  	  	  	  	  	  2.35ml	  	  	  	  	  	  	  	  	  Sterile	  water	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.95ml	  	  	  	  	  	  	  	  10%	  SDS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  62.5µl	  	  	  	  	  	  	  	  10%	  APS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  62.5µl	  	  	  	  	  	  	  	  	  TEMED	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6.25µl	  
6%	  Stacking	  Gel	  	  	  	  	  	  	  	  30%	  Acrylamide	  	  	  	  	  	  	  	  	  	  	  	  	  0.75ml	  	  	  	  	  	  	  	  	  1M	  Tris-­‐HCl	  pH6.8	  	  	  	  	  	  	  	  0.47ml	  	  	  	  	  	  	  	  	  Sterile	  water	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.46ml	  	  	  	  	  	  	  	  10%	  SDS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  37.5µl	  	  	  	  	  	  	  	  10%	  APS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  37.5µl	  	  	  	  	  	  	  	  	  TEMED	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3.75µl	  Gels	  were	  run	  in	  a	  gel	  tank	  under	  SDS	  running	  buffer.	  The	  voltage	  was	  applied	  at	  80V	  for	  30	  minutes	  and	  then	  was	  increased	  to	  200V	  for	  60	  minutes.	  	  
	  10X	  SDS	  Running	  Buffer	  	  	  	  	  	  	  	  	  Tris	  Buffer	  	  	  	  	  	  	  	  	  30.3g	  	  	  	  	  	  	  	  	  Glycine	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  144g	  	  	  	  	  	  	  	  	  SDS	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10g	  Make	  1	  liter	  in	  distilled	  water	  to	  a	  final	  concentration	  1X.	  
Staining	  and	  Destaining	  	  Gels	   were	   removed	   from	   the	   gel	   plates	   and	   washed	   by	   distilled	   water	   and	  stained	   for	   2	   hr	   with	   Coomassie	   Blue	   Stain	   (0.1%	   Coomassie	   blue,	   40%	  Methanol	   and	  10%	  Acetic	   acid).	   Gels	  were	   removed	   from	   the	   Coomassie	  Blue	  Stain,	  washing	   by	   distilled	  water	   and	  destaining	   in	   a	   20%	  Methanol	   and	  10%	  Acetic	  acid	  solution	  until	  the	  bands	  were	  seen	  against	  the	  background.	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2.2	   Purification	   of	   all	   target	   proteins;	   Myobacterium	   smegmatis	  
GluDH,	   Clostridium	   symbiosum	   GluDH	   and	   phenylalanine	  
dehydrogenase	  (PheDH)	  from	  Bacillus	  sphaericus.	  In	   order	   to	   produce	   diffraction	   quality	   crystals	   the	   target	   protein	   must	   be	  purified	   to	  more	   than	   95%	   purity.	   Protein	   purification	   is	   accomplished	   using	  several	  steps	  of	   liquid	  chromatography	   to	   isolate	   the	  desired	  protein	   from	  the	  complex	   mixture	   based	   on	   its	   unique	   physical,	   chemical	   and	   biological	  properties.	   Normally,	   particular	   purification	   protocols	   should	   be	   designed	   for	  every	  specific	  protein.	  Purification	  of	  proteins	  involve	  multiple	  steps,	  utilizing	  a	  combination	   of	   ion	   exchange,	   hydrophobic	   interaction,	   size	   exclusion	   and	  affinity	   chromatography.	   The	   purity	   of	   the	   protein	   of	   interest	   is	  most	   usually	  estimated	  by	  SDS-­‐PAGE	  electrophoresis.	  Bradford	  or	  Lowry	  assays	  can	  be	  used	  most	  often	   to	  measure	   the	   concentration	  of	   the	   target	  protein.	   In	   this	  project,	  purification	  of	  all	  the	  protein	  targets	  utilized	  ion	  exchange,	  hydrophobic	  and	  gel	  filtration	  chromatography.	  
2.2.1	  Cell	  Lysis	  
	  For	  all	  protein	  targets	  the	  first	  step	  in	  the	  purification	  was	  to	  lyse	  the	  cells	  that	  contained	   the	   desired	   protein.	   This	  was	   performed	   by	   sonication,	  which	   uses	  high	  frequency	  sonic	  pulses	  to	  disrupt	  the	  bacterial	  cell	  walls	  and	  membranes.	  Cells	  were	  defrosted,	  suspended	  in	  50mM	  tris-­‐HCl	  buffer,	  pH	  8.0	  and	  disrupted	  by	   sonication	   using	   two	   bursts	   of	   20sec	   at	   16micron	   amplitde.	   Debris	   was	  removed	  by	  centrifugation	  at	  70000g	  for	  10minutes.	  
2.2.2	  Ion	  Exchange	  Chromatography	  	  Separation	   of	   proteins	   by	   ion	   exchange	   chromatography	   depends	   on	   the	  differences	  in	  their	  net	  surface	  charges.	  Protein	  charges	  depend	  on	  two	  factors;	  the	  kind	  of	  amino	  acids	  that	  are	   located	  on	  a	  protein	  surface	  and	  the	  pH	  of	   its	  medium.	  Every	  protein	  has	  a	  particular	  pH,	   called	   the	   isoelectric	  point	   (pI),	   at	  this	   point	   the	   overall	   charge	   on	   the	   protein	   is	   zero.	   If	   the	   pH	   of	   the	   protein	  solution	   is	   lower	   than	   protein	   pI,	   the	   protein	   charge	   will	   be	   positive,but	   the	  overall	  charge	  on	  the	  protein	  will	  be	  negative	  when	  the	  pH	  is	  above	  the	  protein	  pI.	  There	  are	  two	  main	  types	  of	  ione	  xchange	  chromatography;	  anion	  exchange	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chromatography	   utilises	   positively	   charge	   exchangers	   to	   separate	   negatively	  chaged	   particles	   and	   cation	   exchange	   chromatography	   uses	   a	   negatively	  charged	   exchanger	   to	   bind	   positive	   particles.	   At	   low	   ionic	   strength,	   sample	  molecules	  in	  the	  mobile	  phase	  will	  bind	  to	  a	  column	  of	  beads	  (stationary	  phase)	  in	  accordance	  to	  their	  charges.	  The	  ionic	  strength	  of	  the	  mobile	  phase	  can	  then	  be	   increased	  gradually,	  by	  adding	  for	  example	  sodium	  chloride	  or	  another	  salt	  in	   a	   controlled	  manner.	   This	   gradual	   increase	   in	   ionic	   strength	   causes	   elution	  first	  of	  low	  net	  charge	  density	  proteins	  and	  gradually	  those	  with	  higher	  charge	  density.	  
2.2.3	  Hydrophobic	  Chromatography	  Separation	   using	   hydrophobic	   chromatography	   depends	   on	   the	   reversible	  adsorption	   of	   biomolecules	   according	   to	   their	   hydrophobicity.	   This	  method	   is	  normally	   used	   as	   a	   subsequent	   step	   in	   an	   isolation	   project	   when	   the	   protein	  samples	   have	   already	   undergone	   an	   ammonium	   sulfate	   precipitation	   step	   or	  after	   preliminary	   separation	  by	   ion	   exchange	   chromatography.	   In	   these	   cases,	  the	   sample	   contains	   a	  high	   salt	   concentration,	  which	   increases	   the	   interaction	  between	   the	   hydrophobic	   areas	   on	   the	   surface	   of	   a	   protein	   and	   hydrophobic	  groups	  attached	  to	  a	  matrix.	  The	  protein	   is	   thus	  generally	  applied	  to	  a	  column	  under	  high	  salt	  conditions,	  and	  eluted	  with	  decreasing	  concentrations	  of	  salt	  in	  a	   buffer.	   Phenyl	   Toyopearl	   is	   an	   example	   of	   a	   hydrophobic	   chromatography	  matrix,	   and	  consists	  of	   a	  matrix	  of	   cross-­‐linked	  Toyopearl	   forming	  beads	  with	  phenyl	  groups	  exposed	  on	  its	  surface.	  	  	  
2.2.4	  Gel	  Filtration	  The	   gel	   filtration	   technique,	   which	   is	   sometimes	   called	   size	   exclusion	  chromatography,	   separates	  molecules	   according	   to	   differences	   in	   their	   size	   as	  they	   pass	   through	   a	   column	   filled	  with	   porous	   beads.	   Unlike	   ion	   exchange	   or	  affinity	  chromatography,	  molecules	  do	  not	  bind	  to	  the	  chromatography	  medium,	  which	  mean	  that	  buffer	  composition	  does	  not	  directly	  affect	  the	  resolution	  (the	  degree	  of	  separation	  between	  peaks).	  The	  column	  medium	  can	  be	  considered	  as	  a	   set	   of	   beads	   that	   contain	   pores	   of	   different	   sizes.	   Large	  molecules,	   that	   are	  unable	   to	   enter	   these	   pores,	   move	   around	   the	   outside	   of	   the	   beads,	   whereas	  molecules	   that	  are	  small	  enough	  to	  enter	   the	  holes	   in	   the	  beads	  have	  a	   longer	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path	  before	   they	   exit	   the	  beads.	  Therefore,	   the	   large	  molecules	  will	   elute	   first	  from	  the	  column	  and	  the	  smallest	  molecules	  will	  elute	  last.	  	  For	   the	   three	   proteins	   whose	   structures	   are	   described	   in	   this	   thesis,	   a	  combination	  of	  ion	  exchange,	  hydrophobic,	  and	  size	  exclusion	  chromatography	  was	  used	  to	  prepare	  samples	  for	  crystallization.	  The	  precise	  details	  of	  columns	  and	   buffer	   used,	   are	   described	   the	   relevant	   sections	   of	   chapter	   3	   for	   GluDHs	  from	   C.	   symbiosum	   and	   M.	   smegmatis,	   and	   chapter	   5	   for	   PheDH	   from	   B.	  
sphaericus.	  	  	  	  
2.3	  Protein	  crystallization	  
2.3.1	  Robot	  screening	  Crystallization	   conditions	   for	   the	   native	   proteins	   and	   their	   complexes	   were	  initially	   screened	   using	   commercial	   NeXtal	   suites	   (PACT,	   JCSG,	   PEG,	   pHClear,	  Classics	   and	   AmSO4)	   from	   Qiagen,	   with	   a	   sitting-­‐drop	   vapour-­‐diffusion	  approach	  using	  a	  Matrix	  Hydra	  II	  Plus	  one	  robot	  (Thermo	  Fisher	  Scientific,	  USA)	  by	  adding	  0.2µl	  of	  the	  protein	  to	  the	  same	  volume	  of	  precipitant,	  for	  each	  well	  of	  the	  96	   conditions,	   and	   then	  equilibrating	  against	   a	  40µl	   reservoir	  of	   the	   same	  precipitant.	   The	   plate	   was	   centrifuged	   at	   2000rpm	   for	   two	   minutes	   to	   mix	  protein	  and	  precipitants	  before	  incubating	  at	  17°C.	  	  Full	  crystallization	  conditions	  are	  described	  in	  sections	  3.2	  and	  3.7.2	  of	  chapter	  3	  for	  M.	  smegmatis	  GluDH	  and	  C.	  symbiosum	  GluDH	  respectively,	  and	  section	  5.1	  of	  chapter	  5	  for	  B.	  sphaericus	  PheDH.	  	  
2.3.2	  Optimization	  trials	  	  For	   some	   of	   the	   structures	   determined,	   diffraction	   quality	   crystals	  were	   only	  obtained	  after	  optimization	  of	  the	  initial	  screen	  conditions.	  This	  was	  carried	  out	  using	  the	  hanging	  drop	  vapour	  diffusion	  method.	  Similar	  volumes	  from	  protein	  and	   precipitant	   were	   mixed	   in	   a	   ratio	   of	   1:1	   and	   placed	   on	   a	   pre-­‐siliconised	  cover	  slip.	  The	  cover	  slip	  was	  placed	  upside	  down	  on	  the	  reservoir	  containing	  1	  ml	  of	  a	  precipitant	  solution	  and	  sealed	  with	  grease.	  	  
2.4	  X-­‐ray	  Crystallography	  
X-­‐ray	  crystallography	  is	  a	  technique	  used	  in	  structural	  biology	  and	  materials	  science	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Figure	   2.4.	   Gel	   filtration	   chromatography.	   A	   mixture	   of	   proteins	   in	   a	   small	   volume	   is	  applied	   to	   a	   column	   filled	  with	   porous	   beads.	   Because	   large	   proteins	   cannot	   enter	   the	  internal	   volume	   of	   the	   beads,	   they	   emerge	   sooner	   than	   do	   small	   ones.	   This	   figure	   has	  been	  adapted	  from	  Stryer,	  1995.	  	  	  	  
Carbohydrate	  polymer	  bead	  	  Small	  molecules	  enter	  the	  aqueous	  spaces	  within	  beads	  	  Large	  molecules	  cannot	  enter	  beads	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for	   the	   determination	   of	   the	   atomic	   structure	   of	   a	   crystal.	   Solving	   a	   protein	  
structure	   using	   X-­‐ray	   methods	   commonly	   involves	   a	   number	   of	   separate	   steps,	  
growing	   a	   crystal	   (crystallization),	   data	   collection,	   data	   processing,	   determining	  
phases	  and	  structure	  refinement.	  X-­‐ray	  diffraction	  theory	  is	  covered	  in	  a	  number	  of	  
text	   books	   for	   example;	   crystallography	   made	   crystal	   clear,	   by	   Rhodes	   (Rhodes,	  
2010)	  and	   “	  Principles	  of	  protein	   x-­‐ray	   crystallography”	  by	  Drenth	   (Drenth,	  2007).	  
This	   chapter	   describes	   the	   X-­‐ray	   crystallographic	   techniques	   used	   for	   determining	  
the	  protein	  structures	  described	  in	  this	  project.	  
2.4.1	  Protein	  crystallization	  The	  formation	  of	  protein	  crystals	  is	  essential	  to	  the	  structure	  determination	  of	  protein	   by	   X-­‐ray	   crystallography.	  However,	   due	   to	   variations	   in	   size,	   differing	  charge	  distribution,	  and	  stability	  of	  protein	  molecules,	   the	  conditions	  required	  for	  
obtaining	   crystals	   of	   various	   proteins	   vary	   substantially	   and	   the	   crystallization	  
process	   is	   complicated	   and	   time	   consuming.	   Protein	   crystallization	   is	   a	   phase	  
transition	  phenomenon.	  Normally,	  a	  protein	   is	  soluble	   in	  an	  aqueous	  solution	  at	  a	  
certain	   concentration,	   but	   if	   the	   protein	   concentration	   changes	   to	  more	   than	   its	  
solubility	   limit,	   a	  protein	  might	  precipitate	   to	   form	  an	  ordered	  crystalline	  array	   (a	  
crystal),	  or	  under	  some	  conditions,	  it	  may	  form	  an	  amorphous	  precipitate.	  	  
Protein	  crystallization	  is	  dependent	  on	  a	  number	  of	  factors	  including	  the	  purity	  and	  
concentration	  of	   the	  protein	  sample,	  pH,	   temperature,	  and	  the	  concentration	  and	  
kind	   of	   the	   precipitants	   used.	   For	   crystallization,	   the	   purity	   of	   the	   protein	   must	  
usually	   be	   more	   than	   95%.	   Not	   only	   should	   impurities	   be	   absent,	   but	   also	   the	  
protein	  sample	  should	  be	  homogeneous,	  that	  is,	  all	  protein	  molecules	  should	  have	  
the	  same	  protein	  conformation.	  A	  starting	  concentration	  of	  approximately	  10mg/ml	  
is	   often	   used,	   to	   aid	   supersaturation	   of	   the	   sample	   for	   crystallization.	   The	  
temperature	  for	  most	  crystallization	  conditions	  is	  usually	  around	  17°C,	  but	  this	  can	  
be	  varied	  if	  necessary.	  Precipitants	  such	  as	  ionic	  compounds	  (ammonium	  sulphate)	  
and	  organic	  compounds	   (polyethylenglycol	  PEG)	  are	   the	  generally	  used	  agents	   for	  
bringing	   the	   protein	   to	   supersaturation	   to	   induce	   crystal	   formation.	   The	   effect	   of	  
these	  agents	  is	  essentially	  on	  the	  solvent	  rather	  than	  on	  the	  solute	  and	  they	  cause	  
precipitation	  of	  protein	  out	  of	  solution.	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Formation	  of	  a	  protein	  crystal	  can	  be	  broken	  down	  into	  two	  stages:	  the	  nucleation	  
stage	  and	  crystal	  growth.	  As	  shown	  in	  the	  phase	  diagram	  (figure2.4),	  formation	  of	  a	  
nucleus	   and	   subsequent	   crystal	   growth	   happened	   within	   the	   supersaturation	  
region,	   when	   suitable	   conditions	   have	   been	   determined.	   In	   the	   nucleation	   step,	  
where	  the	  level	  of	  supersaturation	  is	  higher	  than	  that	  for	  growth,	  small	  aggregates	  
of	  protein	  are	  formed,	  as	  the	  protein	  molecules	  come	  close	  together,	  producing	  the	  
nuclei	   of	   crystals,	   from	   which	   the	   crystals	   will	   finally	   grow.	   Because	   the	   protein	  
molecules	  coming	  out	  of	  solution	  to	  form	  the	  nuclei,	  the	  concentration	  of	  protein	  in	  
solution	  decreases	  and	  the	  growth	  phase	  of	  the	  crystal	  is	  entered.	  In	  this	  phase,	  the	  
protein	  concentration	  has	  dropped,	  thereby	  leading	  the	  system	  into	  the	  metastable	  
zone,	  where	  no	  more	  nucleation	  happens,	   but	   a	   few	   crystals	  will	   grow	  by	   adding	  
ordered	   layers	  of	  protein	  onto	  the	  nuclei.	  The	  supersaturated	  state	  of	   the	  protein	  
solution	  in	  the	  nucleation	  phase	  is	  crucial	  for	  protein	  crystallization.	  This	  is	  because	  
high	   saturation	   of	   the	   protein	   solution	  will	   cause	   a	   rapid	   growth	   of	  many	   crystal	  
nuclei,	  leading	  to	  an	  excess	  of	  small	  crystals.	  Therefore,	  to	  get	  large	  protein	  crystals	  
it	   is	   essential	   that	   the	   nucleation	   stage	   should	   be	   quite	   short,	   so	   that	   not	   many	  
nuclei	  are	  formed,	  and	  then	  an	  increased	  crystal	  growth	  phase	  should	  arise,	  which	  
means	  the	  crystals	  grow	  large	  enough	  for	  diffraction	  data	  to	  be	  collected.	  	  
There	  is	  no	  recognized	  technique	  for	  predicting	  precisely	  under	  what	  circumstances	  
a	  particular	  protein	  will	   form	  crystals.	  Therefore,	  a	  number	  of	  commercial	  screens	  
such	  as	  the	  Nextal	  Suites	  and	  the	  Hampton	  Research	  Crystal	  Screens	  1	  and	  2,	  can	  be	  
used	  for	  initial	  screens	  of	  protein	  crystallization.	  These	  screens	  use	  several	  common	  
conditions	  of	  crystallization.	  Furthermore,	  by	  using	  a	  modern	  robot,	  a	  great	  number	  
of	   crystallization	   conditions	   can	   be	   screened	   quickly.	   Once	   some	   crystals	   have	  
appeared,	  or	  even	   crystalline	  precipitate,	  optimization	  of	   this	   condition	   should	  be	  
done,	  by	   varying	   the	  parameters	   (precipitant	   concentration,	  pH,	   temperature	  and	  
additives)	  in	  an	  attempt	  to	  obtain	  large	  protein	  crystals.	  	  
2.4.1.1	  Vapour	  diffusion	  method	  	  
	  The	   conversion	   from	   a	   stable	   solution	   to	   a	   supersaturated	   solution	   can	   be	  
accomplished	  by	  increasing	  the	  concentration	  of	  the	  protein	  and	  the	  precipitant	  in	  
the	  protein-­‐precipitant	  mixture.	  The	  physical	  method	  that	  causes	  this	  change	  in	  the	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concentrations	  can	  be	  performed	  through	  dialysis	  or	  diffusion.	  Vapour	  diffusion	   is	  
the	  most	  prevalent	  method	  in	  protein	  crystallization.	  In	  this	  method	  a	  crystallization	  
solution	   is	   mixed	   with	   the	   same	   volume	   of	   the	   protein	   solution	   to	   form	   a	   drop,	  
which	   is	   placed	   in	   an	   enclosed	   environment	   comprising	   a	   larger	   reservoir	   of	   the	  
precipitant	  solution.	  Because	  the	  concentration	  of	  the	  solution	  in	  the	  sample	  is	  less	  
than	   that	   of	   the	   reservoir,	   water	   vapour	   moves	   from	   the	   sample	   drop	   into	   the	  
reservoir,	  until	  a	  supersaturation	  state	  is	  reached	  and	  the	  protein	  might	  crystallize,	  
which	  can	  take	  from	  a	  few	  days	  to	  weeks,	  or	  months.	  	  
There	   are	   two	   techniques	   using	   the	   vapour	   diffusion	   method:	   hanging	   drop	   and	  
sitting	  drop.	  
2.4.1.1.1	  Hanging	  drop	  vapour	  diffusion	  method	  	  
In	   this	   method,	   a	   drop	   (1-­‐10μl)	   of	   the	   crystallization	   solution	   is	   placed	   on	   a	  
siliconized	  microscope	  cover	  slip	  and	  mixed	  with	  an	  equivalent	  amount	  of	  a	  protein	  
solution.	  The	  cover	  slip	  is	  placed	  upside	  down	  on	  the	  reservoir	  containing	  between	  
500	  μl	  to	  1	  ml	  of	  a	  precipitant	  solution	  and	  it	  is	  sealed	  on	  top	  of	  the	  reservoir	  with	  
grease.	  
2.4.1.1.2	  Sitting	  drop	  vapour	  diffusion	  
	  The	   sitting	   drop	   vapour	   diffusion	   method	   depends	   on	   the	   same	   theory	   as	   the	  
hanging	   drop	   vapour	   diffusion	   in	   using	   a	   closed	   system,	   but	   in	   this	  method,	   the	  
protein/precipitant	   drop	   is	   usually	   placed	   on	   a	  micro	   bridge	   above	   the	   reservoir	  
solution.	  Sealing	  tape	  can	  be	  used	  instead	  of	  a	  cover	  slip	  for	  an	  airtight	  closure	  on	  
the	  system.	  The	  sitting	  drop	  method	  is	  used	  preferentially	  with	  proteins	  that	  have	  
a	  low	  surface	  tension,	  which	  can	  make	  it	  difficult	  for	  a	  hanging	  drop	  to	  form.	  The	  
other	   benefit	   of	   this	   method	   is	   that	   it	   is	   easily	   automated	   and	   therefore	   it	   is	  
utilized	  by	  many	  commercially	  available	  crystallization	  robots.	  	  
2.4.2	  Cryocooling	  Protein	   crystals	   are	   very	   sensitive	   to	   X-­‐rays,	   and	   can	   undergo	   considerable	  radiation	  damage	  when	  exposed	  to	  an	  X-­‐ray	  beam	  at	  room	  temperature.	  This	  
damage	  can	  seriously	  reduce	  the	  quality	  of	  the	  data	  that	  can	  be	  collected	  and	  thus	  
the	  structural	  information	  that	  can	  be	  extracted	  from	  the	  crystals.	  Radiation	  	  




	  	  	  	  
	  	  
Figure	   2.5.	   Phase	   diagram	   of	   protein	   crystallization.	   The	   scheme	   shows	   protein	  concentration	  against	  precipitants	  concentration	  during	  a	  crystallization	  vapour	  diffusion	  trail.	   The	   white	   zone	   illustrates	   an	   undersaturation	   region	   where	   crystallization	   will	  never	  occur.	  Because	  of	  the	  protein	  and	  precipitants	  drop	  equilibrates	  with	  the	  reservoir	  solution	   the	   concentration	   of	   protein	   and	   precipitants	   increase	   gradually	   into	   the	  nucleation	  region	  (red	  region	  in	  the	  plot).	  The	  protein	  then	  starts	  to	  come	  out	  of	  solution	  and	   so	   the	   concentration	  drops	  hopefully	   into	   the	   growth	   zone	   (blue	   zone	   in	   the	  plot),	  where	   crystal	   growth	  will	   occur.	   This	   scheme	  has	   been	   adapted	   from	  Rhodes	   (Rhodes,	  2010).	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damage	  is	  caused	  mainly	  by	  a	  primary	  interaction	  between	  the	  X-­‐ray	  photons	  and	  
the	  molecules	   in	  the	  protein	  crystals,	  which	  produces	  free	  radicals.	  The	  extent	  of	  
the	   initial	  damage	   is	  X-­‐ray	  dose	  dependent,	  but	  more	  damage	  can	  happen	  when	  
the	  heat	  produced	  through	  thermal	  vibration	  of	  the	  molecules	  is	  large	  enough	  for	  
the	   diffusion	   of	   the	   reactive	   radicals	   through	   the	   crystal.	   In	   order	   to	   reduce	   the	  
extent	   of	   this	   secondary	   damage,	   a	   protein	   crystal	   can	   be	   kept	   at	   a	   cryo-­‐
tempetature	  (around	  100°	  K),	  which	  has	  the	  effect	  of	  freazing	  the	  reactive	  radicals	  
in	   the	   crystal,	   and	   reducing	   the	  damage.	  Cryo	   temperatures	  are	  accomplished	   in	  
the	  experiment	  by	  positioning	  the	  crystal	  in	  a	  stream	  of	  gaseous	  nitrogen	  at	  100°K	  
on	   the	   collection	   devices.	   Before	   cooling,	   the	   crystal	   should	   be	   transferred	   to	   a	  
cryoprotectant	   solution,	   containing	   the	   precipitant	   solution	   used	   to	   grow	   the	  
crystal	   plus	   an	   anti-­‐freeze	   agent	   such	   as	   a	   low	   molecular	   weight	   polyethylene	  
glycol	   	   (PEG)	  or	  glycerol.	  The	  presence	  of	  these	  agents	  prevents	  the	  formation	  of	  
ice	  crystals	  that	  could	  interfere	  with	  the	  diffraction	  from	  the	  protein	  	  
crystal.	  The	  crystal	   is	  placed	  in	  the	  cryoprotectant	  solution,	  and	  is	  then	  harvested	  
in	  a	  thin	  nylon	  loop	  and	  is	  held	  by	  surface	  tension	  in	  the	  drop	  solution	  inside	  the	  
loop	  and	  stored	  in	  the	  liquid	  nitrogen.	  The	  magnetic	  base	  of	  the	  loop	  is	  attached	  to	  
the	  goniometer	  head,	  which	  allows	  the	  crystal	  to	  be	  rotated	  perpendicularly	  during	  
data	  collection	  and	  for	  the	  precise	  alignment	  of	  the	  crystal	  into	  the	  path	  of	  the	  X-­‐
ray	  beam.	  	  	  
2.4.2	  X-­‐ray	  generation	  X-­‐rays	   are	   electromagnetic	   radiation	   that	   exists	   over	   the	  wavelength	   range	   of	  0.1	  Å	   (hard	  X-­‐rays)	   to	  100	  Å	   (soft	  X-­‐rays).	  The	  wavelengths	  of	   the	  X-­‐rays	   that	  are	  used	  in	  crystallography	  usually	  lie	  between	  2.0	  Å	  and	  0.5	  Å,	  and	  they	  penetrate	  
biological	   macromolecules	   sufficiently	   to	   be	   scattered	   from	   the	   crystal.	   In	  
crystallography	   laboratories	   X-­‐rays	   are	   produced	   by	   various	   sources,	   such	   as	   a	  
rotating	   anode	  generator,	   but	   very	  high	   intensity	  X-­‐rays	   can	  also	  be	   generated	  at	  
synchrotrons.	  
2.4.2.1	  Rotating	  anode	  generator	  
A	  rotating	  anode	  generator	  is	  the	  most	  popular	  X-­‐ray	  generator	  used	  in	  the	  protein	  
crystallography	  laboratories.	  In	  this	  device,	  electrons	  are	  liberated	  from	  the	  heated	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tungsten	  cathode	  and	  are	  accelerated	  towards	  the	  anode,	  through	  a	  high	  potential	  
difference	  (typically	  40kV)	  inside	  the	  evacuated	  lower.	  These	  accelerated	  electrons	  
hit	   and	   interact	   with	   the	   anode	  material	   producing	   a	   beam	   of	   X-­‐rays.	   In	   protein	  
crystallography	   the	  anode	   is	   generally	   a	   copper	   cylinder	   rotating	  at	  high	   speed.	  A	  
large	  proportion	  of	  the	  electron	  energy	   is	  converted	  to	  heat,	  which	   is	  removed	  by	  
cooling	   the	   anode	   with	   circulating	   water.	   A	   copper	   anode	   emits	   X-­‐rays	   at	   two	  
wavelengths,	  CuKα(λ=1.54Å)	   and	  CuKβ	   (λ=1.392Å),	  which	  are	   the	   result	  of	   L	   to	  K	  
shell	  electron	  transitions.	  For	  crystallography	  uses,	  X-­‐rays	  of	  a	  single	  wavelength	  are	  
needed,	  and	  therefore	  a	  graphite	  crystal	  monochromator	  or	  focusing	  mirrors	  can	  be	  
used	  to	  select	  the	  stronger	  CuKα	  X-­‐rays,	  and	  provide	  X-­‐rays	  of	  a	  single	  wavelength	  
at	  1.542Å.	  
2.4.2.2	  Synchrotron	  radiation	  
Synchrotron	   radiation	   is	   electromagnetic	   radiation	   which	   is	   produced	   in	   a	  
synchrotron,	  when	  charged	  particles	  are	  accelerated	   to	  very	  high	  speeds	  using	  an	  
electric	   field	   and	   are	   forced	   to	   travel	   in	   a	   circular	   path	   using	   an	   electromagnet.	  
Synchrotrons	  are	  constructed	  as	  polygons,	  with	  straight	  segments	  lined	  by	  bending	  
magnets.	  These	  bending	  magnets	  are	  located	  at	  the	  corners	  of	  the	  polygon,	  which	  
deflect	  the	  electrons	  to	  promote	  their	  passage	  around	  the	  ring.	  When	  the	  electrons	  
change	  direction	  they	  change	  angular	  velocity,	  resulting	  in	  the	  release	  of	  X-­‐rays	  at	  a	  
tangent	   to	   their	   path.	   To	   produce	   even	   more	   intense	   X-­‐rays,	   “insertion	   devices”	  
could	   be	   inserted	   into	   the	   straight	   segments	   of	   the	   synchrotrons.	   These	   devices	  
extend	   the	   spectrum	   to	   shorter	   wavelength	   and	   can	   be	   divided	   into	   two	   kinds:	  
wigglers	  that	  produce	  a	  number	  of	  sharp	  extra	  bends	  in	  the	  electron	  trajectory,	  and	  
undulators	  that	  are	  similar	  to	  wigglers	  but	  cause	  the	  emission	  of	  radiation	  at	  more	  
specific	  wavelengths.	  
Synchrotron	  radiation	  sources	  have	  many	  advantages	  over	  the	  rotating	  anode	  X-­‐ray	  
source.	  The	  intensity	  of	  the	  beam	  is	  very	  much	  greater.	  This	  increase	  in	  intensity	  can	  
aid	  collecting	  data	  on	  small	  or	  poorly	  diffracting	  crystals.	  Synchrotron	  radiation	  also	  
allows	  the	  collection	  of	  data	  from	  crystals	  with	  large	  unit	  cell	  dimensions	  because	  of	  
the	   lower	  divergence	  of	   the	  beam,	  making	   the	  diffraction	   spots	   sharper	   and	   thus	  
avoiding	  overlap.	  Another	  advantage	  of	  synchrotron	  radiation	  is	  the	  ability	  to	  tune	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the	  wavelength	   (to	   the	   absorption	  edge	  of	   heavy	  metals	   bound	   to	   the	  protein	  or	  
chemically	   incorporated	   into	   the	   protein),	   allowing	   multiwavelength	   anomalous	  
dispersion	  (MAD)	  experiments	  to	  be	  conducted.	  
2.5	  Data	  processing	  	  After	  collection	  of	  the	  diffraction	  pattern	  for	  the	  protein	  crystal	  the	  data	  must	  be	  indexed	  and	  integrated	  together	  to	  generate	  a	  complete	  dataset.	  The	  process	  of	  indexing	  determines	  the	  dimensions	  of	  the	  unit	  cell	  and	  the	  crystal	  space	  group	  by	   measuring	   the	   distance	   between	   diffraction	   spots	   and	   symmetry	   of	   the	  diffraction	   pattern.	   	   When	   the	   parameters	   of	   crystal	   and	   detector	   have	   been	  estimated	  to	  high	  accuracy,	  the	  integration	  of	  the	  data	  set	  can	  be	  achieved.	  The	  process	  of	  integration	  determines	  the	  intensities	  of	  each	  reflection.	  This	  process	  is	   accomplished	   automatically	   using	   MOSFLM	   (in	   home	   source)	   and	   Xia2	   at	  Diamond	  Light	  Source	  with	  XDS	  and	  XSCALE	  (Winter,	  2010).	  	  The	   data	   set	   are	   scaled	   and	   merged	   by	   the	   program	   SCALA	   from	   ccp4	  (Collaborative,	  1994),	  which	  sums	  the	  multiple	  observations	  of	  reflections	  and	  merges	   these	   observations	   into	   average	   intensity.	   In	   this	   program	   the	  differences	   in	   reflection	   intensities	   produced	   by	   external	   effects	   (such	   as	  variation	  of	  the	  beam	  strength	  during	  an	  experiment)	  are	  excluded.	  The	  outputs	  of	  SCALA	  a	  *.mtz	  file	  includes	  the	  determined	  average	  scaled	  intensity	  for	  each	  reflection	   (I),	   the	   associated	   statistical	   errors	   (σI)	   and	   indices	   (h,	   k,	   l).	   The	  quality	   of	   scaled	   and	   merged	   data	   set	   is	   assessed	   using	   various	   methods	   of	  statistical	   analysis.	   The	  major	   indicators	   for	   assessment	   of	   the	   quality	   of	   data	  and	   resolution	   are	   the	   signal	   to	   noise	   ratio	   (I/	   σI),	   Rmerge	   and	   Rpim	   and	  completeness.	   The	   signal	   to	   noise	   ratio	   is	   the	   ratio	   of	   the	   intensity	   over	   the	  standard	  deviation	  for	  that	  intensity	  (I/	  σI)	  and,	  in	  general,	  values	  lower	  than	  2	  indicate	   bad	   quality	   data.	   Rmerge	   and	   Rpim	   calculate	   the	   agreement	   between	  multiple	  measurements	  of	  the	  same	  reflection.	  They	  differ	  in	  the	  application	  of	  a	  correction	  factor	  in	  Rpim	  that	  takes	  the	  multiplicity	  	  (the	  number	  of	  times	  of	  the	  same	   reflection	   are	  measured	   during	   the	   course	   of	   data	   set)	   of	   the	   data	   into	  account.	  Completeness	  is	  a	  measure	  of	  how	  much	  of	  the	  theoretically	  recordable	  data	  has	  actually	  been	  recorded.	  Values	  lower	  than	  90%	  show	  poor	  quality	  data.	  
	  








Figure	   2.8.	   Schematic	  of	  a	   synchrotron	   radiation	  source	   illustrating	   the	   linac,	  booster	  and	  
storage	   rings	   and	   magnetic	   devices	   that	   generate	   X-­‐ray	   radiation.	   Green	   colour	   is	   the	  
bending	  magnet;	  orange	  is	  the	  insertion	  devices	  and	  grey	  is	  the	  generated	  X-­‐ray	  from	  each	  
device.	  This	  figure	  has	  been	  adapted	  from	  (Mitchell	  et	  al,	  1999).	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The	  data	  were	  also	  run	  through	  the	  programme	  Matthews	  coef	  (Kantardjieff	  &	  Rupp,	   2003)	   to	   predict	   the	   solvent	   content	   in	   the	   crystal	   and	   the	   number	   of	  molecules	  in	  the	  asymmetric	  unit	  based	  on	  the	  molecular	  weight	  of	  the	  protein,	  the	  unit	  cell	  volume	  and	  space	  group.	  	  	  	  	  	  
2.6	  Determination	  of	  Phases	  by	  Molecular	  Replacement	  Molecular	   replacement	   can	   be	   used	   to	   solve	   the	   phase	   problem	   in	   X-­‐ray	  crystallography	  (Rossmann,	  1990).	  MR	  depends	  on	  the	  presence	  of	  a	  previously	  solved	   protein	   structure,	  which	   is	   similar	   usually	  with	  more	   than	   25%	  amino	  acid	   sequence	   identity	   to	   the	   unknown	   target	   structure	   from	   which	   the	  diffraction	   data	   are	   obtained	   and	   then	   could	   be	   used	   in	   determination	   of	   the	  target	  structure.	  Molecular	   replacement	   utilizes	   the	   already	   known	   protein	   structure	   for	  structure	   determination	   of	   a	   related	   protein,	   such	   as	   a	   mutant	   protein,	   or	   a	  protein	  with	   close	   sequence	   similarity.	   If	   the	  model	   of	   the	  known	   structure	   is	  close	   to	   that	   of	   the	   target	   structure	   then	   an	   electron	   density	   map	   can	   be	  calculated	   using	   these	   calculated	   phases	   from	   the	   model,	   along	   with	   the	  structure	  factor	  amplitudes	  measured	  in	  the	  diffraction.	  For	  initial	  phases	  to	  be	  calculated,	  the	  model	  must	  be	  placed	  in	  the	  same	  orientation	  in	  the	  unit	  cell	  as	  the	  target	  model.	  Molecular	  replacement	  is	  therefore	  divided	  into	  two	  steps;	  the	  rotation	  function	  (orienting	  the	  model)	  and	  the	  translation	  function	  (moving	  the	  oriented	  model	  to	  the	  position	  occupied	  by	  the	  unknown).	  
2.6.1	  Rotation	  Function	  To	   estimate	   the	   orientation	   and	   position	   of	   the	   unknown	   structure	   the	  Patterson	   function	   can	   be	   used.	   A	   Patterson	   function	   can	   be	   considered	   as	   a	  vector	   map,	   i.e.	   it	   produces	   an	   electron	   density	   map	   of	   the	   vectors	   between	  scattering	  objects	  in	  the	  unit	  cell.	  The	  Patterson	  function	  P(uvw)	  is	  determined	  independently	  of	  the	  phases	  by	  squaring	  the	  F(hkl)	  term	  for	  each	  reflection	  and	  it	  described	  as:	   	  
The	   Patterson	   function	   for	   the	   rotated	   search	   model	   is	   compared	   to	   the	  Patterson	  function	  of	  the	  target	  molecule	  through	  all	  possible	  rotations.	  If	  both	  
P(hkl) = 1V F(hkl)
2
hkl
∑ exp −2πi(hu+ kv+ lw)[ ]
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are	   in	   the	   same	   orientation,	   the	   summation	   of	   the	   peaks	  will	   produce	   a	   large	  value,	  suggesting	  the	  rotation	  solution	  is	  correct.	  
2.6.2	  Translation	  Function	  When	   the	   right	   rotation	   function	   has	   been	   recognized,	   the	   position	   of	   the	  molecule	  in	  the	  unit	  cell	  (the	  three	  positional	  parameters)	  must	  be	  found.	  In	  the	  translation	  function	  a	  new	  Patterson	  is	  calculated	  on	  the	  conversely	  orientated	  (rotated)	   search	   model	   and	   the	   molecular	   replacement	   process	   searches	  through	  the	  three	  position	  parameters	  using	  inter-­‐molecular	  vectors	  to	  find	  the	  position	   of	   the	   molecule	   in	   the	   unit	   cell,	   using	   the	   process	   developed	   by	  Crowther	  and	  Blow	  (Crowther	  &	  Blow,	  1967).	  Having	  placed	  the	  search	  model	  in	  the	  right	  orientation	  and	  position	  in	  the	  unit	  cell,	   an	   initial	   electron	   density	  map	   can	   be	   calculated	   by	   a	   Fourier	   transform,	  using	   the	   observed	   F	   and	   the	   calculated	   phases	   from	   the	   model.	   Phaser	   is	   a	  commonly	  used	  program	  for	  molecular	  replacement	  (McCoy	  et	  al,	  2007).	  	  
2.6.3	  Refinement	  and	  Re-­‐building	  Once	   the	   appropriate	   model	   and	   map	   have	   been	   determined	   using	   the	  molecular	  replacement,	  rounds	  of	  rebuilding	  and	  refinement	  should	  be	  done	  to	  improve	   the	   agreement	   between	   the	   observed	   and	   the	   calculated	   structure	  factor	  amplitudes.	  Rebuilding	   of	   the	   unknown	   model	   in	   this	   thesis	   was	   accomplished	   using	   the	  program	   COOT	   (Emsley	   et	   al,	   2010).	   Rebuilding	   includes	   changing	   the	   amino	  acids	  residues	  in	  the	  model	  to	  those	  in	  the	  target	  structure	  using	  the	  knowledge	  of	   the	  amino	  acid	  sequence	  of	   the	   target	  structure,	   to	  build	  an	   initial	  model	  of	  the	   protein	   structure.	   In	   addition,	   repositioning	   of	   side	   chains,	   adding	   water	  molecules,	  interpreting	  density	  features	  and	  modeling	  ligands	  are	  all	  part	  of	  the	  rebuilding	   process.	   After	   rebuilding,	   the	   model	   and	   observed	   amplitudes	   are	  input	  into	  Refmac5	  (Murshudov	  et	  al,	  2011)	  for	  refinement.	  During	  refinement	  the	  observations	  (structure	  factor	  amplitudes)	  are	  fixed	  and	  the	  parameters	  of	  the	  model	  (x,	  y,	  z	  co-­‐ordinates,	  scales,	  and	  B-­‐factor)	  are	  varied	  to	  give	  maximum	  agreement	   between	   observed	   and	   calculated	   structure	   factor	   amplitudes.	   The	  model	   is	  refined	  again	  and	  a	  new	  electron	  density	  map	  can	  then	  be	  calculated.	  Repeated	   cycles	   of	   refinement	   and	  model	   building	   provide	   better	   phases	   and	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better	   electron	   density	   maps	   are	   obtained.	   Refmac5	   gradually	   minimizes	   the	  differences	  between	  the	  observed	  structure	  factor	  and	  the	  calculated	  structure	  factors	  and	  a	  complete	  model	  can	  be	  built.	  	  
2.6.4	  Rigid	  Body	  Refinement	  Usually	   the	   first	   stage	   of	   refinement	   treats	   segments	   of	   the	   model	   as	   rigid	  bodies,	  which	  are	  refined	  as	  a	  unit	  (rather	  than	  separate	  atoms).	  This	   is	  called	  rigid	   body	   refinement.	   Rigid	   body	   refinement	   uses	   low-­‐resolution	   data	   and	  allows	  more	  accurate	  placement	  of	  a	  model	  obtained	  by	  molecular	  replacement	  into	   an	   electron	   density	   map.	   Rigid	   body	   refinement	   is	   useful	   when	   refining	  models	  with	  multiple	  independent	  domains	  as	  it	  allows	  positional	  refinement	  of	  each	  domain	  individually.	  In	  this	  thesis	  the	  program	  suite	  Phenix	  was	  used	  for	  rigid	  body	  refinement	  (Adams	  et	  al,	  2010).	  
2.6.5	  Monitoring	  the	  Progress	  of	  Refinement	  The	   progress	   of	   refinement	   is	   usually	   determined	   by	   the	   crystallographic	   R	  factor	   that	   is	   defined	   as	   the	   fractional	   differences	   between	   the	   observed	  structure	   factor	   amplitudes,	   from	   the	   experimental	   data,	   and	   calculated	  structure	   factor	   amplitudes	   produced	   from	   the	   model.	   The	   R	   factor	   can	   be	  described	  as:	  	  	   	  	  where	  k	  is	  a	  scale	  factor.	  A	  low	  R	  factor	  means	  that	  the	  model	  agrees	  well	  with	  the	  diffraction	  data.	  Hypothetically	   the	  values	  of	  R	   factor	  can	  range	   from	  zero,	  for	   a	   model	   that	   entirely	   corresponds	   to	   the	   data,	   to	   more	   than	   0.5,	   would	  indicate	  a	  low	  agreement	  between	  the	  two.	  The	  zero	  value	  of	  the	  R	  factor	  would	  be	  perfect,	  but	  because	  of	  the	  limits	  of	  resolution	  it	  is	  not	  possible	  to	  precisely	  determine	  the	  accurate	  position	  of	  all	  atoms	  in	  the	  unit	  cell	  and	  it	  is	  acceptable	  to	  obtain	  an	  R	  factor	  value	  roughly	  10%	  of	  the	  data	  resolution.	  A	  free	  R	  factor,	  Rfree	   is	   determined	   by	   selecting	   a	   small	   random	   subset	   of	   the	   diffraction	   data	  that	   is	  omitted	   from	  the	  refinement	  process,	   so	  as	   to	  prevent	   incorporation	  of	  bias.	   The	   value	   of	   the	   R	   free	   should	   be	   within	   5%	   of	   the	   R	   factor,	   if	   the	  
R = Fobs − k Fcalc( )hkl∑ Fobshkl∑
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differences	   between	   Rfactor	   and	   Rfree	   are	  much	   higher,	   this	   suggests	   that	   the	  model	  has	  been	  over	  fitted	  to	  the	  data	  and	  is	  biased.	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Chapter	   Three:	   Cloning,	   Expression,	   Purification,	  
Crystallization,	  Data	  Collection	  and	  Structure	  Determination	  of	  	  
M.	  smegmatis	  GluDH.	  
	  	  	  	  	  	  	  	  	  	  3.0	  Overview	  	  This	   chapter	  will	   explain	   the	   results	   for	   identification,	   amplification,	   cloning,	  overexpression,	   purification,	   crystallization,	   data	   collection	   and	   structure	  determination	   steps	   for	   the	   glutamate	   dehydrogenase	   protein	   from	   M.	  
smegmatis.	   The	   purification,	   crystallization,	   data	   collection	   and	   structure	  determination	   of	   glutamate	   dehydrogenase	   from	   Clostridium	   symbiosum	  also	  has	  been	  described	  in	  this	  chapter.	  
3.1	  Identification,	  amplification,	  cloning,	  overexpression,	  purification	  of	  M.	  
smegmatis	  GluDH	  
3.1.1	  Identification	  of	  Target	  Gene	  The	   GluDH	   of	  M.	   smegmatis	   is	   encoded	   by	   the	  msmeg_5442	   gene	   and	   it	  was	  identified	   by	   searching	   the	   UniProtKB	   database	   to	   find	   both	   the	   DNA	   and	  protein	  sequence.	  A	  BLAST	  search	  at	  the	  NCBI	  was	  used	  to	  align	  the	  glutamate	  dehydrogenase	   protein	   sequence	   of	   Mycobacterium	   smegmatis	   with	   other	  glutamate	  dehydrogenases	  in	  the	  database.	  
3.1.2	  PCR	  for	  amplification	  of	  M.	  smegmatis	  GluDH	  gene	  (msmeg_5442)	  The	  Polymerase	  Chain	  Reaction	   (PCR)	  was	  used	   to	   amplify	   the	  M.	  smegmatis	  GDH	   gene	   (msmeg5442)	   from	   M.	   smegmatis	   genomic	   DNA	   (strain	   ATCC	  700084	   /	   mc	   (2)155).	   Primers	   were	   designed	   based	   on	   the	   nucleotide	  sequence	   and	   included	   restriction	   sites	   for	   NdeI	   and	   HindIII	   as	   described	   in	  section	  (2.1.1).	  The	  PCR	  products	  were	  run	  on	  a	  1%	  agarose	  gel,	  and	  a	  1.3	  kb	  band	   was	   seen,	   as	   expected	   for	   the	   msmeg5442	   gene	   (1300bp).	   The	   PCR	  products	  were	  purified	  using	  QIAquick®	  gel	   extraction	  kit	   (Qiagen)	  and	  were	  stored	  at	  -­‐20°C	  prior	  to	  use	  in	  cloning.	  Figure3.1	  shows	  the	  PCR	  products	  at	  the	  expected	  size.	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3.1.3	  Cloning	  of	  M.	  smegmatis	  GluDH	  gene	  (msmeg_5442)	  The	  msmeg5442	  gene	  PCR	  product	  was	  digested	  with	  the	  restriction	  enzymes	  NdeI	   and	  Hindiii,	   before	   insertion	   into	   a	  pET21a	  plasmid,	  which	  was	   cleaved	  with	  the	  same	  enzymes	  (see	  section	  2.1.4).	  After	  incubation	  with	  the	  digestion	  mixture	   for	  2	  hours	  at	  37	   °C,	   the	  samples	  were	  analyzed	  on	  a	  1%	  agarose	  gel	  and	  the	  bands	  appeared	  at	  the	  expected	  sizes	  (figure	  3.2).	  The	  digested	  insert	  and	  vector	  were	  purified	  using	  a	  QIAquick®	  gel	  extraction	  kit	  (Qiagen)	  prior	  to	  setting	   up	   the	   ligation	   reaction	   (see	   section	   2.1.5).	   The	   ligation	   mixes	   were	  transformed	  into	  competent	  DH5α	  E.	  coli	  cells	  (Novagen)	  (see	  section	  2.1.5.1).	  As	   plasmid	   pET21a	   carries	   an	   ampicillin	   resistance	   gene,	   the	   resulting	  transformants	   were	   spread	   on	   LB-­‐agar	   plates	   supplemented	   with	   50µg/ml	  ampicillin,	   and	   the	   plates	   were	   incubated	   overnight	   at	   37°C.	   Some	   colonies	  could	  be	  seen	  on	  the	  plate	  and	  were	  screened	  for	  successful	  cloning.	  	  
3.1.4	  Identification	  of	  possible	  clones	  	  	  An	   initial	   screen	   of	   the	   successful	   clones	   was	   curried	   out	   by	   restriction	  digestion.	  A	  number	  of	  colonies	  were	  picked	  up	  from	  the	  plated	  clones	  and	  the	  possible	  constructs	  were	  extracted	  using	  a	  miniprep	  kit	  (Qiagen)	  (see	  section	  2.1.3).	   The	   resultant	   miniprep	   samples	   were	   digested	   with	   the	   restriction	  enzymes	  NdeI	  and	  HindIII	  (see	  section	  2.1.4)	  and	  again	  the	  samples	  were	  run	  on	  the	  1%	  AGE	  to	  verify	  successful	  ligation.	  From	  the	  gel	  picture	  (figure3.2)	  it	  can	   be	   seen	   that	   all	   the	   clones	   gave	   bands	   at	   the	   expected	   size	   (1300	   bp)	  showing	  the	  existence	  of	  the	  desired	  gene	  in	  these	  clones.	  	  
3.1.5	  Expression	  of	  M.	  smegmatis	  GluDH	  
3.1.5.1	  small-­‐scale	  over-­‐expression	  The	  confirmed	  construct	  was	  then	  transformed	  into	  a	  competent	  E.	  coli	  strain,	  BL21(DE3)	  (Novagen),	  and	  plated	  onto	  an	  Amp	  agar	  plate.	  Firstly,	  a	  small-­‐scale	  overexpression	  experiment	  was	  done	  (see	  section	  2.1.6.2	  for	  details)	  to	  test	  the	  expression	  of	  the	  cloned	  gene	  and	  the	  protein	  solubility.	  A	  single	  colony	  from	  the	   transformed	  BL21(DE3):	   pET21a-­‐msmeg5442	  plate	  was	  picked	   and	  used	  to	  prepare	  a	  10ml	  starter	  culture	  using	  LB	  medium	  and	  grown	  overnight.	  One	  ml	   from	   this	   overnight	   culture	  was	   then	  used	   to	   inoculate	  50ml	  of	   LB	  media	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containing	   50µg/mL	   Amp	   in	   a	   conical	   flask	   yielding	   2%	   inoculation.	   Three	  separate	   cell	   cultures	  were	   carried	  out	   from	   the	   starter	   culture	   to	  determine	  the	  protein	   solubility	   at	   various	   temperatures;	   37°C,	   30°C	   and	  25°C.	   The	   cells	  were	  left	  to	  grow	  at	  the	  desired	  temperature	  with	  shaking	  at	  200rpm	  until	  the	  absorbance	  at	  600nm	  reached	  about	  0.6.	  After	  that,	  one	  ml	  from	  each	  of	  the	  cell	  cultures	  were	  transferred	  into	  Eppendorf	  tubes,	  and	  pelleted,	  before	  storage	  at	  -­‐20°C.	   	   These	  were	   used	   on	   SDS-­‐PAGE	   as	   the	   pre-­‐induction	   control	   samples.	  Once	  the	  optical	  density	  of	  the	  cells	  had	  reached	  0.6,	  IPTG	  was	  added	  to	  a	  final	  concentration	  of	  1mM	  to	  induce	  GluDH	  protein	  expression	  by	  these	  cells.	  After	  4	  hours	  induction	  at	  37°C,	  30°C	  and25°C	  on	  a	  rotary	  shaker	  at	  200rpm,	  the	  cells	  were	  harvested	  by	  centrifugation	  at	  1844	  g	  at	  4°C,	  for	  20	  minutes,	  and	  the	  cell	  pellets	  were	  stored	  at	  -­‐80°C	  for	  subsequent	  SDS-­‐PAGE	  analysis.	  Investigation	  of	  the	  expression	  was	  carried	  out	  on	  cell	  pastes.	  The	  cell	  paste	  was	  defrosted,	   suspended	   in	  50mM	  tris-­‐HCl	  buffer,	  pH	  8.0	  and	  disrupted	   by	   sonication	   using	   two	   bursts	   of	   20sec	   at	   16micron	   amplitude.	  Debris	   was	   removed	   by	   centrifugation	   at	   70K	   g	   for	   10	   minutes.	   The	  supernatant	   was	   transformed	   into	   the	   universal	   tube	   and	   pellets	   were	  suspended	  in	  the	  same	  buffer	  and	  disrupted	  by	  the	  same	  way.	  The	  un-­‐induced	  sample	   was	   prepared	   using	   the	   following	   method:	   the	   cell	   pellets	   were	  resuspended	  in	  100µl	   (1X)	  SDS	   loading	  buffer	  plus	  7%	  β-­‐mercaptoethanol	  by	  pipetting	   and	  vortexing.	  The	  β-­‐mercaptoethanol	   reduces	   any	  disulfide	  bonds,	  allowing	  complete	  denaturation.	  The	  cell	  solution	  was	  then	  boiled	  at	  100°C	  for	  10	  minutes	  prior	   to	  centrifugation	  at	  13000	  rpm	  for	  1	  minute	   in	  a	  bench	   top	  centrifuge.	  The	   sample	   is	   then	   ready	   for	   loading	  on	  SDS-­‐PAGE	  gel.	   15µl	   from	  soluble	   (supernatant)	   and	   insoluble	   fraction	   samples	  with	   5µl	   loading	   buffer	  were	  boiled	  for	  10	  minutes	  before	   loading	   into	  12%	  SDS-­‐PAGE	  gel.	  The	  three	  samples,	   soluble,	   insoluble	   fraction	  and	  pre-­‐induction,	  were	   then	  analysed	  by	  12%	  SDS-­‐PAGE	  gel	   electrophoresis	   for	   checking	   expression	   level	   and	  protein	  solubility.	  In	  each	  case	  the	  majority	  of	  the	  protein	  had	  been	  over-­‐expressed	  in	  the	   insoluble	   fraction	  as	   seen	  by	  SDS-­‐PAGE	  analysis	   (fig	  3.3),	  but	   fortunately,	  there	  was	  some	  protein	  in	  a	  soluble	  form.	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Figure	  3.1	  Electrophoretic	  pattern	  of	  agarose	  gel.	  PCR	  products	  of	  GluDH	  gene	  from	  
M.	  smegmatis.	  The	  gel	  agarose	  picture	  shows	  that	  there	  are	  bands	  at	  the	  expected	  size	  (1.3kb),	  compared	  to	  the	  gene	  of	  interest.	  Lane	  1	  is	  a	  hyperladder	  I	  and	  Lanes	  2	  and	  3	  are	  PCR	  products	  for	  the	  desired	  gene.	  	  	  	  	  	  
	  
Figure	  3.2	  A	  picture	  of	  1%	  agarose	  gel	  electrophoresis	  showing	  the	  screening	  results	  for	   the	   possible	   constructs	   of	   pET21a	   with	  M.	   smegmatis	   gene	   after	   digestion	   with	  NdeI	  and	  Hindiii.	  Lane	  1	  is	  a	  hyperladder	  I	  and	  lanes	  1,2	  and	  3	  are	  digested	  samples.	  All	  of	  these	  constructs	  represent	  the	  correct	  cloning.	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3.1.5.2	  Large-­‐scale	  over-­‐expression	  Because	   there	  was	   no	   difference	   in	   protein	   solubility	   in	   the	   over-­‐expression	  tests	  at	  the	  three	  temperatures,	  large-­‐scale	  over-­‐expression	  was	  under	  normal	  conditions	   (growth	   at	   37°C	   with	   1mM	   IPTG).	   Two	   2L	   Erlenmeyer	   flasks	  containing	  500	  ml	  LB,	  supplemented	  with	  50µg/mL	  Amp,	  and	  inoculated	  with	  the	  10ml	  of	  starter	  culture	  were	  used.	  The	  flasks	  were	  left	  to	  grow	  at	  37°C	  with	  shaking	  at	  200rpm	  until	  the	  A600	  reached	  0.6,	  before	  adding	  IPTG	  for	  induction.	  The	   cells	   were	   allowed	   to	   over-­‐express	   for	   four	   hours,	   under	   the	   same	  conditions.	  The	  cells	  were	  centrifuged	  at	  1844	  g	  for	  20	  min	  for	  harvesting	  and	  the	   cell	   pastes	  were	   stored	   at	   -­‐80°C	   prior	   to	   use	   in	   purification	   experiments.	  1ml	  samples	  were	  collected	  at	  the	  pre-­‐induction	  and	  post-­‐induction	  growth	  for	  verification	   at	   the	   expression	   and	   solubility	   levels.	   Figure	   3.3	   illustrates	   the	  large-­‐scale	  protein	  expression	  growth.	  	  
3.1.6	  Purification	  of	  GluDH	  from	  M.	  smegmatis	  
3.1.6.1	  Ion	  exchange	  chromatography	  About	   2	   g	   of	   the	   cell	   paste	   was	   resuspended	   in	   the	   lysis	   buffer	   50mM	   TRIS	  pH=8.0.	   Insoluble	  materials	  were	   separated	  by	   centrifugation	  at	  70,000	  g	   for	  15	  minutes	  and	  the	  resultant	  cell	  free	  extract	  (the	  total	  protein	  about	  330mg)	  was	   applied	   on	   a	   10ml	   DEAE	   FF	   cartridge	   (two	   5ml	   cartridges	   jointed	  together).	  Proteins	  were	  eluted	  by	  100ml	  gradient	  of	  NaCl	   from	  0	   to	  0.5M	   in	  buffer	  A	  (50mM	  TRIS	  pH=8.0).	  4ml	  fractions	  were	  collected	  and	  GluDH	  activity	  was	   checked	   in	   the	   fractions	   according	   to	   the	   assay	   described	   below.	   The	  activity	   is	   represented	  on	   the	   chromatogram	   (figure	  3.5	  b)	   by	   the	  black	   line.	  Fractions	  were	  also	  analysed	  by	  SDS-­‐PAGE	  (12.5%	  tris-­‐glycine	  gel)	  (Laemmli,	  1970)	  (figure	  3.5	  a).	  
3.1.6.2	  GluDH	  assay	  To	  assay	  the	  samples	  for	  GluDH	  activity	  samples	  were	  prepared	  in	  1ml	  plastic	  cuvettes.	  The	  cuvette	  contained	  20mM	  Na+	  glutamate,	  10mM	  NADP+	  in	  0.9ml	  of	  50mM	   Na+	   phosphate	   buffer	   pH	   7.0.	   0.1ml	   of	   the	   protein	   solution	   from	   the	  DEAE	  column	  was	  added	  to	  the	  cuvette,	  the	  solution	  was	  mixed	  and	  placed	  in	  a	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Figure	   3.4:	   	  An	  SDS	  gel	  displaying	   the	   level	  of	  M.	  smegmatis	  GDH	  expression	  during	  large-­‐scale	   growth	   at	   37°C	   with	   1mM	   IPTG.	   Lane	   1	   is	   a	   Mark12,	   lane	   2	   is	   a	   pre-­‐induction	  sample	  and	  land	  3	  is	  a	  post-­‐induction	  sample.	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Helios	   spectrophotometer.	   The	   absorbance	   of	   the	   NADPH	   produced	   by	   the	  reaction	  was	  monitored	  at	  340nm	  for	  1min.	  	  
3.1.6.3	  Hydrophobic	  and	  gel	  filtration	  chromatography	  	  	  	  	  	  	  	  	  	  	  The	  most	  active	  fractions	  23-­‐26	  (figure	  3.5	  b)	  were	  combined,	  (total	  protein	  	  	  	  	  	  	  	  	  	  	  was	  64mg)	  and	  4M	  ammonium	  sulphate	  solution	  was	  added	   to	   the	  sample	   to	  make	  the	  final	  ammonium	  sulphate	  concentration	  1.5M.	  The	  sample	  was	  then	  applied	  to	  a	  5ml	  Phe-­‐HP	  cartridge.	  Elution	  was	  performed	  by	  50ml	  ammonium	  sulphate	   concentration	   gradient	   from	   1.5M	   to	   0	   in	   buffer	   A.	   2.5ml	   fractions	  were	   collected	   and	   analyzed	   for	   GluDH	   activity	   and	   by	   SDS-­‐PAGE	   (12.5%	   a	  Tris-­‐glycine	  gel,	  Laemli)	  (figure	  3.6,	  lanes	  3-­‐9).	  	  The	  most	  active	  fractions	  8-­‐10	  were	   combined	   	   (10mg	   in	   total	   protein)	   and	   the	   volume	   of	   the	   sample	   was	  reduced	  to	  2ml	  using	  a	  VivaSpin	  concentrator	  with	  molecular	  weight	  cut	  off	  of	  30kDa.	   Then	   the	   sample	   was	   applied	   to	   a	   gel	   filtration	   column	   equilibrated	  with	   buffer	   A	   +	   0.5M	   NaCl,	   and	   gel	   filtration	   was	   performed	   with	   the	   same	  buffer.	   2ml	   fractions	   were	   collected	   after	   the	   void	   volume	   and	   were	   again	  analysed	   for	   GluDH	   activity	   and	   by	   SDS-­‐PAGE	   (12.5%	   a	   Tris-­‐glycine	   gel,	  Laemly)	   (figure	  3.6,	   lanes	  11-­‐15).	  The	   fractions	  7-­‐11	  were	  pooled	   to	  prepare	  GluDH	   sample	   for	   crystallization.	   The	   protein	   was	   concentrated	   using	   a	  VivaSpin	  concentrator	  and	  buffer	  was	  exchanged	  with	  10mM	  Tris	  pH8.0	  using	  a	   diafiltration	   cup.	   Finally	   the	   GluDH	   was	   concentrated	   to	   12mg/ml,	   as	  estimated	  by	  method	  of	  (Bradford,	  1976).	  
3.2	  Crystallization	  of	  glutamate	  dehydrogenase	  from	  Mycobacterium	  
smegmatis	  
M.	  smegmatis	  GluDH	  protein	   at	   concentration	  of	   12	  mg/ml	  was	  used	  directly	  after	  purification	   for	  crystallization	   trials.	  Two	  different	  samples,	  protein	  and	  protein	   in	   presence	   of	   250mM	   L-­‐glutamate	   (sodium	   salt,	   pH=7.5)	   plus	   5mM	  NADPH,	  were	   automatically	   checked	   for	   crystallization	  using	  Matrix	  Hydra	   II	  Plus	   one	   robot	   (see	   section	  2.3.1	   for	  details).	   Crystals	  were	   grown	   in	   several	  conditions	   for	   both	   the	   native	   protein	   and	   the	   protein	   with	   substrate	   and	  cofactor.	  The	  best	  crystals	  for	  the	  native	  protein	  appeared	  in	  PEG	  screen	  well	  D7	  containing	  0.1M	  Tris-­‐HCl	  pH=8.5	  with	  25%(w/v)	  PEG3000	  and	  also	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Figure	   3.7.	   Chromatogram	   pictures	   for	   the	   purification	   of	  M.	   smegmatis	   GluDH.	   a)	  Hydrophobic	   chromatography	   (Phe-­‐HP)	   purification	   stage	   showing	   the	   most	   active	  fractions	  8-­‐10.	  b)	  Gel	   filtration	  purification	  step	  showing	  elution	  with	  2	  ml	   fractions	  collected	  throughout.	  	  	  
a	  
b	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PEG-­‐D12,	   which	   comprises	   0.1M	   Tris-­‐HCl	   pH=8.5	   plus	   15%	   PEG20000	  (figure3.10).	   For	   the	   protein	   with	   L-­‐glutamate	   and	   NADPH	   the	   best	   crystals	  grew	  in	  the	  PACT	  screen	  well	  H1,	  containing	  0.2	  M	  sodium	  fluoride,	  0.1	  M	  Bis-­‐Tris	  Propane	  pH=7.5	  and	  20%	  PEG3350	  (figure3.10).	  The	  M.	  smegmatis	  GluDH	  protein	  was	  also	  crystallized	   in	   the	  presence	  of	  100	  mM	  2-­‐oxo-­‐glutarate	  and	  10mM	  NADP+,	  again	  using	  commercial	  screens	  and	  the	  	  Hydra	  II	  Plus	  one	  robot	  (section	  2.3.1).	  Crystals	  grew	  from	  condition	  D8	  of	  the	  Classics	   screen,	   containing	  0.1M	  Sodium	  HEPES	  pH	  7.5	   and	  1.4	  M	   tri-­‐sodium	  	  citrate	   (figure	   3.10).	   Crystals	   from	   this	   condition	  were	   optimized	   by	   varying	  the	   tri-­‐sodium	   citrate	   concentrations	   from	  1.0	   to	   1.8	  M,	   a	   droplet	   containing	  1µl	   protein	   plus	   1µl	   well	   solution	   in	   a	   hanging	   drop	   vapour	   diffusion	  experiment.	  	  	  	  
3.3	  Data	  collection	  from	  crystals	  of	  M.	  smegmatis	  GluDH	  in	  apo	  state	  Crystals	  were	  picked	   from	   those	  grown	   in	   the	  PEG	  suite,	   conditions	  D7	  and	  D12	   (figure3.8	   a	   and	   b),	   according	   to	   their	   size	   and	   overall	   definition	   for	  initial	   diffraction	   analysis.	   The	   crystals	   were	   looped	   and	   soaked	   in	   cryo-­‐protectant	   solution	   consisting	   of	   30%	   ethylene	   glycol	   in	   the	   crystallization	  solution	  and	  immediately	  flash-­‐cooled	  in	  liquid	  nitrogen	  before	  placing	  them	  onto	   the	   detector.	   Preliminary	   diffraction	   tests	   were	   performed	   using	   a	  Rigaku	  007/Mar345	  in-­‐house	  detector	  system.	  Unfortunately,	  the	  diffraction	  from	  all	   the	  protein	  crystals	  of	   the	  enzyme	  glutamate	  dehydrogenase	   in	   the	  apo	   state	   was	   very	   poor	   with	   high	   mosaicity	   and	   overlapping	   diffraction	  pattern.	  One	  reason	   for	   this	  might	  be	  due	   to	  a	  movement	   in	   the	  domains	  of	  the	  hexameric	  GluDH,	  which	   causes	  disruption	  of	   the	  ordering	  of	  molecules	  inside	  the	  crystal,	  leading	  to	  poor	  diffraction.	  Therefore,	  further	  studies	  of	  this	  protein	  were	  carried	  out	  on	  the	  complex	  with	  its	  substrates	  and	  cofactor.	  	  
3.4	  Data	  collection	  and	  processing	  of	  GluDH	  -­‐NADPH-­‐glutamate	  complex	  
crystals	  	  
3.4.1	  Data	  collection	  	  One	  crystal	  was	  harvested	  from	  the	  PACT	  suite,	  condition	  H1	  robot	  screen	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Figure3.8.	  Photographs	  of	  M.	  smegmatis	  GluDH	  crystals.	  a	  and	  b	  are	  the	  crystals	   in	  an	  apo	  state,	  c	  is	  the	  crystal	  in	  complex	  with	  NADPH	  and	  L-­‐glutamate	  and	  d	  is	  the	  crystals	  of	  ternary	  complex	  of	  this	  protein	  with	  NADP+	  and	  2-­‐oxoglutarate.	  	  
	   	  	  	  
a)	  PEG	  D7-­‐Robot	  Screen	  0.1M	  Tris-­‐HCl	  pH=8.5	  25%(w/v)	  PEG3000	   b)	  PEG	  D12-­‐Robot	  Screen	  0.1M	  Tris-­‐HCl	  pH=8.5	  15%	  PEG20000	  
c)	  PACT	  H1-­‐Robot	  Screen	  0.2	  M	  sodium	  fluoride	  0.1	  M	  Bis-­‐Tris	  Propane	  pH=7.5	  20%	  PEG3350	  	  
d)	  Classics	  D8-­‐1	  Robot	  Screen	  0.1M	  HEPES	  Sodium	  Salt	  pH=7.5	  1.4M	  Tri-­‐Sodium	  Citrate	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(figure3.8c)	   for	  data	  collection.	  The	  crystal	  was	   looped	  and	  transferred	   into	  a	  cryoprotectant	   containing	   the	   mother	   liquor	   and	   25%	   ethylene	   glycol.	   This	  crystal	   diffracted	   to	   beyond	   2.7Å	   resolution	   on	   the	   home	   source,	   so	   it	   was	  saved	  in	  the	  liquid	  nitrogen	  and	  taken	  to	  a	  beamline	  I04	  of	  the	  Diamond	  Light	  Source	   Synchrotron	   (DLS),	   Oxford.	   900	   images	  were	   recorded	   at	   100K	   from	  one	   crystal	   with	   a	   rotation	   angle	   of	   0.2°	   and	   an	   exposure	   time	   of	   0.4	   s	   per	  image,	   using	   X-­‐rays	   of	   wavelength	   0.9795	   Å	   (12658	   eV)	   with	   the	   distance	  between	   the	   crystal	   and	   detector	   of	   270mm.	   Diffraction	   data	   were	   collected	  and	  processed	  to	  a	  resolution	  of	  1.78Å	  (Fig	  3.9).	  	  	  
3.4.2	  Data	  processing	  The	  processing	  of	   the	  X-­‐ray	  diffraction	  data	   involved	   several	   steps	   including,	  indexing	   (determination	   of	   the	   unit	   cell),	   measurement	   of	   the	   integrated	  intensities	  and	  merging	  and	  scaling	  the	  integrated	  data.	  Processing	  of	  the	  data	  from	  the	  crystal	  of	  GluDH-­‐NADPH-­‐glutamate	  was	  carried	  out	  at	  DLS	  using	  the	  xia2	  system	  in	  the	  3da	  mode	  (Winter,	  2010).	  The	  data	  were	  indexed	  to	  space	  group	   C121	   with	   the	   unit	   cell	   parameters	   a=114Å,	   b=151.6Å,	   c=162.2Å,	  
α=γ=90°	   and	   β=101.4°.	   The	   asymmetric	   unit	   was	   suggested	   to	   comprise	   six	  subunits	   with	   a	   Vm	   of	   2.34	   according	   to	   the	   probabilities	   for	   the	   Matthews	  Coefficient	   determined	   by	   Mattprob	   (Kantardjieff	   &	   Rupp,	   2003).	   Data-­‐collection	  and	  processing	  statistics	  are	  shown	  in	  Table3.1.	  	  
3.5	  Molecular	  replacement	  and	  model	  building	  of	  the	  M.	  smegmatis	  GluDH	  
in	  complex	  with	  NADPH	  	  As	   a	   number	   of	   GluDH	   structures	   are	   known,	   it	   was	   envisaged	   that	   the	  M.	  
smegmatis	  GluDH	  structure	  could	  be	  determined	  using	  molecular	  replacement.	  The	  search	  model	   for	   the	  molecular	   replacement	  was	  obtained	  by	  comparing	  the	  amino	  acid	  sequence	  of	  M.	  smegmatis	  GluDH	  against	  the	  protein	  data	  bank	  (PDB),	   using	   the	   basic	   local	   alignment	   search	   tool	   (BLAST)	   (Altschul	   et	   al,	  1997).	   The	   GluDH	   from	   Clostridium	   symbiosum	  was	   found	   to	   be	   the	   closest	  homologue	  of	  M.	  smegmatis	  GluDH	  with	  a	  sequence	  identity	  of	  51%.	  Therefore,	  
C.	  symbiosum	  GluDH	   (Accession	  number	   in	  PDB	  1HRD)	  was	  used	   as	   a	   search	  model.	  As	  the	  predicted	  six	  chains	  in	  the	  asymmetric	  unit	  would	  be	  arranged	  as	  a	  complete	  hexamer,	  or	  two	  trimers	  with	  the	  crystallographic	  two-­‐fold	  axis	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Dataset	   Overall	   Low	   High	  
High	   resolution	   limit	  Å	   1.78	   7.96	   1.78	  
Low	  resolution	  limit	  Å	   55.91	   55.91	   1.83	  
Completeness	  %	   97.9	   94.8	   83.6	  
Multiplicity	   3.6	   3.6	   2.8	  
I/sigma	   12.1	   29.4	   2.0	  
Rmerge	   0.060	   0.031	   0.473	  
Rmeas(I)	   0.084	   0.040	   0.625	  
Rmeas	  (I+/-­‐)	   0.083	   0.044	   0.630	  
Rpim	  (I)	   0.044	   0.021	   0.368	  
Rpim	  (I+/-­‐)	   0.056	   0.031	   0.413	  
Total	  observations	   911386	   10195	   43840	  
Total	  unique	   251813	   2809	   15805	  	  




Figure	   3.9.	  Diffraction	  picture	   for	  binary	  complex	  M.	  smegmatis	  GluDH	  with	  NADPH	  and	  L-­‐glutamate.	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building	   the	   hexameric	  molecule,	   a	   trimer	   of	   GluDH	  was	   used	   as	   the	   search	  model	  in	  program	  Phaser	  (McCoy	  et	  al,	  2007).	  	  The	   model	   of	   C.	   symbiosum	   GluDH	   (1HRD)	   was	   edited	   to	   remove	   water	  molecules	  and	  three	  subunits	  A,	  B	  and	  C	  were	  selected	  for	  an	  automated	  search	  in	   Phaser	   (McCoy	   et	   al,	   2007).	   Phaser	   was	   run	   in	   the	   C121	   space	   group,	  searching	  for	  two	  copies	  for	  the	  trimer	  in	  the	  asymmetric	  unit.	  Phaser	  found	  a	  solution	   with	   the	   Z	   score	   10.3	   for	   rotation	   and	   10.4	   for	   translation	   for	   the	  trimer	   one	   and	   Z-­‐score	   of	   rotation	   function=	   9.45	   with	   translation	  function=21.7	  for	  trimer	  two.	  	  The	   initial	   model	   and	   electron	   density	   was	   reasonable	   for	   the	   N-­‐terminal	  domain	   in	   each	   subunit	   but	   the	   electron	   density	   in	   the	   C-­‐terminal	   domain	  (dinucleotide	  domain)	  was	  poor,	  possibly	  due	  to	  a	  different	  orientation	  of	  the	  domains	  compared	  to	  the	  search	  model.	  No	  interpretable	  density	  could	  be	  seen	  at	  the	  active	  site	  for	  the	  cofactor	  or	  the	  substrate	  for	  any	  of	  the	  six	  subunits.	  In	  an	  attempt	  to	  overcome	  this	  problem,	  rigid	  body	  refinement	  was	  carried	  out	  in	  Phenix	   with	   all	   12	   domains	   as	   separate	   entities.	   Although	   the	   density	   had	  improved,	   it	   was	   still	   very	   poor	   for	   some	   loops	   in	   the	   NADP+	   domain.	   The	  Rfactor	   and	  Rfree	  for	   the	   resultant	  model	   from	  Phenix	   refinement	  were	   0.41	  and	  0.47	  respectively.	  This	  Phenix	  model	  was	  then	  subjected	  to	  xyz	  refinement	  in	  Refmac	  of	  the	  CCP4i	  suite	  (Collaborative,	  1994),	  resulting	  in	  a	  structure	  with	  an	   Rfactor	   of	   0.32	   and	   Rfree	  of	   0.36.	   Inspection	   of	   the	   electron	   density	  map	  over	  all	  the	  six	  subunits	  showed	  that	  the	  density	  was	  better	  for	  the	  D	  subunit	  in	  both	   domains,	   and	   that	   there	  was	   positive	   electron	   density	   in	   the	   difference	  map	  relating	  to	  the	  cofactor	  in	  all	  chains,	  but	  no	  density	  could	  be	  seen	  for	  the	  substrate.	   Despite	   presence	   of	   250	   mM	   glutamate	   being	   present	   in	   the	  crystallization	  conditions,	   the	  structure	   is	   thus	  believed	  to	  represent	  a	  binary	  complex	   with	   NADPH	   and	   is	   referred	   to	   as	   the	  M.	   smegmatis	   GluDH-­‐NADPH	  binary	  complex	  for	  the	  rest	  of	  the	  thesis.	  	  Therefore,	  the	  decision	  was	  taken	  to	  use	   the	  chain	  D	   for	   rebuilding	  and	   thus	   the	  sequence	  of	   the	  search	  model	   (C.	  
symbiosum	  GluDH)	   was	   substituted	   with	   the	  M.	   smegmatis	   GluDH	   sequence.	  Loops	  defined	  by	  poor	  electron	  density	  were	  deleted	  from	  the	  model	  and	  the	  first	   two	   residues	   at	   the	   N-­‐terminal	   were	   removed	   as	   well	   due	   to	   the	   poor	  density	  around	  them.	  The	  NADPH	  cofactor	  was	  modeled	  in	  its	  electron	  density	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and	  the	  rebuilt	  subunit	  D	  was	  superimposed	  onto	  the	  other	  subunits	  using	  the	  secondary	   structure-­‐matching	   algorithm	   (SSM	   superpose)	   in	   COOT.	   Several	  cycles	   of	   model	   building	   and	   refinement	   were	   then	   conducted	   using	   COOT	  (Emsley	   et	   al,	   2010)	   and	   REFMAC5	   (Murshudov	   et	   al,	   2011).	   In	   general,	   the	  features	  of	  the	  final	  electron	  density	  map	  were	  fine,	  with	  the	  exception	  of	  the	  regions	  at	  the	  residues	  S193-­‐G205	  and	  M385-­‐E400	  for	  all	  six	  chains	  A,	  B,	  C,	  D,	  E	  and	  F,	  where	  the	  density	  was	  missing.	  In	  addition,	  no	  density	  could	  be	  seen	  for	  residues	  G160-­‐E161	  in	  chains	  A	  and	  D	  and	  residue	  E161	  in	  chain	  F.	  Therefore	  these	   loops	  were	  removed	   in	   the	   final	   structure.	  Although	   this	  structure	   is	   in	  the	  closed	  form,	  there	  is	  no	  electron	  density	  for	  L-­‐glutamate	  and	  no	  substrate	  modeled	  in	  the	  resultant	  structure.	  	  The	  final	  model	  has	  an	  R-­‐factor	  =	  0.20	  with	  R-­‐free	  =	  0.23	  with	  476	  water	  molecules,	  and	  the	  NADPH	  bound	  in	  the	  catalytic	  pocket.	   The	   final	  model	  was	   restrained	   to	   standard	   bond	   lengths	   and	   angles	  and	  the	  root	  mean	  square	  deviations	  (r.m.s.d)	  of	  bond	  lengths=0.02Å	  and	  bond	  angles=2.0°.	  Validation	  of	  the	  final	  structure	  by	  the	  Molprobity	  server	  (Chen	  et	  al,	  2010)	  and	  PROCHECK	  (Laskowski	  et	  al,	  1993)	  showed	  that	  the	  quality	  of	  the	  final	  model	  was	  good	  and	  that	  most	  residues	  lie	  within	  the	  allowed	  regions	  of	  the	  Ramachandran	  plot,	  with	  the	  exception	  of	  6	  residues;	  Asp169	  (in	  subunits	  B,	  C,	  D	  and	  F),	  Gly160	  in	  chain	  E	  and	  Ser193	  in	  subunit	  F,	  which	  were	  outliers,	  as	  shown	  in	  figure3.14.	  
3.6	  Structure	  of	  2-­‐oxoglutarate-­‐NADP-­‐GluDH	  complex	  	  
3.6.1	  Data	  collection	  and	  processing	  for	  low	  resolution	  data	  The	  well-­‐defined	  crystal	  of	  M.	  smegmatis	  GluDH	  in	  complex	  with	  NADP+	  and	  2-­‐oxo-­‐glutarate	  was	  harvested	  from	  the	  Classics	  suite	  condition	  D8	  (figure	  3.8d)	  for	   data	   collection.	   The	   crystal	   was	   looped	   and	   soaked	   in	   cryo-­‐protectant	  solution	   containing	   the	   well	   solution	   (0.1M	   HEPES	   Sodium	   salt	   pH=7.5	   and	  1.4M	   Tri-­‐Sodium	   Citrate)	   with	   30%	   ethylene	   glycol	   before	   saving	   in	   liquid	  nitrogen.	  Data	  was	  collected	  at	  the	  Diamond	  Light	  Source,	  beamline	  I24.	  1800	  images	  were	  collected	  to	  a	  resolution	  2.63Å	  with	  a	  rotation	  angle	  of	  0.2°	  and	  an	  exposure	  time	  of	  0.2	  sec	  per	  image.	  	  	  The	  processing	  of	   the	  X-­‐ray	  diffraction	  data	  was	  carried	  out	  at	  DLS	  using	   the	  xia2	  system	  in	  the	  3da	  mode	  (Winter,	  2010).	  Analysis	  of	  the	  data	  revealed	  that	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Parameters	   	  Resolution	  (Å)	   1.78Å	  Number	  of	  reflections	   239154	  Protein	  molecule	  per	  asymmetric	  unit	  	   6	  Number	  of	  residues	  	   449	  Number	  of	  atoms	   19682	  Number	  of	  water	  molecules	   479	  Ramachandran	  favored	  (%)	  	   97.26	  %	  Ramachandran	  outliers	  (%)	   0.25	  %	  RMS	  bond	  length	  deviation	  (Å2)	  	   	  0.02	  Å	  RMS	  bond	  angle	  deviation	  (°)	   2°	  	  Average	   main	   chain	   B-­‐factors	  (Å2)	   	  25	  Å2	  Average	  side	  chain	  B-­‐factors	  (Å2)	   31	  Å2	  Average	  water	  B-­‐factors	  (Å2)	   	  23	  Å2	  R-­‐factor	  (%)	   0.1956	  Rfree	  (%)	   0.2341	  	  Molprobity	  score	  	   1.54	  92nd	  percentile	  	  	  
Table	  3.2.	  Shows	  the	  final	  refinement	  parameters	  for	  binary	  complex	  of	  M.	  smegmatis	  GluDH	  with	  NADPH.	  




Figure	   3.10.	   Ramachandran	   plot	   for	   the	   final	   structure	   of	   M.	   smegmatis	   GluDH	   +	  NADPH.	  The	  plot	   shows	   that	  97.26%	  of	   the	   residues	   are	  within	   the	   favoured	   region	  and	  0.25%	  are	  outliers.	  This	  figure	  was	  produced	  using	  Molprobity	  server	  (Chen	  et	  al,	  2010).	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Side	  chain	  parameters	  	  
	  	  
	  	  
Main	  chain	  parameters	  	  
	  	  
	  	  
Figure	  3.11.	  Main	  chain	  and	  side	  chain	  parameters	  for	  the	  final	  structure	  of	  M.	  
smegmatis	  GDH	  +	  NADPH.	  This	  figure	  was	  produced	  using	  PROCHECK	  (Laskowski	  et	  al,	  1993).	  	  






Figure	   3.12.	   Electron	   density	   map	   at	   different	   regions	   in	   the	   final	   model	   of	   M.	  
smegmatis	  GluDH	   +	   NADPH.	   Poor	   density	   can	   be	   seen	   at	   the	   beginning	   of	   the	   loop	  missing	  (yellow	  residues)	  and	  better	  density	  for	  the	  region	  of	  the	  N-­‐terminal	  domain	  (light	  grey	  residues).	  	  	  
	  	  	  









	  	   	  	  
Table	  3.3.	  Data-­‐collection	  and	  processing	  statistics	  for	  2.63Å	  resolution	  data.	  	  	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  2.63Å	  dataset	  	  	  
Figure	   3.13.	  Diffraction	   images	   for	  2-­‐oxoglutarate-­‐NADP+	  GluDH	  complex	  dataset	  at	  2.63Å.	  	  	  	  
Dataset	   	  
Space	  group	   H32	  
Resolution	  range	  	  	  	   11.77-­‐2.63	  Å	  
Unit	  cell	  dimension	   	  
a=b	   158.8Å	  
c	   200.1Å	  
Completeness	  (%)	   99.9	  
Multiplicity	   20.0	  
I/sigma	   13.7	  
Rmerge	   0.216	  
Rmeas	  (I)	   0.232	  
Rmeas	  (I+/-­‐)	   0.228	  
Rpim	  (I)	   0.052	  
Rpim	  (I+/-­‐)	   0.071	  
Total	  observations	   579884	  
Total	  unique	   28935	  










	  	   	  	  
Table	  3.4.	  Data-­‐collection	  and	  processing	  statistics	  for	  1.6Å	  resolution	  data.	  	   	  	   	  	  	  	  
	  	  	  	  	  	  	  
Figure	   3.14.	   Diffraction	   images	   for	   2-­‐oxoglutarate-­‐NADP	   GDH	   complex	   dataset	   at	  1.64Å.	  
Dataset	   	  
Space	  group	   H32	  
Resolution	  range	  	  	   4.92-­‐1.64	  	  Å	  
Unit	  cell	  dimension	  	   	  
a=b	   158.5Å	  
c	   199.9Å	  
Completeness	  	   99.9	  %	  
Multiplicity	   9.4	  
I/sigma	   11.1	  
Rmerge	   0.134	  
Rmeas	  (I)	   0.153	  
Rmeas	  (I+/-­‐)	   0.151	  
Rpim	  (I)	   0.049	  
Rpim	  (I+/-­‐)	   0.067	  
Total	  observations	   1102694	  
Total	  unique	   117275	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the	   crystal	   belonged	   to	   H32	   space	   group	  with	   unit	   cell	   dimensions	   of	   a=	   b=	  158.8Å,	   c=	   200.1Å,	  α=γ=90°	   and	  β=120°.	   This	   crystal	   contains	   a	   dimer	   in	   the	  asymmetric	  unit	  with	  a	  Vm	  of	  2.48,	  which	  is	  in	  the	  expected	  range	  of	  Matthews	  Coefficients	   (Kantardjieff	   &	   Rupp,	   2003).	   Data-­‐collection	   and	   processing	  statistics	  are	  shown	  in	  Table	  4.2.	  
3.6.2	  Molecular	  replacement	  and	  structure	  building	  for	  low	  resolution	  
data	  	  	  
Chain	   A	   from	   the	   1.78Å	   model	   of	   the	   GluDH-­‐glutamate-­‐NADPH	   complex	   model	  was	   selected,	   using	  Pdbset	   program	   in	   CCP4i,	   as	   a	   suitable	   search	  model	   for	  molecular	   replacement.	   The	   X-­‐ray	   diffraction	   dataset	   (2.63Å)	   of	   GluDH-­‐2-­‐oxoglutarate-­‐NADP+	  complex	  was	  input,	  and	  Phaser	  was	  run	  to	  find	  two	  copies	  of	  the	  subunit	  in	  the	  asymmetric	  unit.	  Phaser	  solved	  the	  structure	  quickly	  and	  a	  subsequent	  round	  of	  refinement	  using	  Refmac5	  (Murshudov	  et	  al,	  2011)	  gave	  an	   Rfactor	   of	   0.25.	   Inspection	   of	   the	   electron	   density	  map	   and	   the	   resulting	  model	  showed	  good	  density	  for	  the	  backbone	  structure	  with	  clear	  density	  of	  α-­‐helices	   and	   with	   side	   chains	   visible.	   The	   map	   also	   contained	   interpretable	  density	   for	   the	   loops	   (residues	   160	   and	   161,	   residues	   193-­‐209	   and	   residues	  385-­‐400)	   that	  were	  missing	   in	   the	   previous	   structure.	   Unambiguous	   density	  for	   the	   cofactor	   (NADP+)	   and	   reasonable	   electron	   density	   for	   the	   substrate	  were	  also	  present	  in	  this	  map.	  Subsequently,	  the	  three	  missing	  loops	  were	  built	  in	  both	  subunits	  (A	  and	  B)	  using	  COOT	  (Emsley	  et	  al,	  2010),	  and	  the	  cofactor	  and	  substrate	  (2-­‐oxoglutarate)	  were	  modeled.	  After	  this	  a	  series	  of	  refining	  and	  rebuilding	  using	  REFMAC5	  and	  COOT	  was	  completed.	  The	   final	  model	  of	   this	  ternary	   complex	   contains	   894	   residues	   and	   65	  water	  molecules	  with	   NADP+	  and	  2-­‐oxo-­‐glutarate	  bound	  in	  the	  catalytic	  pocket	  in	  each	  subunit.	  The	  R-­‐factor	  was	   0.15	   with	   R-­‐free=0.22	   and	   the	   model	   was	   well	   defined	   in	   the	   electron	  density.	  	  The	  final	  structure	  was	  validated	  by	  Molprobity	  server	  (Chen	  et	  al,	  2010)	  and	  PROCHECK	  (Laskowski	  et	  al,	  1993)	  which	  showed	  that	  the	  quality	  of	  the	  model	  was	  good	  and	  with	  most	  of	  the	  amino	  acid	  residues	  within	  the	  allowed	  regions	  of	  the	  Ramachandran	  plot,	  with	  the	  exception	  of	  Val208	  in	  chain	  A	  and	  B.	  The	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Parameters	   	  Resolution	  (Å)	   2.63Å	  Number	  of	  reflections	   27462	  Protein	  molecule	  per	  asymmetric	  unit	  	   2	  Number	  of	  residues	  	   447	  Number	  of	  atoms	   6980	  Number	  of	  water	  molecules	   65	  Ramachandran	  favoured	  (%)	  	   97.19%	  Ramachandran	  outliers	  (%)	   0.22%	  RMS	  bond	  length	  deviation	  (Å)	  	   0.014Å	  RMS	  bond	  angle	  deviation	  (°)	   1.7	  °	  Average	   main	   chain	   B-­‐factors	  (Å2)	   33Å2	  Average	  side	  chain	  B-­‐factors	  (Å2)	   37Å2	  Average	  water	  B-­‐factors	  (Å2)	   26Å2	  R-­‐factor	  (%)	   0.15	  Rfree	  (%)	   0.22	  Molprobity	  score	  	   1.69	  
99th percentile 
	  
Table	   3.5.	   Shows	   the	   final	   refinement	   parameters	   for	   ternary	   complex	   of	   M.	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root	   mean	   square	   deviations	   (r.m.s.d)	   of	   the	   bond	   lengths=0.014Å	   and	   bond	  angles=1.7°.	  	  
3.6.3	  Data	  collection	  and	  processing	  for	  higher	  resolution	  data	  As	  the	  data	  for	  the	  crystal	  obtained	  from	  the	  robot	  trial	  were	  only	  to	  medium	  resolution	  (2.63Å)	  attempts	  were	  made	  to	  improve	  the	  crystals,	  and	  hence	  the	  resolution	   of	   the	   data,	   by	   optimization	   of	   the	   crystallization	   conditions.	  Therefore,	   the	   Classics	   suite	   D8	   condition	   (0.1M	   HEPES	   Sodium	   Salt	   pH=7.5	  and	  1.4M	  Tri-­‐Sodium	  Citrate)	  was	  optimized	  by	  changing	  the	  concentration	  of	  Tri-­‐Sodium	  Citrate	  from	  1.0M	  to	  1.8M	  in	  steps	  of	  0.2M.	  1	   µl	   protein	   sample	   and	   1	   µl	   crystallization	   solution	  were	   used	   in	   a	   hanging	  drop	  trial	  and	  crystals	  appeared	  after	  two	  weeks	  of	  incubation	  at	  17	  °C,	  in	  the	  original	   condition	   (1.4M	   Tri-­‐Sodium	   Citrate	   and	   0.1M	   HEPES	   Sodium	   Salt	  pH=7.5).	  Crystals	  were	  selected	  for	  data	  collection	  according	  to	  their	  size	  and	  overall	   definition	   and	  were	   looped	   and	   soaked	   in	   a	   cryo-­‐protectant	   solution	  consisting	  of	   the	  crystallization	  solution	  with	  30%	  ethylene	  glycol.	  Data	  were	  collected	   at	   beamline	   IO4-­‐1	   at	   Diamond	   Light	   Source.	   1200	   images	   were	  collected	  to	  a	  resolution	  1.64Å	  with	  a	  rotation	  angle	  of	  0.15°	  and	  an	  exposure	  time	  of	  0.1	  sec	  per	  image,	  using	  X-­‐rays	  of	  wavelength	  0.9200	  Å	  (13476.5	  eV).	  	  	  	  Processing	  of	  the	  X-­‐ray	  diffraction	  data	  was	  carried	  out	  using	  the	  Xia2	  system	  by	   the	   2da	   mode	   (Winter,	   2010).	   Analysis	   of	   these	   data	   revealed	   that	   the	  crystal	   belonged	   to	   the	   same	   space	   group	   as	   before	   (H32	   with	   unit	   cell	  dimensions	   of	   a=	   b=	   158.5Å,	   c=	   199.9Å,	   α=γ=90°	   and	   β=120°).	   The	   crystal	  contained	  a	  dimer	  in	  the	  asymmetric	  unit	  with	  a	  Vm	  of	  2.47.	  
3.6.4	  molecular	  replacement	  structure	  building	  for	  high-­‐resolution	  data	  The	   previous	   2.63Å	   model	   of	   this	   ternary	   complex	   (GluDH-­‐2-­‐oxoglutarate-­‐NADP+)	   was	   refined	   against	   the	   higher	   resolution	   data	   set	   (1.64Å)	   using	  Refmac5,	  resulting	  in	  an	  initial	  structure	  with	  R-­‐factor	  and	  R-­‐free,	  0.22	  and	  0.24	  respectively.	  Rebuilding	  this	  model	  to	  fit	  the	  electron	  density	  was	  performed	  in	  COOT,	   and	   multiple	   cycles	   of	   structure	   refinement	   and	   rebuilding	   were	  conducted	  through	  Refmac5.	  An	  examination	  of	  the	  electron	  density	  map	  over	  the	   two	   subunits	   of	   the	   dimer	   showed	   that	   the	   polypeptide	   chain	   was	   well	  defined	   in	  both	  chains.	  The	  electron	  density	  of	   the	  substrate	  (2-­‐oxoglutarate)	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was	  much	  better	  than	  that	  of	  the	  2.63Å	  structure	  (figure3.15).	  Several	  repeated	  cycles	  were	  carried	  out	  for	  structure	  building,	  refinement	  and	  evaluation	  using	  COOT	  and	  Refmac5.	  The	  final	  structure	  of	  this	  ternary	  complex	  comprises	  894	  residues,	   943	  water	  molecules	   and	   four	  molecules	   of	   ethylene	   glycol.	   The	  R-­‐factor	  was	   0.14	  with	  R-­‐free=0.17	   and	   the	  model	  well	   defined	   in	   the	   electron	  density.	  	  The	  final	  model	  has	  been	  restrained	  to	  standard	  bond	  lengths	  and	  angles	  and	  the	   root	  mean	   square	   deviations	   (r.m.s.d)	   of	   bond	   lengths=0.012Å	   and	   bond	  angles=1.52°.	  Validation	  of	  the	  final	  structure	  by	  Molprobity	  server	  (Chen	  et	  al,	  2010)	   and	   PROCHECK	   (Laskowski	   et	   al,	   1993)	   revealed	   that	   the	   final	  model	  was	   of	   good	   quality	   and	  most	   residues	   lie	  within	   the	   allowed	   regions	   of	   the	  Ramachandran	  plot	  with	  the	  exception	  of	  Val208	  and	  Asp169	  residues	  in	  both	  subunits	  that	  were	  in	  outlier	  regions,	  though	  these	  residues	  were	  fitted	  well	  in	  the	  density	  map.	  	  
3.6.4.1	  Refinement	  of	  the	  substrate	  Inspection	  of	  the	  electron	  density	  at	  the	  active	  site	  of	  the	  two	  subunits	  showed	  clear	  density	  for	  the	  substrate	  and	  cofactor.	  By	  examining	  the	  substrate	  density	  in	  chain	  A	  and	  chain	  B	  it	  was	  found	  that	  there	  were	  two	  density	  blobs	  at	  the	  Cα	  position	  instead	  of	  one	  density	  peak	  for	  the	  carbonyl	  group.	  After	  modeling	  the	  2-­‐oxoglutarate	   in	   its	  density	  and	  refining	   the	  model	  using	  refmac5,	  a	  positive	  density	  could	  be	  seen	  near	  to	  the	  Cα.	  This	  might	  be	  due	  to	  the	  presence	  of	  the	  2-­‐	   oxoglutarate	   in	   two	   conformations.	   Moving	   the	   carbonyl	   group	   into	   the	  positive	   density	   in	   COOT	   and	   refining	   the	   structure	   again	   using	   Refmac5	  resulted	   in	  a	  positive	  density	  blob	   in	   the	  other	  position.	  Two	  molecules	  of	  2-­‐oxoglutarate	  were	  modeled	  with	  occupancy	  0.5	  in	  the	  electron	  density	  in	  two	  subunits	  and	  the	  model	  was	  refined	  using	  refmac5.	  The	  resultant	  structure	  has	  a	  positive	  density	  around	  the	  C2.	  Additionally,	  analysis	  of	  the	  B-­‐factors	  for	  the	  C1,	  C2	  and	  C3	  with	  O5	  for	  the	  two	  2-­‐oxoglutarates	  revealed	  that	  the	  average	  of	  the	  B-­‐factors	  of	  the	  carbon	  atoms	  (C1,	  C2	  and	  C3)	  are	  18.5	  Å2,	  which	  is	  higher	  than	  that	  for	  the	  O5	  (10	  Å2).	  From	  the	  refinement	  of	  these	  models	  above,	  it	  can	  be	  concluded	  that	  the	  substrate	  is	  not	  one	  molecule	  of	  2-­‐oxoglutarate	  and	  does	  not	  look	  likely	  to	  be	  2	  molecules	  of	  2-­‐oxoglutarate.	  In	  addition,	  the	  electron	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Parameters	   	  Resolution	  	   1.64Å	  Number	  of	  reflections	   111037	  Protein	  molecule	  per	  asymmetric	  unit	  	   2	  Number	  of	  residues	  	   447	  Number	  of	  atoms	   7805	  Number	  of	  water	  molecules	   943	  Ramachandran	  favoured	  (%)	  	   98.45%	  Ramachandran	  outliers	  (%)	   0.45%	  RMS	  bond	  length	  deviation	  (Å)	  	   0.012	  Å	  RMS	  bond	  angle	  deviation	  (°)	   1.52°	  Average	   main	   chain	   B-­‐factors	  (Å2)	   11Å2	  Average	  side	  chain	  B-­‐factors	  (Å2)	   19Å2	  Average	  water	  B-­‐factors	  (Å2)	   26	  Å2	  R-­‐factor	  (%)	   0.14	  Rfree	  (%)	   0.17	  Molprobity	  score	  	   1.15	  
99th percentile 	  
Table	   3.6.	   Shows	   the	   final	   refinement	   parameters	   for	   ternary	   complex	   of	   M.	  
smegmatis	  GluDH	  with	  NADP+	  and	  2-­‐oxoglutarate,	  1.64Å	  resolution.	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Side	  chain	  parameters	  
	  	  
	  	  




Figure	   3.15	   Side-­‐chain	   and	   main-­‐chain	   parameters	   for	   the	   final	   model	   of	   GluDH-­‐NADP-­‐2-­‐oxoglutarate	   from	   M.	   smegmatis.	   The	   figure	   produced	   by	   PROCHECK	  (Laskowski	  et	  al,	  1993).	  





Figure	   3.16.	  Ramachandran	  plot	   for	   the	   final	  model	  of	  ternary	  complex	  model	  of	  M.	  
smegmatis	  GluDH	  +	  NADP+	  +	  2-­‐oxoglutarate.	  The	  plot	  displays	  98.45%	  of	  the	  residues	  are	   within	   the	   favoured	   region	   and	   0.45	   %	   are	   outliers.	   This	   figure	   was	   produced	  using	  Molprobity	  server	  (Chen	  et	  al,	  2010).	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  a	   	  	  	  	  	  	  	  	  	  	  	  b	  
	  
Figure	   3.17	   shows	   the	   electron	   density	   maps	   around	   the	   cofactor	   NADP+	   at	   2.63Å	  resolution	  (a)	  and	  at	  1.64Å	  resolution	  (b).	  Maps	  are	  shown	  at	  2-­‐sigma	  counter	  level.	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density	   around	   the	   α-­‐carbon	   (C2)	   looks	   sp3	   (tetrahedral)	   rather	   than	   sp2	  (trigonal).	  2-­‐oxoglutarate	  is	  a	  keto	  acid,	  and	  thus	  there	  exists	  a	  possibility	  that	  this	  compound	  is	  present	  in	  the	  crystal	  as	  a	  gem-­‐diol,	  rather	  than	  the	  keto	  acid.	  	  The	  ketone-­‐gem	  diol	  equilibrium	  in	  aqueous	  solution	   is	  modulated	  by	  groups	  attached	  to	  the	  carbon	  and	  can	  range	  from	  K=10-­‐3	  for	  acetone,	  to	  K=1.2x106	  for	  hexafluoro	  acetone	  (Clayden	  et	  al).	  As	  the	  Cα	  in	  2-­‐oxoglutarate	  is	  attached	  to	  an	  electron	   withdrawing	   carboxylate	   group,	   an	   appreciable	   fraction	   of	   the	  compound	   would	   most	   likely	   be	   in	   the	   gem-­‐diol	   form	   in	   aqueous	   solution.	  Therefore,	  the	  substrate	  was	  modelled	  as	  a	  gem-­‐diol	  2-­‐oxoglutarate	  within	  the	  electron	   density	   and	   refining	   the	   structure	   using	   Refmac5	   showed	   no	  difference	   peaks	   about	   the	   Cα,	   which	   means	   that	   the	   gem	   diol	   form	   of	   2-­‐oxoglutarate	  fits	  the	  density	  perfectly.	  In	  addition,	  analysis	  of	  the	  B	  factors	  for	  O5	  and	  O6	  with	  C1,	  C2	  and	  C3	   for	   the	  diol	  revealed	  that	   the	  B	   factors	   for	   the	  oxygen	   atoms	   (O5	   and	   O6)	   are	   same	   as	   the	   average	   of	   B	   factors	   for	   carbon	  atoms	  (C1,	  C2	  and	  C3).	  	  
3.7	  Glutamate	  dehydrogenase	  from	  Clostridium	  symbiosum	  	  	  Obtaining	   crystal	   structures	   of	   the	   complexes	   of	   substrates,	   cofactors	   and	  products	   of	   a	   particular	   enzyme	   is	   fraught	   with	   difficulty,	   as	   binding	   of	   the	  various	   ligands	   often	   seems	   to	   preclude	   crystallization.	   In	   addition,	   crystal	  contacts	  or	  the	  crystallization	  buffer	  often	  keep	  the	  enzyme	  in	  a	  conformation	  that	  precludes	  substrate	  or	  cofactor	  binding.	  It	  was	  thus	  decided	  early	  on	  in	  the	  project	  to	  also	  study	  glutamate	  dehydrogenases	  from	  other	  bacterial	  species,	  to	  optimize	  the	  chance	  of	  obtaining	  relevant	  complex	  structures.	  To	  this	  end,	  the	  GluDH	  from	  Clostridium	  symbiosum	  was	  used	  as	  another	  source	  of	  the	  enzyme.	  Structures	   of	   the	   apo	   enzyme	   (1.96Å)	   and	   the	   GluDH-­‐	   glutamate	   binary	  complex	   (1.9Å)	  have	  been	   reported	   (Baker	  et	   al,	  1992a;	  Stillman	  et	  al,	  1993)	  and	  deposited	  in	  the	  protein	  data	  bank,	  accession	  numbers	  1HRD	  and	  1BGV	  for	  the	   apo	   enzyme	   and	   the	   binary	   complex	   respectively.	   In	   addition	   a	   GluDH-­‐NAD+	  binary	  complex	  has	  been	  described	  to	  2.5Å	  (Baker	  et	  al,	  1992a;	  Stillman	  et	  al,	  1993).	  As	   the	  crystals	  of	   this	  enzyme	  diffracted	  well	  on	   first	  generation	  synchrotron	  sources,	  using	  X-­‐ray	  film	  to	  collect	  the	  data,	  it	  was	  envisaged	  that	  higher	  resolution	  structures	  could	  now	  be	  obtained.	  In	  addition,	  the	  wealth	  of	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Figure	  3.18.	  Electron	  density	  for	  the	  substrate	  of	  the	  ternary	  complex	  of	  M.	  smegmatis	  GDH	  +	  NADP+	  +	  2-­‐oxoglutarate.	  a	  and	  b	  the	  different	  density	  of	  the	  two	  conformations	  of	  carbonyl	  group,	  c	  the	  electron	  density	  for	  the	  two	  molecules	  of	  2-­‐oxoglutarate	  and	  d	  the	  electron	  density	  for	  the	  gem-­‐diol.	   In	  each	  case	  the	  map	  (countered	  at	  2-­‐sigma)	  is	  shown	  in	  blue,	  with	  the	  positive	  difference	  map	  (countered	  at	  3-­‐sigma)	  in	  green.	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   B	  factor	  with	  occupancy=0.5	  for	  the	  2-­‐oxoglutarate	  	  	   Molecule	  1	   Molecule	  2	  O4	   8	   8	  C5	   12	   11	  O3	   9	   9	  C4	   17	   16	  C3	   16	   19	  C2	   22	   17	  O5	   9	   10	  C1	   18	   17	  O1	   13	   12	  O2	   12	   12	  	  (a)	  	  	   B	  factor	  with	  occupancy=1.0	  for	  the	  gem-­‐diol	  	  	  	  	  	  	  	  	  	  	  	  	  O4	   10	  C5	   12	  O3	   10	  C4	   16	  C3	   19	  C2	   26	  O5	   22	  O6	   21	  C1	   18	  O1	   13	  O2	   13	  	   (b)	  	  	  	  
Table	  3.7.	  	  Shows	  B	  factor	  values	  for	  the	  2-­‐oxoglutarate	  (table	  a)	  and	  gem-­‐diol	  (table	  b).	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crystallization	  screens	  now	  available	  would	  perhaps	  allow	  ternary	  complexes	  of	  the	  enzyme	  to	  be	  crystallized.	  	  
3.7.1	  Purification	  of	  glutamate	  dehydrogenase	  of	  Clostridium	  symbiosum	  Glutamate	  dehydrogenase	  protein	  was	  expressed	  by	  Fiona	  Rodgers	  in	  Sheffield	  according	   to	   the	   previous	  method	   (Teller	   et	   al,	   1992).	   About	   3	   g	   of	   the	   cell	  paste	   was	   resuspended	   in	   the	   lysis	   buffer,	   50mM	   TRIS	   pH=8.0.	   Insoluble	  material	  was	  removed	  by	  centrifugation	  at	  70,000	  g	  for	  15	  minutes	  and	  the	  cell	  free	   extract	   (total	  protein	  125mg)	  was	   loaded	   to	  5ml	  DEAE	  FF	   cartridge	   and	  eluted	  with	  50ml	  NaCl	   gradient	   from	  0	   to	  0.5M.	  2ml	   fractions	  were	   collected	  and	  analyzed	  by	  SDS-­‐PAGE	  (4-­‐12%	  Bis-­‐Tris	  NOVAX	  gel).	  Fractions	  16-­‐21	  were	  combined;	   a	   total	   protein	   of	   54mg.	   4M-­‐ammonium	   sulphate	   solution	   was	  added	  to	  the	  sample	  to	  give	  a	  final	  concentration	  of	  1.5M	  and	  the	  sample	  was	  applied	  on	  a	  5ml	  Phe-­‐HP	  cartridge.	  The	  protein	  was	  eluted	  by	  50ml	  of	  reverse	  gradient	   of	   ammonium	   sulphate	   concentration	   from	   1.5M	   to	   0M	   in	   buffer	   A.	  2ml	  fractions	  were	  collected	  and	  analysed	  by	  SDS-­‐PAGE.	  Fractions	  22-­‐24	  were	  combined	  (total	  protein	  16mg)	  and	  the	  volume	  of	   the	  sample	  was	  reduced	  to	  2ml	  using	  a	  VivaSpin	  concentrator	  with	  a	  molecular	  weight	  cutoff	  of	  30kD	  and	  applied	   on	   a	   gel	   filtration	   column	   equilibrated	   with	   bufferA+0.5M	   NaCl.	   Gel	  filtration	   was	   performed	   at	   flow	   rate	   1.5ml/min	   with	   the	   same	   buffer.	   The	  GluDH	   eluted	   at	   peak	   of	   60ml,	   which	   corresponds	   to	   an	   apparent	   MW	   of	  290kDa	   (a	   hexamer).	   	   2ml	   fractions	   were	   collected	   after	   void	   volume	   and	  analysed	  on	  SDS-­‐PAGE.	  The	  progress	  of	  purification	  was	  analyzed	  by	  SDS-­‐PAGE	  (4-­‐12%	  Bis-­‐Tris	  NOVAX	  gel).	  For	   crystallization	   the	  buffer	   in	   the	   sample	  was	  exchanged	  with	   10mM	  Na+	   Phosphate	   pH	   8.0	   using	   a	   VivaSpin	   concentrator	  with	  the	  diafiltration	  cup	  and	  the	  protein	  was	  concentrated	  to	  11	  mg/ml.	  
3.7.2	  Crystallization	  of	  glutamate	  dehydrogenase	  from	  C.	  symbiosum	  Co-­‐crystallization	   of	   GluDH	   protein	   was	   carried	   out	   using	   the	   hanging-­‐drop	  vapour-­‐diffusion	   technique	   (see	   section	   2.3.2	   for	   details).	   In	   this	   experiment	  1µl	   of	   the	   protein	   sample	   (11mg/ml)	  with	   L-­‐glutamate	   (250mM)	  was	  mixed	  with	   an	   equal	   volume	   of	   25%-­‐50%	   ammonium	   sulphate	   in	   100mM	   sodium	  phosphate	  buffer	  pH=7.0,	  and	  then	  equilibrated	  against	  the	  same	  precipitant	  at	  	  
	   97	  




Figure	   3.19.	   SDS-­‐PAGE	   analysis	   and	   chromatogram	   trace	   of	   C.	   symbiosum	   GluDH	  (MW=49.296	   kDa)	   DEAE	   purification.	   The	   SDS	   gel	   shows	   fractions	   from	   the	   DEAE	  purification	  stage	  of	  C.	  symbiosum	  GluDH.	  Lanes	  are	  ordered	  as	  following:	  1=	  marker	  12,	   2=	   cell	   debris,	   3=	   cell	   free	   extract,	   4=	   fraction4,	   5=	   fraction10,	   6=fraction12,	  7=fraction14	  and	  8-­‐15=fractions	  16-­‐24.	  The	  trace	  shows	  loading	  and	  elution	  with	  2	  ml	  fractions	  collected	  starting	  at	  the	  beginning	  of	  the	  gradient	  at	  50	  ml.	  Arrow	  indicates	  peak	  containing	  GluDH	  protein.	  	  	  	  	  	  	  	  	  	  	  
1	  	  	  2	  	  3	  	  	  4	  	  	  	  5	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  7	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  14	  15	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Figure	   3.20.	   SDS-­‐PAGE	   analysis	   and	   chromatogram	   trace	   of	   C.	   symbiosum	   GluDH	  (MW=49.296	  kDa)	  Phe-­‐HP	  purification.	  The	  SDS	  gel	  shows	  fractions	  from	  the	  Phe-­‐HP	  purification	   stage	   of	   C.	   symbiosum	   GDH.	   Lanes	   are	   ordered	   as	   following:	   1=	   sample	  applied	  on	  Phe-­‐HP	  column,	  2-­‐8=fractions	  20-­‐26,	  9=fraction28,	  10=fraction31	  and	  11=	  marker	  12.	  The	  trace	  shows	  loading	  and	  elution	  with	  2	  ml	  fractions	  collected	  starting	  at	   the	   beginning	   of	   the	   gradient	   at	   50	   ml.	   Arrow	   indicates	   peak	   containing	   GDH	  protein.	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Figure	   3.21.	   SDS-­‐PAGE	   analysis	   and	   chromatogram	   trace	   of	   C.	   symbiosum	   GluDH	  (MW=49.296	  kDa)	  gel	  filtration	  purification.	  The	  SDS	  gel	  shows	  fractions	  from	  the	  gel	  filtration	  purification	  stage	  of	  C.	  symbiosum	  GDH.	  Lanes	  are	  ordered	  as	   following:	  1=	  marker	   12,	   2=	   sample	   applied	   on	   gel	   filtration	   column	   and	   3-­‐7	   fractions10-­‐14.	   The	  trace	  showing	  elution	  with	  2	  ml	  fractions	  collected	  throughout.	  Arrow	  indicates	  peak	  containing	  GDH	  protein.	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17C" .The	   best	   crystals	   grew	   in	   45%	   ammonium	   sulphate	   (in	   100mM	   sodium	  phosphate)	   after	   two	   weeks.	   The	   same	   procedure	   was	   used	   to	   grow	   apo	  crystals,	  and	  then	  these	  were	  used	  to	  soak	  NAD+	  	  into	  the	  crystals	  to	  determine	  the	  mode	  of	  binding	  of	  the	  cofactor	  to	  C.	  symbiosum	  GluDH.	  
3.7.3	  Data	  collection	  and	  processing	  for	  crystals	  of	  C.	  symbiosum	  GluDH	  
with	  L-­‐glutamate	  Crystals	  were	   selected	   for	   data	   collection	   according	   to	   their	   size	   and	   overall	  definition.	  Diffraction	  data	  from	  GluDH-­‐glutamate	  binary	  complex	  crystal	  of	  the	  enzyme	  was	  collected	  at	  the	  Diamond	  Light	  Source,	  beamline	  I02.	  1000	  images	  were	  collected	  with	  a	  rotation	  angle	  of	  0.1°	  and	  an	  exposure	  time	  of	  0.1	  sec	  per	  image	  using	  X-­‐rays	  of	  wavelength	  0.97949	  Å.	  Processing	   the	  X-­‐ray	  diffraction	  datasets	  was	  performed	  by	  Xia2	  system	  using	  the	  3da	  mode	  at	  DLS.	  The	  data	  were	   processed	   to	   a	   resolution	   of	   1.24	   Å	   in	   space	   group	   H32,	   with	   unit	   cell	  parameters	   a=b=	   158.7Å,	   c=101.4Å,	   α=β=90°	   and	   γ=120°.	   This	   crystal	   has	   a	  monomer	   in	   the	   asymmetric	   unit	  with	   a	   Vm	   of	   2.5,	   which	   is	   in	   the	   range	   of	  Matthews	   Coefficients	   (Kantardjieff	   &	   Rupp,	   2003).	   Data-­‐collection	   and	  processing	  statistics	  are	  shown	  in	  Table	  3.5.	  
3.7.4	  Molecular	  replacement	  and	  model	  building	  for	  the	  binary	  complex	  
of	  C.	  symbiosum	  GluDH	  with	  glutamate	  The	   structure	   of	   C.	   symbiosum	   GluDH	   with	   L-­‐glutamate	   (accession	   number	  1BGV)	   (Stillman	   et	   al,	   1993)	   was	   used	   as	   a	   search	   model	   for	   the	   molecular	  replacement.	   Diffraction	   data	   (1.24	   Å)	   were	   input,	   and	   Phaser	   (McCoy	   et	   al,	  2007)	   was	   run	   to	   search	   for	   the	   one	   copy	   subunit	   in	   the	   asymmetric	   unit.	  Phaser	   found	  a	   solution	  with	  Z-­‐score	  of	  24.87	  and	  56.23	   for	   the	   rotation	  and	  translation	   respectively,	   and	   Rfactor=0.27	   with	   Rfree=0.25	   following	   rigid	  body	   refinement	   in	   REFMAC5	   (Murshudov	   et	   al,	   2011).	   Multiple	   cycles	   of	  model	   building	   and	   refinement	   were	   carried	   out	   using	   COOT	   (Emsley	   et	   al,	  2010)	  and	  REFMAC5.	  Clear	  density	  was	  present	  in	  the	  active	  site	  that	  could	  be	  attributed	  to	  L-­‐glutamate.	  The	  final	  model	  contains	  524	  water	  molecules	  with	  L-­‐glutamate	  bound	  in	  the	  active	  site	  with	  an	  Rfactor	  and	  the	  Rfree	  of	  0.13	  and	  0.15,	   respectively.	   The	   root	   mean	   square	   deviations	   (r.m.s.d)	   of	   bond	  lengths=0.0068Å	  and	  bond	  angles=1.26°.	  Validation	  of	  the	  final	  structure	  using	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Table	  3.9.	  Shows	  the	  final	  refinement	  parameters	  for	  binary	  complex	  of	  C.	  symbiosum	  GluDH	  with	  L-­‐glutamate.	  	  
	   Overall	   Low	   High	  
High	  resolution	  limit	   1.24	  Å	   5.55	   1.24	  
Low	  resolution	  limit	   31.09	  	  Å	   31.09	   1.27	  
Completeness	   99.9	  %	   99.5	   100.0	  
Multiplicity	   5.3	   5.8	   5.3	  
I/sigma	   10.3	   25.8	   2.5	  
Rmerge	   0.068	   0.046	   0.540	  
Rmeas	  (I)	   0.085	   0.054	   0.677	  
Rmeas	  (I+/-­‐)	   0.084	   0.055	   0.679	  
Rpim	  (I)	   0.036	   0.022	   0.293	  
Rpim(I+/-­‐)	   0.048	   0.031	   0.406	  
dF/F	   0.067	  
dI/s(dI)	   0.789	  
Total	  observations	  
	   728472	   9418	   53544	  
Total	  unique	  
	   137055	   1623	   10109	  
Parameters	   	  
Resolution	  (Å)	   1.24Å	  
Number	  of	  reflections	   130130	  
Protein	   molecule	   per	  
asymmetric	  unit	  	  
1	  
Number	  of	  residues	  	   449	  
Number	  of	  atoms	   3477	  
Number	  of	  water	  molecules	   524	  
Ramachandran	  favoured	  (%)	  	   97.12%	  
Ramachandran	  outliers	  (%)	   0.22%	  
RMS	  bond	  length	  deviation	  (Å)	  	   0.007Å	  
RMS	  bond	  angle	  deviation	  (°)	   1.26°	  
Average	   main	   chain	   B-­‐factors	  
(Å2)	  
	  15Å2	  
Average	  side	  chain	  B-­‐factors	  (Å2)	   	  19Å2	  
Average	  water	  B-­‐factors	  (Å2)	   	  34	  Å2	  
R-­‐factor	  (%)	   0.13	  
Rfree	  (%)	   0.15	  
Molprobity	  score	  	   0.96	  
99th	  per
centile	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Figure	   3.22.	   Ramachandran	   plot	   for	   C.	   symbiosum	   GluDH	   in	   complex	   with	   L-­‐glutamate.	  The	  plot	  shows	  97.12%	  of	  the	  residues	  are	  within	  the	  favoured	  region	  and	  only	  Val204	  is	  Ramachandran	  outlier.	  This	  revised	  Ramachandran	  plot	  was	  generated	  using	  Molprobity	  server	  (Chen	  et	  al,	  2010).	  	  
	  	  
Figure	   3.23.	   The	   electron	   density	   map	   around	   Val204.	   Map	   is	   shown	   at	   2-­‐sigma	  counter	  level.	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the	   Molprobity	   server	   (Chen	   et	   al,	   2010)	   and	   PROCHECK	   (Laskowski	   et	   al,	  1993)	  showed	  that	  this	  model	  is	  of	  a	  good	  quality	  with	  most	  of	  the	  	  amino	  acid	  residues	   lying	  within	   the	  allowed	  regions	  of	   the	  Ramachandran	  plot	  with	   the	  exception	  of	  Val204	  (figure3.22),	  even	  though	  this	  residue	  has	  a	  good	  electron	  density	  (figure3.23).	  	  
3.7.5	  Data	  collection	  and	  processing	  for	  C.	  symbiosum	  GluDH	  soaked	  in	  
NAD+	  	  Data	   collection	   and	   processing	   for	   C.	   symbiosum	   GluDH	   with	   NAD+	   was	  conducted	   using	   the	   same	   method	   as	   above,	   at	   the	   Diamond	   Light	   Source,	  beamline	  IO4-­‐1.	  Data	  from	  this	  crystal	  was	  processed	  to	  a	  resolution	  1.80	  Å	  and	  was	   indexed	  to	  a	  space	  group	  C2	  with	  the	  unit	  cell	  parameters	  a=136.2	  Å,	  b=	  150.2Å,	  c=91.9Å,	  α=	  γ=90°	  and	  β=129.640°.	  The	  crystal	  contains	  a	  trimer	  in	  the	  asymmetric	  unit	  with	  a	  Vm	  of	  2.46.	  Data-­‐collection	  and	  processing	  statistics	  are	  shown	  in	  Table	  (3.6).	  
3.7.6	  Molecular	  replacement	  and	  model	  building	  for	  binary	  complex	  of	  C.	  
symbiosum	  GluDH	  with	  NAD+	  The	   space	   group	   C2	   for	   these	   crystals	   was	   the	   same	   as	   that	   for	   the	   apo	  structure	  of	  C.	  symbiosum	  GluDH	  (1HRD),	  with	  similar	  cell	  dimensions	  and	  thus	  this	   model	   was	   used	   as	   the	   search	   in	   molecular	   replacement	   using	   Phaser	  (McCoy	  et	  al,	  2007)	  in	  CCP4i.	  The	  three	  subunits	  A,	  B	  and	  C	  were	  selected	  for	  an	   automated	   search	   in	   Phaser.	   The	   Rfactor=0.29	   with	   Rfree=0.31	   following	  refinement	  in	  REFMAC5	  (Murshudov	  et	  al,	  2011).	  The	  fit	  of	  the	  primary	  model	  to	  the	  electron	  density	  was	  generally	  good	  for	  subunits	  A	  and	  B,	  but	  domain	  II	  in	   subunit	   C	  was	  not	   in	   the	  density	  map.	  Rebuilding	   this	   structure	  was	  done	  using	  COOT	  (Emsley	  et	  al,	  2010)	  and	  the	  whole	  domain	  II	  of	  chain	  C	  was	  moved	  to	   fit	   the	   electron	   density.	   Several	   cycles	   of	   model	   building	   and	   refinement	  were	   then	   conducted	   using	   COOT	   (Emsley	   et	   al,	   2010)	   and	   REFMAC5	  (Murshudov	   et	   al,	   2011).	   Inspection	  of	   the	   electron	  density	  within	   the	   active	  site	   for	   all	   subunits	   showed	   that	   there	   was	   clear	   positive	   difference	   density	  linked	  with	   the	  nucleotide-­‐binding	   site	   of	   the	  3	   subunits.	  NAD+	  was	  modeled	  into	  this	  electron	  density	  in	  the	  active	  site	  and	  a	  number	  of	  refinement	  cycles	  were	  carried	  out	  using	  REFMAC5	  (Murshudov	  et	  al,	  2011).	  The	  final	  model	  has	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R-­‐factor	  =	  0.17	  with	  Rfree	  =	  0.22	  and	  500	  water	  molecules,	  in	  addition	  to	  NAD+	  bound	   in	   the	   catalytic	   pocket.	   The	   root	   mean	   square	   deviations	   (r.m.s.d)	   of	  bond	   lengths=0.017Å	  and	  bond	  angles=1.8°.	  The	   final	  structure	  was	  validated	  by	   Molprobity	   server	   (Chen	   et	   al,	   2010)	   and	   PROCHECK	   (Laskowski	   et	   al,	  1993)	  which	  display	  the	  quality	  of	  the	  model	  was	  good	  with	  most	  of	  the	  amino	  acid	  residues	  lying	  within	  the	  allowed	  regions	  of	  Ramachandran	  plot,	  with	  the	  exception	  of	  Val204	  in	  A,	  B	  and	  C	  subunits	  and	  Asp165	  in	  B	  and	  C	  subunits.	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Table	   3.10.	   Data-­‐collection	   and	   processing	   statistics	   for	   C.	   symbiosum	  GluDH	   with	  NAD+.	  	  	  


















Table	   3.11.	   Shows	   the	   final	   refinement	   parameters	   for	   binary	   complex	   of	   C.	  
symbiosum	  GluDH	  with	  NAD+.	  	  	  	  	  	  
	   Overall	   Low	   High	  
High	  resolution	  limit	   1.80	  Å	   8.05	   1.80	  
Low	  resolution	  limit	   52.45	  Å	   52.45	   1.85	  
Completeness	   98.4%	   99.4	   98.6	  
Multiplicity	   3.9	   4.1	   3.9	  
I/sigma	   10.3	   39.1	   1.9	  
Rmerge	   0.084	   0.024	   0.594	  
Rmeas	  (I)	   0.115	   0.031	   0.817	  
Rmeas(I+/-­‐)	   0.112	   0.032	   0.796	  
Rpim(I)	   0.058	   0.015	   0.408	  
Rpim(I+/-­‐)	   0.074	   0.021	   0.523	  
Total	  observations	  
	   499004	   6228	   37509	  
Total	  unique	  
	   129036	   1502	   9563	  
Parameters	   	  
Resolution	  (Å)	   1.8Å	  
Number	  of	  reflections	   122544	  
Protein	   molecule	   per	   asymmetric	  
unit	  	  
3	  
Number	  of	  residues	  	   449	  
Number	  of	  atoms	   11004	  
Number	  of	  water	  molecules	   500	  
Ramachandran	  favoured	  (%)	  	   97.32%	  
Ramachandran	  outliers	  (%)	   0.37%	  
RMS	  bond	  length	  deviation	  (Å)	  	   0.017	  Å	  
RMS	  bond	  angle	  deviation	  (°)	   1.8°	  
Average	  main	  chain	  B-­‐factors	  (Å2)	   	  19Å2	  
Average	  side	  chain	  B-­‐factors	  (Å2)	   	  26Å2	  
Average	  water	  B-­‐factors	  (Å2)	   	  22Å2	  
R-­‐factor	  (%)	   0.17	  
Rfree	  (%)	   0.22	  
Molprobity	  score	  	   1.52	  
93rd	  percentile	  




Figure	   3.24.	   Ramachandran	   plot	   for	   binary	   complex	   of	   C.	   symbiosum	   GluDH	   with	  NAD+.	   The	   plot	   shows	   97.32%	   of	   the	   residues	   are	   within	   the	   favoured	   region.	  Ramachandran	   outliers	   are	   Val204	   in	   A,	   B	   and	   C	   subunits	   and	   Asp165	   in	   B	   and	   C	  subunits.	  This	  revised	  plot	  was	  produced	  using	  Molprobity	  server	  (Chen	  et	  al,	  2010).	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Chapter	   four:	   Structural	   analysis	  of	   glutamate	  dehydrogenase	  
from	  M.	  smegmatis	  and	  C.	  symbiosum	  
4.0	  Introduction	  This	  chapter	  describes	  the	  final	  model	  of	  the	  ternary	  complex	  of	  M.	  smegmatis	  GluDH	  with	  NADP+	  and	  2-­‐oxoglutarate	  as	  well	  as	  the	  structure	  of	  M.	  smegmatis	  GluDH	  with	  NADPH.	   Comparison	   of	   the	   conformational	   changes	   between	   the	  two	  structures	  is	  discussed,	  together	  with	  a	  comparison	  to	  C.	  symbiosum	  GluDH	  and	  other	  GluDHs.	  The	  structural	  basis	  for	  cofactor	  specificity	  in	  the	  glutamate	  dehydrogenases	  is	  also	  discussed.	  	  
4.1	  Subunit	  structure	  of	  M.	  smegmatis	  GluDH	  The	  molecular	  structure	  of	  GluDH	  from	  M.	  smegmatis	  is	  analogous	  to	  that	  seen	  in	   other	   bacterial	   GluDHs	   such	   as	   C.	   symbiosum	   (Baker	   et	   al,	   1992a).	   The	  enzyme	  consists	   of	   six	   identical	   subunits,	   each	   one	   folded	   into	   two	   domains	  separated	   by	   a	   deep	   groove,	  which	   comprises	   the	   catalytic	   pocket.	   Domain	   I	  contains	  the	  N-­‐terminal	  segment	  of	  the	  polypeptide	  chain	  and	  involves	  amino	  acid	  residues	  1-­‐207	  and	  377-­‐449.	  In	  domain	  I,	  the	  first	  amino	  acid	  residues	  1-­‐56	  are	  organized	  into	  a	  cluster	  of	  four	  α-­‐helices	  followed	  directly	  by	  folding	  the	  residues	   59-­‐99	   into	   three	   antiparallel	   strands.	   The	   remaining	   residues	   of	  domain	   I	   then	   fold	   into	   a	   string	   of	   successive	   α/β	   secondary	   structure	  segments.	  In	  this	  domain,	  the	  mixed	  β-­‐sheet	  (four	  parallel/antiparallel	  strands)	  is	  located	  in	  the	  domain	  core	  and	  flanked	  by	  α-­‐helices	  on	  each	  side.	  	  	  	  Domain	  II	  (C-­‐terminal	  domain)	  is	  smaller	  than	  domain	  I	  and	  it	  is	  built	  from	  the	  adjacent	  stretch	  of	  residues	  208-­‐376.	  This	  domain	  comprises	  a	  seven	  stranded	  
β	  sheet	  in	  the	  domain	  centre,	  which	  is	  again	  surrounded	  by	  α-­‐helices	  on	  both	  sides.	   The	   folding	   pattern	   of	   the	   C-­‐terminal	   domain	   is	   similar	   to	   a	   classical	  dinucleotide-­‐binding	   fold,	   but	   one	   of	   the	   β	   strands	   (βg)	   lies	   in	   the	   reverse	  direction.	  The	  whole	  subunit	  is	  built	  from	  13	  α-­‐helices	  with	  241	  residues	  and	  11	  β	  strands	  with	  65	  residues,	  which	  represents	  68	  %	  of	  the	  polypeptide	  chain.	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4.2	  Subunit	  assembly	  The	  subunits	  of	  GluDH	  assemble	  into	  a	  hexamer	  with	  D3-­‐symmetry	  with	  three	  2-­‐	   fold	  axis	  perpendicular	   to	   the	   three-­‐fold	  axis.	  This	  hexamer	   is	   like	  a	   squat	  cylinder	  with	  the	  dimensions	  108	  Å	  in	  the	  direction	  of	  the	  molecular	  3-­‐fold	  axis	  of	  symmetry	  and	  with	  a	  radius	  of	  49	  Å	  through	  the	  largest	  part	  of	  the	  molecule.	  Domain	   I	   and	   domain	   II	   meet	   in	   the	   upper	   part	   around	   the	   three-­‐fold	   axis,	  where	   the	   N-­‐terminal	   domain	   is	   close	   to	   the	   32	   symmetry	   point	   and	   is	  responsible	  for	  all	  intersubuint	  interactions.	  The	  dimer	  interface	  is	  centred	  on	  the	   binding	   between	   the	   extended	   antiparallel	   βa	   in	   domain	   I	   and	   its	   2-­‐fold	  symmetry	  related	  strand	  βa	  (figure	  5.1a),	  from	  the	  adjacent	  subunit.	  	  	  	  There	   are	   three	   separate	   interfaces	   that	   should	   be	   considered	   when	   the	  hexamer	   is	   formed.	  Dimer	   interfaces,	   trimer	   interfaces	  and	  other	   interactions	  that	  are	   formed	  through	   the	  assembly	  of	   the	  hexamer.	  The	  accessible	  surface	  areas	   for	   monomer,	   dimer,	   trimer	   and	   hexamer	   were	   calculated	   using	   the	  Areaimol	   program	   in	   the	   CCP4	   suite.	  Within	   the	   asymmetric	   unit,	   the	   buried	  surface	  area	  for	  the	  dimer	  interface	  between	  the	  two	  subunits	  is	  1400Å2,	  which	  amounts	   to	  7.8%	  of	   the	  total	  solvent	  accessible	  surface	  area	  of	   the	  monomer,	  and	   involves	   40	   residues.	   The	   subunits	   around	   the	   3-­‐fold	   axis	   are	   contacted	  over	  the	  area	  of	  1900Å2	  (10.5%)	  and	  the	  additional	  contacts	  on	  assembly	  of	  the	  hexamer	  include	  buried	  surface	  area	  of	  370	  Å2,	  which	  amounts	  to	  2.0%	  of	  the	  total	   accessible	   surface	   area	   of	   the	   monomer.	   As	   these	   buried	   surface	   areas	  show	  that	  the	  maximum	  contact	  is	  linked	  with	  the	  trimers,	  the	  GluDH	  molecule	  might	   be	   described	   as	   a	   dimer	   of	   trimmers,	   rather	   than	   a	   trimer	   of	   dimers.	  These	   results	   are	   in	   agreement	  with	   the	   findings	   observed	   in	   GluDH	   from	   C.	  
symbiosum	  (Baker	  et	  al,	  1992a).	  	  	  
4.3	   Alternative	   conformations	   of	   Serine	   residues	   in	   a	   ternary	  
complex	  model	  of	  M.	  smegmatis	  GluDH	  Within	   the	   electron	   density	   for	   the	   GluDH/NADP+/2oxo-­‐glutarate	   complex	  there	   were	   clear	   incidences	   of	   alternative	   conformations	   for	   some	   residues.	  These	  included	  Ser16	  and	  Ser339	  in	  both	  subunits.	  Inspection	  of	  the	  difference	  density	  map	  showed	  clear	  positive	  density	  features,	  and	  thus	  the	  side	  chains	  of	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Figure	  4.3.	  Schematic	  diagram	  illustrates	  the	  overall	  organization	  of	  a	  single	  subunit	  of	  M.	  smegmatis	  GluDH	  in	  complex	  with	  NADP+	  and	  2-­‐oxoglutarate	  viewed	  in	  the	  two-­‐fold	   axis;	   α-­‐helices	   appear	   as	   cylinders	   (numbered	   from	   1-­‐18)	   and	   β-­‐strands	   as	  arrows	  (labeled	  from	  a-­‐k).	  	  	  
	  
Figure	   4.4.	  A	  schematic	  diagram	  showing	  the	  connection	  of	   the	  secondary	  structure	  elements.	  α-­‐helices	  appear	  as	  blue	  cylinders	  and	  β-­‐strands	  as	  pink	  arrows.	  	  	  	  	  
Twofold	  axis	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  (a)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (b)	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (c)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (d)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  4.5	  The	  two	  conformations	  of	  the	  side	  chain	  of	  Ser16	  on	  the	  left	  and	  Ser339	  on	  the	  right	  figure	  in	  the	  ternary	  complex	  of	  M.	  smegmatis	  GluDH.	  The	  electron	  density	  map	  is	  contoured	  to	  1.0	  sigma.	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these	   residues	   were	   modelled	   in	   two	   conformations,	   each	   one	   with	   0.5	  occupancies.	  Figure	  5.4	  shows	  both	  residues	  fitting	  in	  the	  electron	  density.	  
4.4	  Binding	  of	  the	  dinucleotide	  with	  the	  enzyme	  
4.4.1	  Comparisons	  between	  dinucleotide	  binding	  dehydrogenases	  Structural	   comparisons	   among	   the	   dehydrogenase	   enzymes	   investigating	   the	  nature	   of	   the	   dinucleotide-­‐binding	   site	   have	   revealed	   that	   the	   secondary	  structure	   features	   of	   the	   cofactor-­‐binding	   domain	   are	   similar	   between	   these	  enzymes.	   The	   dinucleotide	   binding	   domain	   (domain	   II)	   has	   a	   Rossmann	   fold	  and	  it	  is	  composed	  from	  six	  (or	  seven	  in	  GluDHs)	  stranded-­‐parallel	  (one	  strand	  is	   in	   reverse	   direction	   in	   GluDHs)	   β-­‐sheet	   surrounded	   by	   α-­‐helices	   on	   both	  sides	   (Birktoft	  &	  Banaszak,	   1984;	  Hol	   et	   al,	   1978).	   This	   domain	   contains	   the	  conserved	  secondary	  structure	  unit	  (βαβ),	  which	  is	  responsible	  for	  the	  binding	  of	  the	  dinucleotide.	  In	  this	  conserved	  unit,	  the	  α-­‐helix	  which	  connects	  the	  two	  β	  strands	  (βa	  to	  βb)	  is	  named	  the	  dinucleotide	  binding	  helix	  (Birktoft	  &	  Banaszak,	  1984;	   Hol	   et	   al,	   1978).	   	   The	   βαβ	   motif	   (also	   called	   the	   fingerprint	   region)	  possesses	  conserved	  residues	  containing	  a	  glycine	  rich	  loop	  with	  the	  sequence	  GXGXXG	   or	   GXGXXA	   (where	   X	   is	   any	   amino	   acid),	   which	   forms	   a	   linkage	  between	  the	  end	  of	  the	  βa	  and	  the	  start	  of	  the	  dinucleotide	  binding	  helix.	  The	  two	   β-­‐strands	   of	   the	   βαβ	   unit	   are	   formed	   from	   hydrophobic	   amino	   acid	  residues	  and	  are	  protected	  against	  the	  solvent	  on	  one	  side	  by	  the	  hydrophobic	  face	   of	   the	   dinucleotide	   binding	   helix.	   	   The	   other	   significant	   feature	   of	   this	  fingerprint	  region	  is	  that	  an	  acidic	  residue	  frequently	  occurs	  at	  the	  C-­‐terminal	  end	  of	  β-­‐strand	  (βb)	  which	  makes	  hydrogen	  bonds	  with	  the	  2’	  and	  3’	  hydroxyl	  groups	  of	  the	  adenine	  ribose,	  in	  those	  enzymes	  that	  bind	  NAD+	  or	  FAD+	  (Baker	  et	  al,	  1992c).	  
4.4.2	  Recognition	  of	  the	  adenine	  ribose	  3’OH	  	  Analysis	   of	   the	   three-­‐dimensional	   structure	   and	   primary	   sequence	   of	   the	  fingerprint	  region	  in	  a	  number	  of	  dehydrogenase	  enzymes	  has	  shown	  that	  two	  different	  hydrogen-­‐bonding	  patterns	  (type	  I	  and	  type	  II)	  can	  be	  made	  between	  the	   glycine-­‐rich	   turn	   and	   the	   dinucleotide	   (Baker	   et	   al,	   1992c).	   This	   pattern	  appears	  to	  rely	  on	  the	  nature	  of	  the	  last	  amino	  acid	  in	  the	  fingerprint	  sequence	  
	   114	  
(GXGXXG/A).	  These	  six	  residues	  are	  termed	  P1	  to	  P6,	  and	  an	  acidic	  residue	  on	  the	  second	  β	  strand	  (βb)	  is	  termed	  P7.	  In	  the	  same	  study,	  Baker	  and	  co-­‐workers	  showed	   that,	   if	   the	   residue	   at	   P6	   is	   glycine,	   a	   type	   I	   hydrogen	   bonding	  configuration	  can	  be	  formed.	  In	  this	  case,	  the	  oxygen	  atom	  of	  the	  P1	  carbonyl	  group	   interacts	  with	   the	  α-­‐carbon	  of	  P6	  by	  van	  der	  Waals’	   forces,	  permitting	  the	  main	  chain	  N-­‐H	  of	  P2	  to	  direct	   to	   the	  side	  chain	  of	   the	  residue	  at	  P7.	  The	  arrangement	  of	  this	  system	  allows	  the	  formation	  of	  hydrogen	  bonding	  between	  the	   N-­‐H	   of	   P2	   and	   the	   side	   chain	   of	   the	   residue	   at	   P7,	   which	   makes	   two	  hydrogen	  bonds	  with	  2’	  and	  3’	  ribose	  hydroxyls.	  However,	  if	  the	  residue	  at	  a	  P6	  is	   alanine,	   a	   type	   II	   hydrogen	   bonding	   pattern	   can	   be	   seen.	   In	   this	  configuration,	   the	   peptide	   between	   P1	   and	   P2	   is	   forced	   into	   another	  arrangement	  due	   to	  existence	  of	   the	  β	   carbon	  at	  P6,	  which	  permits	   the	  P2	   to	  form	  hydrogen	  bonds	  with	   the	  adenine	   ribose	   (Baker	   et	   al,	   1992c).	   In	   the	  M.	  
smegmatis	  GluDH	  structure	  residue	  P6	  is	  an	  alanine	  (Ala246),	  as	  is	  found	  in	  C.	  
symbiosum	   GluDH	   (Ala241),	   despite	   the	   fact	   that	  M.	   smegmatis	   GluDH	   binds	  NADP+	  preferentially	  (Sarada	  et	  al,	  1980),	  compared	  to	  the	  NAD+	  binding	  of	  C.	  
symbiosum	  GluDH.	  In	  both	  these	  enzymes	  a	  direct	  H-­‐bond	  is	  made	  between	  the	  backbone	  NH	  of	  P2,	  and	  the	  3’OH	  of	  the	  adenine	  ribose	  (figure4.6	  a	  and	  b).	  In	  the	  M.	  smegmatis	  GluDH	  structure	  a	  second	  hydrogen	  bond	   is	   found	  between	  the	   side	   chain	   hydroxyl	   of	   Ser242	   (P2	   and	   the	   3’OH	   of	   the	   ribose	   in	   the	  M.	  
smegmatis	  GluDH.	  In	  the	  C.	  symbiosum	  GluDH	  the	  P2	  residue	  is	  a	  phenylalanine,	  so	  no	  hydrogen	  bond	  can	  be	  made	  between	  the	  side	  chain	  of	  phenylalanine	  and	  the	  3’OH	  of	  adenine	  ribose.	  Figure	  4.6	  shows	  the	  interactions	  between	  the	  3’OH	  adenine	   ribose	   and	   the	   glycine-­‐rich	   turn	   in	   the	  M.	   smegmatis	   GluDH	   ternary	  complex	  and	  the	  C.	  symbiosum	  GluDH	  binary	  complex.	  	  	  
4.4.3	   Binding	   the	   nicotinamide	   ring	   and	   associated	   ribose	   moiety	   and	  
pyrophosphate	  	  The	   conformation	   that	   nicotinamide	   nucleotides	   adopt	   is	   similar	   among	   the	  family	  of	  dehydrogenase	  enzymes,	  with	  the	  exception	  of	  the	  glycosidic	  bond	  of	  the	  nicotinamide	  ribose.	  Based	  on	  the	  configuration	  of	  the	  nicotinamide	  moiety	  around	  the	  glycosidic	  bond,	  these	  enzymes	  can	  be	  classified	  into	  two	  types:	  A	  type	  dehydrogenases,	  which	  eliminate	  the	  hydrogen	  from	  the	  A	  side	  (re-­‐face)	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Figure	   4.6.	   A	   schematic	   diagram	   illustrating	   the	   interaction	   of	   the	   β∝β	   unit	   with	   the	  
cofactor	   for	   a)	   Ternary	   complex	   of	   the	   M.	   smegmatis	   GluDH	   with	   2oxo-­‐glutarate	   and	  
NADP+.	   In	   this	   complex	   the	  β∝β	   motif	   is	   shown	   as	  βe	   α10	  βf	   and	   the	   hydrogen	   bonds	  
between	  3’OH	  adenine-­‐ribose	  and	  Ser242	   (P2)	  can	  be	  seen.	  P1-­‐P6	  residues	   that	  connect	  
the	   βe	   and	   the	   α10	   are	   shown	   in	   yellow	   colour;	   G241-­‐S242-­‐G243-­‐N244-­‐V245-­‐A246	  
(GXGXXA).	  b)	  binary	  complex	  of	  C.	  symbiosum	  GluDH	  with	  NAD+.	  Only	  one	  hydrogen	  bond	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of	   the	  nicotinamide	  where	   the	  NAD(P+)	   adopts	   the	  anti	   form,	   for	   example;	   s-­‐MDH,	   LDH	   and	   ADH,	   and	   the	   B	   type	   dehydrogenases,	   that	   transfer	   the	  hydrogen	  from	  the	  B	  side	  (si-­‐face)	  where	  the	  nicotinamide	  nucleotides	  take	  the	  	  
syn	  conformation,	  such	  as	  GluDHs.	  Examination	  of	  the	  electron	  density	  map	  for	  the	   cofactor	   in	   both	   subunits	   of	   the	   M.	   smegmatis	   GluDH	   ternary	   complex,	  shows	   that	   this	   enzyme	   follows	   the	   pattern,	   with	   the	   conformation	   of	   the	  nicotinamide	  moiety	   and	   its	   linked	   ribose	   ring	  analogous	   to	   that	  observed	   in	  the	  GluDH	  from	  C.	  symbiosum,	  adopting	  the	  syn	  conformation	  (figure4.7a).	  	  As	  a	  result	  of	   this	  conformation,	   the	  carboxyamide	  of	  the	  nicotinamide	  ring	  makes	  four	  hydrogen	  bonds	  with	  adjacent	  groups.	  The	  oxygen	  atom	  of	  the	  CO	  group	  acts	  as	  a	  hydrogen	  bond	  acceptor,	  and	  forms	  two	  bonds	  with	  the	  side	  chains	  γ-­‐OH	   of	   Thr213	   and	   H-­‐N	   of	   Arg209	   residues.	   Furthermore,	   the	   carboxyamide	  NH2	  makes	  two	  hydrogen	  bonds,	  one	  with	  the	  side	  chain	  CO	  of	  Asn244,	  and	  one	  with	   O2PN	   of	   the	   NADP+	   pyrophosphate	   moiety.	   The	   γ-­‐methyl	   group	   of	   the	  Thr213	  side	  chain	  is	  packed	  against	  the	  A	  face	  of	  the	  nicotinamide,	  and	  acts	  to	  protect	   it	   from	  the	  solvent,	  whereas	  the	  B	  face	  points	  towards	  the	  active	  site.	  The	  nicotinamide	  ribose	  lies	  against	  the	  residues	  Ala348	  and	  Asn349	  allowing	  the	  3’	  OH	  and	  2’OH	  to	  make	  hydrogen	  bonds	  with	  N-­‐H	  backbone	  and	  NH	  side	  chain	  of	  Asn349	  respectively.	  Additionally,	  hydrogen	  bonds	  are	  made	  between	  the	   2’OH	   and	   the	   side	   chains	   of	   Arg97	   and	   Asp169	   (figure5.3).	   The	   residues	  Ala323	  and	  Thr324	  are	  stacked	  against	  one	  face	  of	  the	  ribose	  ring,	  close	  to	  the	  C3	  and	  C4	  carbon	  atoms	  of	  the	  ribose.	  	  The	  pyrophosphate	  moiety	  of	  NADP+	  of	  M.	  smegmatis	  GluDH	  ternary	  complex	  is	  accommodated	  at	  the	  N-­‐terminal	  end	  of	  the	  dinucleotide	  binding	  helix	  (∝10),	  with	  the	  helix	  dipole	  stabilizing	  the	  pyrophosphate.	  The	  four	  oxygen	  atoms	  of	  the	   pyrophosphate	   interact	  with	   neighboring	   groups.	   An	   oxygen	   atom	   of	   the	  phosphate	   group	   (O1N)	   binds	   to	   the	  main	   chain	  N-­‐H	   of	   Val245	   by	   hydrogen	  bonding,	  whereas	  the	  O2N	  hydrogen	  bonds	  to	  H-­‐N	  of	  the	  nicotinamide	  moiety.	  Two	   hydrogen	   bonds	   are	   made	   between	   oxygens	   O1A	   and	   O2Ato	   the	   N-­‐H	  backbone	  of	  Gly171	  and	  Gly244,	  respectively.	  	  The	  binding	  of	  the	  NAD+	  dinucleotide	  to	  the	  C.	  symbiosum	  GluDH	  is	  in	  general	  very	  similar	  to	  that	  seen	  for	  NADP+	  in	  M.	  smegmatis	  GluDH.	  The	  residues	  that	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make	   interactions	   with	   the	   dinucleotide	   are	   conserved	   between	   these	   two	  enzymes.	   However	   some	   differences	   in	   the	   interactions	   are	   seen	   in	   the	  nicotinamide	  moiety	  due	  to	  the	  difference	  in	  the	  domain	  closure	  between	  the	  two	  structures.	  For	  instance,	  in	  the	  binary	  complex	  of	  C.	  symbiosum	  GluDH	  with	  NAD+	  that	  is	  in	  the	  open	  form,	  no	  hydrogen	  bond	  can	  be	  seen	  between	  Arg205	  and	  the	  CO	  of	  carboxyamide.	  In	  addition	  the	  interactions	  between	  the	  2’OH	  of	  nicotinamide	   ribose	   with	   Asp165	   and	   Arg93	   are	   not	   made	   and	   O2A	   of	   the	  pyrophosphate	  does	  not	  form	  a	  hydrogen	  bond	  to	  the	  main	  chain	  of	  Gly167.	  All	  of	   these	   residues	   are	   conserved	   in	   M.	   smegmatis	   GluDH	   (Arg209,	   Asp169,	  Arg97	  and	  Gly171,	  respectively),	  but	  do	  interact	  with	  the	  coenzyme	  due	  to	  the	  more	  closed	  nature	  of	  the	  enzyme.	  Table	  4.1	  shows	  the	  hydrogen	  bonds	  made	  between	   the	   cofactor	   and	   GluDH	   in	   both	   these	   complex	   structures;	   ternary	  complex	  M.	  smegmatis	  GluDH	  and	  C.	  symbiosum	  GluDH	  bound	  to	  NAD+.	  	  
4.4.4	   Comparison	   between	   the	   binding	   of	   dinucleotide	   in	   the	   NADPH	  
binary	   complex	   and	   NADP+	   and	   2-­‐oxoglutarate	   ternary	   complex	   of	   M.	  
smegmatis	  GluDH	  The	  cofactor	  is	  bound	  in	  the	  two	  structures	  (GluDH-­‐NADPH	  and	  GluDH-­‐NADP-­‐2xoglutarate)	   in	   a	   very	   similar	  way,	  with	   the	   exception	   of	   the	   binding	   of	   the	  nicotinamide	  moiety.	   In	   the	   ternary	   complex	  model,	   the	   carboxyamide	  of	   the	  nicotinamide	   ring	   forms	   four	  hydrogen	  bonds	  with	   the	  adjacent	  groups;	  O2N	  and	   the	   side	   chains	   of	   Thr213,	   Arg209	   and	   Asn244.	   In	   the	   binary	   complex	  structure,	   however,	   Arg209	   and	   Asn244	   residues	   adopt	   different	  conformations	   compared	  with	   the	   ternary	   complex,	   and	   thus	   do	   not	   interact	  with	   the	   carboxyamide	  moiety.	   	  Moreover,	   superimposing	   the	   two	   structures	  shows	   that	   the	   orientation	   of	   R209	   is	   different	   because	   the	   loop	   that	   this	  residue	   fall	   on,	   is	   also	   in	   a	   different	   conformation,	   which	   is	   related	   to	   the	  missing	   residues	   in	   this	   loop	   in	   the	   electron	   density	   map	   (193-­‐204)	   (figure	  4.11).	  	  
4.4.5	  Coenzyme	  specificity	  	  As	   structures	   of	   both	   the	  NADP+	   complex	   GluDH	   from	  M.	   smegmatis	  and	   the	  NAD+	  complex	  of	  GluDH	  from	  C.	  symbiosum	  have	  been	  determined,	  the	  nature	  of	  coenzyme	  specificity	  in	  GluDHs	  can	  be	  addressed.	  NADP+	  binding	  to	  E.	  coli	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Figure	   4.7.	   A	   schematic	   of	   the	   interaction	   of	   the	   nicotinamide	   ring	   in	   the	   binary	  complex	  structure	  (GluDH-­‐NADPH)	  (blue	  colour)	  and	  ternary	  complex	  model	  (GluDH-­‐NADP+-­‐2oxo-­‐glutarate)	  (yellow	  color)	  for	  M.	  smegmatis	  GluDH.	  In	  the	  binary	  complex	  Arg209	  and	  Asn244	  are	  directed	  away	  from	  the	  carboxyamide	  and	  are	  not	  involved	  in	  nicotinamide	  binding.	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Figure	   4.8.	   Schematic	  diagram	  of	   the	   interactions	  made	  by	   the	  carboxyamide	  of	   the	  nicotinamide	   ring	   with	   neighbouring	   groups	   in	   a)	   M.	   smegmatis	   GluDH	   and	   b)	   C.	  
symbiosum	  GluDH.	  	  	  	   	  	  	  
	  	   	  	  
Figure	  4.9.	  Schematic	  diagram	  of	  the	  2’	  and	  3’OH	  of	  the	  nicotinamide	  ribose	  forming	  hydrogen	  bonding	  interactions	  with	  adjacent	  residues	  (shown	  in	  yellow	  colour),	  for	  a)	  




	  	  	  	  	  	  	  	  
a)	   b)	  
(a)	   (b)	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Figure	   4.10.	   Schematic	   diagram	   illustrating	   the	   pyrophosphate	   binding,	  which	   lies	   at	   the	  end	  of	  α10	  and	  forms	  hydrogen	  bonds	  with	  the	  main	  chains	  of	  Asn244,	  Val245	  (P4	  and	  P5)	  and	  Gly171.	  In	  addition,	  a	  hydrogen	  bond	  between	  the	  H-­‐N	  of	  the	  nicotinamide	  carboxylate	  and	  O2PN	  of	  the	  pyrophosphate	  is	  shown.	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   NAD+/P+	   Hydrogen	  bonds	  of	  NADP+	  in	  M.	  







	  	  i-­‐Side-­‐chain	  of	  Thr213	  	  	  	  	  	  	  	  	  	  	  2.9	  Å	  ii-­‐	  side-­‐chain	  Arg209	  	  	  	  	  	  	  	  	  	  	  	  	  2.86	  Å	  	  i-­‐	  O2PN	  of	  pyrophosphate	  	  	  2.78	  Å	  ii-­‐	  CO	  of	  side-­‐chain	  of	  Asn244	  	  3.33	  Å	  	  	  




2’OH	  	  	  	  
	  
3’OH	  
	  	  	  i-­‐	  NH2	  side-­‐chain	  of	  Asn349	  	  2.85	  Å	  ii-­‐	  side-­‐chain	  of	  Asp169	  	  	  	  	  	  	  	  	  	  2.66	  Å	  iii-­‐	  side-­‐chain	  of	  Arg97	  	  	  	  	  	  	  	  	  	  	  	  2.93	  Å	  	  i-­‐	  main	  chain	  NH2	  of	  Asn349	  	  3.12Å	  
















	  	  i-­‐main	  chain	  NH2	  of	  Val245	  	  2.93	  Å	  ii-­‐	  main	  chain	  NH2	  of	  Asn244	  	  	  	  3.13	  Å	  	  i-­‐	  NH2	  of	  carboxyamide	  	  	  	  2.78	  Å	  	  	  i-­‐	  main	  chain	  NH2	  of	  Gly171	  	  	  2.97	  Å	  	  	  	  i-­‐	  main	  chain	  NH2	  of	  Asn244	  	  2.92	  Å	  	  
	  	  i-­‐	  main	  chain	  NH2	  of	  Val241	  	  2.97	  ii-­‐	  main	  chain	  NH2	  of	  Asn244	  	  	  	  3.27	  Å	  	  i-­‐	  NH2	  of	  carboxyamide	  	  	  	  2.94	  Å	  	  	  i-­‐no	  hydrogen	  bond	  (Gly167)	  ii-­‐side-­‐chain	  of	  Arg285	  3.32	  Å	  	  	  	  	  i-­‐	  main	  chain	  NH2	  of	  Asn244	  	  3.07Å	  	  	  
3’OH	  adenine	  
ribose	  	  
i-­‐NH2	  of	  main	  chain	  of	  Ser242	  	  3.02	  Å	  	  ii-­‐	  side	  chain	  of	  Ser242	  	  	  	  3.12	  Å	  	  	  
i-­‐	  NH2	  of	  main	  chain	  of	  Phe238	  	  	  	  2.94	  Å	  	  
	  Table	  4.1.	  Hydrogen	  bonds	  between	  NAD(P)+	  and	  GluDH	  enzymes.	  	  	  	  
	  	  




msgdh  1  MSELHPKLQAVFEEVSHRNGGEKEFHQAVFEVLQSLGPVVEKHPEYADNAIIRRLCEPERQIIFRVPWVD   70 
csgdh  1  ---MSKYVDRVIAEVEKKYADEPEFVQTVEEVLSSLGPVVDAHPEYEEVALLERMVIPERVIEFRVPWED   67  
 
              hhhhhhhhhhhhhh    hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh    eeeeeeeeee     
  
msgdh  71  DTGHVQINRGFRVEFNSALGPYKGGLRFHPSVYLGIVKFLGFEQIFKNALTGLPIGGGKGGSDFDPKGRS  140  
csgdh  68  DNGKVHVNTGYRVQFNGAIGPYKGGLRFAPSVNLSIMKFLGFEQAFKDSLTTLPMGGAKGGSDFDPNGKS  137 
  
               eeeeeeeeeee          eee     hhhhhhhhhhhhhhhhh        eeeee  hhh      
 
msgdh  141 DAEIMRFCQSFMTELYRHIGEYTDVPAGDIGVGTREIGYLFGQYKRITNRYESGVLTGKGLTWGGSRVRT  210  
csgdh  138 DREVMRFCQAFMTELYRHIGPDIDVPAGDLGVGAREIGYMYGQYRKIVGGFYNGVLTGKARSFGGSLVRP  207 
 
           hhhhhhhhhhhhhhhhhh     eee       hhhhhhhhhhhhhhh     eeee   hhh           
                                         1 2 3 4 5 6                                                   7 
msgdh  211 EATGYGTVFFVDEILQSRGQSFDGKRVVVSGSGNVAIYAIEKVHALGGIVVACSDSGGYVVDEKGIDLDL  280 
csgdh  208 EATGYGSVYYVEAVMKHENDTLVGKTVALAGFGNVAWGAAKKLAELGAKAVTLSGPDGYIYDPEGITTEE  277  
 
            hhhhhhhhhhhhhhhh        eeeee   hhhhhhhhhhhh    eeeeee   eee      hhh    
 
msgdh  281 LKEVKEVQR----ARIDAYAEARGGATQFVSGGSVWNVACDIALPCATQNEVSGDDARALIESGCRIVAE  346  
csgdh  278 KINYMLEMRASGRNKVQDYADKF--GVQFFPGEKPWGQKVDIIMPCATQNDVDLEQAKKIVANNVKYYIE  345 
  
           hhhhhhhh      hhhhhhhh     eee    ee     eeee        hhhhhhhhh   eeeee    
   
msgdh  347 GANMPCTPEAVKLFDQA-GVTFAPGKAVNAGGVATSALEMQQNASRDSWTFDDTEGRLAGIMRRIHDRCL  415  
csgdh  346 VANMPTTNEALRFLMQQPNMVVAPSKAVNAGGVLVSGFEMSQNSERLSWTAEEVDSKLHQVMTDIHDGSA  415  
 
                  hhhhhhhhh    eee hhhh  hhhhhhhhhh          hhhhhhhhhhhhhhhhhhhh    
    
msgdh   416  TTADEYDQPGNYVAGANIAGFTQVADAMLALGLI-  449  
csgdh   416  AAAERYGLGYNLVAGANIVGFQKIADAMMAQGIAW  450  
 
             hhhhhh     hhhhhhhhhhhhhhhhhhh       
 
Figure	   4.11.	   	   Sequence	  alignment	  of	  M.	  smegmatis	  GluDH	  and	   C.	  symbiosum	  GluDH.	  Conserved	  and	  equivalent	  residues	  that	  share	  in	  cofactor	  binding	  are	  highlighted	  in	  yellow	  colour	  and	  those	  involved	  in	  substrate	  binding	  are	  highlighted	  in	  purple.	  The	  glycine	  rich	  turn	  is	  numbered	  from	  1-­‐6	   (P1-­‐P6),	   number	   7	   indicates	   the	   P7	   residue.	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GluDH	  has	  been	  modelled	  recently	  by	  Sharkey	  and	  co-­‐workers	  (Sharkey	  et	  al,	  2013)	  and	  the	  residues	  that	  lies	  at	  P7	  and	  P8	  (at	  the	  C-­‐terminal	  end	  of	  the	   β	   strand	   following	   the	   GXGXXG/A	  motif	   in	   the	   Rossmann	   fold)	   have	  been	   suggested	   as	   the	   determinant	   of	   NADP+/NAD+	   specificity.	   The	   2’	  phosphate	   of	   NADP+	   in	   the	   M.	   smegmatis	   GluDH/NADP+/2oxoglutarate	  complex	  makes	  interactions	  with	  the	  side	  chains	  of	  R291	  and	  K285	  (R292	  and	  K286	  in	  E.	  coli	  GluDH)	  as	  had	  been	  predicted	  by	  Sharkey	  et	  al	  (Sharkey	  
et	   al,	   2013).	   The	   role	   of	   the	   residue	   at	   P7	   has	   remained	   unclear.	   It	   had	  previously	   been	   suggested	   that	   if	   an	   acidic	   residue	   was	   present	   at	   this	  position,	   the	   enzyme	   would	   select	   for	   NAD+,	   as	   the	   carboxylate	   could	  interact	  with	  both	  the	  2’	  and	  3’	  hydroxyls	  of	  the	  adenine	  ribose,	  as	  seen	  in,	  for	   example,	   lactate	   dehydrogenase	   (Adams	   et	   al,	   1973).	   However,	   the	  NAD+-­‐dependent	  C.	  symbiosum	  GluDH	  has	  a	  glycine	  at	  P7,	  and	  the	  NADP+-­‐dependent	   E.	   coli	   and	   M.	   smegmatis	   GluDHs	   have	   an	   aspartate	   at	   this	  position.	   Various	   theories	   for	   altered	   pKs	   of	   this	   residue,	   and	  whether	   it	  makes	  water	  mediated	  hydrogen	  bonds	  have	  been	  put	  forward	  (Baker	  et	  al,	  1992c;	   Dawson),	   but,	   in	   the	  NADP+	   complex	   of	  M.	   smegmatis	  GluDH,	   this	  residue	  points	  away	  from	  the	  adenine	  ribose,	  towards	  the	  N-­‐terminal	  helix	  α12	  of	  the	  α11-­‐loop-­‐	  α12	  motif,	  and	  could	  be	  involved	  in	  the	  stabilization	  of	  the	   helix	   dipole	   of	   this	   helix.	   This	   orientation	   allows	   the	   P7	   residue	   to	  hydrogen	  bond	  to	  the	  NH	  backbone	  of	  Ile292.	  This	  is	  in	  agreement	  with	  the	  position	   of	   the	   equivalent	   residue	   (Val293)	   in	   the	   E.	   coli	   apo	   structure	  (Sharkey	  et	  al,	  2013).	  The	  2’	  phosphate	  also	  makes	  a	  hydrogen	  bond	  to	  the	  side	   chain	   of	   Ser266	   (position	   P8),	  which	   again	   is	   in	   agreement	  with	   the	  model	  proposed	  by	  Sharkey	  et	  al	  for	  E.	  coli	  GluDH	  (Ser264	  is	  the	  equivalent	  residue).	   However,	   the	   structure	   of	   the	   M.	   smegmatis	  GluDH/NADP+/2oxoglutarate	   ternary	   complex,	   which	   is	   in	   a	   very	   closed	  conformation	   (see	   section	   4.5.3),	   reveals	   that	   an	   additional	   interaction	   is	  formed	  between	  the	  2’	  phosphate	  and	  the	  amine	  moiety	  of	  the	  side	  chain	  of	  the	  Lys137,	  which	   lies	   in	  domain	   I.	   This	   interaction	   can	  only	  occur	  when	  the	   cleft	   is	   closed	   and	   perhaps	   enables	   the	   enzyme	   to	   sense	   when	   both	  substrates	  are	  bound.	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Figure	  4.12.	  Shows	  the	  three	  positively	  charged	  residues	  (Lys137,	  Lys285	  and	  Arg291)	  and	   the	   Ser266,	   which	   are	   adjacent	   to	   2’phosphate	   group	   in	   the	   GluDH-­‐NADP+-­‐	   2-­‐oxoglutarate	  complex	  from	  M.	  smegmatis.	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                                                                       123456 
Ms              199  KGLTWGGSRVRTEATGYGTVFFVDEILQSRG--------QSFDGKRVVVSGSGNVAIYAIEKVHALGGIV  260 
Ec              197  KGLSFGGSLIRPEATGYGLVYFTEAMLKRHG--------MGFEGMRVSVSGSGNVAQYAIEKAMEFGARV  258 
PTAD1           192  KGVGFGGSLMRTEATGYGAVYFLQNMLAAQN--------ESIEGKKVLVSGAGNVSLHAAEKATLIGAIV  253 
Pf              258  KNIKWGGSNIRAEATGYGVVYFAENVLKDLN--------DNLENKKCLVSGSGNVAQYLVEKLIEKGAIV  319 
Ab              180  KGINWGGSFIRPEATGYGLIYYVEHMIAHACPEYS----LDRPSTLVAISGSGNVSQFTALKVIELGATV  245 
Bo              201  KPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFGDKTFVVQGFGNVGLHSMRYLHRFGAKC  270 
Sc              179  KGLNWGGSLIRPEATGYGLVYYTQAMIDYATNGKE-----SFEGKRVTISGSGNVAQYAALKVIELGGTV  243 
 
                                                                       123456     
Cs              196  KARSFGGSLVRPEATGYGSVYYVEAVMKHEN--------DTLVGKTVALAGFGNVAWGAAKKLAELGAKA  257 
Pa              177  KPVAFGGSEGRNEATGFGVAVVVRESAKRFG--------IKMEDAKIAVQGFGNVGTFTVKNIERQGGKV  238 
Pg              193  KGFEFGGSRLRPESTGFGAVYFVQNMCKQNG--------VDYKGKTLAISGFGNVAWGVAQKATELGIKV  254 
Bs              186  KPLVLGGSQGRETATAQGVTICIEEAVKKKG--------IKLQNARIIIQGFGNAGSFLAKFMHDAGAKV  247 
Eca             187  KGLNWGGSLVRPEATGFGTMYFANEVLHAHG--------DDIKGKTIAISGFGNVAFGAVLKAKQLGAKV  248 	  
 
 
                           78 
Ms                261  VACSDS-----GGYVVDEKGIDLDLLKEVKEVQRA----RIDAYAEARG---GATQFVS--GGSVWNVAC  316 
Ec                259  ITASDS-----SGTVVDESGFTKEKLARLIEIKASRDG-RVADYA-KEF----GLVYLE--GQQPWSLPV  315 
PTAD1             254  LTVSDS-----KGTIYDAKGLNQEKIDWLKVQKDQHK--PLADYV-EVF----GGEWMA--DQKPWSIKA  309 
Pf                320  LTMSDS-----NGYILEPNGFTKEQLNYIMDIKNNQRL-RLKEYLKYSK----TAKYFE--NQKPWNIPC  377 
Ab                246  LSLSDS-----KGSLISEKGYTKEAIEKIAELKLKGGA-LEAIVDDLGA----GYTYHAGKRPWTLLPQV  305 
Bo                271  ITVGES-----DGSIWNPDGIDPKELEDFKLQHGTIL----------GF----PKAKIY--EGSILEVDC  319 
Sc                244  VSLSDS-----KGCIISETGITSEQVADISSAKVNFKS-LEQIVNEYSTFSENKVQYIAGARPWTHVQKV  307 
 
                           78 
Cs                258  VTLSGP-----DGYIYDPEGITTEEKINYMLEMRASGRNKVQDYA-DKF----GVQFFP--GEKPWGQKV  315 
Pa                239  CAIAEWDRNEGNYALYNENGIDFKELLAYKEANKTLI---------GFP----GAERIT--DEEFWTKEY  293 
Pg                255  VTISGP-----DGYVYDPDGINTPEKFRCMLDLRDSGNDVVSDYVKRFP----NAQFFP--GKKPWEQKV  313 
Bs                248  IGISDA-----NGGLYNPDGLDIPYLLDKRDSFGMVT----------NL----FTDVIT--NEELLEKDC  296 
Eca               249  VTISGP-----DGYIYDENGINTDEKINYMLELRASNNDVVAPFA-EKF----GAKFIP--GKKPWEVPV  306 	  
Figure	  4.13.	  Sequence	  alignment	  of	  a	  number	  of	  NAD+-­‐dependent	  GluDHs	  and	  NADP+-­‐dependent	   GluDHs.	   The	   black	   sequences	   are	   NADP+-­‐dependent	   GluDHs,	   whereas	   the	  blue	   sequences	   are	   NAD+-­‐dependent	   GluDHs.	   The	   residues	   of	   glycine	   rich	   loop,	  GXGXXG/A	  (P1-­‐P6)	  and	  P7	  with	  P8	  are	  designated	  by	  numbers	  overhead	  the	  sequence.	  
Mycobacterium	   smegmatis	   (Ms),	   Escherichia	   coli	   (Ec),	   Psychrobacter	   sp	   TAD1	   (PTAD1),	  
Plasmodium	   falciparum	   (Pf),	   Agaricus	  bisporus	   (Ab),	   Saccharomyces	   cerevisiae	   (Sc),	  
Clostridium	   symbiosum	   (Cs)	   and	   Peptoniphilus	   asaccharolyticus	   (Pa),	   Porphyromonas	  
gingivalis	  (Pg),	  Bacillus.	  subtilis_rocG	  (Bs)	  and	  Entodinium	  caudatum	  (Eca).	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The	   character	   of	   the	  NADP+-­‐binding	   site	   in	  M.	   smegmatis	  GluDH	   shows	   a	  close	  similarity	  with	  bovine-­‐GluDH,	  a	  dual-­‐dependent	  enzyme,	  especially	  in	  the	   vicinity	   of	   residues	   that	   interact	   with	   the	   2’phosphate	   group	   of	   the	  adenine	  ribose.	  The	  two	  basic	  residues	  Lys137	  and	  Lys285	  with	  Ser266	  in	  
M.	  smegmatis	  GluDH	  are	  conserved	  in	  bovine-­‐GluDH	  as	  Lys134,	  Lys295	  and	  Ser276	   respectively.	   However,	   the	   orientation	   of	   the	   Lys137	   in	   M.	  
smegmatis	   	  GluDH	   is	   	  different	   to	  Lys134	   in	  bovine-­‐GluDH	  (both	   residues	  are	   conserved)	   and	   the	   reason	   for	   that	  might	   due	   to	   the	   presence	   of	   the	  Arg291	   in	  M.	  smegmatis	  GluDH	  (which	   is	  equivalent	   to	  Thr257	   in	  bovine-­‐GluDH)	  adjacent	   to	   the	  2’phosphate	  group	   (figure	  4.14).	   In	  both	  enzymes	  these	   residues	   might	   permit	   charge	   compensation	   of	   the	   2’phosphate	  group.	   As	   mentioned	   above	   the	   side	   chain	   of	   Asp265	   (P7)	   makes	   a	  hydrogen	  bond	  with	  the	  main	  chain	  of	  N-­‐H	  of	  Ile292.	  This	  residue	  (Asp265)	  is	  equivalent	  to	  Glu275	  in	  bovine-­‐GluDH,	  which	  forms	  two	  hydrogen	  bonds	  by	   its	  side-­‐chain	  and	  main	  chain	  with	  the	  2’phosphate	  group	  (Smith	  et	  al,	  2001),	  and	  thus	  points	  in	  a	  different	  direction.	  	  
4.5	   Conformational	   change	   of	   GluDH	   from	   C.	   symbiosum	   and	   M.	  
smegmatis	  	  
4.5.1	  Open	  and	  closed	  conformations	  in	  C.	  symbiosum	  GluDH	  	  Several	   enzymes	   undergo	   molecular	   rearrangement	   as	   a	   result	   of	   the	  binding	   of	   substrates	   and	   cofactors	   (Lesk	   &	   Chothia,	   1984).	   In	   such	  enzymes	  the	  catalytic	  pocket	  is	  located	  in	  a	  cleft	  between	  two	  domains	  and	  the	  structural	  rearrangements	  close	  the	  domains	  often	  through	  association	  with	  a	  substrate	  and	  a	  cofactor.	  Domain	  closure	  is	  involved	  in	  the	  catalytic	  activity,	   where	   it	   aids	   in	   orientation	   of	   the	   catalytic	   residues	   about	   the	  substrate,	   differentiates	   against	   unsuitable	   substrates,	   and	   eliminates	  water	  from	  the	  catalytic	  pocket	  (Lesk	  &	  Chothia,	  1984).	  Structural	  studies	  on	  the	  glutamate	  dehydrogenase	  family	  have	  shown	  that	  the	  two	  domains	  of	   the	   enzyme	   subunit	   can	   exist	   in	   a	   number	   of	   different	   conformations,	  including	  an	  open	  form,	  required	  for	  substrate	  binding,	  and	  a	  closed	  form	  essential	  for	  catalysis	  (Baker	  et	  al,	  1992a;	  Smith	  et	  al,	  2001;	  Stillman	  et	  al,	  1993).	  In	  the	  C.	  symbiosum	  GluDH	  for	  example;	  the	  apo	  enzyme	  (1HRD)	  is	  	  
	   127	  
	  	  	  	  	   	  
	  
	  
Figure	   4.14.	   The	   binding	   site	   of	   the	   NADP+	   of	   M.	   smegmatis	   GluDH	   with	   the	  residues	   implicated	   in	   interacting	   with	   the	   2’phosphate	   group	   displayed	   with	  yellow	   carbon	   colour.	   a)	   The	   pink	   color	   residues	   are	   a	   superposition	   of	   the	  corresponding	  residues	  of	  the	  bovine	  GluDH/Glutamate/NADPH	  complex	  (3MVQ).	  
b)	   The	   orange	   color	   residues	   are	   a	   superposition	   of	   the	   corresponding	   residues	  extant	  in	  the	  C.	  symbiosum	  GluDH	  (1HRD).	  	  	  	  	  
a	  
b	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in	  the	  open	  conformation,	  and	  the	  glutamate	  bound	  binary	  complex	  is	  in	  a	  closed	   conformation	   (Baker	   et	   al,	   1992a;	   Stillman	   et	   al,	   1993).	   The	  structural	   rearrangement	   between	   the	   two	   forms	   can	   be	   described	   as	   a	  rigid	  body	  movement	  of	   roughly	  15°	  about	   an	   axis	   lying	  between	   the	   two	  domains	  (Stillman	  et	  al,	  1993).	  
4.5.2	  K89L	  mutant	  of	  apo-­‐enzyme	  of	  C.	  symbiosum	  GluDH	  present	  in	  a	  
closed	  form	  Stillman	   and	   co-­‐workers	   have	   also	   solved	   the	   three-­‐dimensional	   crystal	  structure	  of	  the	  K89L	  mutant	  of	  GluDH	  from	  C.	  symbiosum.	  Comparison	  of	  this	   structure	   with	   the	   previous	   structures	   of	   wild–type	   C.	   symbiosum	  GluDH,	  have	  shown	  that	  the	  structure	  of	  this	  mutant	  is	  similar	  to	  that	  of	  the	  GluDH/L-­‐glutamate	   binary	   complex.	   This	   means	   that	   the	   K89L	   mutant	  enzyme	   adopts	   a	   closed	   conformation,	   even	   in	   the	   absence	   of	   substrate	  (Stillman	  et	   al,	   1999).	   It	   is	   unclear	  whether	   the	  K89L	  mutation	   facilitates	  the	  domain	   closure,	   by	  mimicking	   the	   substrate	  binding	  by	   removing	   the	  positive	   charge	   of	   the	   lysine	   residue,	  which	   lies	   at	   the	   interface	   between	  domain	  I	  and	  domain	  II	  (Stillman	  et	  al,	  1999).	  The	  structure	  of	  the	  wild-­‐type	  apo	  form	  of	  the	  E.	  coli	  GluDH	  also	  adopts	  a	  closed	  conformation	  (4BHT,	  (Sharkey	  et	  al,	  2013),	  showing	  that	  the	  domain	  movement	  in	  GluDH	  is	  not	  dependent	  on	  substrate	  or	  cofactor	  binding.	  To	  determine	   the	   level	   of	   domain	   closure	   in	   the	   structures	  presented	   in	   this	  thesis,	   the	   N-­‐terminal	   domains	   I	   of	   a	   number	   of	   GluDH	   structures	   were	  superimposed	   on	   domain	   I	   of	   the	   A	   subunit	   of	   the	   C.	   symbiosum	   apo	  enzyme	   (1HRD),	   which	   is	   the	   reference	   structure.	   These	   overlapped	  structures	   were,	   in	   turn,	   superimposed	   on	   the	   C-­‐terminal	   domain	   II	   of	  1HRD.	   Using	   the	   superposition	   matrices	   describing	   this	   second	  superposition,	   the	   domain	   movement	   between	   the	   structures	   was	  calculated	  as	  screw	  axis	  rotation,	  using	  the	  method	  of	  Gerstein	  (Gerstein	  et	  al,	  1993).	  The	  results	  of	  these	  analyses	  are	  shown	  in	  table	  4.2.	  In	  each	  case	  the	  rotation	  that	  describes	  domain	  closure	   lies	  between	  the	  domains,	  and	  approximately	  parallel	  to	  α17.	  These	  superpositions	  show	  the	  range	  of	  the	  domain	  movements	  possible	  in	  the	  GluDH	  family.	  Compared	  to	  the	  C.	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Protein	   Subunit	   Rotation	   Distance	  
C.	  symbiosum	  GluDH	  (1HRD)	   	  A	   	  0°	   Cα	  A95-­‐Cα	  G239	  22.4	  Å	  
M.	  smegmatis	  GluDH	  ternary	  complex	   	  A	  B	  
	  25.6°	  25.6°	  
Cα	  H99-­‐Cα	  G243	  13.6Å	  13.6Å	  
C.	  symbiosum	  GluDH	  binary	  complex	  (GluDH-­‐Glutamate)	  1.2	  Å	  
	  A	   	  17.7°	   Cα	  A95-­‐Cα	  G239	  17.5	  Å	  
	  
C.	  symbiosum	  GluDH	  binary	  complex	  (GluDH-­‐NAD+)	  	  
	  A	  B	  C	  
	  3.3°	  3.7°	  16.4°	  
Cα	  A95-­‐Cα	  G239	  21.7	  Å	  20.8	  Å	  17.9	  Å	  
C.	  symbiosum	  GluDH	  binary	  complex	  (GluDH-­‐Glutamate)	  	  (1BGV)	  	  
	  A	   	  15.4°	   Cα	  A95-­‐Cα	  G239	  17.8	  Å	  
K89L	  mutant	  of	  C.	  
symbiosum	  GluDH	  (1K89)	   	  A	   	  15.4°	   Cα	  A95-­‐Cα	  G239	  17.7	  Å	  K89L/S380V	  mutants	  of	  C.	  
symbiosum	  GluDH	  (1AUP)	  
	  A	   	  23.5°	   Cα	  A95-­‐Cα	  G239	  14.9	  Å	  
Bovine	  ternary	  complex	  of	  GluDH	  (GluDH/	  NADPH/Glutamate)	  (3MVQ)	  Bovine	  ternary	  complex	  of	  GluDH	  (GluDH/	  NAD+/2oxoglutarate)	  (1HWY)	  	  
	  A	  	  	  A	  
	  26.5°	  	  	  25.9°	  
Cα	  S96-­‐Cα	  G253	  14.1	  Å	  	  	  13.7	  Å	  	  
Apo	  E.	  coli	  GluDH	  	  (4BHT)	   	  A	   	  14.9°	   Cα	  H98-­‐Cα	  G241	  18.0	  Å	  	  
Table	  4.2.	  Shows	  the	  domain	  motion	  in	  GluDHs.	  The	  relative	  of	  the	  domain	  movement	  is	  described	  by	  the	  rotation	  and	  the	  distance	  between	  the	  two	  domains,	  which	  is	  measured	  at	  the	  equivalent	  residues.	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symbiosum	   apo	   structure	   (1HRD)	   the	   C.	   symbiosum	   L-­‐glutamate	   binary	  complex	   (1BGV)	  has	  a	  domain	  closure	  of	  ≈	  15°.	  The	  1.2Å	  C.	  symbiosum	  L-­‐glutamate	   binary	   complex	   structure	   determined	   here	   has	   a	   slightly	  more	  closed	  structure	  of	  18°,	  whereas	  the	  M.	  smegmatis	  ternary	  complex	  is	   in	  a	  fully	  closed	  form,	  with	  a	  domain	  closure	  of	  ≈	  26°.	  	  Interestingly,	  the	  ternary	  complexes	  of	   bovine	  GluDH	   (NADPH/Glu	  or	  NAD+/oxoglu)	  have	   a	   similar	  	  fully	   closed	   structure	   to	   the	   M.	   smegmatis	   ternary	   complex,	   also	   with	   a	  domain	   closure	   of	   ≈	   26°.	   In	   contrast,	   the	   E.	   coli	   apo	   structure	   adopts	   a	  similar	   closed	   structure	   to	   the	  C.	   symbiosum	  L-­‐glutamate	   binary	   complex	  with	  a	  domain	  closure	  of	  ≈	  15°.	  The	   relative	   domain	   closure	   can	   also	   be	   illustrated	   by	   measuring	   the	  distance	   between	   equivalent	   residues	   in	   the	   two	   domains	   across	   the	  different	   structures.	   As	   there	   are	   some	   variations	   in	   the	   fold	   of	   the	  structures	  around	  helices	  α11	  and	  α12	  in	  domain	  II,	  which	  lie	  at	  the	  jaws	  of	  the	   cleft,	   and	  would	   thus	   give	   ambiguous	   results,	   the	   distance	   compared	  here	  is	  that	  between	  the	  α	  carbons	  of	  the	  second	  glycine	  of	  the	  GXGXXG/A	  turn	  and	  the	  residue	  at	   the	  C-­‐terminal	  end	  of	  βc	  of	  domain	   I	   (His99	   in	  M.	  
smegmatis	  GluDH).	  The	  distance	  between	  these	  two	  α	  carbons	  varies	  from	  22Å	   in	   the	   C.	   symbiosum	  apo	   open	   structure	   (1HRD)	   to	   13.5	   Å	   in	   the	  M.	  
smegmatis	   GluDH	   fully	   closed	   ternary	   complex	   structure	   (table4.2).	  Analysis	  of	   these	  structures	  appears	  to	  show	  that	   the	  movement	  between	  the	  open	  and	  closed	  (15°)	  structures	  is	  not	  dependent	  on	  substrate	  binding,	  as	  closed	  structure	  can	  be	  observed	  without	  substrate.	  However,	   the	   fully	  closed	  structure	   (26°)	   is	  only	  observed	  when	  both	  substrate	  and	  cofactor	  are	   present.	   On	   substrate	   binding	   there	   are	   a	   number	   of	   changes	   in	   the	  torsion	   angles	   of	   the	   side	   chains	   of	   the	   residues	   that	   interact	   with	   the	  glutamate	   or	   2-­‐oxoglutarate	   substrate.	   These	   residues	   (S380,	   K89,	   R205,	  Q114,	   D165,	   K125	   and	   K113)	   in	   C.	   symbiosum	   GluDH	   (table4.3)	   are	  conserved	  across	   the	   family	  and	  so	   the	  mode	  of	  binding	  of	  substrate,	  and	  the	  reaction	  mechanism	  are	  likely	  to	  be	  very	  similar.	  	  One	   aspect	   of	   the	   closed	   structure	   is	   that,	   when	   the	   domains	   close,	  additional	  interactions	  are	  made	  between	  domain	  I	  and	  the	  cofactor	  which	  cannot	  occur	  in	  the	  open	  form;	  these	  extra	  interactions	  are:	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i) The	   side	   chain	   of	   Lys137	  makes	   a	   hydrogen	   bond	   to	   the	   2’phosphate	   of	  NADP+	  	  ii) The	   backbone	   NH	   of	   Gly171	   forms	   a	   hydrogen	   bond	   to	   O1A	   of	   the	  	  pyrophosphate	  (NAD+	  or	  NADP+)	  	  iii) The	   side	   chain	   of	   R205	   interacts	   with	   the	   carbonyl	   of	   the	   nicotinamide	  carboxyamide.	  	  
4.6	  Catalytic	  pocket	  
4.6.1	  Substrate	  binding	  in	  GluDH	  The	   previous	   structure	   of	   the	   C.	   symbiosum	   GluDH/L-­‐glutamate	   binary	  complex	   (1BGV)	   has	   shown	   how	   the	   L-­‐glutamate	   substrate	   is	  accommodated	  in	  the	  active	  site	  of	  the	  enzyme	  (Stillman	  et	  al,	  1993).	  The	  substrate	  binds	  at	  the	  base	  of	  the	  active	  site	  cleft	  between	  domains	  I	  and	  II,	  accommodated	   in	   a	   pocket	   on	   the	   enzyme	   surface.	   Recognition	   of	   the	  substrate	   side	   chain	   occurs	   by	  K89	   and	   S380	   residues,	  which	   interact	   by	  their	  side	  chains	  with	  the	  γ-­‐carboxyl	  group	  of	  L-­‐glutamate.	  The	  side	  chains	  of	  V377	  and	  A163	  form	  hydrophobic	  interactions	  with	  the	  β	  and	  δ-­‐carbon	  atoms	  of	  the	  amino	  acid	  substrate.	  Further	  interactions	  are	  made	  between	  α-­‐amino	   group	   of	   the	   glutamate	   to	   the	   side	   chain	   of	   D165	   and	   the	  main	  chain	  carbonyl	  group	  of	  G164,	  with	   the	  α-­‐carboxyl	  group	   interacting	  with	  the	   side	   chains	   of	   K113	   and	   Q110.	   The	   active	   site	   also	   comprises	   five	  glycine	  residues	  (G122,	  123,	  90,	  91	  and	  G376)	  that	  play	  a	  role	  in	  the	  shape	  of	  the	  catalytic	  pocket	  and	  K125,	  which	  lies	  close	  to	  the	  amino	  group	  of	  the	  substrate.	   This	   structure	   also	   enabled	   a	   reaction	   mechanism	   to	   be	  proposed	   (Stillman	   et	   al,	   1993).	   All	   of	   these	   amino	   acid	   residues	   are	  conserved	  in	  the	  GluDH	  family	  (Britton	  et	  al,	  1993b).	  	  	  This	   thesis	   presented	   a	   high	   resolution	   (1.2	   Å)	   structure	   of	   the	   C.	  
symbiosum	  GluDH/L-­‐glutamate	   complex,	   a	   binary	   complex	   of	   NAD+	   with	  the	  open	  form	  of	  the	  C.	  symbiosum	  GluDH,	  and	  also	  the	  first	  bacterial	  GluDH	  ternary	   complex	   of	   the	  M.	   smegmatis	   GluDH/NADP+/gem-­‐diol	   structure.	  Comparison	  of	  these	  structures	  has	  allowed	  a	  number	  of	  new	  observations	  to	   be	   made	   about	   the	   active	   site	   in	   this	   family	   of	   enzymes.	   These	  observations	  include:	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1-­‐ Arg205	  senses	  binding	  of	  L-­‐glutamate	  As	  well	  as	  the	  previously	  observed	  interactions	  between	  the	  γ-­‐carboxyl	  of	  L-­‐glutamate	  with	   S380	  and	  K89	   in	  C.	  symbiosum	  GluDH,	   the	   side	   chain	  of	  R205	   also	   appears	   to	   sense	   the	   presence	   of	   glutamate	   or	   2-­‐oxoglutarate	  substrates.	   In	   the	   apo	   structures	   (e.g.	   1HRD	   and	   1K89)	   this	   residue	  interacts	   just	  with	  water	  molecule	   in	  the	  cleft,	  whereas	  when	  L-­‐glutamate	  is	   present	   (1BGV	   and	   1.2	   Å	   complex)	   the	   side	   chain	   moves	   towards	   the	  glutamate-­‐binding	  pocket	  and	  interacts	  with	  the	  side	  chain	  carboxyl	  of	  the	  substrate.	  In	  the	  ternary	  complex	  structures	  (e.g.	  diol	  and	  bovine)	  this	  side	  chain	  also	  interacts	  with	  the	  carboxyl	  of	  the	  carboxyamide	  of	  the	  cofactor,	  aiding	   the	  positioning	  of	   the	  nicotinamide	  ring	   to	   the	  alpha	  carbon	  of	   the	  substrate	  (figure	  4.14	  and	  figure	  4.15).	  
2-­‐ The	  position	  of	  the	  substrate	  in	  the	  active	  site	  is	  flexible	  In	   the	   1.2	   Å	   C.	   symbiosum	   GluDH/L-­‐glutamate	   binary	   complex,	   two	  conformations	   of	   the	   γ-­‐carboxyl	   can	   be	   seen	   in	   the	   electron	   density	  (figure4.15),	  one	  where	   the	  γ-­‐carboxyl	   interacts	  with	  R205	  and	  S380	  and	  the	  other	  where	  the	  γ-­‐carboxyl	  interacts	  with	  S380	  and	  K89	  (figure4.17).	  In	  both	   of	   these	   conformations	   of	   the	   L-­‐glutamate	   side	   chain,	   the	   α-­‐carbon,	  amino,	   and	   carboxyl	   groups	   of	   the	   substrate	   lie	   in	   effectively	   the	   same	  place.	   In	   the	   fully	   closed	   M.	   smegmatis	   GluDH/NADP+/gem-­‐diol	   ternary	  complex,	   the	   substrate	   just	   occupies	   one	   position,	   with	   the	   γ-­‐carboxyl	  occupying	   the	  position	   that	  makes	   interactions	  with	   the	  serine	  and	   lysine	  (K93	   and	   S381	   in	  M.	   smegmatis	  GluDH)	   (figure4.16).	   In	   this	   fully	   closed	  ternary	   complex,	   the	   arginine	   residue	   (R209	   in	   M.	   smegmatis	   GluDH)	  moves	  even	  closer	   to	   the	  substrate,	   than	   that	   is	   seen	   in	   the	  closed	  binary	  complex,	   such	   that	   interactions	   are	   made	   to	   the	   γ-­‐carboxyl.	   Thus	   in	   the	  ternary	  complex,	  R209,	  K93	  and	  S381	  all	  make	  stabilizing	  interactions	  with	  the	   γ-­‐carboxyl	   of	   the	   substrate.	   However,	   although	   the	   position	   of	   the	   γ-­‐carboxyl	   in	   the	   ternary	   complex	   is	   the	   same	   as	   one	   of	   those	   seen	   in	   the	  binary	   complex,	   the	   position	   of	   the	   rest	   of	   the	   substrate	   is	   substantially	  different.	   The	   gem-­‐diol	   binds	   in	   an	   extended	   conformation,	   compared	   to	  the	  bent	  conformation	  of	  the	  L-­‐glutamate.	  The	  α-­‐carbon	  of	  the	  gem-­‐diol	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Figure	   4.15.	   Illustrates	   the	   orientation	   of	   the	   arginine	   residue	   (R205)	   from	   C.	  
symbiosum	  GluDH.	   R205	   in	   C.	   symbiosum	   GluDH	   in	   the	   apo	   state	   are	   shown	   in	  orange	   and	   blue	   colour,	   this	   residue	  moves	   away	   from	   the	   substrate,	   but	   in	   the	  GluDH	  that	  bound	  to	  the	  substrate	  (green,	  yellow	  and	  pink)	  the	  arginine	  directs	  to	  the	  substrate.	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occupies	   the	   position	   of	   the	   α-­‐carboxylate	   of	   L-­‐glutamate	   with	   the	   α-­‐carboxylate	  making	  direct	  interactions	  to	  K129,	  K117,	  Q114	  and	  N349.	  This	  difference	   in	  the	  position	  of	   the	  α-­‐carbon	  of	   the	  substrate	  (1.7Å)	  has	  the	   effect	   of	   moving	   the	   oxidized	   substrate	   away	   from	   the	   nicotinamide	  ring	  (figure	  4.17).	  	  
3-­‐ The	  gem-­‐diol	  provides	  a	  model	  for	  the	  carbinolamine	  The	   gem-­‐diol	   bound	   in	   the	  M.	  smegmatis	  GluDH/NADP+/gem-­‐diol	   ternary	  complex	  has	  two	  hydroxyl	  groups	  attached	  to	  the	  sp3	  coordinated	  α-­‐carbon	  of	  the	  ligand	  and	  is	  thus	  a	  good	  model	  for	  the	  carbinolamine	  intermediate.	  One	  of	  these	  hydroxyls	  forms	  interactions	  to	  the	  main	  chain	  NH	  of	  G95,	  the	  carbonyl	   of	   the	   side	   chain	   of	   Q114	   and	   the	   side	   chain	   of	   K129,	   with	   the	  other	   hydroxyl	   lying	   closer	   to	   the	   nicotinamide	   ring	   of	   NADP+	   and	  interacting	  with	  the	  side	  chain	  of	  D169.	  If	  we	  assume	  that	  the	  proposed	  carbinolamine	  binds	   in	  the	  same	  position	  as	  that	  seen	  in	  the	  diol,	  then	  the	  stereochemistry	  of	  the	  carbinolamine	  can	  be	   inferred.	   The	   α-­‐amino	   group	   of	   the	   carbinolamine	   can	   only	   act	   as	   a	  hydrogen	  bond	  donor,	  and	  so	  must	  occupy	  the	  position	  of	  the	  hydroxyl	  on	  diol	   closest	   to	   D169	   and	   the	   nicotinamide	   ring,	   rather	   than	   the	   other	  position,	   which	   must	   act	   as	   a	   hydrogen	   bond	   acceptor.	   This	   would	   then	  mean	  that	  the	  carbinolamine	  has	  the	  S-­‐configuration.	  	  Taken	   together,	   these	   observations	   enable	   an	   extension	   to	   the	   reaction	  mechanism	   proposed	   by	   Stillman	   et	   al	   (Stillman	   et	   al,	   1993),	   which	   is	  summarized	  below	  (using	  C.	  symbiosum	  numbering	  for	  clarity)	  i) As	  the	  majority	  of	  the	  interactions	  with	  the	  dinucleotide	  are	  made	  with	   domain	   II,	   the	   assumption	   can	   be	   made	   that	   a	   fully	   closed	   ternary	  complex	  with	  L-­‐glutamate	  and	  NAD+	  also	  occurs	  as	  part	  of	   in	   the	  enzyme	  mechanism,	  where	  the	  L-­‐glutamate	  occupies	  the	  position	  of	  that	  seen	  in	  the	  ternary	   complex,	   and	   the	   nicotinamide	   ring	   occupies	   that	   seen	   in	   the	  ternary	  complex.	   In	   this	  proposed	  model	   the	  α-­‐carbon	  of	   the	  L-­‐glutamate	  lies	  2.5	  Å	  from	  the	  C-­‐4	  the	  nicotinamide,	  in	  an	  ideal	  orientation	  for	  hydride	  transfer	  (figure4.17),	  with	  D165	  acting	  as	  a	  base	  to	  abstract	  a	  proton	  from	  the	  α-­‐amino	  group.	  The	  hydride	   transfer	  would	  result	   in	   the	   formation	  of	  the	  iminioglutarate.	  





C.	  symbiosum	   K89	   K113	   Q110	   K125	   D165	   R205	   S380	  
M.	  smegamtis	   K93	   K117	   Q114	   K129	   D169	   R209	   S381	  
E.	  coli	   K92	   K116	   Q113	   K128	   D168	   R207	   S380	  
P.	  asaccharolyticus	  	  	   K70	   K94	   M91	   K106	   D146	   R187	   S355	  Bovine	  	   K90	  K147	   K114	  K170	   M111	  M167	   K126	  K183	   N168	  D225	   R211	  R268	   S381	  S438	  	  
Table	  4.3.	  Showing	  the	  conserved	  and	  equivalent	  residues	  that	  are	  responsible	  for	  the	  substrate	  binding	  for	  GluDHs.	  The	  residue	  numbering	  for	  Bovine	  GluDH	  is	  given	  for	  both	  the	  mature	  mitochondrial	  protein	  (upper	  line)	  and	  for	  the	  genomic	  sequence	  including	  the	  N-­‐terminal	  mitochondrial	  targeting	  sequence	  (lower	  line).	  	  	  	  
	  	  	  	  	  	   	  	  	  
	  
	  
Figure	   4.16.	   Electron	   density	   for	   the	   L-­‐glutamate	   of	   1.2Å	   binary	   complex	   of	   C.	  
symbiosum	   GluDH	   with	   L-­‐glutamate.	   The	   different	   density	   for	   the	   two	  conformations	   of	   the	   substrate	   side	   chain	   can	   be	   seen.	   In	   each	   case	   the	   map	  (countered	   at	   1.0	   sigma)	   is	   shown	   in	   blue,	   with	   the	   positive	   difference	   map	  (countered	  at	  3.0	  sigma)	  in	  green.	  	  	  	  	  	  	  	  	  	  
a	   b	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  ii) With	   an	   sp2	   hybridized	   α-­‐carbon,	   the	   imino	   group	   of	   the	  iminoglutarate	   would	   lie	   too	   close	   to	   the	   nicotinamide	   ring,	   but	  interconversion	  to	  the	  extended	  form	  of	  the	  substrate	  would	  move	  the	  α-­‐	  	  carbon	  towards	  the	  position	  seen	  in	  the	  gem-­‐diol	  to	  alleviate	  this	  potential	  steric	   clash	   and	   give	   a	   3.9Å	   distance	   between	   nicotinamide	   C4	   and	   the	  substrate	  Cα.	  iii)	   	   	   	   	   	   	   During	   this	  movement,	   the	  water	  molecule	   hydrogen	   bonded	   to	  K125	   attacks	   the	   iminoglutarate	   to	   give	   the	   S-­‐carbinolamine	  binding	   in	   a	  similar	   way	   to	   that	   seen	   for	   the	   gem-­‐diol	   in	   the	   ternary	   complex.	  	  Subsequent	  collapse	  of	  the	  carbinolamine	  to	  the	  ketone	  and	  the	  change	  of	  sp3	  to	  sp2	  coordination	  of	   the	  Cα,	  would	  result	   in	  the	  carboxyl	  of	   the	  keto	  acid	  lying	  approximately	  parallel	  to	  the	  plane	  of	  the	  nicotinamide	  ring.	  This	  would	   be	   facilitated	   by	   D165	   acting	   as	   a	   base	   to	   abstract	   a	   proton	   from	  K125,	  which,	  in	  turn,	  acts	  as	  a	  base	  to	  remove	  the	  proton	  from	  the	  hydroxyl	  of	  the	  carbinolamine.	  The	  enzyme	  can	  then	  open	  up,	  to	  allow	  release	  of	  the	  products	  and	  proton	  exchange	  of	  D165	  and	  K125	  with	  the	  bulk	  solution.	  	  	  This	   proposed	   mechanism	   provides	   an	   explanation	   for	   how	   the	   enzyme	  avoids	   the	   abortive	   formation	   of	   a	   α-­‐hydroxy	   acid	   when	   the	   reaction	   is	  running	   in	  the	  reverse	  direction.	  The	  α-­‐carbon	  of	   the	  diol	  (or	  presumably	  the	  keto	  acid)	  lies	  3.9	  Å	  away	  from	  C4	  of	  the	  nicotinamide	  and	  thus	  direct	  attack	   by	   the	   hydride	   on	   the	   keto	   acid	   is	   not	   possible.	   Only	  when	   NH4+,	  stabilized	  by	  D109,	  has	  attacked,	  to	  give	  an	  sp3	  hybridized	  α-­‐carbon	  in	  the	  S-­‐carbinolamine,	  does	  the	  substrate	  move	  towards	  the	  nicotinamide	  ring	  to	  allow	  hydride	  transfer	  to	  form	  the	  amino	  acid.	  This	  change	  in	  the	  distance	  between	   the	   substrate	   Cα	   and	   the	   nicotinamide	   C4	   is	   facilitated	   by	  movement	   of	   the	   substrate	   in	   the	   active	   site,	   rather	   than	   by	   the	   domain	  moving,	  which	  has	  the	  consequence	  of	  keeping	  the	  cleft	  closed	  throughout	  the	  reaction	  and	  thus	  preventing	  unwanted	  attack	  by	  bulk	  water.	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Figure	  4.17.	  Shows	  the	  binding	  of	  the	  side	  chain	  of	  R209	  with	  γ-­‐carboxyl	  group	  of	  the	  gem-­‐diol	  and	  the	  carbonyl	  group	  of	   the	  carboxyamide	  of	   the	  nicotinamide	  of	  the	  NADP+	  in	  the	  ternary	  complex	  of	  M.	  smegmatis	  GluDH/gem-­‐diol/NADP+.	  	  	  	  	  
	  
Figure	   4.18.	   The	   two	   conformations	   of	   γ-­‐carboxyl	   of	   the	   L-­‐glutamate	   in	   the	   C.	  
symbiosum	   GluDH	   binary	   complex	   are	   shown	   in	   different	   colors	   (green	   and	  yellow),	  also	  R205	  has	  two	  forms.	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   Hydrogen	  bonds	  of	  possible	  diol in	  
M.	  smegmatis	  GluDH	  ternary	  complex	   Hydrogen	  bonds	  of	  L-­‐glutamate	  in	  	  	  	  	  	  	  	  	  	  	  	  	  	  C.	  symbiosum	  GluDH	  binary	  complex	  PDB	  accession	  number	  1BVG	  	  
	  
α-­‐carboxyl	  group	  
	  i-­‐side-­‐chain	  NH2	  of	  Gln114	  	  3.0	  Å	  ii-­‐	  side-­‐chain	  Lys117	  	  3.17Å	  and	  	  	  	  	  	  	  	  	  	  2.82Å	  iii-­‐	  side-­‐chain	  Lys129	  2.80Å	  vi-­‐	  side-­‐chain	  NH2	  of	  Asn349	  2.87Å	  	  	  






	  i-­‐	  side-­‐chain	  of	  Asp169	  	  	  	  	  	  	  	  	  	  2.99	  Å	  ii-­‐	  main	  chain	  CO	  of	  Gly168	  	  	  3.29	  Å	  iii-­‐	  side-­‐chain	  CO	  of	  Gln114	  	  3.10	  Å	  vi-­‐	  side-­‐chain	  of	  Lys129	  2.41Å	  v-­‐main	  chain	  NH2	  of	  Gly95	  2.86Å	  	  
	  i-­‐	  side-­‐chain	  of	  Asp165	  	  	  	  	  	  	  	  	  2.78	  Å	  ii-­‐	  main	  chain	  CO	  of	  Gly164	  	  2.73	  Å	  	  
γ-­‐carboxyl	  group	   i-­‐	  side-­‐chain	  of	  Lys93	  	  	  2.73Å	  ii-­‐	  side	  chain	  of	  Ser381	  	  	  	  2.55Å	  iii-­‐	  side-­‐chain	  of	  Atg209	  	  2.92	  Å	  	  
i-­‐	  side	  chain	  Lys89	  	  	  	  	  2.56	  Å	  ii-­‐	  side	  chain	  of	  Ser380	  	  	  	  2.64Å	  	  	  
Table	   4.4.	   Showing	   the	   hydrogen	   bonds	   for	   the	   substrate	   interaction	   in	   the	   ternary	  complex	  of	  M.	  smegmatis	  GluDH	  and	  	  	  C.	  symbiosum	  GluDH	  binary	  complex	  (IBVG).	  	  	  	  
	  	   	  
Figure	   4.19.	   Shows	   the	   distance	   between	   the	   C-­‐4	   of	   the	   nicotinamide	   and	   the	   alpha	  carbon	   for	   the	   two	   substrates,	   L-­‐glutamate	   and	   gem-­‐diol.	   The	   α-­‐carbon	   of	   the	   L-­‐glutamate	  lies	  2.5	  Å	  from	  the	  C-­‐4	  of	  the	  nicotinamide,	  which	  allows	  the	  hydride	  transfer	  to	  occur.	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(1) (2)	  
	  	  
	  	  	  	  	  	  	  	  	  	  	   	  	  
(3)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (4)	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Chapter	   five:	   Purification,	   crystallization,	   data	   collection,	  
structural	   determination	   and	   structural	   analysis	   of	  
phenylalanine	  dehydrogenase	  from	  Bacillus	  sphaericus.	  
	  5.0	  Introduction	  This	   chapter	   describes	   the	   results	   for	   purification,	   crystallization,	   data	  collection,	   data	   processing,	   structural	   determination	   and	   structural	  analysis	  of	  phenylalanine	  dehydrogenase	  from	  Bacillus	  sphaericus.	  
5.1	  Purification	  of	  phenylalanine	  dehydrogenase	  (PheDH)	  
5.1.1	  Purification	  of	  single	  mutant	  (N145A)	  PheDH	  Cell	  paste	  of	  B.	  sphaericus	  PheDH	  protein	  was	  provided	  by	  Prof	  Paul	  Engel;	  University	  College	  Dublin.	  The	  cell	  free	  extract	  was	  26ml	  at	  a	  concentration	  4.6mg/ml	  (total	  protein	  120mg).	  17ml	  of	  4M-­‐ammonium	  sulfate	  was	  added	  to	   bring	   the	   concentration	   to	   1.5M.	   Precipitates	   were	   removed	   by	  centrifugation	   at	   70000g	   for	   10min.	   The	   supernatant	   fraction,	   containing	  60mg	   of	   total	   protein	   was	   applied	   to	   a	   5ml	   Phe-­‐HP	   cartridge	   (GE	  Healthcare)	   for	   hydrophobic	   interaction	   chromatography.	   	   Proteins	  were	  eluted	   from	  the	  column	  by	  a	  reverse	  gradient	  of	  ammonium	  sulfate,	   from	  1.5M	   to	   0M	   in	   buffer	   A	   (50mM	   TRIS	   pH=8.0),	   2.5ml	   fractions	   were	  collected.	  All	   fractions	   were	   analysed	   for	   protein	   by	   the	   method	   of	   Bradford	  (Bradford,	   1976)	   and	   fractions	   with	   the	   highest	   protein	   concentration	  	  (fr17-­‐19)	  were	  combined,	  to	  give	  a	  total	  volume	  of	  7.5ml	  at	  3mg/ml.	   	  The	  volume	   of	   the	   sample	   was	   reduced	   to	   1ml	   using	   a	   VivaSpin	   concentator	  with	  a	  molecular	  weight	  cut	  off	  of	  30kDa,	  and	  was	  then	  applied	  to	  a	  16x60	  Superdex200	  gel	  filtration	  column,	  equilibrated	  in	  buffer	  A	  +0.5M	  NaCl.	  Gel	  filtration	  separation	  was	  performed	  with	  the	  same	  buffer	  at	  a	  flow	  rate	  at	  1.5ml/min.	   	   2ml	   fractions	   were	   collected	   	   after	   the	   void	   volume	   of	   the	  column	   had	   been	   discarded.	   Fractions	   were	   analysed	   by	   the	   method	   of	  Bradford	  and	  fractions	  9-­‐11,	  that	  had	  the	  highest	  protein	  concentration,	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Figure	  5.1.	  SDS-­‐PAGE	  gel	  showing	  the	  purification	  progress	  of	  single	  mutant	  PheDH	  protein.	   The	  molecular	   weight	   of	   PheDH	   is	   41.578	   kDa.	   The	   lanes	   are	   arranged	   as	  following:	  1=	  Marker	  12,	  2=	  cell	  debris,	  3=	  cell	   free	  extract,	  4=	  sample	  applied	  on	  a	  Phe-­‐HP	  column,	  5=	  sample	  applied	  on	  a	  gel	  filtration	  column,	  6-­‐11fractions	  8-­‐12	  from	  gel	  filtration	  column.	  	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   5.2.	   Chromatogram	  pictures	   for	   the	  purification	  of	   single	  mutant	  PheDH	  protein.	   (a)	   Hydrophobic	   chromatography	   (Phe-­‐HP)	   purification	   stage	   showing	  the	  most	  active	  fractions	  8-­‐10.	  (b)	  Gel	  filtration	  purification	  step	  showing	  the	  peak	  of	  elutes	  at	  57	  ml.	  
a	  
b	  
1	  	  	  	  	  	  2	  	  	  	  	  3	  	  	  	  	  	  4	  	  	  	  	  5	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  	  9	  	  	  	  10	  	  	  11	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were	   combined	   to	   give	   a	   total	   volume	  of	   6ml	   at	   1.5mg/ml.	   PheDH	  elutes	  from	  the	  column	  at	  57ml,	  which	  corresponds	  to	  apparent	  MW	  of	  370kDa,	  which	   suggests	   that	   PheDH	   is	   probably	   an	   octamer	   (subunit	   molecular	  weight=41.6	  kDa).	  The	  purification	  progress	  was	  analysed	  	  by	  SDS-­‐PAGE	  using	  4-­‐12%	  Bis-­‐Tris	  NOVAX	  gel	  and	  is	  shown	  in	  figure5.1.	  To	   prepare	   PheDH	   for	   crystallisation,	   a	   VivaSpin	   concentrator	   with	   a dialitration	   cup	   was	   used	   to	   change	   the	   buffer	   in	   the	   sample	   to	   40mM	  Glycine-­‐KOH	  pH8.0,	  0.1M	  KCl	  and	   finally	  protein	  was	  concentrated	   to	  10-­‐16mg/ml.	  
5.1.2	  Purification	  of	  wild	  type	  protein	  Wild	   type	   B.	   sphaericus	   PheDH	   was	   purified	   the	   same	   way	   as	   the	   single	  mutant.	   	  3g	  of	  cells	  were	  taken;	  243	  mg	  of	  total	  protein.	  After	  ammonium	  sulphate	   precipitation	   205mg	   of	   total	   protein	   was	   applied	   to	   a	   Phe-­‐HP	  cartridge.	  Fractions	  15-­‐17	  were	  combined	  to	  give	  a	  total	  protein	  of	  60mg,	  which	  was	  concentrated	  and	  applied	  to	  the	  gel	  filtration	  column.	  Fractions	  7-­‐9	   were	   combined	   to	   give	   21mg	   of	   purified	   PheDH.	   The	   samples	   for	  crystallization	  were	  prepared	  the	  same	  way	  as	  for	  the	  N145A	  protein.	  
5.2	  Crystallization	  of	  Bacillus	  sphaericus	  PheDH	  	  
5.2.1	  Crystallization	  of	  single	  mutant	  (N145A)	  PheDH	  with	  NAD+	  The	  protein	  sample	  of	   the	  N145A	  mutant	  PheDH	  from	  B.	  sphaericus	  at	  10	  mg/ml	  was	  mixed	  with	   NAD+	   (to	   a	   final	   concentration	   of	   the	   cofactor	   of	  5mM)	  before	  placing	   the	  sample	   in	  crystallization	   trials	   (see	  section	  2.3.1	  for	  details).	  Four	  initial	  screens,	  PACT,	  JCSG,	  Classics	  and	  PEGs	  suites,	  were	  carried	  out	  using	  a	  hydra	  II	  plus	  one	  robot,	  by	  mixing	  0.2	  µl	  of	  the	  protein	  sample	   with	   0.2	   µl	   of	   crystallization	   solution	   in	   each	   well	   of	   the	   96	  conditions,	   prior	   to	   incubating	   the	   trays	   at	   17°C.	   After	   3	   days,	   hits	   were	  found	  in	  the	  JCSG	  condition	  wells	  B8	  and	  C5,	  and	  crystals	  appeared	  in	  the	  conditions	  of	  PHClear	  well	  G8	  and	  JCSG	  well	  H7	  (figure	  5.5).	  In	  an	  attempt	  to	  get	  higher	  quality	  crystals,	  these	  conditions	  were	  optimized	  using	  the	  	  




Figure	  5.3.	  SDS-­‐PAGE	  gel	  showing	  the	  purification	  steps	  of	  wild	  type	  PheDH	  (MW=	  41.578	  kDa).	  Lane	  1	  shows	  marker	  12.	  Lane	  2	  shows	  cell	  free	  extract.	  	  Lane	  3	  shows	  sample	  applied	  on	  Phe-­‐HP	  column.	  Lane	  4	  shows	  sample	  after	  	  Phe-­‐HP.	  Lane	  5	  sample	  after	  gel	  filtration.	  	  
	  
Figure	   5.4.	   Chromatogram	   traces	   for	   the	   purification	   of	   wild	   type	   PheDH.(a)	  hydrophobic	   chromatography	   (Phe-­‐HP)	   purification	   stage	   and	   (b)	   gel	   filtration	  purification	  step.	  Arrows	  indicate	  peak	  containing	  PheDH	  protein.	  	  
1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  
a	  
b	  
	   145	  












Figure	  5.5.	  Photographs	  of	  Robot	  Screen	  crystals	  of	  single	  mutant	  B.	  sphaericus	  PheDH	  with	  NAD+	  .	  	  	  	  	  	  	   	   	  
Classics	  C5	  0.1M	  Sodium	  acetate	  pH4.6	  2.M	  Ammonium	  sulphate	  	  Classics	  B8	  0.2M	  Magnesium	  Chloride	  0.1M	  Tris	  pH	  7.0	  10%	  (w/v)	  PEG	  8000	  
JCSG	  H7	  0.2M	  Ammonium	  sulphate	  0.1M	  Bis-­‐Tris	  	  pH	  5.5	  25%	  (w/v)	  PEG3350	  	  
PHClear	  G8	  0.1M	  Sodium	  acetate	  pH	  5.0	  20%	  (v/v)	  MPD	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hanging	   drop	   vapour	   diffusion	  method	   as	   described	   in	   section	   2.3.2.	   For	  optimization	   the	   JCSG-­‐H7	   condition,	   the	   concentration	   of	   PEG3350	   was	  altered	   from	  15%	  to	  30%	  and	   the	  pH	  also	  varied	   from	  4.5	   to	  6.0	  and	   the	  tray	   was	   incubated	   at	   17°C.	   The	   pH	   was	   changed	   from	   4.0	   to	   6.0	   for	  optimization	  of	  PHClear	  B8.	  Unfortunately,	  no	  crystals	  grew	  in	  this	  trial.	  	  
5.2.2	  Crystallization	  of	  wild-­‐type	  PheDH	  with	  NADH	  Co-­‐crystallization	  of	  wild-­‐type	  PheDH	  with	  cofactor	  was	  undertaken	  using	  the	  same	  method	  established	  above	  (section	  5.1.1).	  A	  number	  of	  hits	  were	  found	   in	   the	  pHClear	  condition	  wells	  C2,	  C3	  and	  H3,	   JCSG	  condition	  wells	  E10	  and	  H4,	  PEG	  condition	  well	  C12	  and	  Classics	  condition	  well	  B2	  (Figure	  5.6).	   Efforts	  were	  made	   to	   optimize	   the	   crystallization	   conditions	   for	   the	  wild	  type	  protein	  crystals	  by	  using	  a	  hanging	  drop	  vapour	  diffusion	  method	  as	  described	  in	  section	  2.3.2.	  Optimization	  of	  the	  condition	  PHClear	  C3	  was	  the	  only	  condition	  producing	  good	  quality	  crystals.	   In	  this	  experiment	  the	  concentration	  of	  isopropanol	  was	  varied	  from	  1%	  to	  15%.	  The	  best	  crystals	  were	   obtained	   under	   the	   conditions	   with	   0.1	   M	   MES	   pH=6.0	   and	   12%	  isopropanol,	  after	  two	  weeks	  of	  incubation	  at	  17°C	  	  (figure5.7b).	  
5.3	  Data	  collection	  and	  processing	  of	  Phenylalanine	  Dehydrogenase	  
from	  Bacillus	  Sphaericus	  	  
5.3.1	  Single	  mutant	  (N145A)	  of	  phenylalanine	  dehydrogenase	  	  Crystals	   of	   N145A	  mutant	   of	   PheDH	   with	   NAD+	   from	   the	   JCSG-­‐H7	   robot	  screen	   were	   loop	   mounted	   and	   placed	   in	   a	   cryo-­‐protectant	   solution	  consisting	  of	   0.2M	  ammonium	  sulphate,	   0.1M	  Bis-­‐Tris	   pH=5.5,	   25%(w/v)	  PEG3350	  and	  30%	  ethylene	  glycol	  prior	  to	  flash	  cooling	  in	  liquid	  nitrogen.	  Data	  were	   collected	   on	  beamline	   I02	   at	   the	  Diamond	  Light	   Source	   (DLS).	  120	  images	  were	  recorded	  from	  one	  crystal	  with	  rotation	  angle	  of	  0.75°	  and	  an	   exposure	   time	   of	   1.8	   s	   per	   image.	   The	   data	   were	   processed	   to	   a	  resolution	   of	   3.1Å	   using	   Xia2	   system	   in	   the	   3dii	  mode	   (Winter,	   2010)	   at	  DLS.	   The	  data	  were	   indexed	   to	   space	   group	  P4	  with	  unit	   cell	   parameters	  
a=b=123.90,	   c=143.68A ̊,	   α=β=γ=90°.	   Data-­‐collection	   and	   processing	  statistics	  are	  shown	  in	  Table	  5.1.	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Figure	   5.6.	   Pictures	   of	   robot	   screen	   crystals	   of	   wild-­‐type	   B.	   sphaericus	   PheDH	   with	  NADH.	  
PEG	  C12	  0.1	  M	  MES	  pH	  6.5	  15%	  (w/v)	  PEG	  20000	  	  
JCSG	  E10	  0.1M	  BICINE	  Ph	  9.0	  10%	  (w/v)	  PEG6000	  	  	  
PHClear	  H3	  0.1M	  MES	  pH	  6.0	  40%	  (v/v)	  MPD	  
PHClear	  C2	  0.1M	  Citric	  acid	  pH	  5.0	  5%	  (w/v)	  PEG6000	  
Classics	  B2	  	  25%	  (v/v)	  Ethylene	  glycol	   JCSG	  H4	  0.2M	  Calcium	  chloride	  0.1M	  Bis-­‐Tris	  pH	  5.5	  45%	  (v/v)	  MPD	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Figure	  5.7.	  Photographs	  of	  crystals	  for	  wild-­‐type	  B.	  sphaericus	  PheDH	  with	  NADH.	  a) pHClear	  C3-­‐	  Robot	  Screen:	  0.1M	  MES	  pH=6.0	  and	  5%	  Isopropanol;	  Drop	  size	  0.2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  µl	  of	  protein	  +	  0.2	  µl	  precipitant.	  b) pHClear	  C3-­‐	  Hanging	  Drop:	  0.1M	  MES	  pH=6.0	  and	  12%	  Isopropanol;	  drop	  size	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.0µl	  of	  protein	  sample	  +	  1.0µl	  crystallization	  solution.	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5.3.2	  Binary	  complex	  of	  wild	  type	  PheDH	  with	  NADH	  Crystals	   were	   harvested	   for	   data	   collection	   from	   the	   optimization	  experiment	  (0.1M	  MES	  pH=6.0	  +	  12%	  isopropanol)	  based	  on	  their	  size	  and	  overall	   definition.	   These	   crystals	   were	   transferred	   to	   a	   cryoprotectant	  solution	   containing	   the	   mother	   liquor	   and	   30%	   ethylene	   glycol	   prior	   to	  flash	   cooling	   in	   liquid	  nitrogen.	   Initial	   diffraction	   analysis	  was	  performed	  using	  a	  Rigaku007	  rotating	  anode	  generator	  and	  a	  MAR345	  image	  plate.	  3	  images	  were	   collected	  with	  5	  min	  exposure	   time	  per	   image.	  One	  of	   these	  crystals	  diffracted	  to	  beyond	  3.5Å	  resolution	  on	  the	  home	  source	  and	  so	  it	  was	   saved	   in	   liquid	   nitrogen	   and	   taken	   to	   the	   beamline	   IO4	   of	   the	   DLS	  synchrotron,	  Oxford.	  A	   total	  1350	   images	  were	  collected	   from	  this	  crystal	  to	  the	  resolution	  of	  2.5Å	  with	  a	  rotation	  angle	  of	  0.15°	  and	  an	  exposure	  time	  of	  0.5	  s	  per	  image.	  The	  X-­‐ray	  diffraction	  data	  were	  processed	  through	  Xia2	  system	   using	   the	   3dii	   mode	   (Winter,	   2010)	   at	   the	   diamond	   light	   source.	  The	   crystal	   indexed	   to	   space	   group	   C2	   with	   cell	   dimensions;	   a=215.6	   Å,	  b=97.4Å,	   c=202.6,	   α=	   γ=90°	   and	   β=121.69°.	   The	   volume	   of	   the	   unit	   cell	  suggested	  that	  the	  asymmetric	  unit	  contained	  8	  subunits	  of	  the	  PheDH,	  to	  give	  a	  Vm	  of	  2.73	  Å3	  Da-­‐1,	  which	   is	   in	  the	  range	  for	  Matthews	  Coefficients	  (Kantardjieff	  &	  Rupp,	   2003).	   Data-­‐collection	   and	   processing	   statistics	   are	  shown	  in	  Table	  5.2.	  	  
5.4	  Molecular	  replacement	  and	  model	  building	  In	   order	   to	   get	   a	   suitable	   search	   model	   for	   molecular	   replacement,	   the	  amino	  acid	  sequence	  of	  PheDH	  from	  B.	  sphaericus	  was	  queried	  against	  the	  protein	   data	   bank	   using	   the	   Basic	   Local	   Alignment	   Search	   Tool	   (BLAST)	  (Altschul	   et	   al,	   1997).	   The	   best	   homology	   was	   found	   with	   the	   leucine	  dehydrogenase	   from	  B.	   sphaericus	   (PDB	   accession	   number	   1LEH),	  where	  the	   identity	   between	   two	   enzymes	   is	   about	   50%.	   The	   octameric	   B.	  
sphaericus	  LeuDH	   (no	  water)	  was	   trimmed	   to	   a	   tetramer	   using	  Pdbset	   in	  CCP4i	  and	  four	  subunits	  A,	  B,	  C	  and	  D	  in	  the	  form	  of	  the	  two	  dimers	  (A,	  B	  and	  C,	  D)	  were	  selected	  for	  an	  automated	  search	  through	  Phaser	  (McCoy	  et	  al,	  2007)	   in	  CCP4i.	  As	  Vm	  calculations	   indicated	   that	   the	  asymmetric	  unit	  contained	  8	  subunits	  and	  the	  space	  group	  includes	  a	  2-­‐fold	  axis,	  there	  could	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   Overall	   Low	   High	  High	  resolution	  limit	  	  	  	  	  Å	   3.14	  	   14.04	   3.14	  Low	  resolution	  limit	  	  	  	  	  Å	   123.91	  	   123.91	   3.22	  Completeness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  %	   99.8	  	   98.9	   100.0	  Multiplicity	   3.7	   3.5	   3.8	  I/sigma	   12.0	   38.5	   2.5	  Rmerge	   0.124	   0.022	   0.733	  Rmeas(I)	   0.174	   0.032	   0.981	  Rmeas(I+/-­‐)	   0.166	   0.031	   0.984	  Rpim(I)	   0.088	   0.017	   0.491	  Rpim(I+/-­‐)	   0.110	   0.021	   0.650	  Wilson	  B	  factor	   75.918	  Partial	  bias	   0.000	   0.000	   0.000	  Anomalous	  completeness	   94.7	   95.2	   97.3	  Anomalous	  multiplicity	   1.9	   1.9	   1.9	  Anomalous	  correlation	   0.127	   0.003	   0.037	  Anomalous	  slope	   1.134	   0.000	   0.000	  Total	  observations	   141765	   1585	   10832	  Total	  unique	   37897	   451	   2828	  	  
Table	   5.1.	   Data-­‐collection	   and	   processing	   statistics	   for	   the	   single	   mutant	   PheDH	  crystallized	  with	  the	  cofactor.	  	  	  	  
	  
	  	  	  	  	  	  	  
	  	  	  	  	  	  	  
Table	  5.2.	  Data-­‐collection	  and	  processing	  statistics	  for	  the	  binary	  complex	  of	  the	  wild-­‐type	  B.	  sphaericus	  PheDH	  with	  NADH.	  	  
Dataset	   Overall	   Low	   High	  High	  resolution	  limit	  	  	  Å	   2.54	   11.37	   2.54	  Low	  resolution	  limit	  	  	  	  Å	   85.81	  	   85.81	   2.61	  Completeness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  %	   98.9	   99.5	   96.3	  Multiplicity	   3.9	   3.9	   3.5	  I/sigma	   14.0	   68.5	   1.4	  Rmerge	   0.074	   0.017	   0.860	  Rmeas	  (I)	   0.102	   0.032	   1.176	  Rmeas	  (I+/-­‐)	   0.099	   0.023	   1.162	  Rpim	  (I)	   0.050	   0.018	   0.612	  Rpim	  (I+/-­‐)	   0.066	   0.015	   0.776	  Wilson	  B	  factor	   61.752	  Anomalous	  completeness	   95.3	   96.5	   90.6	  Anomalous	  multiplicity	   1.9	   2.1	   1.7	  	  Anomalous	  correlation	   0.072	   0.314	   0.015	  Anomalous	  slope	   1.058	   0.000	   0.000	  Total	  observations	   452222	   5463	   28825	  Total	  unique	   115751	   1397	   8279	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   be	   either	   one	   complete	   octamer	   of	   PheDH	   or	   two	   half-­‐octamers	   in	   the	  asymmetric	  unit.	  Therefore	  the	  X-­‐ray	  dataset	  was	  entered	  and	  Phaser	  was	  run	  in	  the	  C2	  space	  group,	  searching	  for	  two	  copies,	  of	  the	  tetramer.	  Phaser	  found	  a	  solution	  with	  a	  Z-­‐score	  15.12	  for	  rotation	  and	  20.15	  for	  translation	  for	  tetramer	  one	  and	  the	  Z-­‐score	  of	  rotation	  function=12.1	  and	  translation	  function=53.2	  for	  tetramer	  two	  with	  an	  Rfactor=0.40	  and	  Rfree=0.47	  after	  refinement	  of	   the	   resultant	  model	   by	  REFMAC5	   (Murshudov	   et	   al,	   2011).	  This	  solution	   from	  Phaser	  gave	   two	  half-­‐octamers	   in	   the	  asymmetric	  unit,	  with	   the	   crystallographic	   two-­‐fold	   being	   used	   to	   assemble	   the	   octameric	  PheDH	  oligomer,	  suggesting	  a	  correct	  solution.	  However,	  inspection	  of	  the	  resultant	   structure	   and	   the	   electron	  density	  map	   for	   all	   subunits	   showed	  that	   the	  electron	  density	  was	  poor	   for	   this	   initial	  model.	  Therefore,	   to	  get	  the	   C-­‐terminal	   domains	   correct	   in	   the	   density	   map	   for	   all	   subunits,	   the	  model	   was	   subjected	   to	   a	   rigid	   body	   refinement	   using	   REFMAC5	  (Murshudov	   et	   al,	   2011)	   in	   the	   CCP4i	   suite	   at	   6.0Å	   and	  2.6Å.	   The	  Phenix	  software	  suite	  was	  used	  to	  fit	  loops	  that	  were	  disordered,	  before	  restrained	  refinement	   using	   REFMAC5	   (Murshudov	   et	   al,	   2011).	   The	   resultant	  electron	  density	  map	  was	  checked	  for	  this	  model	  and	  it	  was	  found	  that	  the	  electron	   density	   for	   domain	   I	   was	   better	   than	   domain	   II	   for	   the	   whole	  structure.	   Examining	   the	   electron	   density	   within	   the	   active	   site	   for	   all	  subunits	   showed	   that	   there	  was	  a	  positive	  different	  peak	  associated	  with	  the	  nucleotide-­‐binding	  site	  of	  all	  8	  subunits,	  which	  could	  be	  assigned	  to	  the	  cofactor.	  Different	  features	  of	  this	  density	  could	  be	  seen	  for	  the	  eight	  chains	  in	   the	  asymmetric	  unit,	  but	   the	  best	  density	  was	   linked	  with	   the	   chain	  D.	  Thus,	   the	   D	   subunit	   was	   used	   for	   rebuilding	   and	   the	   sequence	   of	   the	   B.	  
sphaericus	  LeuDH	   search	  model	  was	   changed	   to	   the	  B.	   sphaericus	  PheDH	  sequence.	  All	  disordered	  residues	  were	  removed	  from	  the	  model,	  including	  the	  first	  11	  residues	  and	  the	  loops	  at	  the	  residues	  145-­‐155	  and	  223	  to	  234.	  NADH	  was	  then	  modeled	  within	  the	  electron	  density	  in	  the	  active	  site.	  	  The	  rebuilt	  subunit	  D	  was	  superimposed	  onto	  other	  subunits	  using	  secondary	  structure	  matching	  superpose	  (SSM	  superpose)	   through	  COOT	  (Emsley	  et	  al,	   2010).	   Several	   cycles	   of	   model	   building	   and	   refinement	   were	   then	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conducted	  using	  COOT	  (Emsley	  et	  al,	  2010)	  and	  REFMAC5	  (Murshudov	  et	  al,	  2011).	  There	  are	  a	  number	  of	  areas	  in	  the	  electron	  density,	  which	  are	  of	  poor	   quality	   and	   thus	   building	   a	   model	   with	   good	   geometry	   is	   difficult.	  Nevertheless,	   the	   electron	   density	   around	   the	   active	   site	   and	   the	   NADH	  binding	   site	   is	   quite	   good	  and	   some	  useful	  points	   can	  be	  made	  about	   the	  structure.	  
5.5	  Analysis	  of	  the	  B.	  sphaericus	  PheDH	  structure	  
B.	  sphaericus	  PheDH	  is	  an	  octameric	  enzyme	  that	  consists	  of	  eight	  subunits	  of	  381	  amino	  acid	  residues,	  organized	  into	  42-­‐point	  group	  symmetry.	  The	  polypeptide	   chain	   is	   formed	   from	  13	   α-­‐helices	   and	   10	   β-­‐sheets	  with	   163	  and	   46	   residues	   in	   these	   secondary	   structures,	   respectively,	   which	  represents	   ≈	   55%	   of	   the	   whole	   subunit.	   In	   B.	   sphaericus	   LeuDH	   the	  monomer	  contains	  14	  α-­‐helices	  and	  12	  β-­‐strands,	  which	  amounts	   to	  75%	  of	  the	  subunit	  (Baker	  et	  al,	  1995).	  
5.5.1	  Tertiary	  structure	  of	  PheDH	  subuint	  Like	  GluDH	  the	  PheDH	  monomer	  comprises	  two	  domains,	  linked	  by	  flexible	  loops,	   and	   separated	   by	   a	   deep	   groove	   in	   which	   the	   substrates	   bind.	  Domain	   I	   is	   relatively	   larger	   than	  domain	   II	   and	   it	   consists	  of	   amino	  acid	  residues	   1-­‐140	   and	   344-­‐380.	   The	   polypeptide	   chain	   in	   this	   domain	   is	  organized	   into	   a	   cluster	   of	   4	   α-­‐helices	   and	   4	   β-­‐strands.	   The	   secondary	  structure	  units	  begin	  with	  a	  short	  helix	  (residues	  16-­‐20),	  followed	  directly	  by	   three	   segments	   of	   antiparallel	   β-­‐strands.	   The	   remaining	   residues	   are	  organized	  into	  two	  α-­‐helices,	  one	  β-­‐strand	  and	  one	  α-­‐helix.	  This	  domain	  is	  comprised	   of	   four	   parallel/antiparallel	   β-­‐strands,	   surrounded	   by	   four	   α-­‐helices	  on	  both	  sides.	  Domain	  II	  or	  C-­‐terminal	  domain	  (residues	  41-­‐343),	  is	  similar	  to	  the	  Rossmann	  fold	  and	  contains	   five	  parallel	  β-­‐strands	  (βe-­‐	  βh)	  flanked	  by	  seven	  α-­‐helices	  (α5-­‐	  α9).	  One	  domain	  of	  the	  binary	  complex	  of	  B.	  
sphaericus	  PheDH	  is	   illustrated	  in	  figure	  5.8a,	  and	  compared	  to	  the	  GluDH	  in	  figure	  5.8b.	  
5.5.2	  Quaternary	  structure	  	  Two	  subunits	  of	  PheDH	  assemble	  into	  a	  dimer,	  in	  a	  similar	  way	  to	  the	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PheDH 1  -----------------------------------MAKQLEKSSKIGNEDVFQ--KIANHEQIVFCNDPV   33           
LeuDH 1  ------------------------------------------------MEIFKYMEKYDYEQLVFCQDEA   22           
msgdh 1  MSELHPKLQAVFEEVSHRNGGEKEFHQAVFEVLQSLGPVVEKHPEYADNAIIR--RLCEPERQIIFRVPW   68  
                                             hhhhhh      hhhhh  hh    eeeeeeeee 
PheDH 34  -------SGLQAIIAIHDTTLGPALGGTRMYPYKNVDEALEDVLRLSEGMTYKCAAADIDFGGGKAVIIG   96         
LeuDH 23  -------SGLKAVIAIHDTTLGPALGGARMWTYNAEEEAIEDALRLARGMTYKNAAAGLNLGGGKTVIIG   85          
msgdh 69  VDDTGHVQINRGFRVEFNSALGPYKGGLRFHPSVY----LGIVKFLGFEQIFKNALTGLPIGGGKGGSDF  134  
                  eeeeeeeeee          eee     hhhhhhhhhhhhhhhhhhhhh        eeeee 
PheDH  97  DPEKDKSPALFRAFGQFVESLN-----GRFYTGTDMGTTMDDFVHAQKET---------NFINGIPEQYG  152         
LeuDH  86  DPFADKNEDMFRALGRFIQGLN-----GRYITAEDVGTTVDDMDLIHQET---------DYVTGISPAFG  141         
msgdh 135  DPKGRSDAEIMRFCQSFMTELYRHIGEYTDVPAGDIGVGTREIGYLFGQYKRITNRYESGVLTGKGLTWG  204  
                 hhhhhhhhhhhhhhh        eee        hhhhhhhhhh            ee   hh 
PheDH 153  GSGDSSIPTAQGVIYALKATNQYLFGSDSLSGKTYAIQGLGKVGYKVAEQLLKAGADLFV-TDIHENVLN  221        
LeuDH 142  SSGNPSPVTAYGVYRGMKAAAKEAFGSDSLEGLAVSVQGLGNVAKALCKKLNTEGAKLVV-TDVNKAAVS  210        
msgdh 205  GSRVRTEATGYGTVFFVDEILQSRGQ--SFDGKRVVVSGSGNVAIYAIEKVHALGGIVVACSDSGGYVVD  272  
                  hhhhhhhhhhhhhhhhh         eeeee   hhhhhhhhhhhh   eeee ee   hh 
PheDH 222  SIKQKSEELG------------------GSVTIVKSDDIYSVQADIFVPCAMGGIINDKTIPKL---KVK  270         
LeuDH 211  AAVAE-----------------------EGADAVAPNAIYGVTCDIFAPCALGAVLNDFTIPQL---KAK  254        
msgdh 273  EKGIDLDLLKEVKEVQRARIDAYAEARGGATQFVSGGSVWNVACDIALPCATQNEVSGDDARALIESGCR  342  
                hhhhhhhhhh                ee            eeee        hhhhhh      e  
PheDH 271 AVVGSANNQLKDLRHANVLNEKGILYAPDYIVNAGGLIQVADELYGPNKERVLLKTKEIYRSLLEIFNQA  340         
LeuDH 255 VIAGSADNQLKDPRHGKYLHELGIVYAPDYVINAGGVINVADELYGYNRTRAMKRVDGIYDSIEKIFAIS  324         
msgdh 343 IVAEGANMP-CTPEAVKLFDQAGVTFAPGKAVNAGGVATSALEMQQ-NASRDSWTFDDTEGRLAGIMRRI  410 
           eeee      hhhhhhhhh   eee  hhhh  hhhhhhhhhhh     hh   hhhhhhhhhhhhhhh 
PheDH 341 ALDCITTVEAA-----NRKCQKTIEGQQTRNSFFSRGRRPKWNIKE--  381                                  
LeuDH 325 KRDGVPSYVAA-----DRMAEERIAKVAKARSQFLQDQR---NILNGR  364                               
msgdh 411 HDRCLTTADEYDQPGNYVAGANIAGFTQVADAMLALGLI---------  449 
          hhh   hhhhh     hhhhhhhhhhhhhhhhhhh                                                                           
 
 
Figure	   5.8.	   Structural	   sequence	   alignment	   of	   the	   B.	   sphaericus	   PheDH,	   B.	  
sphaericus	   LeuDH	   and	  M.	   smegmatis	   GluDH.	   Secondary	   structure	   segments	   are	  shown	  under	  the	  sequence.	  This	   figure	  was	  generated	  using	  PROMALS3D	  (Pei	  et	  al,	  2008).	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Figure	  5.9.	   Schematic	  diagram	  shows	  the	  overall	  organization	  of	  one	  chain	  of	  B.	  
sphaericus	  PheDH	  (a)	  and	  M.	  smegmatis	  GluDH	  (b).	  The	  PheDH	  subunit	  is	  viewed	  in	   the	   four-­‐fold	  axis	  and	  the	  chain	  of	  GluDH	  is	  viewed	   in	   the	   three-­‐fold	  axis.	  The	  single	   subunits	  of	  both	  enzymes	  are	  organized	   into	   two	  domains	  separated	  by	  a	  deep	   cleft.	   In	   PheDH,	   the	   α-­‐helices	   numbered	   from	   α1-­‐	   α13	   and	   the	   strands	  numbered	  βa-­‐	   βj,	  whereas	   in	  GluDH	   the	  α-­‐helices	   labeled	   from	  α1-­‐	  α18	   and	   the	  strands	  labeled	  βa-­‐	  βk.	  	  	  	  	  	  	  	  
a	  
b	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dimer	  assembly	  in	  GluDH.	  However,	  the	  four	  dimers	  of	  B.	  sphaericus	  PheDH	  assemble	  around	   the	   four-­‐fold	  axis	   to	  give	  an	  octamer	  with	  42-­‐symmetry	  compared	   to	   the	   GluDH	   hexamer.	   The	   main	   contacts	   between	   these	  monomers	   arise	   from	   the	   amino	   acid	   residues	   in	   the	  N-­‐terminal	   domain,	  where	  the	   interactions	  through	  the	  twofold	  axis	  make	  the	  dimers	  and	  the	  contacts	   across	   the	   fourfold	   axis	   form	   the	   octamer.	   The	   domains	   I	   are	  packed	   in	   the	   centre	   of	   the	   oligomer	   and	   the	   closest	   to	   the	  42-­‐symmetry	  point.	   N-­‐	   and	   C-­‐terminal	   domains	   in	   each	   monomer	   meet	   on	   top	   of	   one	  another	  in	  the	  side	  of	  the	  fourfold	  axis.	  The	  PheDH	  octamer	  is	  very	  similar	  to	  the	  B.	  sphaericus	  LeuDH	  octamer	  (figure	  5.10).	  
5.5.3	  Dinucleotide	  binding	  site	  All	  phenylalanine	  dehydrogenases	  use	  NAD+	  as	  a	  cofactor	  in	  their	  reactions	  (Brunhuber	   &	   Blanchard,	   1994).	   Although	   the	   structure	   for	   the	   binary	  complex	  of	  B.	  sphaericus	  PheDH	  with	  NADH	  has	  been	  determined	  only	   to	  medium	   resolution	   (2.5Å),	   the	   nature	   of	   the	   interactions	   between	   the	  dinucleotide	   and	   this	   enzyme	   can	   be	   determined.	   The	   PheDH	   from	   B.	  
sphaericus	  displays	   substantial	   similarity	   for	   the	   secondary	   structure	   and	  fold	   of	   the	   dinucleotide-­‐binding	   domain	   to	   the	   other	   amino	   acid	  dehydrogenases	   GluDH	   and	   LeuDH.	   The	   interaction	   between	   the	   PheDH	  and	   the	   cofactor	   (NADH)	   is	   also	   similar.	   In	   addition,	   primary	   structural	  analysis	  for	  this	  binary	  complex	  shows	  that	  the	  dinucleotide-­‐binding	  region	  includes	  βe-­‐α6-­‐βf	  and	  that	  the	  amino	  acid	  sequence	  of	  the	  glycine	  rich	  loop,	  which	   is	   connected	   the	  end	  of	  βe	  and	   the	  start	  of	  α6,	   is	  GLGKVG	  (P1-­‐P6).	  From	  this	  sequence	  it	  can	  be	  noted	  that	  the	  residue	  at	  the	  P6	  is	  glycine-­‐196,	  in	  agreement	  with	  general	  pattern	  of	  glycine	  at	  P6	  in	  most	  NAD+-­‐dependent	  amino	  acid	  dehydrogenases.	  	  
5.5.3.1	  Mode	  of	  binding	  of	  NADH	  with	  B.	  sphaericus	  PheDH	  enzyme	  As	  mentioned	  above,	  the	  residue	  at	  the	  P6	  position	  is	  glycine	  which	  mean	  a	  type	  I	  hydrogen	  bond	  can	  be	  formed	  in	  this	  complex	  (see	  section	  5.3.2	  for	  details	   about	   type	   I	   hydrogen	   bond)(Baker	   et	   al,	   1992c).	   The	   carbonyl	  group	  of	  G191	  (P1)	  points	  towards	  the	  α-­‐carbon	  of	  G196	  (P6).	  The	  side-­‐	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Figure	  5.10.	  Space	  filling	  illustration	  of	  the	  octameric	  structures,	  of	  PheDH	  (a	  and	  b)	   and	   LeuDH	   (c	   and	   d)	   from	   B.	   sphaericus,	   with	   each	   subunit	   individually	  coloured.	  a	  and	  c	  view	  down	  the	  two-­‐fold	  axis	  applied	  to	  form	  the	  dimer,	  and	  the	  four-­‐fold	  axis	  being	  perpendicular.	  b	  and	  d	  view	  down	  the	  four-­‐fold	  axis.	  	  	  	   	  	  
c	   d	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chain	   carboxyl	   group	   of	   the	   acidic	   residue	   at	   P7	   (Asp214)	   forms	   two	  hydrogen	  bonds	  with	  the	  2’	  and	  3’	  hydroxyl	  groups	  of	  adenine	  ribose,	  and	  also	  makes	  a	  hydrogen	  bond	  to	  the	  backbone	  amide	  nitrogen	  of	  L192	  (P2).	  	  The	   adenine	   ring	   lies	   in	   the	   pocket	   lined	   by	   Gln190,	   Ile215,	   Ala254	   and	  Met255.	   In	   this	  binary	  complex	   the	   side	  chain	   sulphur	  atom	  of	  Met255	   is	  within	   3.03	   Å	   of	   the	   NH2	  of	   the	   adenine	   ring	   and	   could	   perhaps	   form	   a	  hydrogen	  bond.	  As	  has	  been	  seen	   in	   the	   ternary	  complex	  of	  M.	  smegmatis	  GluDH	   (see	   section	   5.3.4	   for	   details)	   the	   pyrophosphate	   moiety	   of	   the	  NADH	   of	   the	   B.	   sphaericus	  PheDH	   binary	   complex	   lies	   at	   the	   end	   of	   the	  dinucleotide	   binding	   helix	   (α6),	   which	   aids	   in	   the	   stabilization	   of	   the	  phosphate	   group	   with	   its	   helix	   dipole.	   An	   oxygen	   atom	   of	   the	   adenine	  phosphate	  (O2A)	  interacts	  with	  the	  backbone	  amide	  nitrogen	  of	  Lys194	  by	  a	   hydrogen	  bond	   (3.2Å).	   The	  main	  N-­‐H	  of	  Val195	  hydrogen	  bonds	   to	   the	  O2N	  of	   the	  pyrophosphate	  moiety,	   and	  O1N	   forms	  a	  hydrogen	  bond	  with	  the	  N-­‐H	  of	  the	  nicotinamide	  moiety,	  (2.76Å).	  	  	  	  	  	  	  By	   examining	   the	   electron	   density	   map	   corresponding	   to	   the	   cofactor	  (NADH)	   it	   can	   be	   seen	   that	   the	   nicotinamide	   moiety	   adopts	   the	   syn	  conformation	  for	  the	  glycosidic	  bond	  between	  the	  nicotinamide	  moiety	  and	  linked	   ribose	   as	   is	   seen	   in	   GluDH.	   As	   a	   result	   of	   this	   conformation,	   the	  oxygen	   atom	   of	   carbonyl	   group	   of	   nicotinamide	   ring	   makes	   a	   hydrogen	  bond	   (2.76Å)	   to	   the	   O1N	   of	   pyrophosphate.	   In	   addition,	   two	   hydrogen	  bonds	  can	  be	  made	  between	   the	  amide	  group	  of	   the	  nicotinamide	  moiety	  and	   the	   side-­‐chain	  hydroxyl	   group	  and	  backbone	  amide	  group	  of	   Ser157,	  where	   the	   lengths	   of	   these	   bonds	   are	   2.48Å	   and	   2.42Å	   respectively.	  Furthermore,	   the	   2’hydroxyl	   group	   of	   the	   nicotinamide	   ribose	   forms	   a	  hydrogen	  bond	   (2.79Å)	   to	   the	   side-­‐chain	  amide	  group	  of	  Asn277	  and	   the	  3’hydroxyl	  group	  hydrogen	  bonds	  (2.53Å)	  to	  the	  backbone	  carbonyl	  group	  of	  Ala254.	  
5.5.4	  Domain	  motion	  As	  has	  been	  described	  at	   length	   in	  chapter	  4	  (section4.5),	  domain	  motion	  during	   the	   catalytic	   cycle	   is	   a	   feature	   of	   the	   amino	   acid	   dehydrogenase	  superfamily.	  In	  addition	  to	  the	  movement	  described	  for	  GluDH,	  X-­‐ray	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Figure	  5.11.	  A	  schematic	  diagram	  of	  one	  subunit	  of	  B.	  sphaericus	  PheDH	  showing	  the	  cofactor	  location.	  	  	   	  	  
	  
Figure	   5.12.	   A	   schematic	   depicts	   the	   βαβ	   motif	   (βe-­‐α6-­‐βf).	   P1-­‐P6	   residues	   that	  
connect	  the	  βe	  and	  the	  α6	  are	  shown	  in	  blue	  colour	  (G91-­‐G96)	  and	  D214	  is	  an	  acidic	  
residue	  P7.	  Type	   I	  hydrogen	  bond	  can	  be	  seen	  between	   the	  side	  chain	  of	  D214	   (P7)	  
and	  NH2	  main	  chain	  of	  L192	  (P2),	  and	  2’	  and	  3’	  hydroxyl	  groups	  of	  adenine	  ribose.	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Figure	  5.13.	  A	  schematic	  diagram	  of	  an	  interaction	  of	  adenine	  ring	  in	  the	  binary	  complex	  structure	  of	  B.	  sphaericus	  PheDH.	  	  	  	   	  
	  	  
Figure	  5.14.	   	  Schematic	   illustrating	  the	  pyrophosphate	  binding	  with	  the	  adjacent	  groups.	  Two	  oxygen	  atoms	   (O2A	  and	  O2N)	  make	  hydrogen	  bonds	   to	   the	  glycine	  rich	  loop	  and	  the	  O1N	  forms	  a	  hydrogen	  bond	  to	  NH2	  of	  nicotinamide.	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Figure	   5.15.	   The	   interaction	   of	   nicotinamide	   ring	   and	   associated	   ribose	   to	   the	  neighbouring	  groups	  in	  the	  binary	  complex	  structure	  of	  B.	  sphaericus	  PheDH	  with	  NADH.	  	  	  	   NADH	   Hydrogen	  bonds	  of	  NADH	  in	  B.	  























	  	  i-­‐	  NH2	  of	  carboxyamide	  	  	  	  	  	  	  	  2.76	  Å	  	  i-­‐Main	  chain	  NH2	  of	  Val195	  	  2.74	  Å	  	  ii-­‐	  Main	  chain	  NH2	  of	  Lys194	  3.2	  Å	  	  
Adenine	  ribose	  	  
	  
2’OH	  
	  	  i-­‐	  Side	  chain	  of	  Asp214	  	  	  	  	  	  	  	  	  	  	  2.83	  Å	  	  	  	  
Table	  5.3.	  Shows	  hydrogen	  bonds	  between	  NADH	  and	  B.	  sphaericus	  PheDH.	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structures	  of	  PheDH	  from	  Rhodococcus	  sp.	  M4	  have	  been	  determined	  for	  a	  number	   of	   cofactor/	   or	   substrate	   or	   inhibitor	   ternary	   complexes.	   In	   each	  one	   of	   these	   structures	   the	   PheDH	  enzyme	  was	   in	   a	   closed	   conformation	  (Brunhuber	  et	  al,	  2000;	  Vanhooke	  et	  al,	  1999).	   	  A	  number	  of	  structures	  of	  
Nocardia	  sp.	  239	  PheDH	  have	  also	  been	  determined	   (Turnbull,	  A.	  P	  et	  al.,	  personal	   communication).	   In	   these	   structures	   the	   free	   enzyme	   and	   the	  binary	  complex	  with	  NADH	  adopt	  the	  open	  form	  with	  the	  structure	  of	  the	  non-­‐productive	   complex	   (PheDH/NAD+/Phenylpyruvate)	   representing	   a	  closed	  form	  for	  this	  protein	  (Turnbull,	  A.	  P	  et	  al.,	  personal	  communication).	  The	  structure	  of	  B.	  sphaericus	  LeuDH	  has	  been	  reported	  as	  the	  apo	  enzyme,	  and	   the	   crystal	   form	   of	   this	   protein	   has	   a	   dimer	   in	   the	   asymmetric	   unit	  (Baker	  et	  al,	  1995).	  Superimposing	  the	  two	  subunits	  showed	  that	  there	  is	  a	  variation	   in	   the	   relative	   orientations	   of	   domains	   I	   and	   II	   in	   the	   two	  subunits,	   with	   one	   subunit	   in	   an	   open	   form,	   and	   the	   other	   in	   a	  conformation	   between	   the	   open	   and	   the	   closed	   form.	   	   Analysis	   of	   the	  crystal	   structure	   for	   the	   binary	   complex	   (PheDH-­‐NADH)	   of	   B.	   sphaericus	  PheDH	   determined	   here	   shows	   that	   this	   complex	   adopts	   the	   open	  conformation,	  which	  is	  similar	  to	  other	  superfamily	  members	  (figure5.10),	  and	   again	   shows	   that	   the	   domain	   positions	   are	   not	   dependent	   on	   the	  presence	  of	  substrates.	  
5.5.5	  Active	  site	  Although	   no	   substrate	   is	   present	   in	   the	   B.	   sphaericus	   PheDH	   structure	  described	  here,	  phenylalanine	   can	  be	  modelled	   into	   the	  active	   site,	   based	  on	   the	   position	   of	   L-­‐glutamate	   in	   GluDH,	   and	   L-­‐phenylalanine	   in	  
Rhodococcus	  sp.	  M4	  PheDH	  (figure	  5.15).	  These	  models,	  in	  conjunction	  with	  the	   sequence	  alignment,	   (figure	  5.16	  and	   table	  5.4)	   show	  conservation	  of	  the	   crucial	   residues	   involved	   in	   the	   active	   site	   (Britton	   et	   al,	   1993b).	   For	  example;	  five	  glycines	  (residues	  90,	  91,	  122,	  123	  and	  376)	  that	  are	  critical	  in	   the	   active	   site	   design	   in	   GluDH	   are	   conserved	   in	  B.	   sphaericus	  PheDH	  (glycine	   residues	  52,	  53,	  88,	  89	  and	  305).	  The	   lysine	   residue	   (K113)	   that	  interacts	   with	   the	   α-­‐carboxyl	   group	   of	   L-­‐glutamate	   in	   GluDH,	   lysine125	  (K125)	  that	  enhances	  the	  nucleophilicity	  of	  the	  water	  molecule	  and	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Figure	   5.16.	   Shows	   the	   distance	   between	   the	   C4	   of	   the	   nicotinamide	   and	   the	  alpha	   carbon	   of	   the	   modelled	   L-­‐phenylalanine.	   The	   distance	   between	   these	  contributors	   involved	   in	   hydride	   transfer	   is	   about	   6.5Å,	   which	   is	   incompatible	  with	  catalysis.	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aspartate165	  (D165),	  which	   is	   involved	   in	  proton	  transfer	   in	   the	  catalytic	  mechanism	   (Stillman	   et	   al,	   1993),	   are	   also	   conserved	   in	   B.	   sphaericus	  PheDH	  (residues	  K79,	  K91	  and	  D133	  respectively).	  Conservation	  of	   these	  crucial	  residues	  between	  the	  GluDH,	  LeuDH	  and	  PheDH	  enzymes	  suggests	  that	   they	   share	   a	   similar	   catalytic	   mechanism.	   In	   contrast	   the	   residues	  involved	  in	  the	  main	  interactions	  with	  the	  substrate	  vary	  between	  GluDH,	  LeuDH	   and	   PheDH.	   In	   C.	   symbiosum	   GluDH,	   the	   γ-­‐carboxyl	   group	   of	   L-­‐glutamate	   interacts	  with	  K89	  and	  S380,	  which	  are	  substituted	  to	  L51	  and	  V310	   in	  PheDH	   from	  B.	  sphaericus,	   but	   in	  Rhodococcus	  sp.	  M4	  PheDH	  are	  A38	  and	  L296,	  respectively.	  These	  changes	  make	  the	  substrate-­‐binding	  site	  more	  hydrophobic	   for	  the	  phenylalanine	  substrate.	   In	  the	  Rhodococcus	  sp.	  M4	   PheDH	   ternary	   complex	  A38	   and	   L296	  make	   direct	   interactions	  with	  phenylalanine	  (3.8Å	  and	  3.9	  Å,	  respectively)	  and	  phenylpyruvate	  (3.8	  Å	  for	  A38	  and	  4.20Å	  for	  L296).	  In	  the	  binary	  and	  ternary	  complex	  structures	  of	  PheDH	   from	  Nocardia	   sp239,	   described	   in	   section	   5.3.4,	   the	   interactions	  between	   the	   phenylalanine	   and	   phenylpyruvate	   with	   the	   enzyme	   are	  similar,	   with	   distances	   of	   4.6Å	   and	   4.9Å,	   to	   Ala31	   and	   Leu285,	   for	  phenylalanine,	   respectively.	   For	   the	   phenylpyruvate	   these	   distances	   are	  4.4Å	  and	  5.3Å,	  respectively.	  This	  suggests	  that	  the	  substrate	  will	  bind	  to	  B.	  
sphaericus	   PheDH	   in	   a	   similar	   way.	   In	   the	   amino	   acid	   dehydrogenases	  (AADH)	   the	  distance	  between	   the	  α-­‐carbon	  of	   the	  modeled	   substrate	  and	  the	   C4	   of	   nicotinamide	   moiety	   of	   NADH	   (the	   contributors	   implicated	   in	  hydride	  transfer)	  is	  about	  6.5Å;	  this	  distance	  is	  incompatible	  with	  catalysis.	  It	  is	  likely	  that	  the	  active	  site	  is	  closed	  by	  moving	  the	  domain	  II,	  excluding	  the	   solvent	   from	   catalytic	   pocket	   and	   bringing	   the	   groups	   involved	   in	  hydride	  transfer	  into	  a	  suitable	  position	  for	  catalysis.	  The	   structure	   of	   B.	   sphaericus	   PheDH	   described	   in	   this	   thesis	   has	   been	  determined	  only	  at	  medium	  resolution	  (2.54	  Å)	  and	  has	  a	  number	  of	  loops	  missing.	  Furthermore,	  only	   the	  binary	  complex	  of	  PheDH	  with	  NADH	  was	  solved	   in	   this	   project.	   Therefore,	   the	   information	   that	   could	   be	   derived	  from	   this	   structure	   was	   limited.	   A	   full	   understanding	   of	   the	  structure/function	  relationship	  in	  the	  PheDH	  enzyme	  family	  needs	  further	  work	  to	  produce	  better	  diffracting	  crystals	  of	  the	  complex	  determined,	  and	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also	  crystals	  of	  other	  binary	  and	   ternary	  complexes	  of	  both	   the	  wild-­‐type	  and	  mutant	  PheDH	  enzymes	  are	  required.	  	  	  	  	  
5.5.6	  Mutant	  of	  B.	  sphaericus	  PheDH	  Numerous	  attempts	  have	  been	  to	  vary	  substrate	  specificity	  in	  B.	  sphaericus	  PheDH	   using	   either	   site-­‐directed	   mutagenesis	   or	   random	   directed	  mutagenesis	   (Chen	   &	   Engel,	   2009;	   Seah	   et	   al,	   2003).	   These	   experiments	  have	  been	  designed	  and	  explained	  based	  on	  either	  the	  Rhodococcus	  sp.	  M4	  PheDH	   structure,	   or	   modelled	   on	   other	   AADH	   structures	   for	   example	   C.	  
symbiosum	  GluDH.	  Although	  the	  B.	  sphaericus	  PheDH	  structure	  determined	  here	  is	  only	  medium	  resolution	  some	  structural	  analysis	  into	  these	  mutant	  experiments	  can	  be	  made.	  
5.5.6.1	  Single	  mutant	  PheDH	  (N145A)	  	  As	  PheDH	  from	  B.	  sphaericus	  is	  relatively	  stable	  it	  is	  a	  candidate	  for	  use	  in	  the	  design	  of	  a	  biosensor	  for	  measuring	  the	  serum	  levels	  of	  phenylalanine,	  that	  are	  elevated	   in	   the	   inherited	  disorder	  disease	  called	  Phenylketonuria	  (PKU)	   (Dooley,	   1992).	   However,	   the	   activity	   of	   B.	   sphaericus	   PheDH	  towards	  L-­‐phenylalanine	  and	  L-­‐tyrosine	  is	  quite	  similar,	  which	  makes	  this	  enzyme	   inappropriate	   for	  use	   in	  monitoring	   the	   levels	  of	  L-­‐phenylalanine	  in	  diagnosis	  the	  Phenylketonuria	  (PKU).	  Nevertheless,	  homology	  modeling	  of	   PheDH	   from	   a	   variety	   of	   sources,	   in	   the	   light	   of	   the	   determined	  structures	   of	   the	   homologous	   enzymes	   LeuDH	   from	   B.	   sphaericus	   and	  GluDH	   from	  C.	   symbiosum	  have	   shown	   that	   an	   asparagine	   residue	   at	   site	  145	  in	  B.	  sphaericus	  PheDH	  is	  equivalent	  to	  a	  valine	  or	  alanine	   in	  PheDHs	  from	  other	   species.	  This	  has	  been	   suggested	   to	  be	   the	  key	   reason	   for	   the	  poor	  differentiation	  by	  B.	  sphaericus	  PheDH	  between	  L-­‐phenylalanine	  and	  L-­‐tyrosine.	   Substitution	   of	   alanine	   or	   valine	   instead	   of	   the	   asparagine	  (N145),	   using	   site	   directed	   mutagenesis,	   increases	   discrimination	   by	   the	  enzyme,	  to	  about	  50-­‐fold,	  between	  L-­‐phenylalanine	  and	  L-­‐tyrosine	  (Seah	  et	  al,	   2002).	   To	   better	   understand	   the	   effect	   of	   this	   mutation,	   a	   tyrosine	  substrate	  molecule	   was	  modeled	   into	   the	  B.	   sphaericus	   PheDH	   structure,	  using	  the	  coordinates	  of	  the	  Norcadia	  PheDH/NADH/Phe	  ternary	  complex	  structure	   (provided	   by	   Dr	   A.P	   Turnbull)	   as	   a	   guide	   (figure	   5.18).	   In	   this	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modeled	   structure,	   it	   can	   be	   seen	   that	   the	   side	   chain	   hydroxyl	   of	   the	  putative	  tyrosine	  substrate	  can	  hydrogen	  bond	  to	  the	  carboxyamide	  group	  of	   the	   side	   chain	   of	   N145.	   In	   the	   N145A	   mutant	   enzyme,	   this	   potential	  hydrogen	   bond	   between	   the	   tyrosine	   substrate	   and	   the	   enzyme	   is	   lost,	  perhaps	   explaining	  why	   the	  B.	   sphaericus	   N145A	  mutant	   PheDH	   shows	   a	  much	   increased	   discrimination	   between	   Phe	   and	   Tyr	   as	   the	   substrate,	  compared	  to	  the	  wild	  type.	  
5.5.6.2	  Triple	  mutant	  proteins	  N145A,	  G124A	  and	  L307V	  A	   number	   of	   site	   directed	   mutants	   of	   PheDH	   have	   been	   produced	   to	  engineer	  the	  protein	  to	  produce	  non-­‐natural	  amino	  acids.	  For	  example;	  the	  triple	  mutant	  N145A,	  G124A	  and	  L307V	  shows	  increased	  activity	  towards	  aliphatic	  amino	  acid	  substrates	  and	  decreased	  catalytic	  activity	  towards	  L-­‐phenylalanine	  (Seah	  et	  al,	  2003).	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PheDHBs          1 M-------------------------AKQLEKSS-------KIGNEDVFQKI--ANHEQIVFCNDP----   32  
LeuDHBs          1 ---------------------------------------------MEIFKYMEKYDYEQLVFCQDE----   21 
PheDHRhC         1 ---------------------------------------------MSIDSALN-WDGEMTVTRFDR----   20  
GDHCs            1 MSKYVDRVIAEVEKKYADEPEFVQTVEEVLSSLGPVVDAHPEYEEVALLERM--VIPERVIEFRVPWEDD   68 
 
                                              hhhhhh             hhhhhhh      eeeeeeee        
  
PheDHBs         33  ---VSGLQAIIAIHDTTLGPALGGTRMYPYKNVDEALEDVLRLSEGMTYKCAAADIDFGGGKAVIIGDPE  99  
LeuDHBs         22  ---ASGLKAVIAIHDTTLGPALGGARMWTYNAEEEAIEDALRLARGMTYKNAAAGLNLGGGKTVIIGDPF  88 
PheDHRhC        21  ---ETGAHFVIRLDSTQLGPAAGGTRAAQYSQLADALTDAGKLAGAMTLKMAVSNLPMGGGKSVIALPAP  87 
GDHCs           69  NGKVHVNTGYRVQFNGAIGPYKGGLRFAPSVN----LSIMKFLGFEQAFKDSLTTLPMGGAKGGSDFDPN 134 
 
                       eeeeeeeeeee          eee     hhhhhhhhhhhhhhhhhhhhh       eeeeee        
 
PheDHBs       100  KDK-----SPALFRAFGQFVESLN-----GRFYTGTDMGTTMDDFVHAQKET---------NFINGIPEQ  150  
LeuDHBs        89     ADK-----NEDMFRALGRFIQGLN-----GRYITAEDVGTTVDDMDLIHQET---------DYVTGISPA  139  
PheDHRhC       88  RHSIDPSTWARILRIHAENIDKLS-----GNYWTGPDVNTNSADMDTLNDTT---------EFVFGRSLE  143  
GDHCs         135  GKS-----DREVMRFCQAFMTELYRHIGPDIDVPAGDLGVGAREIGYMYGQYRKIVGGFYNGVLTGKARS  199 
  
                           hhhhhhhhhhhhhhh        eee       hhhhhhhhhh           eee   hh    
 
PheDHBs        151  YGGSGDSSIPTAQGVIYALKATNQYLFGSDSLSGKTYAIQGLGKVGYKVAEQLLKAGADLF-VTDIHENV  219  
LeuDHBs        140  FGSSGNPSPVTAYGVYRGMKAAAKEAFGSDSLEGLAVSVQGLGNVAKALCKKLNTEGAKLV-VTDVNKAA  208  
PheDHRhC       144  RGGAGSSAFTTAVGVFEAMKATVAHRGL-GSLDGLTVLVQGLGAVGGSLASLAAEAGAQLL-VADTDTER  211  
GDHCs          200  FGGSLVRPEATGYGSVYYVEAVMKHEND--TLVGKTVALAGFGNVAWGAAKKLAELGAKAVTLSGPDGYI  267 
 
                    h        hhhhhhhhhhhhhhhhh         eeeee   hhhhhhhhhhhh   eee eee  hhh   
  
 PheDHBs       220  LNSIKQKSE--------------------ELGGSVTIVKSDDIYSVQADIFVPCAMGGIINDKTIPKL--  267 
 LeuDHBs       209  VSAA-------------------------VAEEGADAVAPNAIYGVTCDIFAPCALGAVLNDFTIPQL--  251 
 PheDHRhC      212  VAH--------------------------AVALGHTAVALEDVLSTPCDVFAPCAMGGVITTEVARTL--  253 
 GDHCs         268  YDPEGITTEEKINYMLEMRASGRNKVQDYADKFGVQFFPGEKPWGQKVDIIMPCATQNDVDLEQAKKIVA  337 
  
                     hhhh   hh                    hhh   ee            eeee        hhhhhh      
  
PheDHBs        268  -KVKAVVGSANNQLKDLRHANVLNEKGILYAPDYIVNAGGLIQVADELYG------PNKERVLLKTKE-I  329  
LeuDHBs        252  -KAKVIAGSADNQLKDPRHGKYLHELGIVYAPDYVINAGGVINVADELYG------YNRTRAMKRVDG-I  313 
PheDHRhC       254  -DCSVVAGAANNVIADEAASDILHARGILYAPDFVANAGGAIHLVGREVLG-----WSESVVHERAVA-I  316 
GDHCs          338  NNVKYYIEVANMPTTNEALRFLMQQPNMVVAPSKAVNAGGVLVSGFEMSQNSERLSWTAEEVDSKLHQVM  407 
 
                       eeeee        hhhhhhhhh   eee hhhh  hhhhhhhhhhh         hhhhhhhhhh h    
        
PheDHBs        330  YRSLLEIFNQAALDCI--TTVEAANRKCQKTIEGQQTRNSFFSRGRRPKWNIKE--  381  
LeuDHBs        314  YDSIEKIFAISKRDGV--PSYVAADRMAEERIAKVAKARSQFLQDQR---NILNGR  364  
PheDHRhC       317  GDTLNQVFEISDNDGV--TPDEAARTLAGRRAREASTTTATA--------------  356  
GDHCs          408  TDIHDGSAAAAERYGLGYNLVAGANIVGFQKIADAMMAQGIAW-------------  450 
 
                    hhhhhhhhhhhhhh     hhhhhhhhhhhhhhhhhhhhhhh                 	  
Figure	   5.17.	   Structure-­‐based	   sequence	   alignment	   of	   PheDH	  and	  LeuDH	   from	  B.	  
sphaericus,	   Rhodococcus	   sp.	   M4	   PheDH	   and	   C.	   symbiosum	  GluDH.	   The	   conserved	  residues	   that	   share	   in	   catalysis	   are	   highlighted	   in	   different	   colors.	   The	   glycine	  residues	   that	   design	   the	   active	   site	   are	   yellow,	   residues	   that	   differentiate	   the	  substrate	  are	  light	  blue	  and	  residues	  that	  bind	  to	  substrate	  backbone	  are	  green.	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   Conserved	  residues	  GluDH	  C.	  symbiosum	   K89	   K113	   Q110	   K125	   D165	   R205	   S380	   G90	   A163	   V377	  GluDH	  M.	  smegamtis	   K93	   K117	   Q114	   K129	   D169	   R209	   S381	   G94	   A167	   V378	  GluDH	  E.	  coli	   K92	   K116	   Q113	   K128	   D168	   R207	   S380	   G93	   A166	   V377	  GluDH	  	  
P.	  asaccharolyticus	  	  	   K70	   K94	   M91	   K106	   D146	   R187	   S355	   G71	   A144	   V352	  Bovine	  	   K90	  	   K114	  	   M111	  	   K126	   D225	   R211	  	   S381	  	   G91	   A223	   V378	  PheDH	  B.	  sphaericus	  	   L51	   K79	   M75	   K91	   D133	   S157	   V310	   G52	   M131	   L307	  LeuDH	  B.	  sphaericus	   L40	   K68	   M65	   K80	   D122	   P146	   V294	   G41	   V120	   V291	  	  
Table	  5.4.	  Shows	  the	  residues	  responsible	  for	  the	  substrate	  binding	  of	  GluDHs,	  PheDH	  and	  LeuDH.	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  5.18.	  A	  tyrosine	  substrate	  modeled	  into	  the	  active	  site	  of	  B.sphaericus	  PheDH,	  based	  on	  the	  position	  of	  the	  phenylalanine	  substrate	  in	  Norcardia	  PheDH/Phe/NADH	  complex.	  In	  the	   wild	   type	   PheDH	   (upper	   picture),	   OH	   of	   the	   tyrosine	   side	   chain	   of	   the	   substrate	  hydrogen	  bonds	  to	  the	  side	  chain	  of	  N145	  residue.	  No	  hydrogen	  bond	  can	  be	  made	  between	  the	  side	  chain	  of	  the	  substrate	  and	  the	  side	  chain	  of	  N145A	  in	  the	  case	  of	  the	  single	  mutant	  PheDH	  (lower	  picture).	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Chapter	  Six:	  Cloning,	  Over-­‐Expression	  and	  Purification	  of	  NDH-­‐
2	  from	  M.	  smegmatis,	  a	  Model	  of	  M.	  tuberculosis	  
6.0	  Introduction	  	  In	  addition	  to	  the	  work	  described	  in	  this	  thesis	  on	  amino	  acid	  dehydrogenases,	  other	   dehydrogenase	   enzymes	   were	   investigated	   for	   potential	  biotechnological	  or	  therapeutic	  use.	  One	  such	  enzyme	  identified	  is	  the	  type	  II	  NADH	   dehydrogenase:	   menaquinone	   oxidoreductase	   (NDH-­‐2)	   of	  
Mycobacterium	   tuberculosis.	   This	   enzyme	   is	   part	   of	   the	   electron	   transport	  chain	   of	   M.	   tuberculosis	   and	   forms	   part	   of	   this	   system	   that	   regulates	   the	  menaquinone	   pool	   (Teh	   et	   al,	   2007).This	   enzyme	   has	   been	   identified	   as	   a	  potential	  drug	   target	   (Warman	  et	  al,	  2013;	  Weinstein	  et	  al,	  2005;	  Yano	  et	  al,	  2006),	   and	   its	   structure	   is	   unknown.	   This	   chapter	   gives	   an	   introduction	   to	  attempts	  to	  try	  to	  elucidate	  the	  three	  dimensional	  structure	  of	  NDH-­‐2.	  	  	  	  
6.1	  Tuberculosis:	  Tuberculosis	   is	   defined	   as	   the	   infectious	   disease	   caused	   by	  Mycobacterium	  
tuberculosis	  complex,	  which	  includes,	  M.	  tuberculosis,	  M.	  bovis,	  M.	  africanum,	  M.	  
microti	   and	  M.	  canettii.	  Although	  all	   these	  organisms	  (except	  M.	  microti)	  may	  cause	   disease	   to	   humans,	   M.	   tuberculosis	   is	   the	   most	   common	   cause	   of	  tuberculosis	   (Palomino	   et	   al,	   2007).	  M.	   tuberculosis	   is	   a	   bacillus	   bacterium	  measuring	   about	   0.53	   μm,	   and	   requires	   a	   special	   stain,	   so	   it	   is	   classified	   as	  acid-­‐fast	  bacilli	   (Wilson	  et	  al,	  2011).	  The	  cell	  wall	  of	  M.	  tuberculosis	   is	  rich	   in	  lipid	   complexes	   such	   as	   mycolic	   acid	   and	   sulpholipids	   (figure	   6.1).	   M.	  
tuberculosis	   is	   an	   aerobe,	   it	   needs	   free	   oxygen	   for	   growth.	   However,	   the	  division	  time	  of	  this	  bacteria	  is	  longer	  than	  for	  other	  bacteria,	  it	  takes	  from	  12	  to	  20	  hours	   to	  double	  and	  may	  require	  many	  weeks	   to	  grow	  visible	  colonies	  (Madkour,	  2001).	  	  
	  	  	  	  	  	  	  	  	  	  	  6.2	  Epidemiology	  of	  tuberculosis:	  	  About	  one	  third	  of	   the	  population	  of	   the	  world	   is	   infected	  by	  mycobacterium	  tuberculosis,	   and	   roughly	   8	   million	   new	   cases	   are	   diagnosed,	   and	  approximately	  two	  million	  deaths	  are	  estimated	  every	  year.	  In	  addition,	  95%	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Figure	   6.1	   The	   cell	   wall	   of	   Mycobacterium	   tuberculosis.(A)	   plasma	   membrane	  
(B)peptidoglycan,	  (C)	  arabinogalactan,	  (D)mannose-­‐capped	  lipoarabinomannan,	  (E)plasma	  
membrane	   and	   cell	   wall-­‐integrated	   proteins,	   (F)	  mycolic	   acid	   and	   (G)	   glycolipid	   surface	  
molecules	   associated	   with	   the	   mycolic	   acids.	   This	   figure	   has	   been	   adapted	   from	  
(Karakousis	  et	  al,	  2004).	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of	  the	  tuberculosis	  cases	  arise	  in	  developing	  countries,	  because	  of	  poverty	  and	  the	   spread	   of	   HIV	   infection.	   The	   two	   central	   reasons	   for	   the	   rapid	  dissemination	   of	   this	   disease	   rapidly	   are	   crowded	   living	   conditions,	   and	   a	  population	  with	  little	  native	  resistance.	  Nearly	  all	  infections	  of	  M.	  tuberculosis	  are	  a	  result	  inhalation	  of	  the	  infected	  particles	  with	  tubercle	  bacilli.	  Moreover,	  these	  particles	  are	  spread	  by	  the	  airborne	  way	  from	  the	  infected	  persons	  with	  pulmonary	   tuberculosis	   during	   coughing	   or	   sneezing	   to	   individuals	   who	  become	  infected	  after	  inhalation	  these	  particles	  (Malani,	  2010).	  	  
6.3	  Treatment	  of	  Tuberculosis:	  	  There	   are	   number	   of	   special	   antibiotics	   which	   are	   considered	   as	   the	   most	  effective	   drugs	   against	   mycobacterium	   tuberculosis,	   and	   are	   used	   as	   the	  backbone	   in	   the	   treatment	   of	   this	   disease.	   These	   antibiotics	   are	   isoniazid,	  ethambutol	   and	   pyrazinamide.	   Furthermore,	   the	   medicines	   of	   anti-­‐tuberculosis	   are	   separated	   into	   a	   number	   of	   groups	   depending	   on	   the	  effectiveness	  of	  these	  drugs;	  isoniazid,	  rifampicin,	  ethambutol	  and	  pyrazamide	  are	  used	  as	  the	  frontline	  drugs	  to	  cure	  the	  tuberculosis	  infections	  (Blumberg	  et	  al,	  2003).	  Patients	  need	  second	  line	  drugs	  if	  drug	  resistant	  TB	  appears.	  These	  drugs	   consist	   of:	   fluoroquinolone,	   cycloserine,	   ethionamide	   and	   para-­‐aminosalicylic	   acid,	   and	   some	   intravenous	   agents	   like	   streptomycin,	  capreomycin,	  kanamycin	  and	  amikacin.	  Third	  line	  drugs	  are	  required	  when	  the	  infected	  person	  has	  an	  extremely	  drug	  resistant	  form	  (Blumberg	  et	  al,	  2003).	  
6.4	  Mechanism	  of	  action	  of	  anti-­‐tuberculosis	  agents:	  	  The	  most	  potent	  drugs,	  which	  currently	  are	  used	   to	   treat	  M.	  tuberculosis,	   are	  isoniazid,	   rifampin,	   ethambutol	   and	   pyrazamide.	   Isoniazid	   and	   ethambutol	  work	   by	   preventing	   synthesis	   of	   mycolic	   acid,	   a	   main	   constituent	   of	   the	  mycobacterium	  cell	  wall,	  and	  rifampin	  acts	  by	  inhibiting	  the	  synthesis	  of	  RNA	  polymerase.	   The	   mode	   of	   action	   of	   pyrazamide	   is	   not	   known	   (Wilson	   et	   al,	  2011)	  	  
	  	  	  	  	  	  	  	  	  	  	  6.4.1	  Mechanism	  of	  action	  of	  isoniazid	  and	  rifampin:	  	  Isoniazid	  (INH)	  is	  a	  pro-­‐drug	  and	  converted	  to	  the	  active	  form	  (the	  isonicotinic	  acyl	  radical)	  by	  the	  catalase-­‐peroxidase	  enzyme,	  which	  is	  encoded	  by	  the	  KatG	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gene.	   Activated	   isoniazid	   binds	   covalently	   to	   NADH,	   to	   produce	   isonicotinic	  acyl	  NADH	  complex,	  which	  attaches	  to	  a	  long-­‐chain	  enoyl-­‐acyl	  carrier	  protein	  reductase	   (InhA),	   leading	   to	   the	   inhibition	   of	   this	   enzyme	   and	   thus	  mycolic	  acid	  biosynthesis,	  a	  major	  component	  of	  mycobacterium	  cell	  wall,	  which	  leads	  to	  death	  of	  the	  cell	  (Rozwarski	  et	  al,	  1998;	  Vilcheze	  &	  Jacobs,	  2007).	  Rifampicin	  works	   by	   binding	   to	   the	   prokaryotic	   RNA	   polymerase,	   hence	   inhibiting	  transcription	  to	  RNA	  and	  thus	  protein	  translation.	  This	  inhibition	  is	  due	  to	  the	  tight	   binding	   between	   the	   RNA	   polymerase	   β-­‐subunit	   and	   Rifampicin.	  Structural	  studies	  of	  the	  rifampicin-­‐RNA	  polymerase	  complex	  have	  shown	  that	  this	  antibiotic	  prevents	  the	  synthesis	  of	  RNA	  by	  interference	  with	  the	  initiation	  stage	  (Floss	  &	  Yu,	  2005).	  
6.5	  Drug	  resistant	  tuberculosis:	  	  Although	   the	   drugs	   described	   above	   are	   a	   successful	   treatment	   in	   many	  tuberculosis	  infections,	  there	  is	  a	  worrying	  trend	  of	  drug	  resistant	  forms	  of	  the	  disease	  appearing	  (World-­‐Health-­‐Organization,	  2013).	  In	  multi-­‐drug	  resistant	  TB	  (MDR-­‐TB),	   the	  mutant	  bacteria	  are	  resistant	   to	   isoniazid	  or	  rifampicin.	   In	  extensively	  drug	  resistant	  TB	  (XDR-­‐TB),	  the	  bacterial	  strains	  are	  also	  resistant	  to	   fluoroquinolone	   antibiotics	   and	   the	   second-­‐line,	   intravenous	   antibiotics,	  cryptomycin,	  kanamycine	  and	  amikacin	  (Gillespie,	  2002).	  	  	  	  	  
M.	  tuberculosis	   resistant	   to	   isoniazid	   INH	   is	   associated	  with	  mutations	   in	   the	  KatG	   gene,	   which	   encodes	   the	   activator	   of	   INH	   catalase-­‐peroxidase	   enzyme	  that	  results	  in	  a	  reduction	  the	  activity	  of	  this	  enzyme.	  Thus	  strains	  that	  have	  a	  mutation	   in	  KatG	  are	  expected	   resistant	   to	   INH	  due	   to	  a	  decreased	  ability	   to	  produce	   the	   INH-­‐NAD	  adduct	   that	   inhibits	   InhA	   (Vilcheze	   and	   Jacobs,	   2007).	  Another	   mechanism	   of	   resistance	   is	   the	   alteration	   of	   NADH/NAD+	   ratio.	   A	  mutation	  in	  the	  ndh	  gene	  that	  encodes	  NADH	  dehydrogenase	  (NdhII)	  causes	  a	  decrease	  in	  NdhII	  activity,	  leading	  to	  accumulation	  of	  NADH,	  the	  substrate	  for	  NdhII.	  This	  accumulation	  of	  NADH	  works	  as	  a	  competitive	  inhibitor	  for	  binding	  to	  InhA	  and	  protects	  InhA	  against	  the	  inhibitory	  effect	  of	  the	  INH-­‐NAD	  adduct	  (Vilcheze	  et	  al,	  2005).	  The	  most	   common	  resistance	  of	   rifampicin	   is	  attributed	   to	  a	  mutation	   in	   the	  rpoB	   gene,	   which	   encodes	   the	   β-­‐subunit	   of	   RNA	   polymerase,	   which	   is	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responsible	   for	   the	   activity	   of	   prokaryotic	  RNA-­‐polymerase	   and	   is	   the	   target	  for	   rifampicin.	   Therefore,	   amutation	   in	   this	   gene	   leads	   to	   a	   reduction	   in	   the	  affinity	  of	  RNA-­‐polymerase	  to	  the	  antibiotic,	  which	  usually	  attaches	  tightly	  to	  the	  wild-­‐type	  enzyme.	  This	  reduction	  in	  affinity	  between	  rifampicin	  and	  RNA	  polymerase	   is	   associated	   with	   decreasing	   susceptibility	   of	   the	   bacteria	   to	  inhibition	  by	  this	  antibiotic	  (Floss	  &	  Yu,	  2005).	  
6.6	  Development	  of	  new	  antibiotics:	  Three	   approaches	   can	   be	   directed	   towards	   overcoming	   this	   increased	  resistance.	  Firstly,	  the	  use	  of	  good	  hygiene	  in	  a	  hospital	  setting	  is	  paramount.	  Secondly,	   the	   proper	   use	   of	   current	   antibiotics	   should	   be	   encouraged	   and	  regulated.	   Thirdly	   the	   development	   of	   novel	   antimicrobial	   agents	   could	  overcome	   the	   antibiotic	   resistance	   problem.	   There	   are	   several	   methods	   to	  develop	  new	  antibiotics	  including	  structure-­‐based	  drug	  design.	  
	  	  	  	  	  	  	  	  	  	  	  6.6.1	  Structure-­‐based	  drug	  design:	  	  Structure-­‐based	   drug	   design	   requires	   a	   high	   resolution,	   three-­‐dimensional	  structure	  of	  the	  protein	  molecule,	  to	  which	  small	  molecule	  drugs	  are	  targeted.	  Typically,	   a	   structure	   will	   be	   available	   of	   one	   molecule	   in	   complex	   with	   its	  target.	  Using	  this	  knowledge	  it	  is	  possible	  to	  design	  the	  best	  possible	  inhibitor	  to	   interact	   with	   the	   selected	   target,	   in	   a	   process	   of	   rational	   drug	   design	  (Congreve	  et	  al,	  2005).	  The	  application	  of	  structure-­‐based	  drug	  design	  extends	  from	   helping	   in	   validation	   of	   a	   protein	   target	   to	   molecular	   modeling	   and	  design,	  to	  organic	  synthesis,	  and	  the	  drug	  optimization	  stage.	  This	  method	  has	  succeeded	   in	   discovering	   some	   drugs	   that	   have	   been	   manufactured	   and	  arrived	  at	   the	  market,	  AIDS	  drugs	   for	  example:	  Agenerase	  and	  Viracept	  were	  designed	   using	   the	   crystal	   structure	   of	   HIV	   protease	   (Lapatto	   et	   al,	   1989;	  Miller	   et	   al,	   1989).	   The	   flu	   drug	   Relenza	   was	   developed	   using	   the	   crystal	  structure	   of	   neuraminidase	   (Varghese,	   1999).	   Furthermore,	   development	   of	  experimental	   approaches	   and	   bioinformatics	   research	   has	   caused	   a	   leap	   of	  activity	  in	  structure-­‐based	  drug	  design	  over	  the	  last	  years	  (Arcus	  et	  al,	  2006).	  This	  has	  led	  to	  the	  discovery	  of	  more	  than	  40	  compounds,	  which	  have	  entered	  clinical	  trials	  (Congreve	  et	  al,	  2005).	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6.7	  Organization	  of	  respiratory	  chain	  of	  Mycobacterium	  tuberculosis:	  	  Although	   TB	   is	   the	   cause	   of	   death	   about	   2	   million	   people	   annually	   (World-­‐Health-­‐Organization,	  2013)	  there	   is	  no	  clear	  description	  of	   the	  pathways	  and	  components	   of	   central	   energy	   metabolism.	   Indeed,	   most	   information	  concerning	  the	  organization	  of	   the	  electron	  transport	  chain	  of	  M.	  tuberculosis	  is	  mainly	  dependent	  on	  genomic	  data	  (Cole	  et	  al,	  1998;	  Galagan,	  2014).	  	  
	  	  	  	  	  	  	  	  	  	  6.7.1	  Respiratory	  chain	  (Electron	  Transport	  Chain):	  	  The	  respiratory	  chain	   is	  a	  series	  of	  protein	  complexes	  bound	  to	   the	  bacterial	  cell	   membrane,	   and	   is	   the	   energy	   factory	   of	   respiratory	   organisms.	   The	  electron	   transport	   chain	   catalyzes	   the	  movement	  of	   electrons	   from	  NADH	  or	  succinate	  (reducing	  substrates)	  to	  an	  electron	  acceptor.	  In	  aerobic	  conditions	  oxygen	   acts	   as	   the	   electron	   acceptor,	   while	   sulfate	   or	   nitrate	   receive	   the	  electrons	  under	  anaerobic	  conditions.	  The	  movement	  of	  electrons	  through	  the	  respiratory	  chain	  is	  coupled	  to	  protons	  pumping	  across	  the	  membrane,	  when	  more	   electrons	   flow,	   more	   protons	   move	   outside	   the	   membrane	   causing	   a	  proton	   gradient	   and	   a	   membrane	   potential,	   that	   allows	   the	   ATP	   synthase	  enzyme	  to	  produce	  ATP	  from	  ADP	  and	  Pi	  (Hatefi,	  1985;	  Kana	  et	  al,	  2009)	  	  
	  	  	  	  	  	  	  	  	  	  6.7.2	  Electron	  transport	  chain	  of	  M.	  tuberculosis:	  	  The	   respiratory	   chain	   of	  M.	   tuberculosis	   is	   similar	   to	   those	   found	   in	   other	  bacteria.	   It	   catalyzes	   transmission	   of	   electrons	   from	   NADH	   or	   succinate	   to	  oxygen,	  which	  is	  preferred	  as	  the	  electron	  acceptor,	  because	  M.	  tuberculosis	  is	  categorized	   as	   an	   aerobe.	   This	   pathway	   can	   produce	   substantial	   energy	   for	  exponential	  growth	  in	  oxygen	  rich	  conditions	  (Teh	  et	  al,	  2007).	  	  According	  to	  genomic	  data,	  the	  electron	  transport	  chain	  of	  M.	  tuberculosis	  is	  a	  branched	   pathway	   terminating	   in	   two	   terminal	   oxidases	   (Weinstein	   et	   al,	  2005).	   The	   first	   oxidase	   enzyme	   is	   cytochrome	   bd	   oxidase	   (quinol	   oxidase),	  which	  is	  induced	  under	  low-­‐oxygen	  states	  in	  Mycobacterium	  smegmatis,	  and	  it	  is	  necessary	  for	  bacterial	  growth	  under	  aerobic	  conditions	  (Kana	  et	  al,	  2001).	  The	   second	   enzyme	   is	   aa3-­‐type	   cytochrome	   oxidase	   that	   is	   essential	   for	  exponential	   growth	   in	   rich	   oxygen	   milieu	   (Weinstein	   et	   al,	   2005).	   Both	  pathways	   chains	   are	   supplied	   by	   the	   menaquinol	   pool	   (MQH2),	   that	   is	  produced	   by	   4	   oxidoreductase	   enzymes,	   these	   are:	   succinate	   menaquinone	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oxidoreductase	  (SQR),	  and	  two	  types	  of	  NADH:menaquinone	  oxidoreductase	  ,	  a	  multimeric	  type	  I	  NADH	  dehydrogenase	  (complex	  I)	  ,where	  redox	  activity	  is	  linked	   to	  proton	  pumping	   ,and	   a	   type	   II	  NADH:menaquinone	  oxidoreductase	  (NDH-­‐2),	  which	  exists	   in	  two	  forms,	  ndh	  and	  ndhA.	  The	  redox	  activity	  of	  this	  enzyme	  is	  not	  linked	  to	  proton	  pumping	  (Fisher	  et	  al,	  2009).	  The	  cytochrome	  bc1	  complex	  works	  as	  a	   linking	  enzyme,	  oxidizing	  menaquinone	  and,	   in	  turn,	  reducing	   cytochrome	   c.	   The	   genome	   of	   M.	   tuberculosis	   also	   encodes	   two	  anaerobic	  respiratory	  complex	  genes,	  nitrate	  reductase	  narGHJI,	  and	  fumarate	  reductase	  frdABCD	  and,	  lastly,	  the	  ATP	  synthase	  super	  complex	  which	  uses	  the	  proton	  motive	  force	  through	  the	  bacterial	  membrane	  to	  generate	  ATP	  (figure	  6.2)	   (Fisher	   et	   al.,	   2009(Weinstein	   et	   al,	   2005).	   Of	   the	   4	   enzymes	   that	  contribute	   to	   the	   menaquinol	   pool,	   the	   typeII	   NADH:	   menaquinone	  oxidoreductase	  (NDH-­‐2)	  has	  been	  validated	  as	  a	  drug	  target	   for	   tuberculosis.	  This	  enzyme	  play	  a	  significant	  role	  in	  feeding	  MQH2	  during	  infection,	  as	  well	  as	  one	   of	   the	   essential	   adaptation	   processes	   of	   M.	   tuberculosis	   against	  extracellular	   stress,	   which	   results	   in	   an	   upregulation	   of	   NDH-­‐2	   over	   NDH-­‐1	  (Teh	  et	  al.,	  2007,	  Fisher	  et	  al.,	  2009,	  (Weinstein	  et	  al,	  2005).	  	  	  	  
6.7.3	  Type	  II	  NADH:	  Menaquinone	  oxidoreductase	  (NDH-­‐2)	  of	  M.	  
tuberculosis:	  	  	  The	   structure	   of	   the	   NDH2	   from	   M.	   tuberculosis	   is	   unknown	   and	   the	   data	  concerning	   structure	   and	   function	   of	   this	   is	   limited	   to	   genomic	   data	   and	  modeling	  studies	  depend	  on	   the	  sequence	  similarity	  with	  solved	  structure	  of	  dehydrogenase	  enzymes	  for	  example,	  lipoamide	  dehydrogenase	  	  (Fisher	  et	  al.,	  2009).	   These	   enzymes	   share	   24%	   sequence	   similarity.	   According	   to	   those	  studies,	   the	  M.	   tuberculosis	   NDH2	   structure	   can	   be	   predicted.	   It	   is	   made	   up	  from	   a	   single	   polypeptide	   chain	   containing	   463	   amino	   acids	   in	   length	   with	  molecular	   weight	   49,619	   Da.	   It	   has	   two	   GXGXXG	  motifs	   in	   β-­‐α-­‐β	   structures,	  which	  are	  used	  for	  binding	  the	  dinucleotides.	  	  
6.7.4	   Type	   II	   NADH:	   menaquinone	   oxidoreductase	   catalyzes	   the	   first	  
reaction	  in	  electron	  transport	  chain	  of	  M.	  tuberculosis	  	  Results	   obtained	   from	   transposon-­‐insertion	   mutation	   experiments	   suggest	  that	   type	   I	   NDH	   and	   the	   second	   type	   II	   NADH	   dehydrogenase	   ndhA	   are	   not	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essential	  for	  M.	  tuberculosis	  growth	  in	  vitro.	  However,	  transposon	  disruption	  of	  the	  type	  II	  NDH	  gene	  (NDH-­‐2)	  is	  lethal	  and	  it	  is	  necessary	  for	  optimal	  growth	  of	  Mycobacterium	   tuberculosis	   in	   vitro	   (Sassetti	   &	   Rubin,	   2003).	   In	   addition,	  mutations	   in	   the	   NDH-­‐2	   gene	   give	   conditional	   mortality	   on	  Mycobacterium	  
smegmatis	   (Miesel	  et	  al,	  1998).	  Furthermore,	   inhibition	  of	  NDH-­‐2	  enzyme	  by	  the	  antibiotic	  phenothiazine	  leads	  to	  inhibition	  of	  M.	  tuberculosis	  growth	  both	  
in	  vitro	  and	  in	  vivo	  (Weinstein	  et	  al,	  2005).	  It	  is	  likely	  that	  NDH-­‐2	  acts	  as	  the	  major	  NADH	  oxidoreductase	  of	  the	  electron	  transport	   chain	   in	   exponential	   growth	   in	   environments	   rich	   in	   oxygen	   and	  nutrients	   (Teh	   et	   al,	   2007).	   However,	   because	   human	  mitochondria	   possess	  just	   type	   I	   NADH	   dehydrogenase,	   while	   NDH-­‐2	   is	   the	   unique	   NADH	  dehydrogenase	   in	   the	  M.	  tuberculosis	   respiratory	  chain,	   this	  enzyme	  can	  be	  a	  valuable	  drug	  target.	  	  
6.8	  Aims	  of	  project	  As	   stated	   above,	   the	   type	   II	   oxidoreductase	   acts	   as	   the	   major	   dehydrogenase	  enzyme	   in	   the	   electron	   transport	   chain	   of	   M.tuberculosis.	   However,	   because	  human	  mitochondria	  possess	  just	  the	  type	  I	  NADH	  dehydrogenase,	  while	  NDH-­‐2	  is	  the	  unique	  NADH	  dehydrogenase	  in	  the	  Mtb	  respiratory	  chain,	  the	  NDH-­‐2	  enzyme	  could	  be	  a	  valuable	  drug	   target.	   	  Knowledge	  about	  3D	  structure	   is	  a	  vital	   tool	   in	  the	   discovery	   of	   possible	   lead	   inhibitors	   and	   ultimately	   in	   the	   design	   and	  optimization	   of	   possible	   drug	   compounds.	   There	   is	   currently	   no	   high	   resolution	  structure	   known	   for	   NDH-­‐2.	   The	   overall	   aim	   of	   this	   project	   therefore,	   was	   to	  determine	   the	   structure	   of	   NDH-­‐2	   to	   analyze	   inhibitor	   binding	   to	   this	   protein.	  Therefore,	  attempts	  were	  made	  to:	  	  1-­‐	  Clone	  the	  gene	  which	  encodes	  NDH-­‐2	  protein	  from	  M.	  smegmatis	  a	  model	  of	  tuberculosis	  (the	  identities	  =	  371/454	  (81%)).	  	  2-­‐	  Express	  and	  purify	  NDH-­‐2	  protein.	  	  3-­‐	  Crystallize	  this	  protein.	  	  4-­‐	  Determine	  the	  structure	  of	  NDH-­‐2	  protein.	  	  5-­‐	  Analysis	  of	  inhibitor	  binding	  to	  NDH-­‐2.	  	  
	  
	  




Figure	   6.2.	   Putative	   organization	   of	   the	   M.	   tuberculosis	   respiratory	   chain.	   NADH:	  
Menaquinone	   oxidoreductase	   includes	   type	   I	   and	   type	   II	   NADH.	   This	   figure	   has	   been	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6.9	  Identification	  of	  Mycobacterium	  tuberculosis	  ndh	  gene,	  which	  
encodes	  NDH-­‐2	  protein:	  	  The	   ndh	   gene	   was	   identified	   by	   searching	   the	   tuberculist	   website	  (http://genolist.pasteur.fr/TubercuList)	   to	   obtain	   both	   the	   DNA	   and	   protein	  sequences.	   A	  BLAST	   search,	   at	   the	  NCBI	   (http://blast.ncbi.nlm.nih.gov/)	  was	  used	   for	   aligninig	   the	   (NDH-­‐2)	   protein	   sequence	   of	  M.	   tuberculosis	   with	  M.	  
smegmatis	  proteins.	  The	  alignment	  results,	  which	  are	  presented	  in	  figure	  6.4,	  have	  shown	  that	  there	  is	  82%	  identity	  between	  NDH-­‐2	  of	  M.	  tuberculosis	  and	  
M.	  smegmatis	  NDH-­‐2.	  Therefore,	  the	  NDH-­‐2	  of	  M.	  smegmatis	   is	  a	  good	  model	  of	  
M.	  tuberculosis	  NDH-­‐2.	  	  
6.10	  PCR	  for	  amplification	  of	  M.	  smegmatis	  NDH2	  gene	  (M.	  smeg3621)	  Polymerase	  Chain	  Reaction	  (PCR)	  was	  used	  to	  amplify	  the	  M.	  smegmatis	  NDH2	  gene	   (msmeg3621)	   from	  M.	  smegmatis	   genomic	  DNA	   (strain	  ATCC	  700084	  /	  mc	   (2)155).	   Primers	   were	   designed	   based	   on	   the	   nucleotide	   sequence	   and	  included	   restriction	   sites	   for	   NdeI	   and	   BamHI.	   For	   the	   PCR	   reaction	   the	  following	  materials	  were	  added	  to	  the	  PCR	  tube:	  	   Sterile	  H2O	   27.5µl	  	  DNA	  Polymerase	  Buffer	  5x	   10µl	  dNTPs	  (5mM)	   2.5µl	  Forward	  primer	  (5µM)	   4.0µl	  Reverse	  primer	  (5µM)	   4.0	  µl	  Genomic	  DNA	  (M.	  smegmatis)	   2.0µl	  DNA	  polymerase	   1.0	  µl	  
Total	  volume	   50	  µl	  	  	  The	  tube	  was	  then	  placed	  in	  a	  PCR	  machine	  and	  the	  reaction	  was	  set	  up	  under	  the	  following	  conditions:	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Initial	  denaturation	   95°C	   2	  min	   	  Denaturation	   95°C	   1	  min	   	  Annealing	   60°C	   1:30	  min	  Elongation	   72°C	   2:00	  min	  Final	  Elongation	   72°C	   7.0	  min	   	  	  The	  PCR	  products	  were	  run	  on	  a	  1%	  agarose	  gel,	  and	  a	  1.4	  kb	  band	  was	  seen,	  as	   expected	   for	   the	   msmeg3621	   gene	   (1400bp).	   The	   PCR	   products	   were	  purified	  using	  QIAquick®	  gel	  extraction	  kit	   (Qiagen)	   (see	  section	  2.1.2.1)	  and	  were	  stored	  at	  -­‐20°C	  prior	  use	  in	  cloning.	  Figure	  6.5	  shows	  the	  PCR	  products	  at	  the	  expected	  size.	  	  
6.11	  Cloning	  of	  M.	  smegmatis	  NDH2	  gen	  (M.	  smeg3621)	  The	  msmeg3621	  gene	  PCR	  product	  was	  digested	  with	  the	  restriction	  enzymes	  NdeI	   and	   BamHI,	   before	   insertion	   into	   pET14b	   plasmid,	   which	   was	   cleaved	  with	  the	  same	  enzymes.	  After	  incubating	  the	  digestion	  mixture	  for	  2	  hours	  at	  37	  °C,	  the	  samples	  were	  analyzed	  on	  a	  1%	  agarose	  gel	  and	  the	  digested	  insert	  and	  vector	  were	  purified	  using	  a	  QIAquick®	  gel	  extraction	  kit	  (Qiagen)	  prior	  to	  setting	   up	   the	   ligation	   reaction	   (see	   section	   2.1.5).	   The	   ligation	   mixes	   were	  transformed	  into	  competent	  DH5α	  E.	  coli	  cells	  (Novagen)	  (see	  section	  2.1.5.1).	  As	   plasmid	   pET14b	   has	   an	   ampicillin	   resistance	   gene,	   the	   resulting	  transformants	   were	   spread	   on	   LB-­‐agar	   plates	   supplemented	   with	   50µg/mL	  ampicillin,	   and	   the	   plates	   were	   incubated	   overnight	   at	   37°C.	   Some	   colonies	  could	  be	  seen	  on	  the	  plate	  and	  were	  screened	  for	  successful	  cloning.	  	  
6.12	  Identification	  of	  successful	  clones	  	  A	   first	   screen	   of	   the	   possible	   clones	   was	   done	   by	   restriction	   digestion.	   A	  number	   of	   colonies	  were	   picked	   up	   from	   the	   plated	   clones	   and	   the	   possible	  constructs	   were	   extracted	   using	   a	  miniprep	   kit	   (Qiagen)	   (see	   section	   2.1.3).	  The	   resultant	  miniprep	   samples	  were	   digested	  with	   the	   restriction	   enzymes	  
25	  cycles	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NdeI	  and	  BamHI	  (see	  section	  2.1.4)	  and	  again	  the	  samples	  were	  run	  on	  the	  1%	  AGE	  to	  verify	  successful	  ligation.	  From	  the	  gel	  picture	  (figure6.6)	  it	  can	  be	  seen	  that	   some	   clones	   gave	   bands	   at	   the	   expected	   size	   (1400	   bp)	   showing	   the	  existence	  of	  the	  desired	  gene	  in	  these	  clones.	  
6.13	  Expression	  of	  M.	  smegmatis	  NDH2	  The	  confirmed	  construct	  was	  then	  transformed	  into	  a	  competent	  E.	  coli	  strain,	  BL21	  (DE3)	  (Novagen),	  and	  plated	  onto	  an	  Ampciline	  agar	  plate.	  A	  small-­‐scale	  overexpression	   experiment	  was	   done	   (see	   section	   2.1.6.2	   for	   details)	   to	   find	  the	  appropriate	  conditions	  to	  produce	  a	  soluble	  protein.	  The	  suitable	  condition	  was	   found	   to	   be	   37°C,	   1mM	   IPTG	   and	   induction	   time	   5	   hours.	   Two	   2L	  Erlenmeyer	   flasks	   containing	   500	  ml	   LB,	   supplemented	  with	   50µg/mL	  Amp,	  and	  inoculated	  with	  the	  10ml	  of	  starter	  culture	  were	  used.	  The	  flasks	  were	  left	  to	   grow	   at	   37°C	   with	   shaking	   at	   200rpm	   until	   the	   A600	   reached	   0.6,	   before	  adding	  IPTG	  for	   induction	  (final	  concentration	  1mM).	  The	  cells	  were	  allowed	  to	   over-­‐express	   for	   five	   hours,	   under	   the	   same	   conditions.	   The	   cells	   were	  centrifuged	  at	  1844	  g	  for	  20	  min	  for	  harvesting	  and	  the	  cell	  pastes	  were	  stored	  at	  -­‐80°C	  prior	  to	  use	  in	  purification	  experiments.	  
6.14	  Purification	  of	  NDH2	  from	  M.	  smegmatis	  The	  cells	  thawed	  on	  ice	  and	  suspended	  in	  3ml	  BugBuster	  (Novagen)	  with	  5µl	  of	  benzonase	  and	  the	  mixture	  was	  mixed	  by	  vortex.	  The	  suspension	  was	  kept	  on	  ice	  for	  30min	  after	  that	  it	  was	  centrifuged	  at	  4C°	  and	  4500	  rpm	  for	  30min	  and	  the	  proteins	  in	  the	  supernatant	  were	  collected.	  His-­‐tagged	  NDH-­‐2	  protein	  was	  purified	  by	  metal-­‐chelating	  chromatography	  using	  Ni-­‐NTA	  resin	  (Qiagen)	  at	   4C°.	   1ml	   of	   Ni-­‐NTA	   resin	   Qiagen	   was	   pre-­‐equilibrated	   with	   phosphate	  buffered	  saline	  PBS	  (50mM	  NaH2PO4,	  400mM	  NaCl,	  pH=8.0)	  and	  it	  was	  mixed	  with	   the	   supernatant.	   After	   that	   the	   mixture	   was	   rotated	   at	   4C°	   for	   30min	  before	   packing	   onto	   a	   gravity	   column.	   Contaminants	  were	  washed	  out	   using	  PBS	   buffer	   and	   the	   target	   protein	   was	   eluted	   with	   elution	   buffer	   (50mM	  NaH2PO4,	   400mM	   NaCl,	   pH=8.0	   and	   250mM	   Imidazole).	   The	   elution	   was	  collected	  in	  0.5	  ml	  fractions.	  After	  cell	  lysis	  the	  greater	  part	  of	  NDH-­‐2	  protein	  was	   in	   soluble	   form.	  Further	  purification	  was	  carried	  out	  using	  gel	   filtration,	  the	  volume	  of	  the	  sample	  was	  reduced	  to	  1ml	  using	  a	  VivaSpin	  concentator	  	  	  












 Mtb   5    EPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVATGIISE  64 
             P A    RH+VVIIGSGFGGL AAK LKRADVD+KLIARTTHHLFQPLLYQVATGIISE 
Msmeg  3    HPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGIISE  62 
 
Mtb    65  GEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAGAGQSY  124 
63   
 
           GEIAPATRVILRKQKNAQVLLGDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQSY  122 
 
Mtb    125 FGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGPTGVEM  184 
           FGNDHFAEFAPGMKSIDDALELRGRIL AFEQAERSSDP RRAKLLTFTVVGAGPTGVEM 
Msmeg  123 FGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGVEM  182 
 
Mtb    185 AGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLGVEIQL  244 
           AGQIAELA+ TL+G+FRHID T+ARVILLDAAPAVLPPMG KLG++A ARL+K+GVE+QL 
Msmeg  183 AGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEVQL  242 
 
Mtb    245 GAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRAGRVQV  304 
           GAMVTDVDRNGITVKDSDGT+RRIESACKVWSAGVSAS LG+DLAEQS VELDRAGRV+V 
Msmeg  243 GAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRVKV  302 
 
Mtb    305 LPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAEREPFQYF  364 
            PDL++PG+PNVFVVGDMAAVEGVPGVAQGAIQG +Y A  IK E++G +P  R PF+YF 
Msmeg  303 QPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFEYF  362 
 
Mtb    365 DKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVTFLSTR  424 
           DKGSMATVSRFSAVAK+GPVEF+GF AWL WLVLHL YL+GFKTKI TLLSW VTFLST+ 
Msmeg  363 DKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLSTK  422 
 
Mtb    425  RGQLTITDQQAFARTRLEQLAELAAEAQGSAASA  458 
            RGQLTIT+QQA+ARTR+E+L E+AA  Q +  +A 
Msmeg  423  RGQLTITEQQAYARTRIEELEEIAAAVQDTEKAA  456 	  	  
	  	  
Figure	  6.3.	  a)	  Sequence	  alignment	  of	  M.	  tuberculosis	  (Mtb)	  NDH-­‐2	  and	  its	  homologues	  from	  
M.	   smegmatis	   (Msmeg)	   NDH-­‐2.	   Identities	   =	   371/454	   (82%),	   Positives	   =	   409/454	   (90%),	  Gaps	  =	  0/454	  (0%).	  b)	  Hydrophpbicity	  plot	  of	  the	  NDH-­‐2	  protein	  from	  M.	  smegmatis.	  	  
a	  
Msmeg      GEIAP TRV+LRKQ+N QVLLG+VTHIDL  + V S LLGHTY TPYDSLI+AAGAGQSY 
b	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Figure	   6.4.	   Electrophoretic	   pattern	   of	   agarose	   gel.	   PCR	   products	   of	   ndh	   gene	   from	   M.	  
smegmatis.	  The	  numbers	  at	  the	  top	  represents	  the	  five	  different	  PCR	  reaction	  products	  .The	  agarose	   gel	   picture	   shows	   that	   there	  were	   bands	   at	   the	   expected	   size	   (1.4	   kb),	   and	   they	  might	  be	  the	  gene	  of	  interest.	  	  	  
	  	  	  	  
Figure	   6.5.	  A	  picture	  of	  a	  1%	  AGE	  gel	   showing	   the	   screening	   results	   for	   the	   recombinant	  pET14b	  with	   the	  Mycobacterium	  smegmatis	  ndh	  gene	   that	  had	  been	  digested	  by	  NdeI	  and	  BamHI.	  Some	  of	  these	  lanes	  represent	  the	  correct	  cloning.	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with	   a	   molecular	   weight	   cut	   off	   of	   30kDa,	   and	   was	   then	   applied	   to	   a	  Superdex200	  gel	  filtration	  column,	  equilibrated	  in	  buffer	  A	  +0.5M	  NaCl.	  Gel	  	  filtration	   separation	   was	   performed	   with	   the	   same	   buffer	   at	   a	   flow	   rate	   at	  1.5ml/min.	  	  2ml	  fractions	  were	  collected	  	  after	  the	  void	  volume	  of	  the	  column	  had	  been	  discarded.	  Fractions	  were	  analysed	  by	  10%	  SDS-­‐PAGE	  (figure6.7	  and	  6.9).	   It	   can	  be	   seen	   from	   figure	  6.9	   that	  NDH-­‐2	   is	  present	   in	  all	   the	   fractions	  from	   the	   gel-­‐filtration	   column,	   perhaps	   indicating	   that	   the	   protein	   is	   not	  correctly	  folded,	  and	  not	  interacting	  with	  the	  column	  in	  a	  specific	  manner.	  As	  NDH-­‐2	  is	  believed	  to	  be	  a	  monotopic	  membrane	  protein,	   interacting	  with	  the	  membrane	  at	  a	  C-­‐terminal	  helix,	  it	  is	  perhaps	  not	  suprising	  that	  the	  full	  length	  protein	  behaved	  anomalously.	  One	   strategy	   to	   overcome	   this	   apparent	   misfolding	   would	   be	   to	   design	   a	  truncated	  construct	   in	  an	  attempt	   to	   improve	   the	  solubility.	  However,	  at	   this	  point	   in	   the	   project	   the	   structure	   of	   the	   NDH-­‐2	   from	   Caldalkalibacillus	  
thermarum	  was	   determined	   (Heikal	   et	   al,	   2014).	   This	   protein	   shares	   31%	  sequence	   identity	   of	  M.	   tuberculosis	  NDH-­‐2	   (figure6.4),	   whereas	   the	   identity	  between	  M.	  smegmatis	  NDH-­‐2	  and	  of	  M.	  tuberculosis	  NDH-­‐2	  is	  82%	  (figure6.3).	  	  The	   structure	   reported	   is	   of	   the	   full	   length	   enzyme,	   but	   expression	   and	  purification	   were	   undertaken	   in	   the	   presence	   of	   the	   detergent	   n-­‐octyl-­‐β-­‐D-­‐glucopyranoside.	  Analysis	  of	   the	  structure	  of	   the	  C.	  thermarum	  NDH-­‐2	  shows	  that	   a	  C-­‐terminal	  domain	   comprising	  of	   three	   antiparallel	   β-­‐strands	   and	   two	  amphipathic	  α-­‐helices	  is	  responsible	  for	  anchoring	  to	  the	  membrane	  (Heikal	  et	  al,	   2014).	   Indeed	   if	   the	   protein	   is	   truncated	   at	   residue	   Ile379,	   removing	   this	  domain,	  overexpressed	  NDH-­‐2	  appears	  in	  the	  cytoplasmic	  fraction,	  rather	  than	  with	  the	  membrane,	  indicating	  importance	  of	  these	  residues	  as	  the	  membrane	  anchor	  (Heikal	  et	  al,	  2014).	  Although	  the	  structure	  of	  a	  bacterial	  NDH-­‐2	  is	  now	  known,	   it	   would	   still	   be	   useful	   to	   obtain	   the	   structure	   of	   this	   enzyme	   from	  mycobacterial	  source.	  To	  this	  end	  the	  use	  of	  detergents	  in	  the	  expression	  and	  purification	   of	   M.	   smegmatis	   NDH-­‐2	   should	   be	   investigated,	   as	   well	   as	  producing	  possible	  truncated	  constructs,	  removing	  the	  C-­‐terminal	  membrane-­‐anchoring	  domain.	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Figure	   6.6.	   Sequence	   alignment	   of	  M.	   tuberculosis	   NDH-­‐2	   (Query)	   with	   Caldalkalibacillus	  
thermarum	  NDH-­‐2	  (subject).	  Identities	  =	  124/405	  (31%),	  Positives	  =	  198/405	  (48%),	  Gaps	  =	  37/405	  (9%).	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Figure	   6.7.	   10%	   SDS.PAGE	   analysis	   of	   purification	   of	   NDH-­‐2.	   Lane1=(M12)	   molecular	  weight	   markers	   (kDa),	   lane2=pre-­‐induction,	   lane3=pellet	   and	   lane5-­‐14	   eluted	   fractions	  from	  Ni-­‐HP	  5ml.	  	  
	  
Figure	  6.8.	  Chromatogram	  picture	  for	  the	  purification	  of	  NDH-­‐2	  from	  M.	  smegmatis	  using	  Ni-­‐NTA	  column.	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Figure	   6.9.	   10%	   SDS.PAGE	   analysis	   of	   purification	   of	   NDH-­‐2	   protein,	   lane	   M	   (M12)	  molecular	  weight	  markers	  (kDa).	  Lane1=	  sample	  applied	  on	  gel	  filtration	  column	  and	  lanes	  2-­‐16	  eluted	  fractions	  from	  gel	  filtration	  (superdex200).	  	  	  
Figure	  6.10.	  Chromatogram	  picture	  for	  the	  purification	  of	  NDH-­‐2	  from	  M.	  smegmatis	  using	  gel	  filtration	  column.	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Chapter	  seven:	  Conclusion	  and	  future	  work	  
7.1	  Conclusion	  	  
7.1.1	  Introduction	  	  	  The	   work	   presented	   in	   this	   thesis	   had	   the	   aim	   of	   providing	   a	   greater	  understanding	   of	   the	   structure/	   function	   relationships	   in	   the	   amino	   acid	  dehydrogenase	  family	  as	  an	  aid	  to	  help	  in	  the	  biotechnological	  exploitation	  of	  these	   enzymes	   as,	   for	   example,	   biosensors	   or	   in	   the	   production	   of	   chiral	  intermediates	  for	  the	  pharmaceutical	  industry.	  	  To	  this	  end,	  the	  first	  structure	  of	  M.	   smegmatis	  GluDH	   was	   determined	   at	   high	   resolution,	   in	   two	   different	  forms,	   the	   GluDH/NADP+/2oxoglutarate	   ternary	   complex	   at	   1.64Å	   and	   the	  GluDH/NADPH	   binary	   complex	   at	   1.78	   Å.	   	   In	   addition,	   the	   binary	   complex	  structures	  of	  C.	  symbiosum	  GluDH,	  with	  NAD+	  or	  L-­‐glutamate,	  have	  also	  been	  determined,	  at	  1.80	  Å	  and	  1.24Å,	  respectively.	  Analysis	  of	  these	  structures	  has	  provided	   new	   information	   about	   the	   conformational	   changes	   of	   the	   protein	  during	   the	   reaction,	   the	   movement	   of	   the	   substrate	   within	   the	   active	   site	  during	   the	   reaction	   mechanism	   and	   also	   structural	   aspects	   of	   cofactor	  specificity	   among	   this	   enzyme	   family.	   In	   addition,	   the	   first	   structure	   of	   the	  PheDH	   from	  B.	   sphaericus	  was	   determined	   at	  medium	   resolution	   (2.5Å)	   and	  preliminary	  experiments	  were	  undertaken	  on	  NDH2	  from	  M.	  smegmatis.	  
7.1.2	  Conformational	  changes	  in	  GluDH	  The	  level	  of	  domain	  motion	  in	  the	  GluDHs	  family	  is	  described	  in	  section	  4.5	  of	  this	  thesis.	  The	  1.24	  Å	  binary	  complex	  of	  C.	  symbiosum	  GluDH	  with	  L-­‐glutamate	  was	  in	  a	  closed	  form,	  similar	  to	  that	  seen	  for	  the	  structure	  determined	  at	  1.9	  Å,	  previously	  ((Stillman	  et	  al,	  1993)	  and	  PDB	  code:	  1BGV).	  However,	  despite	  the	  fact	  that	  these	  two	  structures	  were	  derived	  from	  crystals	  grown	  in	  very	  similar	  conditions,	   the	   alignment	   of	   the	   two	   domains	   in	   the	   subunit	   of	   the	   two	  structures	   is	  different,	  with	   the	  1.24	  Å	  structure	  determined	  here	  adopting	  a	  slightly	  more	   closed	   structure	   than	   that	   of	   1BGV	   (17.7°	   for	   1.24	  Å	   structure	  and	  15.4°	   for	  1BGV	  structure).	  These	  differences	  are	  also	  reflected	   in	  slightly	  different	   cell	   dimensions	   between	   these	   two	   structures,	   with	   1BGV	  crystallizing	   in	   space	  group	  R32	  with	  a=162.8	  Å	  and	  c=102.8	  Å,	  whereas	   the	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1.24	  Å	  structure	  crystallizes	  in	  the	  same	  space	  group,	  but	  with	  a=158.7	  Å	  and	  c=101.4	  Å,	  a	  change	  of	  some	  3%	  in	  the	  a	  direction	  and	  1%	  in	  the	  c	  direction.	  This	   change	   in	   the	   relative	   domain	   closure	   also	   affects	   the	   position	   of	   the	  glutamate	  in	  the	  active	  site	  of	  the	  enzyme.	  In	  the	  1.24	  Å	  structure	  the	  electron	  density	  clearly	  shows	  that	  the	  glutamate	  binds	  in	  two	  different	  conformations	  at	  the	  side	  chain	  carboxyl	  end,	  with	  one	  interacting	  with	  K89	  and	  S380,	  and	  the	  other	  interacting	  with	  S380	  and	  R205.	  This	  latter	  residue	  (R205)	  also	  adopts	  a	  different	  conformation	  to	  that	  seen	  in	  1BGV,	  swinging	  closer	  to	  the	  active	  site	  in	   the	  1.24	  Å	   structure	   (figure7.1).	   In	   addition,	   although	   the	   alpha	   carbon	  of	  the	   glutamate	   in	   the	   two	   structures	   adopts	   a	   similar	   position,	   the	   alpha	  carboxyl	  group	  of	  the	  glutamate	  in	  the	  1.24	  Å	  structure	  moves	  closer	  to	  Gly91,	  with	   one	   of	   the	   carboxyl	   oxygens	   occupying	   the	   same	   space	   as	   the	   catalytic	  water	   in	   1BGV	   (figure7.2).	   These	   structures	   show	   that	   the	   glutamate	   is	   not	  fixed	   within	   the	   active	   site	   of	   the	   enzyme,	   and	   can	   adopt	   different	  conformations	  and	  interactions	  with	  the	  enzyme.	  	  As	  might	  have	  been	  expected,	   the	  C.	  symbiosum	  GluDH/NAD+	  complex	  was	   in	  an	  open	  form,	  similar	  to	  that	  seen	  for	  the	  apo	  form	  of	  the	  enzyme	  ((Baker	  et	  al,	  1992a),	   pdb	   code,1HRD).	   The	   ternary	   complex	   of	  M.	   smegmatis	  GluDH	   with	  NADP+	  and	   2-­‐oxoglutarate	   adopted	   a	   hyper	   closed	   form,	   which	   is	   similar	   to	  that	  seen	   in	  the	  ternary	  complex	  of	  bovine	  GluDH	  (NADPH/Glu,).	   In	  contrast,	  the	   structure	   of	   the	  wild-­‐type	   apo	   form	   of	   the	  E.	  coli	  GluDH	   adopts	   a	   closed	  conformation	   ((Smith	   et	   al,	   2001),	   PDB,	   1HWZ).	   Analysis	   of	   these	   structures	  shows	   that	   the	  domain	  motion	  between	   the	  open	  and	  closed	  structure	   is	  not	  necessarily	   associated	   with	   the	   binding	   of	   substrate,	   but	   so	   far,	   the	   hyper	  closed	  form	  has	  only	  been	  observed	  when	  both	  the	  substrate	  and	  cofactor	  are	  bound	  to	  the	  enzyme.	  	  
7.1.3	  Catalytic	  pocket	  of	  GluDH	  A	   comparison	   between	   the	   GluDHs	   structures	   that	   have	   been	   determined	   in	  this	  project,	   has	   allowed	   some	  new	  annotations	   to	  be	  made	  about	   the	   active	  site	  in	  these	  enzymes.	   	  In	  the	  M.	  smegmatis	  GluDH	  ternary	  complex	  structure,	  the	   electron	   density	   clearly	   indicated	   that	   the	   2-­‐oxoglutarate	   that	   had	   been	  added	  to	  the	  crystallization	  solution	  had	  bound	  to	  the	  enzyme	  in	  its	  gem	  diol	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Figure	   7.1.	   A	   schematic	   diagram	   shows	   the	   interaction	   of	   the	   side	   chain	   carboxyl	  group	   of	   L-­‐glutamate	   in	   binary	   complex	   (1.24Å)	   of	   the	   C.	   symbiosum	   GluDH	   with	  glutamate	   and	   1BGV.	   The	   two	   conformations	   of	   γ-­‐carboxyl	   and	   R205	   of	   the	   L-­‐glutamate	   in	  C.	  symbiosum	  GluDH	  binary	  complex	  (1.24Å)	  are	  shown	  in	  yellow	  color	  and	  L-­‐glutamate,	  R205	  of	  1BGV	  are	  shown	  in	  pink	  color.	  	  	  	  
	  
Figure	  7.2.	  Shows	  the	  different	  position	  of	  the	  α-­‐carboxyl	  group	  of	  L-­‐glutamate	  in	  C.	  
symbiosum	   GluDH/L-­‐glutamate	   (1.24Å),	   yellow	   color	   and	   1BGV,	   pink	   color.	   The	   α-­‐carboxyl	  group	  of	  the	  substrate	  of	  1.24Å	  binary	  complex	  (yellow	  color)	  moves	  toward	  G91	  residue	  and	  one	  oxygen	  atom	  occupies	  the	  water	  position	  in	  1BGV.	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form.	   The	   side	   chain	   of	   R209	   (M.	   smegmatis	   GluDH	   –	   R205	   in	   C.	   symbiosum	  GluDH)	   seems	   to	   sense	   the	   presence	   of	   the	   substrate.	   In	   the	   presence	   of	   L-­‐glutamate	   or	   2oxoglutarate,	   this	   arginine	   side	   chain	   moves	   towards	   the	  binding	   cleft	   and	   interacts	   with	   the	   γ-­‐carboxyl	   group	   of	   the	   substrate	  (figure7.3).	   In	   addition,	   in	   the	   ternary	   complex	   structures,	   it	   also	   makes	   a	  hydrogen	   bond	   to	   the	   carboxyamide	   oxygen	   of	   the	   nicotinamide	   ring	   of	  NADP+(figure7.5).	   This	   residue	   is	   conserved	   in	   most	   of	   the	   GluDHs	   from	  prokaryotic	   and	   eukaryotic	   species,	   for	   example	   in	   the	   ternary	   complex	   of	  bovine-­‐GluDH	  the	  side	  chain	  of	  R211	  directs	  to	  the	  substrate	  γ-­‐carboxyl	  group	  and	  forms	  a	  hydrogen	  bond.	  In	  the	  E.	  coli	  GluDH	  apo	  enzyme	  structure,	  R207	  points	   in	   the	   opposite	   direction	   to	   the	   empty	   substrate	   binding	   pocket	  suggesting	  that	  this	  residue	  can	  sense	  the	  presence	  of	  substrate	  (figure7.4).	  	  	  In	   the	  M.	   smegmatis	  GluDH/NADP+/2oxoglutarate	   ternary	   complex	   the	   gem-­‐diol	  binds	  in	  an	  extended	  form,	  which	  is	  considered	  to	  be	  a	  good	  model	  for	  the	  proposed	  carbinolamine	  intermediate.	  Indeed	  the	  O5	  hydroxyl	  of	  the	  gem-­‐diol	  adopts	   the	   same	   position	   as	   the	   catalytic	   water	   molecule	   in	   the	   1.9	   Å	   C.	  
symbiosum	  GluDH/L-­‐glu	  complex	  (1BGV)	  (figure7.6).	  As	  the	  interactions	  made	  to	  this	  hydroxyl	  of	  the	  gem	  diol	  include	  the	  hydrogen	  bond	  donors	  Lys129	  and	  the	  main	  chain	  NH	  of	  Gly95,	  then	  this	  hydroxyl	  must	  be	  in	  the	  position	  of	  the	  hydroxyl	  of	   the	  carbinolamine,	  with	   the	  NH2	  of	   the	  carbinolamine	  occupying	  the	  position	  of	  the	  second	  hydroxyl	  (O6),	  on	  the	  nicotinamide	  ring	  side	  of	  the	  substrate.	   If	   we	   assume	   that	   the	   gem-­‐diol	   is	   a	   good	   model	   for	   the	  carbinolamine,	   then	  the	  attack	  by	  ammonia	   to	   the	  keto	  acid	  must	  come	  from	  the	  pro-­‐S	  side	  of	  the	  ketone,	  to	  generate	  the	  S-­‐carbinolamine.	  	  In	  another	  unexpected	  twist,	  with	  the	  gem-­‐diol	  binding	   in	  the	  extended	  form	  observed,	  the	  alpha	  carbon	  of	  the	  gem-­‐diol	  lies	  in	  a	  different	  position	  to	  that	  of	  the	  L-­‐glutamate	  in	  the	  binary	  structures,	  some	  1.4	  Å	  further	  away	  from	  the	  C4	  of	   the	   nicotinamide	   ring.	   In	   this	   conformation,	   Asp169	   (M.	   smegmatis	  numbering)	   is	   too	   far	   away	   to	   act	   as	   a	   base	   to	   remove	   the	   proton	   from	   the	  carbinolamine	  hydroxyl	  to	  form	  the	  keto	  acid,	  as	  proposed	  in	  the	  mechanism	  of	  Stillman	  (Stillman	  et	  al,	  1993)(	  figure7.7).	  However,	  Asp	  169	  can	  remove	  a	  proton	   from	   the	   amine	   of	   Lys	   129,	  which	   in	   turn,	   can	   then	   act	   as	   a	   base	   to	  remove	  the	  hydroxyl	  proton	  and	  thus	  form	  the	  ketone.	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Figure	  7.3.	   Illustrates	  the	  different	  orientations	  of	  arginine	  residue	  in	  GluDHs.	  In	  M.	  
smegmatis	   GluDH	   (R209,	   yellow	   color)	   and	   bovine	   GluDH	   (R211,	   pink	   color)	   this	  residue	  directs	  to	  the	  active	  side	  and	  bind	  to	  the	  γ-­‐carboxyl	  of	  the	  substrate.	  In	  E.	  coli	  GluDH	  in	  the	  apo	  state	  the	  arginine	  (R207,	  gray	  color)	  points	  away	  from	  the	  substrate.	  	  	  	  	  	  	  	  
 
Ms        199  KGLTWGGSRVRTEATGYGTVFFVDEILQSRG--------QSFDGKRVVVSGSGNVAIYAIEKVHALGGIV  260      
Ec        197  KGLSFGGSLIRPEATGYGLVYFTEAMLKRHG--------MGFEGMRVSVSGSGNVAQYAIEKAMEFGARV  258     
Pf        258  KNIKWGGSNIRAEATGYGVVYFAENVLKDLN--------DNLENKKCLVSGSGNVAQYLVEKLIEKGAIV  319     
Cs        196  KARSFGGSLVRPEATGYGSVYYVEAVMKHEN--------DTLVGKTVALAGFGNVAWGAAKKLAELGAKA  257     
Pa        177  KPVAFGGSEGRNEATGFGVAVVVRESAKRFG--------IKMEDAKIAVQGFGNVGTFTVKNIERQGGKV  238     
Bo        201  KPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFGDKTFVVQGFGNVGLHSMRYLHRFGAKC  270 	  
	  
Figure	  7.4.	  Sequence	  alignment	  of	  a	  number	  of	  GluDHs.	  Highlighted	  Arginine	  residue	  is	   conserved	   in	   these	  enzymes.	  Mycobacterium	  smegmatis	  (Ms),	  Escherichia	  coli	  (Ec),	  
Plasmodium	   falciparum	   (Pf),	   Clostridium	   symbiosum	   (Cs),	   Peptoniphilus	  
asaccharolyticus	  (Pa)	  and	  Bovine	  (Bo). 	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Figure	  7.5.	  Shows	  the	  binding	  of	  the	  side	  chain	  of	  R209	  with	  γ-­‐carboxyl	  group	  of	  the	  gem-­‐diol	  and	  carbonyl	  group	  of	  the	  carboxyamide	  of	  nicotinamide	  of	  the	  NADP+.	  	  	  	  
	  
Figure	   7.6.	   Shows	   the	   distance	   between	   the	   C4	   of	   the	   nicotinamide	   and	   the	   alpha	  carbon	  for	  the	  two	  substrates,	  L-­‐glutamate	  (1BGV)	  and	  gem-­‐diol.	  The	  α-­‐carbon	  of	  the	  L-­‐glutamate	   lies	   2.5	   Å	   from	   the	   C-­‐4	   of	   the	   nicotinamide,	   which	   allows	   the	   hydride	  transfer	  to	  occur.	  The	  adjacent	  residues	  and	  water	  molecule	  can	  be	  seen.	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Figure	   7.7.	   A	   schematic	   diagram	   highlighting	   the	   position	   of	   D169	   in	   the	   M.	  
smegmatis	   GluDH	   ternary	   complex.	   This	   residue	   is	   in	   the	   wrong	   orientation	   to	  abstract	  a	  proton	  from	  the	  hydroxyl	  group	  of	   the	  carbinolamine	  (O5).	  However,	   this	  side	  chain	  could	  abstract	  a	  proton	  from	  the	  amino	  group	  of	  K129,	  which,	  in	  turn,	  can	  take	  the	  proton	  from	  the	  carbinolamine	  hydroxyl.	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In	   the	   reductive	   amination	   reaction	   direction,	   the	   next	   step	   in	   the	   reaction	  after	   the	   formation	   of	   the	   carbinolamine	   is	   the	   dehydration	   to	   the	   imino-­‐glutarate	   intermediate.	   This	   can	   occur,	   again	   using	   Asp	   169	   and	   Lys	   129.	  However,	   the	   variation	   in	   the	   position	   of	   the	   substrate	   observed	   in	   the	  structures	   determined	   here	   would	   suggest	   that,	   as	   the	   iminoglutarate	   is	  formed,	   the	   alpha	   carbon	   would	   move	   towards	   the	   nicotinamide	   ring,	   to	   a	  suitable	   position	   for	   hydride	   transfer,	   again	   from	   the	   pro-­‐S	   side	   of	   the	  iminoglutarate,	   to	   produce	   the	   product,	   S-­‐glutamate	   (L-­‐glutamate).	   This	  alteration	   in	   the	   distance	   between	   the	   Cα	   of	   the	   substrate	   and	   C4	   of	   the	  nicotinamide	   of	   the	   cofactor	   is	   assisted	   by	   the	   substrate	   movement	   in	   the	  catalytic	  pocket,	  rather	  than	  by	  the	  domain	  motion.	  	  This	  variation	   in	   the	  position	  of	   the	   substrate	  and	  product	  of	   the	   reaction	   in	  the	   active	   site	   of	   the	   hyper-­‐closed	   form	   of	   the	   enzyme,	   also	   suggests	   a	  mechanism	   whereby	   the	   enzyme	   can	   protect	   against	   the	   formation	   of	   a	  hydroxyl-­‐acid,	   rather	   than	   the	   amino	   acid,	   in	   the	   reduction	   direction,	   as	   the	  alpha	   carbon	   of	   the	   2-­‐oxoacid	   is	   too	   far	   from	   the	   C4	   for	   hydride	   transfer	   to	  occur,	  before	  attack	  of	  ammonia	  has	  happened.	  The	  similarity	  in	  structure	  and	  conservation	  of	  the	  crucial	  residues	  involved	  in	  the	  active	  site	  of	  GluDHs	  from	  both	  prokaryotes	  and	  eukaryotes	  would	  suggest	  that	  this	  proposed	  movement	  of	  the	  substrate	  in	  the	  active	  site	   is	  a	  universal	  mechanism.	   Indeed,	  given	  the	  similarity	   in	   the	  active	  site	  of	  GluDH	  to	  PheDH	  and	  LeuDH	  (Britton	  et	  al,	  1993a)	  it	  is	  probable	  that	  a	  similar	  mechanism	  also	  occurs	  in	  the	  wider	  amino-­‐acid	  dehydrogenase	  superfamily.	  
7.2	  Phenylalanine	  Dehydrogenase	  The	   structure	   of	   B.	   sphaericus	   PheDH	   in	   complex	   with	   NADH	   has	   been	  determined	  at	  medium	  resolution	   (2.5	  Å).	  The	  essential	   residues	   involved	   in	  the	  catalysis	  are	  conserved	  between	  GluDH,	  LeuDH	  and	  PheDH,	  which	  suggests	  that	   they	   share	   a	   similar	   catalytic	   mechanism.	   However,	   the	   residues	  responsible	  for	  recognition	  of	  the	  substrate	  are	  varied	  between	  these	  enzymes.	  In	   the	  C.	  symbiosum	  GluDH,	   the	  side	  chain	  carboxyl	  group	  of	   the	  L-­‐glutamate	  binds	   to	  K89	  and	  S380,	  which	  make	   the	  active	   site	  pocket	  more	  hydrophilic,	  and	   these	   residues	   are	   changed	   to	   hydrophobic	   residues	   in	   B.	   sphaericus	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PheDH	   (L51	   and	  V310)	   and	  Rhodococcus	  sp.	  M4	  PheDH	   (A38	   and	  L296)	   and	  also	  in	  B.	  sphaericus	  LeuDH	  (L40	  and	  V294).	  The	  interaction	  of	  phenylalanine	  and	  phenylpyruvate	  with	   the	  PheDHs	  enzymes	   from	  Rhodococcus	  sp.	  M4	  and	  
Nocardia	  sp.	  239	  is	  similar,	  which	  suggests	  that	  the	  binding	  of	  the	  substrate	  to	  
B.	  sphaericus	  PheDH	  would	  follow	  the	  same	  pattern.	  Therefore,	  phenylalanine	  was	  modelled	  into	  the	  active	  site	  of	  B.	  sphaericus	  PheDH.	  The	  distance	  between	  the	   hydride	   transfer	   partners	   in	   this	  model	   is	   6.5	  Å,	  which	   is	   too	   far	   for	   the	  transfer	  to	  occur.	   Indeed,	   in	  the	  ternary	  complex	  structures	  of	  bovine-­‐GluDH,	  
Rhodococcus	  sp.	  M4	  PheDH	  and	  Nocardia	  sp.	  239	  PheDH	  the	  nicotinamide	  C4	  to	  alpha	  carbon	  distance	  is	  around	  4	  Å,	  the	  van	  der	  Waals	  packing	  distance,	  and	  still	  not	  close	  enough	  for	  catalysis,	  which	  supports	  the	  idea	  that	  the	  substrate	  moves	  within	  the	  active	  site	  during	  the	  reaction	  to	  be	  in	  the	  suitable	  position	  for	  hydride	  transfer.	  	  	  
7.3	  Cofactor	  specificity	  	  Determination	  the	  binary	  complex	  structure	  of	  C.	  symbiosum	  GluDH/NAD+	  and	  the	   ternary	   complex	   of	   M.	   smegmatis	   GluDH/NADP+/2oxoglutarate	   has	  allowed	   the	   nature	   of	   the	   cofactor	   specificity	   to	   be	   examined.	   A	   comparison	  between	  these	  structures	  with	  the	  structures	  of	  other	  GluDHs	  (for	  example	  the	  NADP(H)	   dependent	   E.	   coli	   GluDH)	   has	   supported	   the	   suggestion	   that	   the	  residues	   at	   P7	   and	   P8	   at	   the	   C-­‐terminal	   end	   of	   the	   β-­‐strand	   following	   the	  GXGXXG/A	  helix	  in	  domain	  2	  (the	  Rossmann	  fold)	  determine	  the	  NADP+/NAD+	  specificity	   (Oliveira	   et	   al,	   2012;	   Sharkey	   et	   al,	   2013)	   In	  M.	  smegmatis	  GluDH,	  these	  residues	  are	  Asp265	  (P7)	  and	  Ser266	  (P8),	  which	  are	  in	  agreement	  with	  most	  of	  the	  NADP(H)	  dependent	  GluDHs	  (figure7.8).	  	  The	   interaction	  of	   the	  2’	  phosphate	  of	   the	  cofactor	   to	  M.	  smegmatis	  GluDH	  is	  similar	   to	   that	   seen	   in	   bovine-­‐GluDH,	   a	   dual-­‐cofactor	   dependent	   enzyme	  (Smith	  et	  al,	  2001).	  In	  both	  enzymes	  the	  residues	  that	  stabilize	  the	  2’phosphate	  group	   are	   conserved.	   These	   residues	   are	   Lys137,	   Lys285	   and	   Ser266	   in	  M.	  
smegmatis	  GluDH	   and	   Lys134,	   Lys295	   and	   Ser276	   in	   bovine-­‐	   GluDH.	   In	   the	  NAD+-­‐dependent	   C.	   symbiosum	   GluDH,	   these	   residues	   are	   substituted	   by	  Asn133,	  Arg285	  and	  Pro262,	  which	  make	  the	  2’phosphate	  binding	  pocket	  too	  small	  to	  accommodate	  this	  group	  and	  also	  less	  positively	  charged.	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                                                                       123456 
Ms              199  KGLTWGGSRVRTEATGYGTVFFVDEILQSRG--------QSFDGKRVVVSGSGNVAIYAIEKVHALGGIV  260 
Ec              197  KGLSFGGSLIRPEATGYGLVYFTEAMLKRHG--------MGFEGMRVSVSGSGNVAQYAIEKAMEFGARV  258 
PTAD1           192  KGVGFGGSLMRTEATGYGAVYFLQNMLAAQN--------ESIEGKKVLVSGAGNVSLHAAEKATLIGAIV  253 
Pf              258  KNIKWGGSNIRAEATGYGVVYFAENVLKDLN--------DNLENKKCLVSGSGNVAQYLVEKLIEKGAIV  319 
Ab              180  KGINWGGSFIRPEATGYGLIYYVEHMIAHACPEYS----LDRPSTLVAISGSGNVSQFTALKVIELGATV  245 
Bo              201  KPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFGDKTFVVQGFGNVGLHSMRYLHRFGAKC  270 
Sc              179  KGLNWGGSLIRPEATGYGLVYYTQAMIDYATNGKE-----SFEGKRVTISGSGNVAQYAALKVIELGGTV  243 
 
                                                                       123456     
Cs              196  KARSFGGSLVRPEATGYGSVYYVEAVMKHEN--------DTLVGKTVALAGFGNVAWGAAKKLAELGAKA  257 
Pa              177  KPVAFGGSEGRNEATGFGVAVVVRESAKRFG--------IKMEDAKIAVQGFGNVGTFTVKNIERQGGKV  238 
Pg              193  KGFEFGGSRLRPESTGFGAVYFVQNMCKQNG--------VDYKGKTLAISGFGNVAWGVAQKATELGIKV  254 
Bs              186  KPLVLGGSQGRETATAQGVTICIEEAVKKKG--------IKLQNARIIIQGFGNAGSFLAKFMHDAGAKV  247 
Eca             187  KGLNWGGSLVRPEATGFGTMYFANEVLHAHG--------DDIKGKTIAISGFGNVAFGAVLKAKQLGAKV  248 	  
 
 
                           78 
Ms                261  VACSDS-----GGYVVDEKGIDLDLLKEVKEVQRA----RIDAYAEARG---GATQFVS--GGSVWNVAC  316 
Ec                259  ITASDS-----SGTVVDESGFTKEKLARLIEIKASRDG-RVADYA-KEF----GLVYLE--GQQPWSLPV  315 
PTAD1             254  LTVSDS-----KGTIYDAKGLNQEKIDWLKVQKDQHK--PLADYV-EVF----GGEWMA--DQKPWSIKA  309 
Pf                320  LTMSDS-----NGYILEPNGFTKEQLNYIMDIKNNQRL-RLKEYLKYSK----TAKYFE--NQKPWNIPC  377 
Ab                246  LSLSDS-----KGSLISEKGYTKEAIEKIAELKLKGGA-LEAIVDDLGA----GYTYHAGKRPWTLLPQV  305 
Bo                271  ITVGES-----DGSIWNPDGIDPKELEDFKLQHGTIL----------GF----PKAKIY--EGSILEVDC  319 
Sc                244  VSLSDS-----KGCIISETGITSEQVADISSAKVNFKS-LEQIVNEYSTFSENKVQYIAGARPWTHVQKV  307 
 
                           78 
Cs                258  VTLSGP-----DGYIYDPEGITTEEKINYMLEMRASGRNKVQDYA-DKF----GVQFFP--GEKPWGQKV  315 
Pa                239  CAIAEWDRNEGNYALYNENGIDFKELLAYKEANKTLI---------GFP----GAERIT--DEEFWTKEY  293 
Pg                255  VTISGP-----DGYVYDPDGINTPEKFRCMLDLRDSGNDVVSDYVKRFP----NAQFFP--GKKPWEQKV  313 
Bs                248  IGISDA-----NGGLYNPDGLDIPYLLDKRDSFGMVT----------NL----FTDVIT--NEELLEKDC  296 
Eca               249  VTISGP-----DGYIYDENGINTDEKINYMLELRASNNDVVAPFA-EKF----GAKFIP--GKKPWEVPV  306 
 	  
Figure	   7.8.	   Sequence	   alignment	   of	   a	   number	   of	   NAD+-­‐dependent	   GluDHs	   and	   NADP+-­‐dependent	  GluDHs.	   The	   black	   sequences	   are	  NADP+-­‐dependent	  GluDHs,	  whereas	   the	   blue	  sequences	  are	  NAD+-­‐dependent	  GluDHs.	  The	  residues	  of	  glycine	  rich	   loop,	  GXGXXG/A	  (P1-­‐P6)	   and	   P7	   with	   P8	   are	   designated	   by	   numbers	   overhead	   the	   sequence.	  Mycobacterium	  
smegmatis	   (Ms),	   Escherichia	   coli	   (Ec),	   Psychrobacter	   sp	   TAD1	   (PTAD1),	   Plasmodium	  
falciparum	   (Pf),	   Agaricus	  bisporus	   (Ab),	   Saccharomyces	   cerevisiae	   (Sc),	   Clostridium	  
symbiosum	   (Cs)	   and	   Peptoniphilus	   asaccharolyticus	   (Pa),	   Porphyromonas	   gingivalis	   (Pg),	  
Bacillus.	  subtilis_rocG	  (Bs)	  and	  Entodinium	  caudatum	  (Eca).	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Structural	  analysis	  of	  B.	  sphaericus	  PheDH	  in	  complex	  with	  NADH	  shows	  that	  the	  interaction	  of	  the	  cofactor	  with	  domain	  II	  of	  the	  enzyme	  is	  similar	  to	  that	  observed	   in	   B.	   sphaericus	   LeuDH	   (Baker	   et	   al,	   1995).	   However,	   the	  nicotinamide	   ring	   binding	   is	   quite	   different	   between	   the	   two	   proteins.	   In	  LeuDH	  the	  side-­‐chain	  hydroxyl	  groups	  of	  Thr150	  and	  Ser147	   form	  hydrogen	  bonds	   to	   the	   carboxyamide	   moiety	   of	   the	   nicotinamide	   ring.	   These	   two	  residues	  are	  conserved	  in	  B.	  sphaericus	  PheDH	  as	  Thr161	  and	  Ser158,	  but	  they	  do	  not	  bind	  to	  the	  nicotinamide	  ring.	  Instead,	  Ser157	  (equivalent	  of	  Pro146	  in	  LeuDH)	   makes	   a	   hydrogen	   bond	   to	   the	   carboxyamide	   in	   PheDH.	   The	  nicotinamide	  ring	  takes	  the	  syn	  conformation	  for	  the	  glycosidic	  bond	  between	  the	   nicotinamide	   moiety	   and	   the	   associated	   ribose.	   This	   is	   similar	   to	   that	  observed	   in	  all	  GluDHs	  and	  also	  resembles	   the	  conformation	   for	   the	  cofactor	  seen	  in	  Nocardia	  sp.	  239	  PheDH	  and	  B.	  sphaericus	  LeuDH.	  	  
 
7.4	  Further	  Work	  	  The	   work	   described	   in	   this	   thesis	   has	   provided	   further	   insights	   into	   the	  reaction	  mechanism	  of	  the	  amino	  acid	  dehydrogenase	  superfamily.	  However,	  a	  number	  of	  extra	  experiments	  can	  be	  proposed	  that	  could	  further	  explain	  this	  enzyme	  superfamily.	  
• Higher	   resolution	   structure	   of	   B.	   sphaericus	   PheDH	   (with	   and	   without	  substrates)	  –	  Although	  the	  first	  structure	  of	  this	  enzyme	  has	  been	  determined,	  the	  medium	   resolution	   (and	   the	   fact	   that	   a	   number	  of	   loops	   are	  disordered)	  has	   meant	   that	   only	   limited	   information	   can	   be	   gleaned	   from	   this	   enzyme	  structure.	  Despite	  numerous	  attempts	  to	  produce	  better	  diffracting	  crystals	  of	  both	   the	  wild	   type	  and	   two	  site	  directed	  mutants,	   further	  experiments	  using	  different	   conditions,	   substrate	   combinations	   and	   perhaps	   inhibitors	   could	  produce	  a	  better	  crystal	  form.	  	  
• Ternary	  complex	  of	  M.	  smegmatis	  GluDH.	  The	  NADP+/2oxoglutarate	  structure	  determined	   here	   has	   given	   crucial	   insights	   into	   the	   reaction	   mechanism.	  However,	   this	   structure	   is	   of	   a	   non	   productive	   ternary	   complex.	   It	  might	   be	  possible	   to	  produce	   crystals	  of	  M.	  smegmatis	  GluDH	   in	   complex	  with	  NADPH	  and	   2oxoglutarate,	   as	   without	   ammonia,	   this	   complex	   should	   also	   be	   non-­‐productive	  and	  thus	  a	  single	  species	  should	  be	  present	  in	  the	  crystal.	  In	  such	  a	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complex,	   the	   cofactor	   would	   be	   reduced	   and	   the	   substrate	   oxidised,	   in	   the	  same	  oxidation	  states	  as	  that	  seen	  in	  the	  reaction.	  
• In	   addition,	   crystallizations	   could	   be	   attempted	   for	   productive	   complexes	   of	  the	  enzyme,	  as	  perhaps	  the	  density	  for	  the	  substrates	  would	  not	  be	  ambiguous,	  if	  the	  crystals	  diffracted	  to	  a	  similar	  resolution	  to	  those	  described	  in	  this	  thesis.	  	  	  
• Clarification	  that	  the	  2-­‐oxoglutarate	  binds	  as	  a	  gem-­‐diol	  in	  the	  ternary	  complex	  of	   M.	   smegmatis	   GluDH.	   Although	   it	   is	   well	   known	   that	   ketones	   with	   an	  electron	   withdrawing	   group	   adjacent	   to	   the	   carbonyl	   have	   appreciable	  amounts	  of	  the	  gem-­‐diol	  present	  in	  aqueous	  solution	  (Berg	  et	  al,	  2002)	  direct	  experiments	   could	   be	   undertaken	   to	   show	   this	   is	   the	   case	   for	   the	   structure	  described	  here.	  Firstly,	  NMR	  and	  IR	  spectroscopy	  can	  be	  used	  on	  a	  solution	  of	  2-­‐oxoglutarate	   to	   show	   the	   proportion	   of	   the	   gem-­‐diol	   present.	   Secondly,	   it	  may	   be	   possible	   to	   use	   mass	   spectrometry	   on	   the	   crystals	   to	   measure	   the	  enzyme-­‐substrate	  complex	  and	  show	  the	  presence	  directly.	  
• Mutants	  of	  GluDH.	  A	  number	  of	  residues	  in	  the	  active	  site	  of	  GluDH	  have	  been	  produced	   and	   characterized,	   for	   example	   D165N	   for	   C.	   symbiosum	   GluDH	  (Paradisi	   et	   al,	   2005)	   and	   structures	   of	   ternary	   complexes	   of	   the	   equivalent	  mutants	   in	  M.	  smegmatis	  GluDH	  would	  further	  explain	  the	  mechanism	  of	   this	  enzyme.	  
• New	  constructs	  of	  the	  Type	  II	  NADH:	  Menaquinone	  oxidoreductase	  (NDH-­‐2)	  of	  
M.	  tuberculosis.	  Following	  the	  successful	  structure	  determination	  of	  the	  NDH2	  from	  Caldalkalibacillus	   thermarum	   (Heikal	   et	   al,	   2014),	   this	   structure	   can	   be	  used	   to	   design	   alternative	   constructs	   of	  NDH2	   that	  might	   crystallize.	   As	   this	  enzyme	   is	  a	  possible	   target	   for	  novel	  antimicrobial	   agents,	   a	   structure	  of	   the	  mycobacterial	   enzyme	   could	  be	   very	  useful	   in	   designing	  potential	   inhibitors.	  This	  work	   can	  be	  extended	   to	  other	   species,	   such	  as	  Plasmodium	  falciparum,	  another	   pathogenic	   organism	   where	   NDH2	   has	   potential	   to	   be	   a	   target	   for	  antimicrobials	  (Fisher	  et	  al,	  2009).	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  AppendixI:	  X-­‐ray	  crystallography	  Theory	  	  	  	  	  	  	  	  	  	  	  	  	  1.0	  X-­‐Rays	  diffraction	  X-­‐rays	  radiation	  can	  be	  considered	  as	  electromagnetic	  waves	  with	  an	  oscillating	  electrical	   field.	  When	   X-­‐rays	   interact	   with	   an	   atom	   at	   particular	   frequency	   the	  orbiting	  electrons	   start	   to	  oscillate	   emitting	  a	   radiation	  with	   the	   same	   identical	  frequency	  as	  the	  incident	  X-­‐ray,	  but	  are	  180°	  out	  of	  phase	  with	  it.	  This	  is	  known	  as	  coherent	   scattering.	   However,	   X-­‐rays	   can	   also	   collide	  with	   atoms	   in	   a	   different	  manner,	   giving	   rise	   to	   incoherent	   scattering.	   In	   this	   case,	   X-­‐rays	   interact	   with	  loosely	   bound	   electrons	   leading	   to	   the	   deviation	   of	   the	   X-­‐ray	   from	   its	   initial	  direction.	   This	   causes	   the	   X-­‐ray	   to	   lose	   energy	   and	   therefore	   its	  wavelength	   is	  altered.	   In	   X-­‐ray	   crystallography	   incoherent	   scattering	   is	   generally	   ignored	  because	   of	   the	   fact	   that	   the	   sum	   of	   cooperative	   coherent	   scattering	   becomes	  bigger	  than	  the	  incoherent	  contribution.	  	  
	  	  	  	  	  	  	  	  	  	  1.1	  Bragg’s	  Law	  	  In	  1913	  Sir	  W.L.Bragg	  derived	  a	  simple	  equation	  to	  describe	  why	  the	  set	  of	  lattice	  planes	   in	   a	   crystal	   appear	   to	   produce	   a	   reflection	   at	   a	   particular	   angle	   of	  incidence.	  This	  is	  Bragg’s	  Law	  and	  can	  be	  expressed	  as:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nλ	  =	  2d	  sinθ 	  	  
d	   is	   the	   distance	   in	   angstroms	   that	   separate	   planes	   with	   indices	   h,k,l;	   θ	   is	   the	  angle	   between	   incident	   and	   diffracted	   rays;	   n	   is	   an	   integer	   and	   	   λ	   is	   the	  wavelength	  of	  the	  incident	  	  X-­‐ray	  beam.	  Constructive	  interference	  happens	  when	  the	   distance	  2dsinθ	   is	   equal	   to	   an	   integral	   number	   of	  wavelengths	   because	   the	  emitted	  waves	  will	  be	  in	  phase	  and	  will	  contribute	  to	  a	  diffraction	  spots.	  If	  the	  X-­‐rays	  strike	  at	  an	  angle	  that	  does	  not	  meet	  the	  Bragg	  conditions,	  they	  will	  be	  out	  of	  phase	  and	  interfere	  destructively,	  and	  so	  not	  produce	  a	  reflection.	  The	  intensity	  of	  each	  diffracted	  beam	  depends	  on	  how	  much	  electron	  density	  is	  sampled	  by	  the	  set	  of	  planes	  from	  which	  the	  diffracted	  X-­‐rays	  originate.	  
	  	  	  	  	  	  	  	  	  	  1.2	  Scattering	  by	  an	  atom	  Clouds	  of	  electrons	  density	  surrounding	   the	  atoms	   interact	  with	   the	   incident	  X-­‐ray	  beam.	  Scattering	  depends	  on	  the	  number	  of	  electrons	  and	  their	  distribution	  in	  the	  cloud.	  The	  atomic	  scattering	  factor	  ƒ	  is	  the	  total	  wave	  scattered	  by	  an	  atom	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Figure	   1.0.	   Diagram	   illustrating	   of	   Bragg’s	   Law.	   AB	   =	   d	   sinθ	   =	   BC,	   the	   path	   length	  difference	  =	  2d	  sinθ,	  which	  must	  an	  integral	  number	  of	  wavelength	  (nλ)	  for	  constructive	  interference.	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  integrated	  over	  the	  volume	  of	  the	  atom:	  
	  where	  r	   is	  the	  position	  of	  the	  electron	  in	  the	  cloud	  from	  the	  centre	  of	  the	  atom,	  
ρ(r)	   is	   the	  electron	  density	  at	   that	  position	  and	  vector	  S	   is	   the	  direction	  of	   the	  scattered	  wave.	  
	  	  	  	  	  	  	  	  	  	  1.3	  Scattering	  by	  a	  unit	  cell	  The	  total	  scattering	  by	  n	  atoms	  at	  position	  rj	  (j=1,	  2,	  3,	  4,	  …,	  n)	  in	  an	  isolated	  unit	  cell	  is	  the	  sum	  of	  the	  scattering	  from	  single	  atoms	  in	  the	  unit	  cell:	  
	  
where	  F(S)	  is	  the	  atomic	  structure	  factor,	  and	  is	  a	  function	  of	  the	  electron	  density	  distribution	  within	  the	  unit	  cell	  that	  can	  be	  stated	  as	  continuous.	  	  
	  	  	  	  	  	  	  	  	  	  1.4	  Scattering	  by	  a	  crystal	  The	   total	   wave	   scattered	   by	   a	   crystal	  K(S)	   is	   the	   sum	   of	   overall	   the	   unit	   cells	  scattering	   within	   the	   crystal.	  	  	  	  	  	  	  	  	  	   	  
Where	  a,b	  and	  c	  are	  the	  axial	  directions	  in	  the	  crystal	  and	  n1,	  n2	  and	  n3	  represent	  the	   number	   of	   unit	   cells	   along	   those	   axial	   directions.	   The	   integers	   t,u	   and	   ν	  correspond	   to	   the	   translation	   steps	   relating	   the	   origins	   of	   the	   unit	   cells	   along	  these	   vectors.	   Due	   to	   the	   large	   number	   of	   the	   unit	   cells	   and	   because	   their	  scattering	   vectors	   are	  pointing	   in	   different	   directions,	   a	   crystal	   only	   scatters	  X-­‐rays	  in	  phase	  if	  the	  Laue	  conditions	  a.S=h,	  b.S=k	  and	  c.S=l	  are	  met	  where	  h,k	  and	  l	  are	  integers.	  	  	  Diffraction	  from	  a	  crystal	  consists	  of	  reflections	  with	  reciprocal	  lattice	  indices	  of	  h,	  k,	  and	  l,	  each	  receiving	  a	  contribution	  from	  every	  atom	  in	  the	  unit	  cell.	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that	  fulfill	  Bragg’s	  Law.	  The	  Ewald	  sphere	  has	  a	  radius	  1/λ,	  with	  the	  crystal	  at	  the	  center.	   The	   perimeter	   of	   the	   sphere	   represents	   reciprocal	   space	   where	   a	  diffraction	  spot	  will	  be	  generated	  when	  Bragg,s	  Law	  is	  satisfied.	  By	  rotation	  the	  crystal	   in	   the	   X-­‐ray	   beam,	   various	   lattice	   points	   (h	   k	   l)	   contact	   the	   surface	   of	  sphere	  and	  the	  reflection	  can	  be	  measured.	  	  
	  	  	  	  	  	  	  	  	  	  2.0	  Calculation	  of	  Electron	  Density	  If	  x,	  y	  and	  z	  are	  fractional	  coordinates	  in	  the	  unit	  cell	   in	  which	  h,	  k	  and	   l	  are	  the	  indices	  for	  a	  reflection	  in	  the	  reciprocal	  lattice	  and	  V	  in	  the	  volume	  of	  the	  cell,	  the	  structure	  factor	  F(S)	  can	  be	  written	  as	  F(hkl):	  	   	  
The	  electron	  density	   for	  every	  position	  x,	  y,	  z	   in	  the	  unit	  cell	  ρ(xyz),	   is	  given	  by	  the	  Fourier	  transform	  of	  F(hkl)	  and	  can	  be	  written:	  
	  
F(hkl)	  is	  a	  wave	  with	  amplitude	  of	  ⏐F(hkl)	  ⏐	  and	  the	  phase	  of	  α(hkl)	  so	  that:	  
	  All	  of	  the	  ⏐F(hkl)	  ⏐	  can	  be	  measured	  experimentally	  because	  the	  intensity	  of	  any	  given	  reflection	  within	  the	  diffraction	  pattern	  is	  proportional	  to	  the	  square	  of	  its	  structure	  factor	  amplitude.	  The	  phase	  information	  should	  be	  measured	  because	  it	  is	  not	  possible	  to	  determine	  it	  directly	  from	  the	  experimental	  data.	  This	  is	  what	  is	  known	  in	  x-­‐ray	  crystallography	  as	  the	  phase	  problem.	  The	  phase	  problem	  can	  be	  solved	   using	   several	   techniques	   involving	   isomorphous	   replacement,	   multiple-­‐wavelength	  anomalous	  dispersion	  and	  molecular	  replacement.	  
	   	  	   	  










ρ(xyz) = 1V F(hkl)exp(−2πi(hx + ky+ lz))hkl
∑
F(hkl) = F(hkl) exp(iα(hkl))
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Figure	   1.1.	   Schematic	   represents	  of	   the	  Ewald	   sphere.	  The	   radius	   is	  1/λ,	   origin	  of	   the	  reciprocal	  lattice	  is	  O,	  s0	  indicates	  the	  direction	  of	  the	  incoming	  beam	  and	  s	  indicates	  the	  direction	  of	  the	  scattered	  beam.	  This	  scheme	  has	  been	  adapted	  from	  (Drenth,	  2007).	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